0001193125-23-139497.txt : 20230509 0001193125-23-139497.hdr.sgml : 20230509 20230509165514 ACCESSION NUMBER: 0001193125-23-139497 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 130 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230509 DATE AS OF CHANGE: 20230509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WisdomTree, Inc. CENTRAL INDEX KEY: 0000880631 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 133487784 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-10932 FILM NUMBER: 23903051 BUSINESS ADDRESS: STREET 1: 250 WEST 34TH STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-801-2080 MAIL ADDRESS: STREET 1: 250 WEST 34TH STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 FORMER COMPANY: FORMER CONFORMED NAME: WisdomTree Investments, Inc. DATE OF NAME CHANGE: 20090401 FORMER COMPANY: FORMER CONFORMED NAME: INDEX DEVELOPMENT PARTNERS INC DATE OF NAME CHANGE: 20020812 FORMER COMPANY: FORMER CONFORMED NAME: FINANCIAL DATA SYSTEMS DATE OF NAME CHANGE: 19951120 10-Q 1 d452823d10q.htm 10-Q 10-Q
Table of Contents
falseQ10000880631--12-31Large Accelerated FilertrueGains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.Excludes 15,521 participating securities and 31 potentially dilutive non-participating common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands). 0000880631 2023-01-01 2023-03-31 0000880631 2022-01-01 2022-03-31 0000880631 2023-03-31 0000880631 2022-12-31 0000880631 2022-06-16 2022-07-15 0000880631 2018-04-11 0000880631 2022-03-31 0000880631 2023-05-04 0000880631 2022-01-01 2022-12-31 0000880631 2023-03-17 2023-03-17 0000880631 2021-12-31 0000880631 wt:FederalAgencyMember 2022-12-31 0000880631 us-gaap:EquipmentMember 2022-12-31 0000880631 wt:WisdomTreeTrustMember 2022-12-31 0000880631 wt:WisdomtreeManagementJerseyLimitedMember 2022-12-31 0000880631 wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2022-12-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcostMember 2022-12-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcostMember 2022-12-31 0000880631 wt:SecurrencyincconvertiblenotecarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincconvertiblenotecostMember 2022-12-31 0000880631 wt:SecurrencyincsubtotalcarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincsubtotalcostMember 2022-12-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecarryingvalueMember 2022-12-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecostMember 2022-12-31 0000880631 wt:OnrampinvestincseriesafourpreferredstockcarryingvalueMember 2022-12-31 0000880631 wt:OnrampinvestincpreferredstockcostMember 2022-12-31 0000880631 wt:OtherInvestmentscarryingValueMember 2022-12-31 0000880631 wt:OtherInvestmentsCostMember 2022-12-31 0000880631 wt:SecurrencyIncMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember 2022-12-31 0000880631 wt:SeriesARedeemableConvertiblePreferredStockMember 2022-12-31 0000880631 wt:WisdomtreeETFMember 2022-12-31 0000880631 wt:WisdomtreeETFMember wt:AffiliatedBlockchainEnabledFundsMember 2022-12-31 0000880631 us-gaap:SeriesAPreferredStockMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AllOtherCorporateBondsMember 2022-12-31 0000880631 us-gaap:AllOtherCorporateBondsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AllOtherCorporateBondsMember 2022-12-31 0000880631 us-gaap:AllOtherCorporateBondsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2022-12-31 0000880631 wt:FederalAgencyMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2022-12-31 0000880631 wt:FederalAgencyMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2022-12-31 0000880631 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000880631 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 wt:EuropeanBusinessSegmentMember 2022-12-31 0000880631 wt:WisdomtreeETFMember 2022-12-31 0000880631 srt:MinimumMember 2022-12-31 0000880631 srt:MaximumMember 2022-12-31 0000880631 srt:WeightedAverageMember 2022-12-31 0000880631 wt:TwothousandandtwentyonenotesMember 2022-12-31 0000880631 wt:TwothousandandtwentynotesMember 2022-12-31 0000880631 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-12-31 0000880631 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2022-12-31 0000880631 wt:TwoFinancialInstitutionsMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000880631 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-12-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0000880631 wt:FnalityInternationalLimitedMember 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:SecurrencyConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:SecurrencyConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:SecurrencyConvertibleNoteMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 wt:RighttomanageassetundermanagementMember 2022-12-31 0000880631 us-gaap:SoftwareDevelopmentMember 2022-12-31 0000880631 wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2022-12-31 0000880631 wt:WetfTradingSecuritiesMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:SecurrencyConvertibleNoteMember 2022-12-31 0000880631 wt:FederalAgencyMember 2023-03-31 0000880631 wt:SecurrencyIncMember 2023-03-31 0000880631 wt:EmployeesAndDirectorsMember 2023-03-31 0000880631 us-gaap:EquipmentMember 2023-03-31 0000880631 wt:WisdomTreeTrustMember 2023-03-31 0000880631 wt:WisdomtreeManagementJerseyLimitedMember 2023-03-31 0000880631 wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2023-03-31 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2023-03-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcostMember 2023-03-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcostMember 2023-03-31 0000880631 wt:SecurrencyincconvertiblenotecarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincconvertiblenotecostMember 2023-03-31 0000880631 wt:SecurrencyincsubtotalcarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincsubtotalcostMember 2023-03-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecarryingvalueMember 2023-03-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecostMember 2023-03-31 0000880631 wt:OnrampinvestincseriesafourpreferredstockcarryingvalueMember 2023-03-31 0000880631 wt:OnrampinvestincpreferredstockcostMember 2023-03-31 0000880631 wt:OtherInvestmentscarryingValueMember 2023-03-31 0000880631 wt:OtherInvestmentsCostMember 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember 2023-03-31 0000880631 wt:FnalityInternationalLimitedMember 2023-03-31 0000880631 us-gaap:OtherInvestmentsMember 2023-03-31 0000880631 wt:SeriesARedeemableConvertiblePreferredStockMember 2023-03-31 0000880631 wt:WisdomtreeETFMember 2023-03-31 0000880631 wt:WisdomtreeETFMember wt:AffiliatedBlockchainEnabledFundsMember 2023-03-31 0000880631 wt:AdvisoryFeesMember 2023-03-31 0000880631 wt:ThroughMarchThirtyFirstTwoThousandFiftyEightMember 2023-03-31 0000880631 wt:AprilOneTwoThousandFiftyEightAndThereafterMember 2023-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2023-03-31 0000880631 wt:FederalAgencyMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 wt:FederalAgencyMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 wt:FederalAgencyMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2023-03-31 0000880631 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:FixedIncomeInvestmentsMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:OtherInvestmentCompaniesMember 2023-03-31 0000880631 wt:EuropeanBusinessSegmentMember 2023-03-31 0000880631 wt:WisdomtreeETFMember 2023-03-31 0000880631 srt:MinimumMember 2023-03-31 0000880631 srt:MaximumMember 2023-03-31 0000880631 srt:WeightedAverageMember 2023-03-31 0000880631 wt:TwoThousandAndTwentyThreeNotesMember 2023-03-31 0000880631 wt:TwothousandandtwentyonenotesMember 2023-03-31 0000880631 wt:TwothousandandtwentynotesMember 2023-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-03-31 0000880631 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2023-03-31 0000880631 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2023-03-31 0000880631 wt:TwoFinancialInstitutionsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:SecurrencyseriesaconvertiblepreferredstockMember us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member wt:SecurrencyseriesaconvertiblepreferredstockMember us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member wt:SecurrencyseriesaconvertiblepreferredstockMember us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000880631 wt:SecurrencyseriesaconvertiblepreferredstockMember us-gaap:FairValueMeasurementsNonrecurringMember 2023-03-31 0000880631 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2023-03-31 0000880631 wt:CourtofturinandcourtofmilanMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:SecurrencyConvertibleNoteMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 wt:RighttomanageassetundermanagementMember 2023-03-31 0000880631 wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2023-03-31 0000880631 wt:WetfTradingSecuritiesMember 2023-03-31 0000880631 us-gaap:AccountingStandardsUpdate201601Member wt:FnalityInternationalLimitedConvertibleNoteMember 2023-03-31 0000880631 us-gaap:AccountingStandardsUpdate201601Member wt:SecurrencyConvertibleNoteMember 2023-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:FnalityConvertibleNoteMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:SecurrencyConvertibleNoteMember 2023-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2022-01-01 2022-03-31 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2022-01-01 2022-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomTreeTrustMember 2022-01-01 2022-03-31 0000880631 wt:WisdomtreeManagementJerseyLimitedMember wt:AdvisoryServicesMember 2022-01-01 2022-03-31 0000880631 wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember wt:AdvisoryServicesMember 2022-01-01 2022-03-31 0000880631 wt:AdvisoryServicesMember 2022-01-01 2022-03-31 0000880631 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000880631 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000880631 wt:OtherServicesIncomeMember 2022-01-01 2022-03-31 0000880631 us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember 2022-01-01 2022-03-31 0000880631 wt:DeferredConsiderationObligationMember 2022-01-01 2022-03-31 0000880631 country:US 2022-01-01 2022-03-31 0000880631 country:JE 2022-01-01 2022-03-31 0000880631 country:IE 2022-01-01 2022-03-31 0000880631 wt:FinancialInstrumentsOwnedAtFairValueMember 2022-01-01 2022-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-01-01 2023-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0000880631 us-gaap:ReportableSubsegmentsMember 2023-01-01 2023-03-31 0000880631 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitsMember 2023-01-01 2023-03-31 0000880631 wt:EmployeesAndDirectorsMember 2023-01-01 2023-03-31 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2023-01-01 2023-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2023-01-01 2023-03-31 0000880631 us-gaap:EquipmentMember srt:MaximumMember 2023-01-01 2023-03-31 0000880631 us-gaap:EquipmentMember srt:MinimumMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyseriesapreferredstockMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomTreeTrustMember 2023-01-01 2023-03-31 0000880631 wt:WisdomtreeManagementJerseyLimitedMember wt:AdvisoryServicesMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember 2023-01-01 2023-03-31 0000880631 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000880631 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000880631 wt:OtherServicesIncomeMember 2023-01-01 2023-03-31 0000880631 us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember 2023-01-01 2023-03-31 0000880631 wt:UnrecognizedTaxBenefitsMember 2023-01-01 2023-03-31 0000880631 wt:InterestAndPenaltiesMember 2023-01-01 2023-03-31 0000880631 wt:DeferredConsiderationObligationMember 2023-01-01 2023-03-31 0000880631 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-01-01 2023-03-31 0000880631 wt:AtTwentyFifthPercentileMember 2023-01-01 2023-03-31 0000880631 wt:BelowTwentyFifthPercentileMember 2023-01-01 2023-03-31 0000880631 srt:MaximumMember wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-03-31 0000880631 srt:MinimumMember wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-03-31 0000880631 wt:At85thPercentileForGrantsMadeIn2021Member 2023-01-01 2023-03-31 0000880631 wt:At100thPercentileForGrantsMadeIn2019And2020Member 2023-01-01 2023-03-31 0000880631 wt:AtFiftyPercentileMember 2023-01-01 2023-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-03-31 0000880631 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000880631 country:US 2023-01-01 2023-03-31 0000880631 country:JE 2023-01-01 2023-03-31 0000880631 country:IE 2023-01-01 2023-03-31 0000880631 wt:ConvertibleSeniorNotesMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember 2023-01-01 2023-03-31 0000880631 wt:FnalityInternationalLimitedMember 2023-01-01 2023-03-31 0000880631 wt:TwoThousandAndTwentyThreeNotesMember 2023-01-01 2023-03-31 0000880631 wt:WisdomtreeAssetManagementCanadaIncMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyIncMember 2023-01-01 2023-03-31 0000880631 wt:FnalityConvertibleNoteMember 2023-01-01 2023-03-31 0000880631 wt:TwothousandandtwentynotesMember 2023-01-01 2023-03-31 0000880631 wt:VestingCappedIfTsrisNegativeMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000880631 wt:FinancialInstrumentsOwnedAtFairValueMember 2023-01-01 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:SecurrencyConvertibleNoteMember 2023-01-01 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:FnalityConvertibleNoteMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyseriesapreferredstockMember 2019-12-31 0000880631 wt:SecurrencyseriesbconvertiblepreferredstockMember 2021-03-31 0000880631 us-gaap:SubsequentEventMember 2029-12-31 0000880631 us-gaap:SubsequentEventMember 2031-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:SecurrencyConvertibleNoteMember 2022-01-01 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member wt:FnalityConvertibleNoteMember 2022-01-01 2022-12-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2023-02-14 2023-02-14 0000880631 wt:ConvertibleSeniorNotesMember 2023-02-14 2023-02-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-02-14 2023-02-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2023-02-14 0000880631 wt:TwothousandandtwentynotesMember 2023-02-14 0000880631 wt:ConvertibleSeniorNotesMember 2023-02-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2021-06-14 2021-06-14 0000880631 wt:ConvertibleSeniorNotesMember 2021-06-14 2021-06-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2021-06-14 2021-06-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2021-06-14 0000880631 wt:ConvertibleSeniorNotesMember 2021-06-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-06-16 2020-06-16 0000880631 wt:ConvertibleSeniorNotesMember 2020-06-16 2020-06-16 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2020-06-16 2020-06-16 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-06-16 0000880631 wt:ConvertibleSeniorNotesMember 2020-06-16 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-08-13 2020-08-13 0000880631 wt:ConvertibleSeniorNotesMember 2020-08-13 2020-08-13 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2020-08-13 2020-08-13 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-08-13 0000880631 wt:ConvertibleSeniorNotesMember 2020-08-13 0000880631 wt:TwothousandandtwentynotesMember 2020-01-01 2020-12-31 0000880631 wt:TwothousandandtwentynotesMember 2020-12-31 0000880631 wt:TwothousandandtwentyonenotesMember 2021-01-01 2021-12-31 0000880631 wt:TwothousandandtwentyonenotesMember 2021-12-31 0000880631 wt:TwoThousandAndTwentyThreeNotesMember 2023-05-31 0000880631 us-gaap:PreferredStockMember wt:AcquisitionOfEtfsBusinessMember us-gaap:SeriesAPreferredStockMember 2018-04-01 2018-04-11 0000880631 wt:AcquisitionOfEtfsBusinessMember 2018-04-11 0000880631 us-gaap:CommonStockMember wt:AcquisitionOfEtfsBusinessMember 2018-04-11 0000880631 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-04-11 0000880631 wt:UnrecognizedTaxBenefitsIncludingInterestAndPenaltiesMember 2022-03-31 0000880631 wt:StockholderRightAgreementMember 2023-03-17 2023-03-17 0000880631 us-gaap:CommonStockMember wt:StockholderRightAgreementMember 2023-03-17 0000880631 wt:SeriesANonVotingConvertiblePreferredStockMember wt:StockholderRightAgreementMember 2023-03-17 0000880631 wt:StockholderRightAgreementMember 2023-03-17 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2022-02-22 0000880631 srt:MaximumMember 2022-02-22 0000880631 wt:WisdomtreeAssetManagementCanadaIncMember 2020-02-19 2020-02-19 0000880631 wt:WisdomtreeAssetManagementCanadaIncMember srt:MaximumMember 2020-02-19 0000880631 wt:WisdomtreeAssetManagementCanadaIncMember srt:MinimumMember 2020-02-19 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2022-02-22 2022-02-22 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-01-31 0000880631 us-gaap:RetainedEarningsMember 2021-12-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:RestatementAdjustmentMember 2021-12-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000880631 us-gaap:CommonStockMember 2021-12-31 0000880631 wt:DeferredConsiderationObligationMember 2021-12-31 0000880631 us-gaap:RetainedEarningsMember 2022-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000880631 us-gaap:CommonStockMember 2022-03-31 0000880631 wt:DeferredConsiderationObligationMember 2022-03-31 0000880631 us-gaap:RestrictedStockMember 2022-12-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000880631 wt:PerformanceBasedRestrictedStockUnitsMember 2022-12-31 0000880631 us-gaap:ReportableSubsegmentsMember 2022-12-31 0000880631 us-gaap:ReportableSubsegmentsMember 2023-03-31 0000880631 us-gaap:RestrictedStockMember 2023-03-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitsMember 2023-03-31 0000880631 us-gaap:RetainedEarningsMember 2022-12-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000880631 us-gaap:CommonStockMember 2022-12-31 0000880631 wt:InterestAndPenaltiesMember 2022-12-31 0000880631 wt:UnrecognizedTaxBenefitsMember 2022-12-31 0000880631 wt:DeferredConsiderationObligationMember 2022-12-31 0000880631 wt:InterestAndPenaltiesMember 2023-03-31 0000880631 wt:UnrecognizedTaxBenefitsMember 2023-03-31 0000880631 us-gaap:RetainedEarningsMember 2023-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000880631 us-gaap:CommonStockMember 2023-03-31 0000880631 wt:DeferredConsiderationObligationMember 2023-03-31 iso4217:USD utr:Year xbrli:shares utr:Day xbrli:pure utr:Month iso4217:CAD iso4217:EUR iso4217:GBP iso4217:USD xbrli:shares utr:oz utr:Y

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form
10-Q
 
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
or
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
    
    
    
    
.
Commission File Number
001-10932
 
WisdomTree, Inc.
(Exact name of registrant as specified in its charter)
 
 
Delaware
  
13-3487784
(State or other jurisdiction of
incorporation or organization)
  
(IRS Employer
Identification No.)
   
250 West 34
th
Street
3
rd
Floor
New York, New York
  
10119
(Address of principal executive offices)
  
(Zip Code)
212-801-2080
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
  
Trading Symbol(s)
  
Name of each exchange on which registered
Common Stock, $0.01 par value
Preferred Stock Purchase Rights
  
WT
  
The New York Stock Exchange
The New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒  Yes    ☐  No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒  Yes    ☐  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer  
☒
    Accelerated filer   ☐
       
Non-accelerated
filer		   ☐    Smaller reporting company  
☐
       
         Emerging growth company   ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act   ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☐    No  ☒
As of May 4, 2023, there
 were 149,263,168 shares of the registrant’s Common Stock, $0.01 par value per share, outstanding.

Table of Contents

WISDOMTREE, INC.

Form 10-Q

For the Quarterly Period Ended March 31, 2023

TABLE OF CONTENTS

 

PART I: FINANCIAL INFORMATION

      4  

ITEM 1.

    FINANCIAL STATEMENTS      4  

ITEM 2.

    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS      33  

ITEM 3.

    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK      50  

ITEM 4.

    CONTROLS AND PROCEDURES      51  

PART II: OTHER INFORMATION

      51  

ITEM 1.

    LEGAL PROCEEDINGS      51  

ITEM 1A.

    RISK FACTORS      51  

ITEM 2.

    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS      51  

ITEM 3.

    DEFAULTS UPON SENIOR SECURITIES      52  

ITEM 4.

    MINE SAFETY DISCLOSURES      52  

ITEM 5.

    OTHER INFORMATION      52  

ITEM 6.

    EXHIBITS      53  

Unless otherwise indicated, references to “the Company,” “we,” “us,” “our” and “WisdomTree” mean WisdomTree, Inc. and its subsidiaries.

WisdomTree®, WisdomTree Prime™ and Modern Alpha® are trademarks of WisdomTree, Inc. in the United States and in other countries. All other trademarks are the property of their respective owners.

 

2

Table of Contents
P5DP5DP5DP5DP10DP10DP10DP10D0.1
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form
10-Q,
or Report, contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect our results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in the section entitled “Risk Factors” included in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2022. If one or more of these or other risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Report and the documents that we reference in this Report and have filed with the Securities and Exchange Commission, or the SEC, as exhibits to this Report, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.
In particular, forward-looking statements in this Report may include statements about:
 
  •  
anticipated trends, conditions and investor sentiment in the global markets and exchange-traded products, or ETPs;
 
  •  
anticipated levels of inflows into and outflows out of our ETPs;
 
  •  
our ability to deliver favorable rates of return to investors;
 
  •  
competition in our business;
 
  •  
whether we will experience future growth;
 
  •  
our ability to develop new products and services;
 
  •  
our ability to maintain current vendors or find new vendors to provide services to us at favorable costs;
 
  •  
our ability to successfully implement our strategy related to digital assets and blockchain-enabled financial services, including WisdomTree Prime
™
, and achieve its objectives;
 
  •  
our ability to successfully operate and expand our business in
non-U.S.
markets;
 
  •  
the effect of laws and regulations that apply to our business; and
 
  •  
actions of activist stockholders.
The forward-looking statements in this Report represent our views as of the date of this Report. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Therefore, these forward-looking statements do not represent our views as of any date other than the date of this Report.
 
3
PART I: FINANCIAL INFORMATION
 
ITEM 1.
FINANCIAL STATEMENTS
WisdomTree, Inc. and Subsidiaries
Consolidated Balance Sheets
(In Thousands, Except Per Share Amounts)
 
    
  March 31,  

2023
     
  December 31,  
2022
  
     
    
(unaudited)
         
Assets
                  
Current assets:
                  
Cash and cash equivalents (Note 3)
      $ 119,099            $ 132,101   
Financial instruments owned, at fair value (including $45,214 and $25,283 invested in WisdomTree products at March 31, 2023 and December 31, 2022, respectively) (Note 5)
      130,180            126,239   
Accounts receivable (including $32,446 and $24,139 due from related parties at March 31, 2023 and December 31, 2022, respectively)
      35,496            30,549   
Prepaid expenses
      5,877            4,684   
Income taxes receivable
      1,799            —   
Other current assets
      291            390   
    
 
 
     
 
 
  
Total current assets
      292,742            293,963   
Fixed assets, net
      515            544   
Indemnification receivable (Note 20)
      —            1,353   
Securities
held-to-maturity
      253            259   
Deferred tax assets, net (Note 20)
      5,871            10,536   
Investments (Note 7)
      26,902            35,721   
Right of use assets—operating leases (Note 12)
      1,153            1,449   
Goodwill (Note 22)
      85,856            85,856   
Intangible assets, net (Note 22)
      603,968            603,567   
Other noncurrent assets
      507            571   
    
 
 
     
 
 
  
Total assets
      $ 1,017,767            $ 1,033,819   
    
 
 
     
 
 
  
Liabilities and stockholders’ equity
                  
Liabilities
                  
Current liabilities:
                  
Convertible notes—current (Note 10)
      $ 59,884            $ 59,197   
Fund management and administration payable
      27,830            36,521   
Deferred consideration—gold payments (Note 9)
      17,984            16,796   
Compensation and benefits payable
      9,341            24,121   
Income taxes payable
      —              1,599   
Operating lease liabilities (Note 12)
      1,041            1,125   
Accounts payable and other liabilities
      14,846            9,075   
    
 
 
     
 
 
  
Total current liabilities
      130,926            148,434   
Convertible notes (Note 10)
      273,767            262,019   
Deferred consideration—gold payments (Note 9)
      161,847            183,494   
Operating lease liabilities (Note 12)
      120            339   
Other noncurrent liabilities (Note 20)
      —              1,353   
    
 
 
     
 
 
  
Total liabilities
      566,660            595,639   
Preferred stock—Series A
Non-Voting
Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $86,638 and $77,969 at March 31, 2023 and December 31, 2022, respectively) (Note 11)
      132,569            132,569   
    
 
 
     
 
 
  
Contingencies (Note 13)
                  
Stockholders’ equity
                  
Preferred stock, par value $0.01; 2,000 shares authorized:
      —              —   
Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 149,291 and 146,517 at March 31, 2023 and December 31, 2022, respectively
      1,493            1,465   
Additional
paid-in
capital
      292,971            291,847   
Accumulated other comprehensive loss
      (954)           (1,420)  
Retained earnings
      25,028            13,719   
    
 
 
     
 
 
  
Total stockholders’ equity
      318,538            305,611   
    
 
 
     
 
 
  
Total liabilities and stockholders’ equity
      $     1,017,767            $ 1,033,819   
    
 
 
     
 
 
  
The accompanying notes are an integral part of these consolidated financial statements
 
4
WisdomTree, Inc. and Subsidiaries
Consolidated Statements of Operations
(In Thousands, Except Per Share Amounts)
(Unaudited)
 
                 
    
Three Months Ended

March 31,
    
2023
  
2022
Operating Revenues:
                 
Advisory fees
     $ 77,637      $ 76,517  
Other income
      4,407       1,851  
    
 
 
 
  
 
 
 
Total revenues
      82,044       78,368  
    
 
 
 
  
 
 
 
Operating Expenses:
                 
Compensation and benefits
      27,398       24,787  
Fund management and administration
      17,153       15,494  
Marketing and advertising
      4,007       4,023  
Sales and business development
      2,994       2,609  
Contractual gold payments (Note 9)
      4,486       4,450  
Professional fees
      3,715       4,459  
Occupancy, communications and equipment
      1,101       753  
Depreciation and amortization
      109       47  
Third-party distribution fees
      2,253       2,212  
Other
      2,257       1,845  
    
 
 
 
  
 
 
 
Total operating expenses
      65,473       60,679  
    
 
 
 
  
 
 
 
Operating income
      16,571       17,689  
Other Income/(Expenses):
                 
Interest expense
      (4,002 )      (3,732 ) 
Gain/(loss) on revaluation of deferred consideration—gold payments (Note 9)
      20,592       (17,018 ) 
Interest income
      1,083       794  
Impairments (Note 7)
      (4,900 )      —  
Loss on extinguishment of convertible notes (Note 10)
      (9,721 )      —  
Other losses, net
      (2,007 )      (24,707 ) 
    
 
 
 
  
 
 
 
Income/(loss) before income taxes
      17,616       (26,974 ) 
Income tax expense/(benefit)
      1,383       (16,713 ) 
    
 
 
 
  
 
 
 
Net income/(loss)
     $ 16,233      $ (10,261 ) 
    
 
 
 
  
 
 
 
Earnings/(loss) per share—basic
     $ 0.10      $ (0.08 ) 
    
 
 
 
  
 
 
 
Earnings/(loss) per share—diluted
     $ 0.10      $ (0.08 ) 
    
 
 
 
  
 
 
 
Weighted-average common shares—basic
      143,862         142,782  
    
 
 
 
  
 
 
 
Weighted-average common shares—diluted
          159,887       142,782  
    
 
 
 
  
 
 
 
Cash dividends declared per common share
     $ 0.03      $ 0.03  
    
 
 
 
  
 
 
 
The accompanying notes are an integral part of these consolidated financial statements
 
5
WisdomTree, Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income/(Loss)
(In Thousands)
(Unaudited)
 
                 
    
Three Months Ended

March 31,
  
    
2023
    
2022
  
Net income/(loss)
     $ 16,233        $ (10,261)   
Other comprehensive income/(loss)
                 
Foreign currency translation adjustment, net of income taxes
      466         (486)   
    
 
 
    
 
 
  
Other comprehensive income/(loss)
      466         (486)   
    
 
 
    
 
 
  
Comprehensive income/(loss)
     $     16,699        $     (10,747)   
    
 
 
    
 
 
  
The accompanying notes are an integral part of these consolidated financial statements
 
6
WisdomTree, Inc. and Subsidiaries
Consolidated Statements of Changes in Stockholders’ Equity
(In Thousands)
(Unaudited)
 
      
For the Three Months Ended March 31, 2023
      
Common Stock
   
Additional
Paid-In

Capital
   
Accumulated
Other
Comprehensive
Loss
   
Retained

Earnings/

(Accumulated
Deficit)
   
Total
      
Shares
Issued
   
Par
Value
Balance—January 1, 2023
        146,517       $ 1,465       $ 291,847       $ (1,420 )      $ 13,719       $ 305,611  
Restricted stock issued and vesting of restricted stock units, net
        3,379        34        (34 )       —        —        —  
Shares repurchased
        (605 )       (6 )       (3,378 )       —        —        (3,384 ) 
Stock-based compensation
        —        —        4,536        —        —        4,536  
Other comprehensive income
        —        —        —        466        —        466  
Dividends
        —        —        —        —        (4,924 )       (4,924 ) 
Net income
        —        —        —        —        16,233        16,233  
      
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
Balance—March 31, 2023
            149,291       $     1,493       $     292,971       $       (954 )      $     25,028       $   318,538  
      
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
      
For the Three Months Ended March 31, 2022
      
Common Stock
   
Additional
Paid-In

Capital
   
Accumulated

Other

Comprehensive
Income
   
Accumulated

Deficit
   
Total
    
Shares
Issued
   
Par
Value
Balance—January 1, 2022
        145,107      $ 1,451      $ 289,736      $ 682      $ (22,445 )     $ 269,424  
Restricted stock issued and vesting of restricted stock units, net
        2,042        21        (21 )       —        —        —  
Shares repurchased
        (589 )       (6 )       (3,388 )       —        —        (3,394 ) 
Stock-based compensation
        —        —        2,936        —        —        2,936  
Other comprehensive loss
        —        —        —        (486 )       —        (486 ) 
Dividends
        —        —        (4,842 )       —        —        (4,842 ) 
Net loss
        —        —        —        —        (10,261 )       (10,261 ) 
      
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
Balance—March 31, 2022
            146,560       $   1,466       $   284,421       $       196       $     (32,706 )     $   253,377  
      
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements
 
7
WisdomTree, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(In Thousands)
(Unaudited)
 
                 
    
Three Months Ended

March 31,
    
        2023        
   
        2022        
Cash flows from operating activities:
                  
Net income/(loss)
     $ 16,233       $ (10,261 ) 
Adjustments to reconcile net income/(loss) to net cash used in operating activities:
                  
(Gain)/loss on revaluation of deferred consideration—gold payments
      (20,592 )       17,018  
Advisory and license fees paid in gold, other precious metals and cryptocurrency
      (12,760 )       (16,052 ) 
Loss on extinguishment of convertible notes
      9,721        —  
Impairments
      4,900        —  
Deferred income taxes
      4,783        5,273  
Stock-based compensation
      4,536        2,936  
Contractual gold payments
      4,486        4,450  
Losses on investments
      3,919        163  
(Gains)/losses on financial instruments owned, at fair value
      (1,954 )       5,142  
Amortization of issuance costs—convertible notes
      579        645  
Amortization of right of use asset
      319        89  
Depreciation and amortization
      109        47  
Changes in operating assets and liabilities:
                  
Accounts receivable
      (4,791 )       (3,710 ) 
Prepaid expenses
      (1,161 )       (2,264 ) 
Gold and other precious metals
      8,332        11,959  
Other assets
      167        (52 ) 
Intangibles—software development
      (452 )       —  
Fund management and administration payable
      3,638        3,199  
Compensation and benefits payable
      (27,271 )       (23,690 ) 
Income taxes payable
      (3,418 )       (4,228 ) 
Operating lease liabilities
      (326 )       (97 ) 
Accounts payable and other liabilities
      5,606        6,741  
    
 
 
 
   
 
 
 
Net cash used in operating activities
      (5,397 )       (2,692 ) 
    
 
 
 
   
 
 
 
Cash flows from investing activities:
                  
Purchase of financial instruments owned, at fair value
      (20,278 )       (25,461 ) 
Purchase of investments
      —        (6,863 ) 
Purchase of fixed assets
      (26 )       (54 ) 
Proceeds from the sale of financial instruments owned, at fair value
      18,290        13,639  
Proceeds from
held-to-maturity
securities maturing or called prior to maturity
      6        18  
    
 
 
 
   
 
 
 
Net cash used in investing activities
      (2,008 )       (18,721 ) 
    
 
 
 
   
 
 
 
Cash flows from financing activities:
                  
Repurchase of convertible notes (See Note 10)
      (124,317 )       —  
Dividends paid
      (4,821 )       (4,842 ) 
Shares repurchased
      (3,384 )       (3,394 ) 
Convertible notes issuance costs
      (3,548 )       —  
Proceeds from the issuance of convertible notes (Note 10)
      130,000        —  
    
 
 
 
   
 
 
 
Net cash used in financing activities
      (6,070 )       (8,236 ) 
    
 
 
 
   
 
 
 
Increase/(decrease) in cash flow due to changes in foreign exchange rate
      473        (665 ) 
    
 
 
 
   
 
 
 
Net decrease in cash and cash equivalents
      (13,002 )       (30,314 ) 
Cash and cash equivalents—beginning of year
      132,101        140,709  
    
 
 
 
   
 
 
 
Cash and cash equivalents—end of period
     $ 119,099       $ 110,395  
    
 
 
 
   
 
 
 
Supplemental disclosure of cash flow information:
                  
Cash paid for income taxes
     $ 1,422       $ 2,123  
    
 
 
 
   
 
 
 
Cash paid for interest
     $ 801       $             —  
    
 
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements
 
8
WisdomTree, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(In Thousands, Except Share and Per Share Amounts)
1. Organization and Description of Business
WisdomTree, Inc., through its global subsidiaries (collectively, “WisdomTree” or the “Company”), is a global financial innovator, offering a well-diversified suite of exchange-traded products (“ETPs”), models and solutions. Building on its heritage of innovation, the Company is also developing next-generation digital products and structures, including digital or blockchain-enabled mutual funds (“Digital Funds”) and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime
™
. The Company has the following wholly-owned operating subsidiaries:
 
  •  
WisdomTree Asset Management, Inc.
is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (“WTT”) and WisdomTree exchange-traded funds (“ETFs”). The WisdomTree ETFs are issued in the U.S. by WTT. WTT is a
non-consolidated
Delaware statutory trust registered with the SEC as an
open-end
management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.
 
  •  
WisdomTree Management Jersey Limited
(“ManJer”) is a Jersey based management company providing management services to seven issuers (the “ManJer Issuers”) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and
leveraged-and-inverse
strategies.
 
  •  
WisdomTree Multi Asset Management Limited
(“WTMAML”) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (“WMAI”) in respect of the ETPs issued by WMAI. WMAI is a
non-consolidated
public limited company domiciled in Ireland.
 
  •  
WisdomTree Management Limited
(“WML”) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (“WTICAV”) in respect of the WisdomTree UCITS ETFs issued by WTICAV. WTICAV is a
non-consolidated
public limited company domiciled in Ireland.
 
  •  
WisdomTree UK Limited
(“WTUK”) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.
 
  •  
WisdomTree Europe Limited
is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK. WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.
 
  •  
WisdomTree Ireland Limited
is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.
 
  •  
WisdomTree Digital Commodity Services, LLC
is a New York based company that has been formed to serve as the sponsor of the WisdomTree Bitcoin Trust and WisdomTree Ethereum Trust, each an ETF currently under review with the SEC.
 
  •  
WisdomTree Digital Management, Inc. (“WT Digital Management”) is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (“WTDT”) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S. by WTDT. WTDT is a Delaware statutory trust registered with the SEC as an open-end management investment company. Each Digital Fund will use blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but will not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies. 
 
  •  
WisdomTree Digital Movement, Inc
. is a New York based company operating as a money services business registered with the Financial Crimes Enforcement Network (“FinCEN”) and seeking state money transmitter licenses to operate a platform for the purchase, sale and exchange of digital assets, while also providing digital wallet services through WisdomTree Prime
™
to facilitate such activity.
 
  •  
WisdomTree Securities, Inc
. is a New York based limited purpose broker-dealer (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds.
 
9
2. Significant Accounting Policies
Basis of Presentation
These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of financial condition, results of operations, and cash flows for the periods presented. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Consolidation
The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.
The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.
Segment and Geographic Information
The Company, through its subsidiaries in the U.S. and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company’s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.
Foreign Currency Translation
Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income/(Loss) as a component of other comprehensive (loss)/income.
Use of Estimates
The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.
Revenue Recognition
The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
Contractual Gold Payments
Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note 9).
Marketing and Advertising
Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.
Depreciation and Amortization
Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows:
 
Equipment
      3 to 5 years  
Internally-developed software
      3 years  
The assets listed above are recorded at cost less accumulated depreciation and amortization.
 
10
Stock-Based Awards
Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.
Third-Party Distribution Fees
The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETFs and for including WisdomTree ETFs on third-party customer platforms and recognizes these expenses as incurred.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.
Accounts Receivable
Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.
Impairment of Long-Lived Assets
The Company performs a review for the impairment of long-lived assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.
Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)
Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or
available-for-sale
(“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.
Securities
Held-to-Maturity
The Company accounts for certain of its securities as
held-to-maturity
on a trade date basis, which are recorded at amortized cost. For
held-to-maturity
securities, the Company has the intent and ability to hold these securities to maturity and it is not
more-likely-than-not
that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity.
Held-to-maturity
securities are placed on
non-accrual
status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on
held-to-maturity
securities placed on
non-accrual
status is recognized on a cash basis as interest income if and when received.
The Company reviews its portfolio of
held-to-maturity
securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.
Investments in pass-through government-sponsored enterprises (“GSEs”) are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.
 
11
Investments
The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321,
Investments – Equity Securities
(“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.
Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).
Goodwill
Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring
re-evaluation,
if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.
Goodwill is allocated to the Company’s U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.
Goodwill is assessed for impairment annually on November 30
th
. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.
Intangible Assets
Indefinite-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values.
Finite-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.
The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30
th
.
Software Development Costs
Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.
Leases
The Company accounts for its lease obligations in accordance with ASC Topic 842,
Leases
(“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting
right-of-use
asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement,
right-of-use
assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term.
ASC 842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and
non-lease
components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.
 
12
Deferred Consideration—Gold Payments
Deferred consideration represents the present value of an obligation to pay gold to a third party into perpetuity and is measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note 9). Changes in the fair value of this obligation are reported as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.
Convertible Notes
Convertible notes are carried at amortized cost, net of issuance costs. In accordance with Accounting Standards Update (“ASU”)
2020-06,
Debt – Debt with Conversion and Other Options
, the Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.
Contingencies
The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.
Contingent Payments
The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.
Earnings per Share
Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series A
non-voting
convertible preferred stock (Note 11) and unvested share-based payment awards that contain
non-forfeitable
rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the
two-class
method. Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).
Diluted EPS is calculated under the treasury stock method and the
two-class
method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards, the Series A
non-voting
convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series A
non-voting
convertible preferred stock and the convertible notes are computed under the
if-converted
method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price.
Income Taxes
The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is
more-likely-than-not
that some portion or all the deferred tax assets will not be realized.
Tax positions are evaluated utilizing a
two-step
process. The Company first determines whether any of its tax positions are
more-likely-than-not
to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.
The Global Intangible
Low-Taxed
Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.
Non-income
based taxes are recorded as part of other liabilities and other expenses.
 
13
3. Cash and Cash Equivalents
Of the total cash and cash equivalents of $119,099 and $132,101 at March 31, 2023 and December 31, 2022, $118,306 and $131,104, respectively, were held at two financial institutions. At March 31, 2023 and December 31, 2022, cash equivalents were approximately $336 and $930, respectively.
Certain of the Company’s subsidiaries are required to maintain a minimum level of regulatory capital, which was $28,726 and $25,988 at March 31, 2023 and December 31, 2022, respectively. These requirements are generally satisfied by cash on hand.
4. Fair Value Measurements
The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. ASC 820,
Fair Value Measurement
, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:
 
Level 1   –   Quoted prices for identical instruments in active markets.
     
Level 2   –   Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
     
Level 3   –   Instruments whose significant drivers are unobservable.
The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2023 and 2022, there were no transfers between Levels 2 and 3.
 
                                                                                                     
    
March 31, 2023
  
    
Total
     
Level 1
     
Level 2
  
Level 3
  
Assets:
                                   
Recurring fair value measurements:
                                   
Cash equivalents
   
  $
336
 
   
  $
336
 
   
  $
—
 
  
  $
—  
 
Financial instruments owned, at fair value
                             
 
  
 
ETFs
   
 
33,728
 
   
 
33,728
 
   
 
—
 
  
 
—  
 
U.S. treasuries
   
 
2,993
 
   
 
2,993
 
   
 
—
 
  
 
—  
 
Pass-through GSEs
   
 
81,046
 
   
 
23,352
 
   
 
  57,694
 
  
 
—  
 
Other assets—seed capital (WisdomTree blockchain-enabled funds)
                             
 
  
 
U.S. treasuries
   
 
4,901
 
   
 
4,901
 
   
 
—
 
  
 
—  
 
Equities
   
 
4,937
 
   
 
4,937
 
   
 
—
 
  
 
—  
 
Fixed income
   
 
1,915
 
   
 
—
 
   
 
1,915
 
  
 
—  
 
Other
   
 
660
 
   
 
—
 
   
 
660
 
  
 
—  
 
Investments in Convertible Notes
                                   
Securrency, Inc.—convertible note (Note 7)
   
 
10,051
 
   
 
—
 
   
 
—
 
  
 
10,051  
 
Fnality International Limited—convertible note (Note 7)
   
 
7,451
 
   
 
—
 
   
 
—
 
  
 
7,451  
 
    
 
 
     
 
 
     
 
 
 
  
 
 
  
Total
   
  $
    148,018
 
   
  $
    70,247
 
   
  $
    60,269
   
  
  $
      17,502  
 
    
 
 
     
 
 
     
 
 
 
  
 
 
  
 
14
                                                                                                     
    
March 31, 2023
  
    
Total
     
Level 1
     
Level 2
     
Level 3
  
Non-recurring
fair value measurements:
                                    
Securrency, Inc.—Series A convertible preferred stock
(1)
   
  $
    3,588
 
   
  $
—
 
   
  $
—
 
   
  $
3,588  
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Liabilities:
                                    
Recurring fair value measurements:
                                    
Deferred consideration (Note 9)
   
  $
    179,831
 
   
  $
            —
 
   
  $
        —
 
   
  $
    179,831  
 
    
 
 
     
 
 
     
 
 
     
 
 
  
   
    
December 31, 2022
  
    
Total
     
Level 1
     
Level 2
     
Level 3
  
Assets:
                                    
Recurring fair value measurements:
                                    
Cash equivalents
   
  $
930 
 
   
  $
930 
 
   
  $
— 
 
   
  $
—
 
Financial instruments owned, at fair value
                                    
ETFs
   
 
23,772 
 
   
 
23,772 
 
   
 
— 
 
   
 
—
 
U.S. treasuries
   
 
2,980 
 
   
 
2,980 
 
   
 
— 
 
   
 
—
 
Pass-through GSEs
   
 
96,837 
 
   
 
23,290 
 
   
 
73,547 
 
   
 
—
 
Corporate bonds
   
 
885 
 
   
 
— 
 
   
 
885 
 
   
 
—
 
Other assets—seed capital (WisdomTree blockchain-enabled funds)
   
 
1,765 
 
   
 
— 
 
   
 
1,765 
 
   
 
—
 
Investments in Convertible Notes
            
 
 
 
                  
Securrency, Inc.—convertible note (Note 7)
   
 
14,500 
 
   
 
— 
 
   
 
— 
 
   
 
14,500
 
Fnality International Limited—convertible note (Note 7)
   
 
6,921 
 
   
 
— 
 
   
 
— 
 
   
 
6,921
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
  $
  148,590 
 
   
  $
  50,972 
 
   
  $
  76,197 
 
   
  $
21,421
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Non-recurring
fair value measurements:
                                    
Other investments
(2)
   
  $
312 
 
   
  $
— 
 
   
  $
— 
 
   
  $
312
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Liabilities:
                                    
Recurring fair value measurements:
                                    
Deferred consideration (Note 9)
   
  $
200,290 
 
   
  $
— 
 
   
  $
— 
 
   
  $
   200,290
 
    
 
 
     
 
 
     
 
 
     
 
 
  
 
(1)
Fair value determined on March 31, 2023.
(2)
Fair value determined on May 10, 2022.
Recurring Fair Value Measurements—Methodology
Cash Equivalents (Note 3)
– These financial assets represent cash invested in highly liquid investments with original maturities of less than 90 days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.
Financial instruments owned (Note 5)
– Financial instruments owned are investments in ETFs, U.S. treasuries, pass-through GSEs, corporate bonds, equities, fixed income and other assets. ETFs, U.S. treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass-through GSEs, corporate bonds and fixed income include consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level 2. Pass-through GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1.
 
15
Fair Value Measurements classified as Level
 3
– The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:
 
        
Three Months Ended,

March 31,
  
        
2023
    
2022
  
   
Investments in Convertible Notes (Note 7)
                 
   
Beginning balance
      $ 21,421       $ —  
    
  
Purchases
      —       6,863  
   
Net unrealized losses
(1)
      (3,919 )      (163 ) 
        
 
 
    
 
 
  
   
Ending balance
      $ 17,502       $ 6,700  
        
 
 
    
 
 
  
   
Deferred Consideration (Note 9)
                 
   
Beginning balance
      $     200,290       $ 228,062  
   
Net realized losses
(2)
      4,486       4,450  
   
Net unrealized (gains)/losses
(3)
      (20,592 )      17,018  
   
Settlements
      (4,353 )      (4,353 ) 
        
 
 
    
 
 
  
   
Ending balance
      $ 179,831        $     245,177    
        
 
 
    
 
 
  
 
(1)
Recorded in other losses, net in the Consolidated Statements of Operations.
(2)
Recorded as contractual gold payments expense in the Consolidated Statements of Operations.
(3)
Recorded as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.
5.  Financial instruments owned
These instruments consist of the following:
 
        
    March 31,    

2023
    
    December 31,    
2022
  
          
  
Financial instruments owned
                 
   
Trading securities
      $ 117,767       $ 124,474  
   
Other assets—seed capital (WisdomTree blockchain-enabled funds)
      12,413       1,765  
        
 
 
    
 
 
  
           $     130,180         $     126,239   
        
 
 
    
 
 
  
The Company recognized net trading gains/(losses) on financial instruments owned that were still held at the reporting dates of $4,722 and ($4,316) during the three months ended March 31, 2023 and 2022, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations.
6.  Securities
Held-to-Maturity
The following table is a summary of the Company’s securities
held-to-maturity:
 
                                            
       
    March 31,    

2023
   
    December 31,    

2022
 
Debt instruments: Pass-through GSEs (amortized cost)
      $           253          $           259    
      
 
 
 
   
 
 
 
During the three months ended March 31, 2023 and 2022, the Company received proceeds of $6 and $18, respectively, from
held-to-maturity
securities maturing or being called prior to maturity.
The following table summarizes unrealized losses, gains and fair value (classified as Level 2 within the fair value hierarchy) of securities
held-to-maturity:
 
                                            
       
    March 31,    

2023
   
    December 31,    
2022
 
Cost/amortized cost
      $ 253      $ 259  
 
Gross unrealized losses
      (17 )       (20 ) 
 
Gross unrealized gains
      —        —  
      
 
 
 
   
 
 
 
 
Fair value
      $           236        $           239    
      
 
 
 
   
 
 
 
An allowance for credit losses was not provided on the Company’s
held-to-maturity
securities as all securities are investments in pass-through GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.
 
16
The following table sets forth the maturity profile of the securities
held-to-maturity;
however, these securities may be called prior to the maturity date:
 
                                
       
    March 31,    

2023
   
    December 31,    

2022
 
Due within one year
      $ —        $ —  
 
Due one year through five years
      —        —  
 
Due five years through ten years
      26        27  
 
Due over ten years
      227        232  
      
 
 
 
   
 
 
 
 
Total
      $           253          $           259    
      
 
 
 
   
 
 
 
7. Investments
The following table sets forth the Company’s investments:
 
      
       
        March 31, 2023        
     
        December 31, 2022        
  
      
Carrying

Value
     
Cost
     
Carrying

Value
     
Cost
  
 
Securrency, Inc.—Series A convertible preferred stock
      $ 3,588          $ 8,112          $ 8,488          $ 8,112    
 
Securrency, Inc.—Series B convertible preferred stock
      5,500          5,500          5,500          5,500    
 
Securrency, Inc.—convertible note
      10,051          15,000          14,500          15,000    
      
 
 
     
 
 
     
 
 
     
 
 
  
 
Subtotal—Securrency, Inc.
      $ 19,139          $ 28,612          $ 28,488          $ 28,612    
 
Fnality International Limited—convertible note
      7,451          6,863          6,921          6,863    
 
Other investments
      312          250          312          250    
      
 
 
     
 
 
     
 
 
     
 
 
  
         $     26,902          $     35,725          $  35,721          $     35,725    
      
 
 
     
 
 
     
 
 
     
 
 
  
Securrency, Inc. – Preferred Stock
The Company owns approximately 22% (or 17 % on a fully-diluted basis) of the capital stock of Securrency, Inc. (“Securrency”), a developer of institutional-grade blockchain-based financial and regulatory technology, issued as a result of strategic investments totaling $13,612. In consideration of such investments, the Company received 5,178,488
shares of Series A convertible preferred stock (“Securrency Series A Shares”) in December
 2019 and 2,004,665
shares of Series B convertible preferred stock (“Securrency Series B Shares”) in March 2021. The Securrency Series B Shares contain a liquidation preference that is pari passu with shares of Series
B-1
convertible preferred stock (which are substantially the same as the Securrency Series B Shares except that they have limited voting rights) and senior to that of the holders of the Securrency Series A Shares, which are senior to the holders of common stock. Otherwise, the Securrency Series A Shares and Securrency Series B Shares have substantially the same terms, are convertible into common stock at the option of the Company and contain various rights and protections including a
non-cumulative
 
6.0
%
dividend, payable if and when declared by the board of directors of Securrency. In addition, the Securrency Series A Shares and Securrency Series B Shares (together with the Securrency Series
B-1
convertible preferred stock) are separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at
least
60
% of the
Securrency 
Series A Shares (at any time on or after December 31, 2029) and
90
%
of the Securrency Series B Shares (at any time on or after March 31, 2031).
These investments are accounted for under the measurement alternative prescribed in ASC 321, as they do not have a readily determinable fair value and are not considered to be
in-substance
common stock. The investments are assessed for impairment and similar observable transactions on a quarterly basis. During the three months ending March, 31, 2023, the Company recognized an impairment of $4,900
on its Securrency Series A Shares to reduce the carrying value of its investment to fair value. Fair value was determined using the probability-weighted expected return method (“PWERM”), a valuation approach that estimates fair value assuming various outcomes.
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy):
 
    
March 31,

2023
  
Conversion of Securrency Series A Shares upon a future equity financing
      33.3%  
Redemption of Securrency Series A Shares upon a corporate transaction
      33.3%  
Default
      33.4%  
There was no impairment recognized during the three months ended March 31, 2022 based upon a qualitative assessment.
 
17
Securrency – Convertible Note
In April and November 2022, the Company participated in a convertible note financing, making an aggregate investment of $15,000 in convertible notes of Securrency. In consideration for its investment, the Company was issued a 7% Convertible Promissory Note maturing on
October 20, 2023.
The notes are convertible into either common stock or a class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency’s common stock that is issued in the event of a future equity financing of Securrency. The notes will convert at a conversion price equal to a discount of 25% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round.
The notes are redeemable upon the occurrence of a corporate transaction for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted, in accordance with the terms of the notes, to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion may occur upon the election by the holders of a
majority-in-interest
of the aggregate principal amount of outstanding notes. If no such election is made, Securrency may elect to pay or convert the notes in its sole discretion.
The notes are accounted for at fair value. Fair value is determined by the Company using PWERM. During the three months ended March 31, 2023, the Company recognized an unrealized loss of $4,449 when
re-measuring
the notes to fair value.
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 
    
  March 31,  

2023
   
  December 31,  

2022
Conversion of note upon a future equity financing
        33.3%          60%
Redemption of note upon a corporate transaction
        33.3%          25%
Default
        33.4%          15%
Time to potential outcome (in years)
          0.56          0.33
Fnality International Limited – Convertible Note
In February 2022, the Company participated in a convertible note financing, making an investment of £5,000 ($6,863) in convertible notes of Fnality International Limited (“Fnality”), a company incorporated in England and Wales and focused on creating a
peer-to-peer
digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross-border payments from a single pool of liquidity. In consideration for its investment, the Company was issued a 5% Convertible Unsecured Loan Note maturing on December 31, 2023.
The note is convertible into equity shares in the event of a future equity financing of Fnality. The note will convert at a conversion price equal to the lower of (i) a discount of 20% to lowest price paid per equity share issued pursuant to such future financing round and (ii) an amount paid per share subject to a
pre-money
valuation cap. Mandatory conversion may occur on or after the maturity date or, if earlier, in the event a future financing round has not been completed within a specified time from an initial closing of such financing round (“Long Stop Date”), upon the approval of holders of at least 75% of the outstanding notes. The note is also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date.
The note is redeemable upon the occurrence of a change of control for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption may also occur on or after maturity or prior to maturity upon approval by holders of at least 50% and 75%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events.
The note is accounted for at fair value. Fair value is determined by the Company using the PWERM and is also remeasured for changes in the British pound and U.S. dollar exchange rate. During the three months ended March 31, 2023, the Company recognized a gain of $530 when
re-measuring
the notes to fair value.
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 
    
  March 31,  

2023
  
  December 31,  

2022
Conversion of note upon a future financing round
          85%         85%
Redemption of note upon a change of control
          10%         10%
Default
            5%           5%
Time to potential outcome (in years)
          0.08         0.25
 
18
8. Fixed Assets, net
The following table summarizes fixed assets:
 
    
March 31,

2023
     
December 31,
2022
  
Equipment
     $             997          $             962    
Less: accumulated depreciation
      (482)          (418)   
    
 
 
     
 
 
  
Total
     $ 515          $ 544    
    
 
 
     
 
 
  
9. Deferred Consideration
Deferred consideration represents an obligation the Company assumed in connection with its acquisition of the European exchange-traded commodity, currency and
leveraged-and-inverse
business of ETFS Capital Limited (“ETFS Capital”) which occurred on April 11, 2018 (“ETFS Acquisition”). The obligation is for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March 31, 2058 and then subsequently reduced to 6,333 ounces of gold per year continuing into perpetuity (“Contractual Gold Payments”).
The Contractual Gold Payments are paid from advisory fee income generated by any Company-sponsored financial product backed by physical gold and are subject to adjustment and reduction for declines in advisory fee income generated by such products, with any reduction remaining due and payable until paid in full. ETFS Capital’s recourse is limited to such advisory fee income and it has no recourse back to the Company for any unpaid amounts that exceed advisory fees earned. ETFS Capital ultimately has the right to claw back Gold Bullion Securities Ltd. (a physically backed gold ETP issuer) if the Company fails to remit any amounts due.
The Company determined the present value of the deferred consideration of $179,831 and $200,290 at March 31, 2023 and December 31, 2022 using the following assumptions:
 
    
March 31,
2023
    
December 31,
2022
  
Forward-looking gold price (low)—per ounce
      $ 1,999        $ 1,858  
Forward-looking gold price (high)—per ounce
      $ 3,567        $ 3,126  
Forward-looking gold price (weighted average)—per ounce
      $ 2,401        $         2,237  
Discount rate
              13.3%        11.0%  
Perpetual growth rate
      1.5%        1.3%  
Fair value as of March 31, 2023 was determined using an equal weighting of a discounted cash flow approach and market approach. The forward-looking gold prices at March 31, 2023 were extrapolated from the last observable CMX exchange price (beyond 2028) and the weighted-average price per ounce was derived from the relative present values of the annual payment obligations. The perpetual growth rate at March 31, 2023 was determined based upon the increase in observable forward-looking gold prices through 2028. This obligation is classified as Level 3 as the discount rate, the extrapolated forward-looking gold prices and perpetual growth rate are significant unobservable inputs. An increase in spot gold prices, forward-looking gold prices and the perpetual growth rate would result in an increase in deferred consideration, whereas an increase in the discount rate would reduce the fair value.
Current amounts payable were $17,984 and $16,796 and long-term amounts payable were $161,847 and $183,494 at March 31, 2023 and December 31, 2022, respectively.
During the three months ended March 31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:
 
    
Three Months Ended

March 31,
  
    
2023
     
2022
  
Contractual Gold Payments
     $ 4,486        $ 4,450    
Contractual Gold Payments—gold ounces paid
      2,375          2,375    
Gain/(loss) on revaluation of deferred consideration—gold payments
(1)
     $     20,592        $     (17,018)   
 
(1)
 
Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.
 

19
10. Convertible Notes
On February 14, 2023, the Company issued and sold $130,000 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2023 Notes”) pursuant to an indenture dated February 14, 2023, between the Company and U.S. Bank Trust Company, National Association, as trustee (or its successor in interest, the “Trustee”), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Rule 144A”).
On June 14, 2021, the Company issued and sold $150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2021 Notes”) pursuant to an indenture dated June 14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A.
On June 16, 2020, the Company issued and sold $150,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the “June 2020 Notes”) pursuant to an indenture dated June 16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. On August 13, 2020, the Company issued and sold $25,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June 16, 2020, and constitute a further issuance of, and form a single series with, the Company’s June 2020 Notes (the “August 2020 Notes” and together with the June 2020 Notes, the “2020 Notes”).
In connection with the issuance of the 2023 Notes, the Company repurchased $115,000 in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $9,721 during the three months ended March 31, 2023.
After the issuance of the 2023 Notes (and together with the remaining 2020 Notes and the 2021 Notes, the “Convertible Notes”), the Company had $340,000 in aggregate principal amount of Convertible Notes outstanding.
Key terms of the Convertible Notes are as follows:
 
    
  2023 Notes  
     
  2021 Notes  
     
  2020 Notes  
  
Principal outstanding
      $130.0        $150.0        $60.0    
Maturity date (unless earlier converted, repurchased or redeemed)
      August 15, 2028        June 15, 2026        June 15, 2023    
Interest rate
      5.75%        3.25%        4.25%    
Conversion price
      $9.54        $11.04        $5.92    
Conversion rate
      104.8658        90.5797        168.9189    
Redemption price
      $12.40        $14.35        $7.70    
 
  •  
Interest rate:
Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and June 15 and December 15 of each year for the 2020 Notes and the 2021 Notes.
 
  •  
Conversion price:
Convertible at an initial conversion rate into shares of the Company’s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.
 
  •  
Conversion:
Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.
 
  •  
Cash settlement of principal amount:
Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.
 
  •  
Redemption price:
The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective
 
20
 
Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.
 
  •  
Limited investor put rights:
Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.
 
  •  
Conversion rate increase in certain customary circumstances:
In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853 shares, 144.9275 shares and 270.2702 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2021 Notes and 2020 Notes, respectively (the equivalent of 59,767,426 shares of the Company’s common stock), subject to adjustment.
 
  •  
Seniority and Security:
The Convertible Notes rank equal in right of payment, and are the Company’s senior unsecured obligations, but are subordinated in right of payment to the Company’s obligations to make certain redemption payments (if and when due) in respect of its Series A
Non-Voting
Convertible Preferred Stock (Note 11).
The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Convertible Notes outstanding may declare the entire principal amount of all the Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.
The following table provides a summary of the carrying value of the Convertible Notes at March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
  
December 31, 2022
    
2023
Notes
  
2021
Notes
  
2020 Notes
  
Total
  
2021 Notes
  
2020 Notes
  
Total
Principal amount
     $  130,000      $  150,000      $  60,000      $   340,000      $   150,000      $   175,000      $   325,000  
Plus: Premium
      —       —       250       250       —       250       250  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Gross proceeds
      130,000       150,000       60,250       340,250       150,000       175,250       325,250  
Less: Unamortized issuance costs
      (3,465)       (2,768)       (366)
    (6,599)       (2,981)       (1,053)       (4,034)  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Carrying amount
      126,535      $ 147,232      $ 59,884      $ 333,651      $ 147,019      $ 174,197      $ 321,216  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Effective interest rate
(1)
      6.25%       3.83%       5.18%       5.00%       3.83%       5.26%       4.60%  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
        
                                                                                                   
(1)
Includes amortization of the issuance costs and premium.
Interest expense on the Convertible Notes during the three months ended March 31, 2023 and 2022 was $4,002 and $3,732, respectively. Interest payable of $3,243 and $621 at March 31, 2023 and December 31, 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.
The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $331,766 and $320,513 at March 31, 2023 and December 31, 2022, respectively. The
if-converted
value of the Convertible Notes did not exceed the principal amount at March 31, 2023 and December 31, 2022.
11. Series A Preferred Stock
On April 10, 2018, the Company filed a Certificate of Designations of Series A
Non-Voting
Convertible Preferred Stock (the “Series A Certificate of Designations”) with the Delaware Secretary of State establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series A Preferred Stock (defined below). The Series A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company’s common stock on an
as-converted
basis. The Series A Preferred Stock has no voting rights, is not transferable and has the same priority with regard to dividends, distributions and payments as the common stock.
As described in the Series A Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attribution parties) would beneficially own more than 9.99% of the Company’s outstanding common stock immediately after giving effect to such conversion.
 
21
In connection with the completion of the ETFS Acquisition, the Company issued 14,750 shares of Series A
Non-Voting
Convertible Preferred Stock (the “Series A Preferred Stock”), which are convertible into an aggregate of 14,750,000 shares of common stock. The fair value of this consideration was $132,750, based on the closing price of the Company’s common stock on April 10, 2018 of $9.00 per share, the trading day prior to the closing of the acquisition.
The following is a summary of the Series A Preferred Stock balance:
 
    
March 31,

2023
  
December 31,
2022
Issuance of Series A Preferred Stock
    $     132,750     $     132,750  
Less: Issuance costs
      (181 )      (181 ) 
    
 
 
 
  
 
 
 
Series A Preferred Stock—carrying value
    $ 132,569     $ 132,569  
    
 
 
 
  
 
 
 
Cash dividends declared per share (quarterly)
    $ 0.03     $ 0.03  
    
 
 
 
  
 
 
 
Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer’s control. ETFS Capital has the right to redeem all the Series A Preferred Stock specified to be converted during the period of time specified in the Series A Certificate of Designations in the event that: (a) the number of shares of the Company’s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series A Preferred Stock requested by ETFS Capital to be converted; or (b) ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per Series A Preferred Stock as it would have received had each outstanding Series A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law.
Any such redemption will be at a price per Series A Preferred Stock equal to the dollar volume-weighted average price for a share of common stock for the
30-trading
day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. Such redemption payment will be made in one payment no later than 10 business days following the last day of the Company’s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series A Preferred Stock was $86,638 and $77,969 at March 31, 2023 and December 31, 2022, respectively.
The carrying amount of the Series A Preferred Stock was not adjusted as it was not probable that the Series A Preferred Stock would become redeemable.
12. Leases
The Company has entered into operating leases for its office facilities (including its corporate headquarters) and equipment. The Company has no finance leases.
The following table provides additional information regarding the Company’s leases:
 
    
Three Months Ended

March 31,
  
    
        2023        
     
        2022        
  
Lease cost:
                  
Operating lease cost
    $ 319          $ 89      
Short-term lease cost
      56            276      
    
 
 
     
 
 
  
Total lease cost
    $ 375          $             365      
    
 
 
     
 
 
  
Other information:
                  
Cash paid for amounts included in the measurement of operating liabilities (operating leases)
    $             326          $ 97      
    
 
 
     
 
 
  
Right-of-use
assets obtained in exchange for new operating lease liabilities
      n/a            n/a      
    
 
 
     
 
 
  
Weighted-average remaining lease term (in years)—operating leases
      1.0            1.3      
    
 
 
     
 
 
  
Weighted-average discount rate—operating leases
      6.5%         4.4%   
    
 
 
     
 
 
  
None of the Company’s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company’s ability to pay dividends or incur additional financing obligations.
 
22
The following table discloses future minimum lease payments at March 31, 2023 with respect to the Company’s operating lease liabilities:
            
 
Remainder of 2023
     $ 803    
 
2024
      397    
 
2025
      —    
 
2026
      —    
 
2027
      —    
 
2028 and thereafter
      —    
      
 
 
  
 
Total future minimum lease payments (undiscounted)
     $         1,200    
      
 
 
  
The following table reconciles the future minimum lease payments (disclosed above) at March 31, 2023 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets:
 
            
 
Amounts recognized in the Company’s Consolidated Balance     Sheets
         
 
Lease liability—short term
    $ 1,041    
 
Lease liability—long term
      120    
      
 
 
  
 
Subtotal
      1,161    
 
Difference between undiscounted and discounted cash flows
      39    
      
 
 
  
 
Total future minimum lease payments (undiscounted)
      $       1,200    
      
 
 
  
13. Contingencies
The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.
Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP
In December 2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (“WT Ireland”) were served with a writ of summons to appear before the Court of Milan, Italy. In January 2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (“3OIL”) in March 2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures’ closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.
In February 2022, the Court of Udine ruled in the Company’s favor. Also in February 2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL.
In March 2022, WMAI and WTUK were served with writs of summons to appear before the Court of Turin and the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers.
Total damages sought by all investors are approximately €15,800 ($17,186) at March 31, 2023.
The Company is currently assessing these claims with its external counsel. An accrual has not been made with respect to these matters at March 31, 2023 and December 31, 2022.
14. Variable Interest Entities
VIEs are entities with any of the following characteristics: (i) the entity does not have enough equity to finance its activities without additional financial support; (ii) the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii) the entity is structured with
non-substantive
voting rights.
Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities’ economic performance. Such power is conveyed through the entities’ boards of directors and the Company does not have control over the boards.
 
23
The following table presents information about the Company’s variable interests in
non-consolidated
VIEs:
 
    
      March 31,      

2023
     
      December 31,      

2022
     
                                                    
Carrying Amount—Assets (Securrency):
                  
Preferred stock—Series A Shares
    $ 3,588         $ 8,488    
Preferred stock—Series B Shares
      5,500          5,500    
Convertible note
      10,051          14,500    
    
 
 
     
 
 
  
Subtotal—Securrency
    $ 19,139         $ 28,488    
Carrying Amount—Assets (Fnality):
                    
Convertible note
      7,451          6,921    
Carrying Amount—Assets (Other investments):
      312          312    
    
 
 
     
 
 
  
Total (Note 7)
    $ 26,902         $ 35,721    
    
 
 
     
 
 
  
 
Maximum exposure to loss
    $         26,902         $         35,721    
    
 
 
     
 
 
  
15. Revenues from Contracts with Customers
The following table presents the Company’s total revenues from contracts with customers:
 
    
Three Months Ended March 31,
  
    
2023
     
2022
  
Revenues from contracts with customers:
                  
Advisory fees
     $ 77,637         $ 76,517    
Other
      4,407          1,851    
    
 
 
     
 
 
  
Total operating revenues
     $       82,044         $       78,368    
    
 
 
     
 
 
  
The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity’s performance in transferring control of services to the customer.
Substantially all the Company’s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note 16). These advisory fees are recognized over time, are earned from the Company’s ETPs and are calculated based on a percentage of the ETPs’ average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.
Other income includes revenues
the Company earns
from swap providers associated with certain of the Company’s European-listed ETPs, the nature of which are either based on a percentage of the ETPs’ average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due
,
which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
Geographic Distribution of Revenue
The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside:
 
    
Three Months Ended March 31,
  
    
2023
     
2022
  
Revenues from contracts with customers:
                  
United States
     $ 49,681         $ 46,229    
Jersey
      29,053          28,598    
Ireland
      3,310          3,541    
    
 
 
     
 
 
  
Total operating revenues
     $     82,044         $     78,368    
    
 
 
     
 
 
  
 
24
16. Related Party Transactions
The Company’s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S. WisdomTree ETFs and WisdomTree UCITS ETFs. The Board of Trustees and Board of Directors (including certain officers of the Company) of the related parties are primarily responsible for overseeing the management and affairs of the entities for the benefit of their stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other
non-distribution
services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs’ average daily net assets. A majority of the independent members of the Board of Trustees are required to annually approve the advisory agreements of the U.S. WisdomTree ETFs and these agreements may be terminated by the Board of Trustees upon notice.
The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:
 
    
March 31,

2023
     
December 31,

2022
     
            
Receivable from WTT
     $ 17,124         $ 16,399    
Receivable from ManJer Issuers
      12,790          4,485    
Receivable from WMAI and WTICAV
      2,532          3,255    
    
 
 
     
 
 
  
Total
     $       32,446         $       24,139    
    
 
 
     
 
 
  
The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30 days aged and are collected shortly after the applicable reporting period.
The following table summarizes revenues from advisory services provided to related parties:
 
    
Three Months Ended March 31,
     
            
    
2023
     
2022
  
Advisory services provided to WTT
     $ 49,487         $ 46,070    
Advisory services provided to ManJer Issuers
      24,840          26,905    
Advisory services provided to WMAI and WTICAV
      3,310          3,542    
    
 
 
     
 
 
  
Total
     $       77,637         $       76,517    
    
 
 
     
 
 
  
The Company also has investments in certain WisdomTree products of approximately $45,214 and $25,283 at March 31, 2023 and December 31, 2022, respectively. This includes $12,413 and $1,765,
respectively, of investments in certain consolidated affiliated blockchain-enabled funds advised by WT Digital Management, referred to herein as “other assets–seed capital.” Net unrealized and realized gains/(losses) related to trading WisdomTree products during the three months ended March 31, 2023 and 2022
were $422 and ($806), respectively, which are recorded in other losses, net on the Consolidated Statements of Operations.
17. Stock-Based Awards
On July 15, 2022, the Company’s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000 shares of common stock (less one share for every share granted under the 2016 Equity Plan since March 31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March 31, 2022) in the form of stock options and other stock-based awards.
The Company grants equity awards to employees and directors which include restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and stock options. Certain awards described below are subject to acceleration under certain conditions.
 
Stock options:
   
Generally issued for terms of ten years and may vest after at least one year of service and have an exercise price equal to the Company’s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black-Scholes option pricing model.
   
RSAs/RSUs:
   
Awards are valued based on the Company’s stock price on grant date and generally vest ratably, on an annual basis, over three years.
 
25
PRSUs:    These awards cliff vest three years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company’s total shareholder return (“TSR”) compares to a peer group of other publicly traded asset managers over the three-year period. A Monte Carlo simulation is used to value these awards.
   
    
The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:
 
•   If the relative TSR is below the 25
th
percentile, then 0% of the target number of PRSUs granted will vest;
 
•   If the relative TSR is at the 25th percentile, then 50% of the target number of PRSUs granted will vest;
 
•   If the relative TSR is above the 25th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50th percentile and capped at 200% of the target number of PRSUs granted for performance at the 85th percentile (or 100th percentile for grants made in 2020); and
 
•   If the Company’s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.
Stock-based compensation expense during the three months ended March 31, 2023 and 2022 was $4,536 and $2,936, respectively.
A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows:
 
       
March 31, 2023
     
Unrecognized Stock-
Based

Compensation
   
Weighted-Average

Remaining
  Vesting Period (Years)  
 
Employees and directors
    $             30,415                  2.10
A summary of stock-based compensation award activity (shares) during the three months ended March 31, 2023 is as follows:
 
    
RSA
  
RSU
  
PRSU
Balance at January 1, 2023
      3,391,082       141,963       668,188  
Granted
      3,273,263       73,855       576,240
(1)
 
Vested
      (1,498,171 )      (26,837 )      (83,158 )
(2)
 
Forfeited
      (11,885 )       (233 )       (24,955 )
(2)
 
    
 
 
 
  
 
 
 
  
 
 
 
Balance at March 31, 2023
          5,154,289           188,748             1,136,315  
    
 
 
 
  
 
 
 
  
 
 
 
 
                                                                                
 
 
 
(1)
Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. A Monte-Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning
90-day
average stock prices; (ii) valuation date stock prices; (iii) historical stock price volatilities ranging from 37% to 56% (average 47%); (iv) correlation coefficients based upon the price data used to calculate the historical volatilities; (v) a risk free interest rate of 3.8%; and (vi) an expected dividend yield of 0%.
 
 
(2)
The payout on PRSUs vesting in January 2023 was 77%. The remainder of the awards were forfeited.
18. Stockholder Rights Plan
On March 17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March 17, 2023, between the Company and Continental Stock Transfer & Trust Company, as Rights Agent (the “Stockholder Rights Agreement”).
Pursuant to the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i) one Right (as defined below) for each outstanding share of common stock, par value $0.01 per share, of the Company’s common stock and (ii) 1,000 Rights for each outstanding share of Series A Preferred Stock”, to stockholders of record as of the close of business on March 28, 2023 (the “Record Date”). In addition, one Right will automatically attach to each share of common stock and 1,000 Rights will automatically attach to each share of Series A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each “Right” entitles the registered holder thereof to purchase from the Company a unit consisting of one
ten-thousandth
of a share (a “Unit”) of Series B Junior Participating Cumulative Preferred Stock, par value $0.01 per share, of the Company (the “Series B Preferred Stock”) at a cash exercise price of $32.00 per Unit (the “Exercise Price”), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below.
 
26
Initially, the Rights are not exercisable and are attached to and trade with all shares of common stock and Series A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series A Preferred Stock and will become exercisable upon the earlier of (i) the close of business on the tenth calendar day following the first public announcement that a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired beneficial ownership of 10% (or 20% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than 20% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule 13G pursuant to Rule
13d-1(b)
or Rule
13d-1(c)
of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the “Stock Acquisition Date”), or (ii) the close of business on the tenth business day (or such later day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the “Distribution Date”). A person or group who beneficially owned 10% or more (or 20% or more in the case of passive stockholders) of the Company’s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own 10% or more (or 20% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement.
For purposes of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership.
In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of
Series B 
Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units of
Series B 
Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the “Subscription Right”). In the event that, at any time following the Stock Acquisition Date, (i) the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii) any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii) 50% or more of the Company’s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the “Merger Right”). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void.
The Rights may be redeemed in whole, but not in part, at a price of $0.01 per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i) the time at which any person becomes an Acquiring Person or (ii) the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.
The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).
Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company.
The Rights are not exercisable until the Distribution Date and will expire at the close of business on March 16, 2024; provided that if the Company’s stockholders have not ratified the Stockholder Rights Agreement by the close of business on the first day after the Company’s 2023 annual meeting of stockholders (including any adjournments or postponements thereof), the Rights will expire at such time, in each case, unless previously redeemed or exchanged by the Company.
 
27
The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a “Qualifying Offer” (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i) a fully financed
all-cash
tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii) an offer that is otherwise in the best interests of the Company’s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a “Qualifying Offer,” including if the consideration offered in a proposed transaction is stock of the acquiror.
Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board
of Directors
 
has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the “Special Meeting”) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90th business day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10th business day thereafter.
19. Earnings/(Loss) Per Share
The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented:
 
      
Three Months Ended

March 31,
Basic Earnings/(Loss) per Share
     
          2023          
   
          2022          
Net income/(loss)
       $ 16,233       $ (10,261 ) 
Less: Income distributed to participating securities
        (498 )       (549 ) 
Less: Undistributed income allocable to participating securities
        (1,206 )         —    
      
 
 
 
   
 
 
 
Net income/(loss) available to common stockholders—Basic EPS
       $ 14,529       $ (10,810 ) 
     
Weighted average common shares (in thousands)
        143,862          142,782  
      
 
 
 
   
 
 
 
Basic earnings/(loss) per share
       $         0.10       $ (0.08 )     
      
 
 
 
   
 
 
 
 
      
Three Months Ended

March 31,
Diluted Earnings/(Loss) per Share
     
          2023          
   
          2022          
Net earnings/(loss) available to common stockholders
       $ 14,529       $ (10,810 ) 
Add back: Undistributed income allocable to participating securities
        1,206        —    
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive
        (1,202 )         —    
      
 
 
 
   
 
 
 
Net income/(loss) available to common stockholders—Diluted EPS
       $ 14,533       $ (10,810 )     
      
 
 
 
   
 
 
 
Weighted Average Diluted Shares (in thousands)
:
                    
Weighted average common shares
        143,862        142,782  
Dilutive effect of common stock equivalents, excluding participating securities
        569        —    
      
 
 
 
   
 
 
 
Weighted average diluted shares, excluding participating securities (in thousands)
        144,431        142,782  
      
 
 
 
   
 
 
 
Diluted earnings/(loss) per share
       $ 0.10       $ (0.08 ) 
      
 
 
 
   
 
 
 
Diluted earnings/(loss) per share presented above is calculated using the
two-class
method as this method results in the lowest diluted earnings per share amount for common stock. During the three months ended March 31, 2022, there were no dilutive common stock equivalents as the Company reported a net loss for the period. Total antidilutive
non-participating
common stock equivalents were 695 and 509 for the three months ended March 31, 2023 and 2022, respectively.
 
28
There were no potential common shares associated with the conversion options embedded in the Convertible Notes included in weighted average diluted shares for the three months ended March 31, 2023 and 2022 as the Company’s average stock price was lower than the conversion price.
The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:
 
      
Three Months Ended

March 31,
Reconciliation of Weighted Average Diluted Shares (in thousands)
     
2023
   
2022
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations
        159,887        142,782
(1)
 
Less: Participating securities:
                    
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11)
        (14,750 )       —    
Potentially dilutive restricted stock awards
        (706 )       —    
      
 
 
 
   
 
 
 
Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above
              144,431            142,782  
      
 
 
 
   
 
 
 
 
(1)
 
Excludes 15,521 participating securities and 31 potentially dilutive
non-participating
common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands).
20. Income Taxes
Effective Income Tax Rate – Three Months Ended March 31, 2023 and March 31, 2022
The Company’s effective income tax rate during the three months ended March 31, 2023 was 7.9% resulting in income tax expense of $1,383. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a
non-taxable
gain on revaluation of deferred consideration and a $1,353 reduction in unrecognized tax benefits (including interest and penalties). These items were partly offset by a
non-deductible
loss on extinguishment of our convertible notes and an increase in the deferred tax asset valuation allowance on losses recognized on the Company’s investments.
The Company’s effective income tax rate during the three months ended March 31, 2022 of 62.0% resulted in an income tax benefit of $16,713. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a $19,897 reduction in unrecognized tax benefits (including interest and penalties), a lower tax rate on foreign earnings and tax windfalls associated with the vesting of stock-based compensation awards. These items were partly offset by a
non-taxable
loss on revaluation of deferred consideration and an increase in the deferred tax asset valuation allowance on losses recognized on securities owned.
Deferred Tax Assets
A summary of the components of the Company’s deferred tax assets at March 31, 2023 and December 31, 2022 is as follows:
 
        
March 31,

2023
     
December 31,

2022
  
 
Deferred tax assets:
                  
 
Capital losses
      $         17,740             $         17,541       
 
Unrealized losses
      4,781             3,821       
 
NOLs—Foreign
      1,625             1,609       
 
Accrued expenses
      1,527             6,030       
 
Goodwill and intangible assets
      1,038             1,085       
 
Stock-based compensation
      865             1,526       
 
Interest carryforwards
      476             —       
 
Operating lease liabilities
      260             313       
 
Foreign currency translation adjustment
      254             173       
 
NOLs—U.S.
      127             255       
 
Outside basis differences
      122             122       
 
29
        
March 31,

2023
     
December 31,
2022
  
 
Other
      355             341       
      
 
 
     
 
 
  
 
Deferred tax assets
      29,170             32,816       
      
 
 
     
 
 
  
 
Deferred tax liabilities:
                  
 
Fixed assets and prepaid assets
      150             278       
 
Unremitted earnings—European subsidiaries
      246             205       
 
Right of use assets—operating leases
      260             313       
      
 
 
     
 
 
  
 
Deferred tax liabilities
      656             796       
      
 
 
     
 
 
  
 
Total deferred tax assets less deferred tax liabilities
      28,514             32,020       
 
Less: Valuation allowance
      (22,643)            (21,484)      
      
 
 
     
 
 
  
 
Deferred tax assets, net
      $ 5,871             $ 10,536       
      
 
 
     
 
 
  
Net Operating and Capital Losses—U.S.
The Company’s tax effected net operating losses (“NOLs”) at March 31, 2023 were $127, which expire in 2024. The net operating loss carryforwards have been reduced by the impact of annual limitations described in the Internal Revenue Code Section 382 that arose as a result of an ownership change.
The Company’s tax effected capital losses at March 31, 2023 were $17,740. These capital losses expire between the years 2023 and 2028.
Net Operating Losses—Europe
One of the Company’s European subsidiaries generated NOLs outside the U.S. These tax effected NOLs, all of which are carried forward indefinitely, were $1,625 at March 31, 2023.
Valuation Allowance
The Company’s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is
more-likely-than-not
that these deferred tax assets will not be realized.
Uncertain Tax Positions
Tax positions are evaluated utilizing a
two-step
process. The Company first determines whether any of its tax positions are
more-likely-than-not
to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.
In connection with the ETFS Acquisition, the Company accrued a liability for uncertain tax positions and interest and penalties at the acquisition date. The Company also recorded an offsetting indemnification asset provided by ETFS Capital as part of its agreement to indemnify the Company for any potential claims. The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:
 
      
Total
   
Unrecognized
Tax Benefits
   
Interest and
Penalties
Balance at January 1, 2023
        $         1,353      $         957      $         396  
Decrease—Lapse of statute of limitations
        (1,353 )         (957 )         (396 )   
      
 
 
 
   
 
 
 
   
 
 
 
Balance at March 31, 2023
        $ —        $ —        $ —    
      
 
 
 
   
 
 
 
   
 
 
 
 
 
(1)
The gross unrecognized tax benefits were accrued in British pounds.
Income Tax Examinations
The Company is subject to U.S. federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions. As of March 31, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the years before 2018.
Undistributed Earnings of Foreign Subsidiaries
ASC
740-30
Income Taxes provides guidance that US companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $246 and $205 at March 31, 2023 and December 31, 2022, respectively.
 
30
21. Shares Repurchased
On February 22, 2022, the Company’s Board of Directors approved an increase of $85,709 to the Company’s share repurchase program to $100,000 and extended the term for three years through April 27, 2025. Included under the Company’s share repurchase program are purchases to offset future equity grants made under the Company’s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company’s books and records.
During the three months ended March 31, 2023 and 2022, the Company repurchased 604,505 and 588,694 shares of its common stock, respectively, under this program for an aggregate cost of $3,384 and $3,394, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company’s books and records.
As of March 31, 2023, $96,591,597 remained under this program for future purchases.
22. Goodwill and Intangible Assets
Goodwill
The table below sets forth goodwill which is tested annually for impairment on November 30
th
:
 
    
Total
  
Balance at January 1, 2023
    $               85,856      
Changes
      —      
    
 
 
  
Balance at March 31, 2023
    $ 85,856      
    
 
 
  
Goodwill arising from the ETFS Acquisition of $84,057 is not deductible for tax purposes as the acquisition was structured as a stock acquisition occurring in the U.K. The remainder of the goodwill is deductible for U.S. tax purposes.
Intangible Assets
The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30
th
:
 
Balance at March 31, 2023
  
Item
   
Gross Asset
     
Accumulated
Amortization
     
Net Asset
  
ETFS acquisition
     $     601,247        $         —           $     601,247   
Software development
      2,822         (101)           2,721   
    
 
 
     
 
 
     
 
 
  
Balance at March 31, 2023
     $ 604,069        $ (101)          $ 603,968   
    
 
 
     
 
 
     
 
 
  
 
Balance at December 31, 2022
  
Item
   
Gross Asset
     
Accumulated
Amortization
     
Net Asset
  
ETFS acquisition
     $     601,247        $         —           $     601,247   
Software development
      2,370         (50)           2,320   
    
 
 
     
 
 
     
 
 
  
Balance at December 31, 2022
     $ 603,617        $ (50)          $ 603,567   
    
 
 
     
 
 
     
 
 
  
ETFS Acquisition (Indefinite-Lived)
In connection with the ETFS Acquisition, which was completed on April 11, 2018, the Company identified intangible assets valued at $601,247 related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.
Software Development (Finite-Lived)
Internally-developed software is amortized over a useful life of three years. During the three-month period ended March 31, 2023, the Company recognized amortization expense on internally-developed software of $51.
 
31
As of March 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows:
 
Remained of 2023
     $ 656      
2024
      940      
2025
      891      
2026
      234      
2027
      —      
2028 and thereafter
      —      
    
 
 
  
Total expected amortization expense
     $       2,721      
    
 
 
  
The weighted-average remaining useful life of the finite-lived intangible assets is 2.9 years.
23. Contingent Payments
Sale of Canadian ETF Business
On February 19, 2020, the Company completed the sale of all the outstanding shares of
WisdomTree Asset Management Canada, Inc.
to CI Financial Corp. The Company received CDN $3,720 (USD $2,774) in cash at closing and was paid CDN $3,000 (USD $2,360) and CDN $2,000 (USD $1,477) of additional cash consideration based upon the achievement of certain AUM growth targets as determined on the
18-month
and the
36-month
anniversaries of the closing date, respectively.
A gain of $1,477 was recognized during the three months ended March 31, 2023, from remeasuring the contingent payment to its realizable value. These gains were recorded in other losses, net.
24. Subsequent Events
The Company evaluated subsequent events through the date of issuance of the accompanying consolidated financial statements.
There were no events requiring disclosure. 
32

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes and the other financial information included elsewhere in this Report. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below. For a more complete description of the risks noted above and other risks that could cause our actual results to materially differ from our current expectations, please see Item 1A “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. We assume no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

Executive Summary

We are a global financial innovator, offering a well-diversified suite of ETPs, models and solutions. We empower investors to shape their future and support financial professionals to better serve their clients and grow their businesses. We leverage the latest financial infrastructure to create products that provide access, transparency and an enhanced user experience. Building on our heritage of innovation, we are also developing next-generation digital products and structures, including Digital Funds and tokenized assets, as well as our blockchain-native digital wallet, WisdomTree Prime™.

We have approximately $90.7 billion in AUM as of March 31, 2023. Our family of ETPs includes products that provide exposure to equities, commodities, fixed income, leveraged-and-inverse, currency, cryptocurrency and alternative strategies. We have launched many first-to-market products and pioneered alternative weighting we call “Modern Alpha,” which combines the outperformance potential of active management with the benefits of passive management to offer investors cost-effective funds that are built to perform. Most of our equity-based funds employ a fundamentally weighted investment methodology, which weights securities based on factors such as dividends, earnings or investment factors, whereas most other industry indexes use a capitalization weighted methodology. These products are distributed through all major channels in the asset management industry, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers primarily through our sales force. We believe technology is altering the way financial advisors conduct business and through our Advisor Solutions program we offer technology-enabled and research-driven solutions including portfolio construction, asset allocation, practice management services and digital tools to help financial advisors address technology challenges and grow and scale their businesses.

We are at the forefront of innovation and believe that tokenization and leveraging the utility of blockchain technology is the next evolution in financial services. We are building the foundation that will allow us to lead in this coming evolution. WisdomTree Prime™, our blockchain-native digital wallet, is currently in beta testing and positions us to expand our blockchain-enabled financial services product offerings with a new direct-to-consumer channel where spending, saving and investing are united. As we continue to pursue our digital assets strategy, we are embracing a concept we refer to as “responsible DeFi,” which we believe upholds the foundational principles of regulation in this innovative and quickly evolving space. We believe that our expansion into digital assets will complement our existing core competencies in a holistic manner, diversify our revenue streams and contribute to our growth.

We were incorporated under the laws of the state of Delaware on September 19, 1985 as Financial Data Systems, Inc., were renamed WisdomTree Investments, Inc. on September 6, 2005, and ultimately renamed WisdomTree, Inc. on November 7, 2022.

 

33

Table of Contents

Assets Under Management

WisdomTree ETPs

We offer ETPs covering equity, commodity, fixed income, leveraged-and-inverse, currency, alternatives and cryptocurrency. The chart below sets forth the asset mix of our ETPs at March 31, 2023, December 31, 2022 and March 31, 2022:

 

LOGO

Market Environment

The outlook for the first quarter of 2023 improved as developed markets continued to stave off a recession despite rising interest rates. The outlook for emerging markets has improved since the zero-Covid policy was abandoned in China. In March, gold prices increased to over $2,000 per ounce for the first time in over a year amid market volatility sparked by the Silicon Valley Bank’s collapse and further turbulence in the banking sector.

The S&P 500, MSCI EAFE (local currency), MSCI Emerging Markets Index (U.S. dollar) and gold prices increased by 7.5%, 7.7%, 4.0% and 9.2%, respectively, during the quarter. In addition, the European and Japanese equities markets both appreciated with the MSCI EMU Index and MSCI Japan Index increasing 12.3% and 7.3%, respectively, in local currency terms for the quarter. Also, the U.S. dollar weakened 1.8%, 2.6% and 1.3% versus the euro, British pound and the Japanese yen, respectively, the during the quarter.

 

34

Table of Contents

U.S. Listed ETF Industry Flows

U.S. listed ETF net flows for the three months ended March 31, 2023 were $467 billion. Fixed income and U.S. equity gathered the majority of those flows.

 

LOGO

                Source: Morningstar

 

35

Table of Contents

European Listed ETP Industry Flows

European listed ETP net flows were $71.1 billion for the three months ended March 31, 2023. Equities and fixed income gathered the majority of those flows.

 

LOGO

                Source: Morningstar

Our Operating and Financial Results

We operate as an ETP sponsor and asset manager, providing investment advisory services globally through our subsidiaries in the U.S. and Europe.

U.S. Listed ETFs

The AUM of our U.S. listed exchange traded funds, or U.S. listed ETFs, increased from $56.0 billion at December 31, 2022 to $61.3 billion at March 31, 2023 due to net inflows and market appreciation.

 

36

Table of Contents

LOGO

European Listed ETPs

The AUM of our European listed (including internationally cross-listed) ETPs, or European listed ETPs, increased from $26.0 billion at December 31, 2022 to $29.5 billion at March 31, 2023, due to net inflows and market appreciation.

 

LOGO

 

37

Table of Contents

Consolidated Operating Results

The following table sets forth our revenues and net income/(loss) for the most recent five quarters.

 

LOGO

 

  •  

Revenues – Total revenues increased 4.7% from the three months ended March 31, 2022 to $82.0 million due to higher average AUM and higher other income from large flows into some of our European products. These items were partly offset by a lower average advisory fee.

 

  •  

Expenses – Total operating expenses increased 7.9% from the three months ended March 31, 2022 to $65.5 million primarily due to higher compensation from increased headcount and stock-based compensation expense, fund management and administration costs and other expenses. These increases were partly offset by lower professional fees.

 

  •  

Other Income/(Expenses) – Other income/(expenses) includes interest income and interest expense, gains/(losses) on revaluation of deferred consideration–gold payments, impairments, loss on extinguishment of convertible notes and other losses and gains. Further information is provided herein.

 

  •  

Net income/(loss) – We reported net income of $16.2 million and a net loss of ($10.3) million during the three months ended March 31, 2023 and 2022, respectively.

Expense Guidance Update for the Year Ending December 31, 2023

Compensation Expense

Our compensation expense for the year ending December 31, 2023 is currently estimated to range from $100.0 million to $106.0 million. This range considers variability in incentive compensation, with drivers including the magnitude of our flows, our share price performance in relation to our peers as well as revenue, operating income and operating margin performance. Given the strong start to 2023, we anticipate trending toward the high end of this range.

Discretionary Spending

Discretionary spending includes, marketing, sales, professional fees, occupancy and equipment, depreciation and amortization and other expenses. During the three months ended March 31, 2023, our discretionary spending was $13.2 million. We currently estimate our discretionary spending for the year ending December 31, 2023 to range from $56.0 million to $59.0 million (unchanged from our guidance provided last quarter), as we anticipate an uptick in marketing spend.

Not included in the guidance above are potential non-recurring expenses in response to an activist campaign, including $1.0 million incurred during the three months ended March 31, 2023.

Gross Margin

We define gross margin as total operating revenues less fund management and administration expenses. Gross margin percentage is calculated as gross margin divided by total operating revenues. Our gross margin was 79.1% during the three months ended March 31, 2023. Our gross margin guidance for the year ending December 31, 2023 is estimated to be 78% given anticipated product launches, changes in other income which may rise or fall depending upon the magnitude of flows of our European-listed products and uncertain market conditions.

 

38

Table of Contents

Contractual Gold Payments

We currently estimate our contractual gold payments expense for the year ending December 31, 2023 to be approximately $18.0 million (unchanged from our guidance provided last quarter) taking into consideration current gold prices.

Third-Party Distribution Fees

We currently estimate third-party distribution fees to range from $8.0 million to $9.0 million (unchanged from our guidance provided last quarter) for the year ending December 31, 2023. Given the AUM on our platforms we anticipate trending toward the high end of this guidance.

Interest Expense

Our interest expense for the year ending December 31, 2023 is currently estimated to be $15.0 million. Our interest cost for the three months ended June 30, 2023 is estimated to be $4.1 million, which should then reduce to $3.5 million per quarter going forward upon the settlement of $60.0 million in aggregate principal amount of our 2020 Notes (defined below) maturing in June 2023.

Income Tax Expense

We currently estimate that our consolidated normalized effective tax rate will be 23% (unchanged from our guidance provided last quarter). This estimated rate may change and is dependent upon our actual taxable income earned in relation to our forecasts.

This normalized effective tax rate excludes items that are non-recurring and not core to our operating business including but not limited to the impact of any revaluation on deferred consideration – gold payments, the loss on extinguishment of convertible notes, remeasurement of contingent consideration from the sale of our former Canadian ETF business, gains and losses on financial instruments owned and investments, valuation allowances on capital losses, reductions in unrecognized tax benefits and any stock-based compensation windfalls or shortfalls.

 

39

Table of Contents

Key Operating Statistics

The following table presents key operating statistics that serve as indicators for the performance of our business:

 

     Three Months Ended  
     March 31,
2023		     December 31,
2022		   March 31,
2022		  

GLOBAL ETPs (in millions)

       

Beginning of period assets

     $ 81,993         $ 70,878           $ 77,479     

Inflows/(outflows)

      6,341          5,264       1,319     

Market appreciation/(depreciation)

      2,406          5,851       609     

End of period assets

     $ 90,740         $ 81,993      $ 79,407     
  

 

 

    

 

 

 

  

 

 

  

Average assets during the period

     $         87,508        $         77,649      $         77,809     

Average advisory fee during the period

      0.36%               0.36%               0.40%  

Number of ETPs—end of the period

      350          348       341     

US LISTED ETFs (in millions)

       

Beginning of period assets

     $ 55,973         $ 48,043      $ 48,210     

Inflows/(outflows)

      4,012          4,232       2,250     

Market appreciation/(depreciation)

      1,298          3,698       (1,838)    

End of period assets

     $ 61,283         $ 55,973      $ 48,622     
  

 

 

    

 

 

 

  

 

 

  

Average assets during the period

     $ 59,430         $ 53,655      $ 47,499     

Number of ETPs—end of the period

      80          79       77     

EUROPEAN LISTED ETPs (in millions)

       

Beginning of period assets

     $ 26,020         $ 22,835      $ 29,269     

Inflows/(outflows)

      2,329          1,032       (931)    

Market appreciation/(depreciation)

      1,108          2,153       2,447     

End of period assets

     $ 29,457         $ 26,020      $ 30,785     
  

 

 

    

 

 

 

  

 

 

  

Average assets during the period

     $ 28,078         $ 23,994      $ 30,310     

Number of ETPs—end of the period

      270          269       264     

PRODUCT CATEGORIES (in millions)

       

Commodity & Currency

       

Beginning of period assets

     $ 22,097         $ 19,561      $ 24,598     

Inflows/(outflows)

      2,003          796       (1,053)    

Market appreciation/(depreciation)

      824          1,740       2,757     
  

 

 

    

 

 

 

  

 

 

  

End of period assets

     $ 24,924         $ 22,097      $ 26,302     
  

 

 

    

 

 

 

  

 

 

  

Average assets during the period

     $ 23,806         $ 20,345      $ 25,891     

U.S. Equity

       

Beginning of period assets

     $ 24,112         $ 20,952      $ 23,860     

(Outflows)/inflows

      (149)         1,021       779     

Market appreciation/(depreciation)

      571          2,139       (901)    
  

 

 

    

 

 

 

  

 

 

  

End of period assets

     $ 24,534         $ 24,112      $ 23,738     
  

 

 

    

 

 

 

  

 

 

  

Average assets during the period

     $ 24,726         $ 23,492      $ 23,134     

Fixed Income

       

Beginning of period assets

     $ 15,273         $ 11,695      $ 4,356     

Inflows/(outflows)

      3,513          3,393       1,242     

Market (depreciation)/appreciation

      (78)         185       (180)    
  

 

 

    

 

 

 

  

 

 

  

End of period assets

     $ 18,708         $ 15,273      $ 5,418     
  

 

 

    

 

 

 

  

 

 

  

Average assets during the period

     $ 17,176         $ 13,962      $ 4,691     

 

40

Table of Contents
     Three Months Ended
     March 31,
2023		   December 31,
2022		   March 31,
2022

International Developed Market Equity

       

Beginning of period assets

     $ 10,195           $ 9,183           $ 11,894       

Inflows/(outflows)

      450       40       97  

Market appreciation/(depreciation)

      788       972       (569 ) 
  

 

 

 

  

 

 

 

  

 

 

 

End of period assets

     $ 11,433      $ 10,195      $ 11,422  
  

 

 

 

  

 

 

 

  

 

 

 

Average assets during the period

     $         10,879      $         10,000      $         11,543  

Emerging Market Equity

       

Beginning of period assets

     $ 8,116      $ 7,495      $ 10,375  

Inflows/(outflows)

      486       (53 )      189  

Market appreciation/(depreciation)

      209       674       (573 ) 
  

 

 

 

  

 

 

 

  

 

 

 

End of period assets

     $ 8,811      $ 8,116      $ 9,991  
  

 

 

 

  

 

 

 

  

 

 

 

Average assets during the period

     $ 8,666      $ 7,770      $ 10,116  

Leveraged & Inverse

       

Beginning of period assets

     $ 1,754      $ 1,523      $ 1,775  

Inflows/(outflows)

      43       59       (2 ) 

Market (depreciation)/appreciation

      (12 )      172       83  
  

 

 

 

  

 

 

 

  

 

 

 

End of period assets

     $ 1,785      $ 1,754      $ 1,856  
  

 

 

 

  

 

 

 

  

 

 

 

Average assets during the period

     $ 1,757      $ 1,623      $ 1,830  

Alternatives

       

Beginning of period assets

     $ 310      $ 306      $ 261  

(Outflows)/inflows

      (18 )      12       29  

Market appreciation/(depreciation)

      14       (8 )      3  
  

 

 

 

  

 

 

 

  

 

 

 

End of period assets

     $ 306      $ 310      $ 293  
  

 

 

 

  

 

 

 

  

 

 

 

Average assets during the period

     $ 308      $ 305      $ 275  

Cryptocurrency

       

Beginning of period assets

     $ 136      $ 163      $ 357  

Inflows/(outflows)

      13       (4 )      37  

Market appreciation/(depreciation)

      90       (23 )      (11 ) 
  

 

 

 

  

 

 

 

  

 

 

 

End of period assets

     $ 239      $ 136      $ 383  
  

 

 

 

  

 

 

 

  

 

 

 

Average assets during the period

     $ 190      $ 152      $ 324  

Closed ETPs

       

Beginning of period assets

     $ —      $ —      $ 3  

Inflows/(outflows)

      —       —       1  
  

 

 

 

  

 

 

 

  

 

 

 

End of period assets

     $ —      $ —      $ 4  
  

 

 

 

  

 

 

 

  

 

 

 

Average assets during the period

     $ —      $ —      $ 5  

Headcount

      279       273       253  

Note: Previously issued statistics may be restated due to fund closures and trade adjustments

Source: WisdomTree

 

41

Table of Contents

Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

Selected Operating and Financial Information

 

     Three Months Ended
March 31,		              Change              Percent
        Change        
             2023                      2022          

AUM (in millions)

            

Average AUM

     $ 87,508         $ 77,809         $ 9,699          12.5 %   
  

 

 

     

 

 

     

 

 

     

 

 

 

Operating Revenues (in thousands)

            

Advisory fees

     $ 77,637         $ 76,517         $ 1,120          1.5 %   

Other income

      4,407          1,851          2,556          138.1 %   
  

 

 

     

 

 

     

 

 

     

 

 

 

Total revenues

     $ 82,044         $ 78,368         $ 3,676          4.7 %   
  

 

 

     

 

 

     

 

 

     

 

 

 

Average AUM

Our average AUM increased 12.5 % from $77.8 billion at March 31, 2022 to $87.5 billion at March 31, 2023 due to net inflows partly offset by market depreciation.

Operating Revenues

Advisory fees

Advisory fee revenues increased 1.5% from $76.5 million during the three months ended March 31, 2022 to $77.6 million in the comparable period in 2023 due to higher average AUM, partly offset by a decline in our average advisory fee. Our average advisory fee decreased from 0.40% during the three months ended March 31, 2022 to 0.36% during the comparable period in 2023 due to AUM mix shift.

Other income

Other income increased 138.1% from $1.9 million during the three months ended March 31, 2022 to $4.4 million in the comparable period in 2023 primarily due to large flows into some of our European products.

Operating Expenses

 

(in thousands)

    Three Months Ended
March 31,		   Change   Percent
    Change    
   2023   2022

Compensation and benefits

      $ 27,398        $ 24,787        $ 2,611       10.5%   

Fund management and administration

      17,153       15,494       1,659       10.7%   

Marketing and advertising

      4,007       4,023       (16 )      (0.4%)  

Sales and business development

      2,994       2,609       385       14.8%   

Contractual gold payments

      4,486       4,450       36       0.8%   

Professional fees

      3,715       4,459       (744 )       (16.7%)  

Occupancy, communications and equipment

      1,101       753       348       46.2%   

Depreciation and amortization

      109       47       62       131.9%   

Third-party distribution fees

      2,253       2,212       41       1.9%   

Other

      2,257       1,845       412       22.3%   
  

 

 

 

  

 

 

 

  

 

 

 

  

 

 

 

Total operating expenses

      $        65,473       $        60,679       $        4,794                7.9%   
  

 

 

 

  

 

 

 

  

 

 

 

  

 

 

 

 

42

Table of Contents
     Three Months Ended
March 31,		  

As a Percent of Revenues:

    2023      2022  

Compensation and benefits

      33.5%          31.5%  

Fund management and administration

      20.9%          19.8%  

Marketing and advertising

      4.9%          5.1%  

Sales and business development

      3.6%          3.3%  

Contractual gold payments

      5.5%          5.7%  

Professional fees

      4.5%          5.7%  

Occupancy, communications and equipment

      1.3%          1.0%  

Depreciation and amortization

      0.1%          0.1%  

Third-party distribution fees

      2.7%          2.8%  

Other

      2.8%          2.4%  
  

 

 

     

 

 

  

Total operating expenses

      79.8%          77.4%  
  

 

 

     

 

 

  

Compensation and benefits

Compensation and benefits expense increased 10.5% from $24.8 million during the three months ended March 31, 2022 to $27.4 million in the comparable period in 2023 due to increased headcount and higher stock-based compensation expense. Headcount was 253 and 279 at March 31, 2022 and 2023, respectively.

Fund management and administration

Fund management and administration expense increased 10.7% from $15.5 million during the three months ended March 31, 2022 to $17.2 million in the comparable period in 2023 primarily due to higher average AUM, product launches and inflows. We had 77 U.S. listed ETFs and 264 European listed ETPs at March 31, 2022 compared to 80 U.S. listed ETFs and 270 European listed ETPs at March 31, 2023.

Marketing and advertising

Marketing and advertising expense was essentially unchanged from the three months ended March 31, 2022.

Sales and business development

Sales and business development expense increased 14.8% from $2.6 million during the three months ended March 31, 2022 to $3.0 million in the comparable period in 2023 primarily resulting from increases in conference and events spending as well as market data costs.

Contractual gold payments

Contractual gold payments expense was essentially unchanged from the three months ended March 31, 2022. This expense was associated with the annual payment of 9,500 ounces of gold and was calculated using the average daily spot price of $1,874 and $1,889 per ounce during the three months ended March 31, 2022 and 2023, respectively.

Professional fees

Professional fees decreased 16.7% from $4.5 million during the three months ended March 31, 2022 to $3.7 million in the comparable period in 2023 primarily due to lower expenses incurred in response to an activist campaign.

Occupancy, communications and equipment

Occupancy, communications and equipment expense increased 46.2% from $0.8 million during the three months ended March 31, 2022 to $1.1 million in the comparable period in 2023 as we signed new office leases in the U.S. and Europe.

Depreciation and amortization

Depreciation and amortization expense increased 131.9% from $0.05 million during the three months ended March 31, 2022 to $0.1 million in the comparable period in 2023 due to amortization of software development costs.

Third-party distribution fees

Third-party distribution fees were essentially unchanged from the three months ended March 31, 2022.

 

43

Table of Contents

Other

Other expenses increased 22.3% from $1.8 million during the three months ended March 31, 2022 to $2.3 million in the comparable period in 2023 primarily due to higher insurance, public relations, travel and directors expenses.

Other Income/(Expenses)

 

     Three Months Ended
March 31,		      Change      Percent
Change		  

(in thousands)

    2023      2022  

Interest expense

     $ (4,002)        $ (3,732)         $ (270)           7.2%   

Gain/(loss) on revaluation of deferred consideration

      20,592          (17,018)          37,610           n/a     

Interest income

      1,083          794           289           36.4%   

Impairments

      (4,900)         —           (4,900)          100.0%   

Loss on extinguishment of convertible notes

      (9,721)         —           (9,721)          100.0%   

Other losses, net

      (2,007)         (24,707)          22,700         (91.9%)  
  

 

 

     

 

 

     

 

 

     

 

 

  

Total other income/(expenses), net

     $ 1,045         $ (44,663)         $ 45,708         n/a     
  

 

 

     

 

 

     

 

 

     

 

 

  

 

     Three Months Ended March 31,  

As a Percent of Revenues:

    2023      2022  

Interest expense

      (4.9%)         (4.8%)   

Gain/(loss) on revaluation of deferred consideration

      25.1%          (21.7%)   

Interest income

      1.3%          1.0%   

Impairments

      (6.0%)         —      

Loss on extinguishment of convertible notes

      (11.8%)         —      

Other losses, net

      (2.4%)         (31.5%)   
  

 

 

     

 

 

  

Total other income/(expenses), net

      1.3%          (57.0%)   
  

 

 

     

 

 

  

Interest expense

Interest expense increased 7.2% from $3.7 million during the three months ended March 31, 2022 to $4.0 million in the comparable period in 2023 due to a higher level of debt outstanding and a higher effective interest rate. Our effective interest rate during the three months ended March 31, 2022 and 2023 was 4.6% and 5.0%, respectively.

Gain/(loss) on revaluation of deferred consideration

We recognized a loss on revaluation of deferred consideration of ($17.0) million and a gain on revaluation of deferred consideration of $20.6 million during the three months ended March 31, 2022 and 2023, respectively. The gain recognized during the three months ended March 31, 2023, was primarily due to an increase in the discount rate used to compute the present value of the annual payment obligations, partly offset by higher gold prices. The magnitude of any gain or loss is highly correlated to changes in the discount rate and the magnitude of the change in the forward-looking price of gold.

Interest income

Interest income increased 36.4% from $0.8 million during the three months ended March 31, 2022 to $1.1 million in the comparable period in 2023 due to rising interest rates.

Impairments

During the three months ended March 31, 2023, we recognized a non-cash impairment charge of $4.9 million on the Securrency Series A Shares.

Loss on Extinguishment of Convertible Notes

During the three months ended March 31, 2023, we recognized a loss on extinguishment of convertible notes of $9.7 million arising from the repurchase of $115.0 million in aggregate principal amount of our 2020 Notes.

Other losses, net

Other net losses were $2.0 million for the first quarter of 2023. This quarter includes a non-cash charge of $1.4 million arising from the release of a tax-related indemnification asset upon the expiration of the statute of limitations (an equal and offsetting benefit has been recognized in income tax expense). This quarter also includes losses on our investments of $3.9 million. These items were partly offset by gains on our financial instruments owned of $2.0 million and a gain of $1.5 million related to the remeasurement of contingent consideration payable to us from the sale of our former Canadian ETF business. Gains and losses also generally arise from the sale of gold earned from management fees paid by our physically-backed gold exchange-traded products (“ETPs”), foreign exchange fluctuations and other miscellaneous items.

 

44

Table of Contents

Income Taxes

Our effective income tax rate for the first quarter of 2023 was 7.9%, resulting in income tax expense of $1.4 million. The effective tax rate differs from the federal statutory rate of 21% primarily due to a non-taxable gain on revaluation of deferred consideration and a reduction in unrecognized tax benefits upon the expiration of the statute of limitations. These items were partly offset by a non-deductible loss on extinguishment of our convertible notes and an increase in the deferred tax asset valuation allowance on losses recognized on our investments.

Our effective income tax rate for the three months ended March 31, 2022 of 62.0% resulted in an income tax benefit of $16.7 million. Our tax rate differs from the federal statutory rate of 21% primarily due to a $19.9 million reduction in unrecognized tax benefits (including interest and penalties), a lower tax rate on foreign earnings and tax windfalls associated with the vesting of stock-based compensation awards. These items were partly offset by a non-taxable loss on revaluation of deferred consideration and an increase in the deferred tax asset valuation allowance on losses recognized on securities owned.

Non-GAAP Financial Measurements

In an effort to provide additional information regarding our results as determined by GAAP, we also disclose certain non-GAAP information which we believe provides useful and meaningful information. Our management reviews these non-GAAP financial measurements when evaluating our financial performance and results of operations; therefore, we believe it is useful to provide information with respect to these non-GAAP measurements so as to share this perspective of management. Non-GAAP measurements do not have any standardized meaning, do not replace nor are superior to GAAP financial measurements and are unlikely to be comparable to similar measures presented by other companies. These non-GAAP financial measurements should be considered in the context with our GAAP results. The non-GAAP financial measurements contained in this Report include:

 

  •  

Adjusted net income and diluted earnings per share. We disclose adjusted net income and diluted earnings per share as non-GAAP financial measurements in order to report our results exclusive of items that are non-recurring or not core to our operating business. We believe presenting these non-GAAP financial measures provides investors with a consistent way to analyze our performance. These non-GAAP financial measures exclude the following:

 

  •  

Unrealized gains or losses on the revaluation of deferred consideration: Deferred consideration is an obligation we assumed in connection with the ETFS Acquisition that is carried at fair value. This item represents the present value of an obligation to pay fixed ounces of gold into perpetuity and is measured using forward-looking gold prices. Changes in the forward-looking price of gold and changes in the discount rate used to compute the present value of the annual payment obligations may have a material impact on the carrying value of the deferred consideration and our reported financial results. We exclude this item when arriving at adjusted net income and diluted earnings per share as it is not core to our operating business. The item is not adjusted for income taxes as the obligation was assumed by a wholly-owned subsidiary of ours that is based in Jersey, a jurisdiction where we are subject to a zero percent tax rate.

 

  •  

Gains or losses on financial instruments owned: We account for our financial instruments owned as trading securities, which requires these instruments to be measured at fair value with gains and losses reported in net income. We exclude these items when calculating our non-GAAP financial measurements as the gains and losses introduce volatility in earnings and are not core to our operating business.

 

  •  

Tax shortfalls and windfalls upon vesting and exercise of stock-based compensation awards: GAAP requires the recognition of tax windfalls and shortfalls within income tax expense. These items arise upon the vesting and exercise of stock-based compensation awards and the magnitude is directly correlated to the number of awards vesting/exercised as well as the difference between the price of our stock on the date the award was granted and the date the award vested or was exercised. We exclude these items when determining adjusted net income and diluted earnings per share as they introduce volatility in earnings and are not core to our operating business.

 

  •  

Other items: Loss on extinguishment of convertible notes, impairments, remeasurement of contingent consideration payable to us from the sale of our former Canadian ETF business, unrealized gains and losses recognized on our investments, changes in deferred tax asset valuation allowance and expenses incurred in response to an activist campaign are excluded when calculating our non-GAAP financial measurements.

 

45

Table of Contents
     Three Months Ended

Adjusted Net Income and Diluted Earnings per Share:

   

 

  March 31,  
2023

     March 31,  
2022

Net income/(loss), as reported

    $ 16,233     $ (10,261 )  

(Deduct)/add back: (Gain)/loss on revaluation of deferred consideration

      (20,592 )       17,018  

Add back: Loss on extinguishment of convertible notes, net of income taxes

      9,623       —  

Add back: Impairments

      4,900       —  

Deduct: Remeasurement of contingent consideration – sale of former Canadian ETF business

      (1,477 )      —  

(Deduct)/add back: (Gains)/losses on financial instruments owned, net of income taxes

      (1,479 )      3,893  

Add back: Increase in deferred tax asset valuation allowance on financial instruments owned and investments

      477       2,010  

Add back: Unrealized loss recognized on our investments, net of income taxes

      2,966       124  

Deduct: Tax windfalls upon vesting and exercise of stock-based compensation awards

      (185 )      (565 ) 

Add back: Expenses incurred in response to an activist campaign, net of income taxes

      732       1,844  
  

 

 

 

  

 

 

 

Adjusted net income

    $ 11,198     $ 14,063  

Deduct: Income distributed to participating securities

      (498 )      (549 ) 

Deduct: Undistributed income allocable to participating securities

      (672 )      (1,041 ) 
  

 

 

 

  

 

 

 

Adjusted net income available to common stockholders

      10,028       12,473  

Weighted average diluted shares, excluding participating securities (See Note 11 to our Consolidated Financial Statements)

            144,431           142,814  
  

 

 

 

  

 

 

 

Adjusted earnings per share—diluted

    $ 0.07     $ 0.09  
  

 

 

 

  

 

 

 

Liquidity and Capital Resources

The following table summarizes key data regarding our liquidity, capital resources and use of capital to fund our operations:

 

         March 31,
2023		    December 31,
2022		  
 

Balance Sheet Data (in thousands):

      
 

Cash and cash equivalents

    $ 119,099       $ 132,101  
 

Financial instruments owned, at fair value

      130,180         126,239  
 

Accounts receivable

      35,496         30,549  
 

Securities held-to-maturity

      253         259  
    

 

 

 

   

 

 

  
 

Total: Liquid assets

      285,028         289,148  
 

Less: Total current liabilities

      (130,926)        (148,434)  
 

Less: Other assets—seed capital (WisdomTree blockchain-enabled funds)

      (12,413)        (1,765)  
 

Less: Regulatory capital requirements

      (28,726)        (25,988)  
    

 

 

 

   

 

 

  
 

Total: Available liquidity

    $             112,963       $             112,961  
    

 

 

 

   

 

 

  

 

        Three Months Ended March 31,
     

 

            2023            

               2022            
 

Cash Flow Data (in thousands):

    
  Operating cash flows   $ (5,397 )    $ (2,692 ) 
  Investing cash flows     (2,008 )        (18,721 )   
  Financing cash flows     (6,070 )      (8,236 ) 
  Foreign exchange rate effect     473       (665 ) 
   

 

 

 

  

 

 

 

  Decrease in cash and cash equivalents   $               (13,002 )    $               (30,314 ) 
   

 

 

 

  

 

 

 

Liquidity

We consider our available liquidity to be our liquid assets, less our current liabilities and regulatory capital requirements of certain European subsidiaries. Liquid assets consist of cash and cash equivalents, financial instruments owned, at fair value, accounts receivable and securities held-to-maturity. Our financial instruments owned, at fair value are highly liquid investments. Accounts receivable are current assets and primarily represent receivables from advisory fees we earn from our ETPs. Our current liabilities consist primarily of convertible notes maturing in the next 12 months, payments owed to vendors and third parties in the normal course of business, deferred consideration and accrued incentive compensation for employees.

 

46

Table of Contents

Cash and cash equivalents decreased by $13.0 million during the three months ended March 31, 2023 due to $130.0 million of proceeds from the issuance of convertible notes, $18.3 million of proceeds from the sale of financial instruments owned, at fair value and $0.4 million from other activities. These increases were offset by $124.3 million used to repurchase convertible notes, $20.3 million used to purchase financial instruments owned, at fair value, $5.4 million used in operating activities, $4.8 million used to pay dividends, $3.5 million used to cover convertible notes issuance costs and $3.4 million used to repurchase our common stock.

Cash and cash equivalents decreased by $30.3 million during the three months ended March 31, 2022 due to $25.5 million used to purchase securities owned, $6.9 million used to purchase investments, $4.8 million used to pay dividends on our common stock, $3.4 million used to repurchase our common stock, $2.7 million of net cash used in operating activities and $0.6 million used in other activities. These decreases were partly offset by $13.6 million of proceeds from the sale of securities owned.

Issuance of Convertible Notes

On February 14, 2023, we issued and sold $130.0 million in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2023 Notes”) pursuant to an indenture dated February 14, 2023, between us and U.S. Bank Trust Company, National Association, as trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Rule 144A”).

On June 14, 2021, we issued and sold $150.0 million in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2021 Notes”) pursuant to an indenture dated June 14, 2021, between us and the trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A.

On June 16, 2020, we issued and sold $150.0 million in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the “June 2020 Notes”) pursuant to an indenture dated June 16, 2020, between us and the trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. On August 13, 2020, we issued and sold $25.0 million in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June 16, 2020, which constitute a further issuance of, and form a single series with, our June 2020 Notes (the “August 2020 Notes” and together with the June 2020 Notes, the “2020 Notes”).

In connection with the issuance of the 2023 Notes, we repurchased $115.0 million in aggregate principal amount of the 2020 Notes. As a result of this repurchase, we recognized a loss on extinguishment of approximately $9.7 million during the three months ended March 31, 2023.

After the issuance of the 2023 Notes (and together with the remaining 2020 Notes and the 2021 Notes, the “Convertible Notes”), we had $340.0 million in aggregate principal amount of Convertible Notes outstanding.

Key terms of the Convertible Notes are as follows:

 

                  2023 Notes                      2021 Notes                      2020 Notes          
 

Principal outstanding

      $130.0        $150.0        $60.0  
 

Maturity date (unless earlier converted, repurchased or redeemed)

      August 15, 2028        June 15, 2026        June 15, 2023  
 

Interest rate

      5.75%        3.25%        4.25%  
 

Conversion price

      $9.54        $11.04        $5.92  
 

Conversion rate

      104.8658        90.5797        168.9189  
 

Redemption price

      $12.40        $14.35        $7.70  

 

  •  

Interest rate: Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and June 15 and December 15 of each year for the 2020 Notes and the 2021 Notes.

 

  •  

Conversion price: Convertible at an initial conversion rate into shares of our common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.

 

  •  

Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of our common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of our common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by us in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in

 

47

Table of Contents
 

respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.

 

  •  

Cash settlement of principal amount: Upon conversion, we will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At our election, we will also settle our conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of our common stock or a combination of cash and shares of its common stock.

 

  •  

Redemption price: We may redeem for cash all or any portion of the Convertible Notes, at our option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of our common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.

 

  •  

Limited investor put rights: Holders of the Convertible Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.

 

  •  

Conversion rate increase in certain customary circumstances: In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853 shares, 144.9275 shares and 270.2702 shares of our common stock per $1,000 principal amount of the 2023 Notes, 2021 Notes and 2020 Notes, respectively (the equivalent of 59,767,426 shares of our common stock), subject to adjustment.

 

  •  

Seniority and Security: The Convertible Notes rank equal in right of payment, and are our senior unsecured obligations, but are subordinated in right of payment to our obligations to make certain redemption payments (if and when due) in respect of its Series A Non-Voting Convertible Preferred Stock (See Note 11 to our Consolidated Financial Statements).

The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the trustee or the holders of not less than 25% in aggregate principal amount of the Convertible Notes outstanding may declare the entire principal amount of all the Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.

Capital Resources

Our principal source of financing is our operating cash flow. We believe that current cash flows generated by our operating activities and existing cash balances should be sufficient for us to fund our operations for the foreseeable future.

Our ability to satisfy our contractual obligations as they arise are discussed in the section titled “Contractual Obligations” below.

Use of Capital

Our business does not require us to maintain a significant cash position. However, certain of our subsidiaries are required to maintain a minimum level of regulatory capital, which at March 31, 2023 was approximately $28.7 million in the aggregate. Notwithstanding these regulatory capital requirements, we expect that our main uses of cash will be to fund the ongoing operations of our business. We also maintain a capital return program which includes a $0.03 per share quarterly cash dividend and authority to purchase our common stock through April 27, 2025, including purchases to offset future equity grants made under our equity plans.

During the three months ended March 31, 2023, we repurchased 604,505 shares of our common stock under the repurchase program for an aggregate cost of $3.4 million. Currently, approximately $96.6 million remains under this program for future purchases.

Contractual Obligations

Convertible Notes

We currently have $340.0 million in aggregate principal amount of Convertible Notes outstanding, of which $60.0 million, $150.0 million and $130.0 million are scheduled to mature on June 15, 2023, June 15, 2026 and August 15, 2028, respectively, unless earlier converted, repurchased or redeemed. Conditional conversions or a requirement to repurchase the Convertible Notes upon the occurrence of a fundamental change may accelerate payment.

 

48

Table of Contents

The Convertible Notes require cash settlement of the principal amount, while settlement of the conversion obligation in excess of the aggregate principal amount may be satisfied in either cash, shares of our common stock or a combination of cash and shares of our common stock. We anticipate settling the $60.0 million in aggregate principal amount of 2020 Notes scheduled to mature in June 2023 and may settle and/or refinance the remaining obligations when due.

See the section titled “Issuance of Convertible Notes” above for additional information.

Deferred Consideration—Gold Payments

Deferred consideration represents an obligation we assumed in April 2018 in connection with our acquisition of the European exchange-traded commodity, currency and leveraged-and-inverse business of ETFS Capital. The obligation is for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March 31, 2058 and then subsequently reduced to 6,333 ounces of gold per year continuing into perpetuity (“Contractual Gold Payments”). The present value of the deferred consideration was $179.8 million at March 31, 2023.

The Contractual Gold Payments are paid from advisory fee income generated by any of our sponsored financial products backed by physical gold with no recourse back to us for any unpaid amounts that exceed advisory fees earned.

Operating Leases

Total future minimum lease payments with respect to our operating lease liabilities were $1.2 million at March 31, 2023. Cash flows generated by our operating activities and existing cash balances should be sufficient to satisfy the future minimum lease payments.

See Note 12 to our Consolidated Financial Statements for additional information.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet financing or other arrangements and have neither created nor are party to any special-purpose or off-balance sheet entities for the purpose of raising capital, incurring debt or operating our business.

Critical Accounting Policies and Estimates

Goodwill and Intangible Assets

Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. We test goodwill for impairment at least annually and at the time of a triggering event requiring re-evaluation, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

Goodwill is allocated to our U.S. Business and European Business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.

Goodwill is assessed for impairment annually on November 30th. When performing our goodwill impairment test, we consider a qualitative assessment, when appropriate, and the market approach and its market capitalization when determining the fair value of the reporting unit. The results of our most recent analysis indicated no impairment based upon a quantitative assessment.

Indefinite-lived intangible assets are tested for impairment at least annually and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair value is less than their carrying value. We may rely on a qualitative assessment when performing our intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for our intangible assets is November 30th. The results of our most recent analysis indicated no impairment based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including projected revenue growth rates ranging from 3% to 8% (5% weighted average) and a weighted average cost of capital of 11.0%.

Investments

We account for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed within ASU 2016-01, Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities,

 

49

Table of Contents

to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.

Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).

See Note 8 to our Consolidated Financial Statements for information.

Deferred Consideration—Gold Payments

Deferred consideration represents the present value of an obligation to pay gold to a third party into perpetuity and is measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate. The weighted average forward-looking gold price per ounce, discount rate and perpetual growth rate were $2,401, 13.3% and 1.5%, respectively, at March 31, 2023. Changes in the fair value of this obligation are reported as (gain)/loss on revaluation of deferred consideration–gold payments on our Consolidated Statements of Operations.

During the three months ended March 31, 2023, we reported a gain on deferred consideration—gold payments of $20.6 million. A 1.0% increase in the weighted average forward-looking gold price per ounce would have decreased this reported gain by $1.3 million, a 1 percentage point increase in the discount rate would have increased this reported gain by $12.9 million and a 1 percentage point increase in the perpetual growth rate would have decreased this reported gain by $9.3 million. See Note 9 to our Consolidated Financial Statements for additional information.

Revenue Recognition

We earn substantially all of our revenue in the form of advisory fees from our ETPs and recognize this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which we have a right to invoice.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The following information, together with information included in other parts of this Management’s Discussion and Analysis of Financial Condition and Results of Operations, describes key aspects of our market risk.

Market Risk

Market risk to us generally represents the risk of changes in the value of our ETPs that results from fluctuations in securities or commodity prices, foreign currency exchange rates against the U.S. dollar, and interest rates. Nearly all our revenues are derived from advisory agreements for the WisdomTree ETPs. Under these agreements, the advisory fee we receive is based on the average market value of the assets in the WisdomTree ETP portfolios we manage.

Fluctuations in the value of the ETPs are common and are generated by numerous factors such as market volatility, the global economy, inflation, changes in investor strategies and sentiment, availability of alternative investment vehicles, domestic and foreign government regulations, emerging markets developments and others. Accordingly, changes in any one or a combination of these factors may reduce the value of investment securities and, in turn, the underlying AUM on which our revenues are earned. These declines may cause investors to withdraw funds from our ETPs in favor of investments that they perceive as offering greater opportunity or lower risk, thereby compounding the impact on our revenues. We believe challenging and volatile market conditions will continue to be present in the foreseeable future.

Interest Rate Risk

We invest our corporate cash in short-term interest earning assets, primarily in federal agency debt instruments, WisdomTree fixed income ETFs, U.S. treasuries, corporate bonds, money market instruments at a commercial bank and other securities which totaled $134.3 million and $130.8 million as of March 31, 2022 and 2023, respectively. During the three months ended March 31, 2023, we recognized losses on these securities of $2.0 million and any losses recognized in the future may be material to our operating results. We do not anticipate that changes in interest rates will have a material impact on our financial condition or cash flows.

In addition, our Convertible Notes bear interest at fixed rates of 5.75%, 3.25% and 4.25% for the 2023 Notes, 2021 Notes and 2020 Notes, respectively. Therefore, we have no direct financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Notes changes primarily when the market price of our common stock fluctuates or interest rates change.

 

50

Table of Contents

Exchange Rate Risk

We are subject to currency translation exposure on the results of our non-U.S. operations, primarily in the United Kingdom and Europe. Foreign currency translation risk is the risk that exchange rate gains or losses arise from translating foreign entities’ statements of earnings and balance sheets from functional currency to our reporting currency (the U.S. dollar) for consolidation purposes. The advisory fees earned on our international listed ETPs are predominantly in U.S. dollars (and also paid in gold ounces, as described below); however, expenses for corporate overhead are generally incurred in British pounds. Currently, we do not enter into derivative financial instruments aimed at offsetting certain exposures in the statement of operations or the balance sheet but may seek to do so in the future.

Exchange rate risk associated with the euro is not considered to be significant.

Commodity and Cryptocurrency Price Risk

Fluctuations in the prices of commodities and cryptocurrencies that are linked to certain of our ETPs could have a material adverse effect on our AUM and revenues. In addition, a portion of the advisory fee revenues we receive on our ETPs backed by gold, other precious metals and cryptocurrencies are paid in the underlying metal or cryptocurrency. In addition, we pay gold ounces to satisfy our deferred consideration obligation (See Note 9 to our Consolidated Financial Statements). While we readily sell the gold, precious metals and cryptocurrencies that we earn under these advisory contracts, we still may maintain a position. We currently do not enter into arrangements to hedge against fluctuations in the price of these commodities and cryptocurrencies and any hedging we may undertake in the future may not be cost-effective or sufficient to hedge against this exposure.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of March 31, 2023, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2023, our disclosure controls and procedures were effective at a reasonable assurance level in ensuring that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules, regulations and forms of the SEC, including ensuring that such material information is accumulated by and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

During the quarter ended March 31, 2023, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We may be subject to reviews, inspections and investigations by the SEC, Commodity Futures Trading Commission (CFTC), National Futures Association (NFA), state and foreign regulators, as well as legal proceedings arising in the ordinary course of business. See Note 13 to our Consolidated Financial Statements for additional information regarding claims brought by investors in our WisdomTree WTI Crude Oil 3x Daily Leveraged ETP totaling approximately €15.8 million ($17.2 million).

ITEM 1A. RISK FACTORS

You should carefully consider the information set forth in Part 1, Item1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent sales of Unregistered Securities

None.

Use of Proceeds

Not applicable.

 

51

Table of Contents

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table provides information with respect to purchases made by or on behalf of the Company or any “affiliated purchaser” of shares of our common stock.

 

      Total Number  
of Shares
Purchased		   Average Price
   Paid Per Share   		     Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
      or Programs       		   Approximate
Dollar Value of
Shares that
  May Yet Be Purchased  
Under the Plans or
Programs

Period

                 (in thousands)

January 1, 2023 to January 31, 2023

     602,327     $ 5.60       602,327    

February 1, 2023 to February 28, 2023

     —     $ —       —    

March 1, 2023 to March 31, 2023

     2,178     $ 5.62       2,178    
 

 

 

 

    

 

 

 

  

Total

                 604,505         $             5.60                   604,505         $             96,592      
 

 

 

 

    

 

 

 

  

 

 

 

On February 22, 2022, our Board of Directors approved an increase of $85.7 million to our share repurchase program and extended the term for three years through April 27, 2025. During the three months ended March 31, 2023, we repurchased 604,505 shares of our common stock under this program for an aggregate cost of approximately $3.4 million. As of March 31, 2023, $96.6 million remained under this program for future repurchases.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

 

52

Table of Contents

ITEM 6. EXHIBITS

EXHIBIT INDEX

 

    Exhibit    
    Number    		   

Description

    3.1    Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
    3.2    Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Name Change) (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 7, 2022)
    3.3    Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Declassification of Board of Directors) (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on July 20, 2022).
    3.4    Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Increase in Authorized Shares) (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on July 20, 2022).
    3.5    Certificate of Designations of Series A Non-Voting Convertible Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on April 13, 2018)
    3.6    Certificate of Designations of Series B Junior Participating Cumulative Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Registration Statement on Form 8-A filed with the SEC on March 20, 2023)
    3.7    Fourth Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 7, 2022)
    4.1    Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
    4.2    Amended and Restated Stockholders Agreement among the Registrant and certain investors dated December 21, 2006 (incorporated by reference to Exhibit 4.2 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
    4.3    Securities Purchase Agreement among the Registrant and certain investors dated December 21, 2006 (incorporated by reference to Exhibit 4.3 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
    4.4    Securities Purchase Agreement among the Registrant and certain investors dated October 15, 2009 (incorporated by reference to Exhibit 4.4 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
    4.5    Third Amended and Restated Registration Rights Agreement dated October 15, 2009 (incorporated by reference to Exhibit 4.5 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
    4.6    Investor Rights Agreement, dated April 11, 2018, between the Registrant and ETFS Capital (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on April 13, 2018)
    4.7    Indenture, dated as of June 16, 2020, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 17, 2020)
    4.8    Form of Global Note, representing the Registrant’s 4.25% Convertible Senior Notes due 2023 (included as Exhibit A to the Indenture filed as Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 17, 2020)
    4.9    Indenture, dated as of June 14, 2021, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 14, 2021)
    4.10    Form of Global Note, representing the Registrant’s 3.25% Convertible Senior Notes due 2026 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on June 14, 2021)
    4.11    Indenture, dated as of February 14, 2023, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2023)
    4.12    Form of Global Note, representing the Registrant’s 5.75% Convertible Senior Notes due 2028 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on February 14, 2023)

 

53

Table of Contents

    Exhibit    

    Number    

   

Description

  4.13

    Stockholder Rights Agreement, dated March 17, 2023, between the Registrant and Continental Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form 8-A filed with the SEC on March 20, 2023)

   4.14

    Amendment No. 1 to Stockholder Rights Agreement, dated as of May 4, 2023, between the Registrant and Continental Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on May 5, 2023).

  10.1(1)

    Amendment to Employment Agreement between the Registrant and Alexis Marinof, dated April 21, 2023

  10.2(1)

    Form of Amendment, dated April 21, 2023, to Employment Agreements between the Registrant and each of Jonathan Steinberg, Peter M. Ziemba, R. Jarrett Lilien and Marci Frankenthaler

  10.3(1)

    WisdomTree, Inc. Executive Severance Plan

  10.4(1)

    Form of Employee Confidentiality, Assignment and Restrictive Covenant Agreement executed by participants of the WisdomTree, Inc. Executive Severance Plan

  31.1(1)

    Rule 13a-14(a) / 15d—14(a) Certification

  31.2(1)

    Rule 13a-14(a) / 15d—14(a) Certification

  32.1(2)

    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101(1)

    Financial Statements from the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2023, formatted in XBRL: (i) Consolidated Balance Sheets at March 31, 2023 (Unaudited) and December 31, 2022; (ii) Consolidated Statements of Operations and Comprehensive Income/(Loss) for the three months ended March 31, 2023 and March 31, 2022 (Unaudited); (iii) Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2023 and March 31, 2022 (Unaudited) (iv) Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and March 31, 2022 (Unaudited); and (v) Notes to Consolidated Financial Statements, as blocks of text and in detail.

101.SCH(1)

    Inline XBRL Taxonomy Extension Schema Document

101.CAL(1)

    Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF(1)

    Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB(1)

    Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE(1)

    Inline XBRL Taxonomy Extension Presentation Linkbase Document

104(1)

    Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)

 

(1) 

Filed herewith.

(2) 

Furnished herewith.

 

54

Table of Contents

SIGNATURE

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 9th day of May 2023.

 

WISDOMTREE, INC.
By:  

/s/ Jonathan Steinberg

  Jonathan Steinberg
 

Chief Executive Officer

(Principal Executive Officer)

WISDOMTREE, INC.
By:  

/s/ Bryan Edmiston

  Bryan Edmiston
  Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

 

55

EX-10.1 2 d452823dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

 

1 King William Street

London, EC4N 7AF

+44 (0)20 7448 4330

infoEU@wisdomtree.com

www.wisdomtree.com

    LOGO

21 April 2023

Private & Confidential

Alexis Marinof

[Address]

Deed of variation to Employment Contract

Dear Alexis

I am writing further to our recent discussions about making certain changes to your contract of employment with WisdomTree Europe Ltd (the “Company”) dated 8 June 2017, as amended (the “Employment Contract”).

We have agreed as follows:

Severance Terms

Involuntary Termination

A new clause 19, titled “Involuntary Termination”, is hereby inserted in your Employment Contract as follows:

19.1 Upon the Employee’s Involuntary Termination and provided the Employee (i) enters into a Settlement Agreement within 60 days after the date of Termination (or such shorter period as set forth in the Settlement Agreement) and complies with such Settlement Agreement and (ii) complies with the terms of this agreement, the Company will pay, in the manner set for the below, as severance to the Employee (or in the case of the Employee’s subsequent death, the legal representative of the Employee’s estate or such other person or persons as the Employee shall have designated by written notice to the Company), an amount equal to the sum of:

(a) the Annual Base Salary, less any Annual Base Salary received by the Employee during Garden Leave;

(b) the Termination Year Cash Incentive Compensation; and

(c) the Average Cash Incentive Compensation.

19.2 Notwithstanding anything to the contrary in any applicable Award agreement:

(a) any Awards held by the Employee that would have vested during the Post-Employment Period shall immediately accelerate and become fully vested and exercisable or nonforfeitable, as applicable, as of the later of (A) the date of Termination or (B) the effective date of the Settlement Agreement (the “Accelerated Vesting Date”), provided that in order to effectuate the accelerated vesting contemplated by this subsection, the unvested portion of an Employee’s Awards that would otherwise be forfeited on the date of Termination will be delayed until the earlier of (x) the effective date of the Settlement Agreement (at which time the acceleration contemplated by this subclause (a) will occur) or (y) the date that the Settlement Agreement can no longer become fully effective (at which time the entire unvested portion of such Awards will be forfeited);

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

(b) vesting of the Employee’s Awards shall otherwise cease as of the date of Termination, but the Employee’s Awards that remain unvested as of the Accelerated Vesting Date and that were not forfeited pursuant to clause (a)(A)(y) above will remain outstanding until the last day of the Post-Employment Period; and

(c) if a Change of Control occurs during the Post-Employment Period, the Employee shall be entitled to any accelerated vesting with respect to the Awards that the Employee would have been entitled to if the Employee had remained employed through the date of the Change of Control. For the avoidance of doubt, no accelerated vesting pursuant to this clause 19.2 will occur unless the Employee enters into a fully effective Settlement Agreement within 60 days after the date of Termination (or such shorter period as set forth in the Settlement Agreement) and complies with such Settlement Agreement.

19.3 The Termination Year Cash Incentive Compensation shall be paid when the Company pays to non-terminated senior executives their year-end incentive compensation for the Termination Year, but in no event later than March 15 of the calendar year following the Employee’s date of Termination. The Annual Base Salary and Average Cash Incentive Compensation shall be paid out in substantially equal monthly instalments in accordance with the Company’s payroll practice over 12 months commencing within 60 days after the date of Termination; provided the Employee has entered into a Settlement Agreement prior to the payment date. Notwithstanding the foregoing, if the Employee breaches any of the Continuing Obligations, all payments under this Clause 19 shall immediately cease, but the Employee shall be entitled to retain any payments made to the Employee prior to any breach by the Employee of the Continuing Obligations.

Change of Control

A new clause 21, titled “Change of Control”, is hereby inserted in your Employment Contract as follows:

21.1 The provisions of this clause 21 shall apply in lieu, and expressly supersede, the provisions of clause 19 and 20 regarding severance pay and benefits upon a termination of employment, if such termination of employment occurs within 18 months after the occurrence of a Change of Control. Upon a Post-Change of Control Termination, providing that the Employee is in compliance with and undertakes to continue to comply with the Employee’s obligations during Garden Leave (if applicable) and the Twelve Month Restrictive Covenant, and provided that the Employee’s employment is not terminated in accordance with clause 15.3, the Company will pay, in the manner set forth below, as compensation for loss of employment, a severance payment to the Employee (or in the case of the Employee’s subsequent death, the legal representative of the Employee’s estate or such other person or persons as the Employee shall have designated by written notice to the Company) calculated by aggregating the following:

(a) an amount equivalent to 1.75 times the Employee’s Annual Base Salary less any Annual Base Salary received by the Employee during Garden Leave;

(b) an amount equivalent to Average Cash Incentive Compensation multiplied by the fraction obtained by dividing the number of days employed by the Company during the Termination Year (save for any days spent on Garden Leave) by 365; and

(c) an amount equivalent to 1.75 times the Average Cash Incentive Compensation.”

(d) notwithstanding anything to the contrary in any applicable Time-Based Award agreement, Time-Based Awards held by the Employee that would have vested in the 21-month period following the date of Termination shall immediately accelerate and become fully vested and exercisable or nonforfeitable, as applicable, as of the Accelerated Vesting Date, provided that in order to effectuate the accelerated vesting contemplated by this subsection, the unvested portion of an Employee’s Time-Based Awards that would otherwise be forfeited on the date of Termination will be delayed until the earlier of (x) the effective date of the Settlement Agreement (at which time acceleration will occur) or (y) the date that the Settlement Agreement can no longer become fully effective (at which time the unvested portion of such Time-Based Awards will be forfeited), and (B) Performance-Based Awards will vest in accordance with the terms of the applicable Performance-Based Award agreement.

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

21.2 The severance payment set out in clause 21.1 shall be paid in a lump sum within 60 days after the date of Termination, provided the Employee has entered into a Settlement Agreement prior to the payment date.”

21.3 The Company agrees to maintain, for a period of at least six years after the Employee’s date of Termination, directors’ and officers’ liability insurance insuring the Employee (in his or her capacity as an officer and/or director) and other officers and directors, with a limit of liability not less than the aggregate of the respective amounts set forth in the policy or policies maintained by the Company immediately prior to the Change of Control.

21.4 Notwithstanding the foregoing, if the Employee breaches any Continuing Obligations, all payments under this clause 21 shall immediately cease, but the Employee shall be entitled to retain any payments made to the Employee prior to any breach by the Employee of the Continuing Obligations. However, if the Employee breaches the Twelve-Month Restrictive Covenant, the Company shall be entitled to recover from the Employee a pro-rata portion of the payments made to the Employee under this clause 21 that correspond to the proportionate period of time that the Employee was in breach of the Twelve-Month Restrictive Covenant.”

Post-Termination Restrictions

In consideration for allowing, you to benefit from the Severance Terms, and in light of your promotions within the business since the date of the Employment Contract, we have agreed that certain updates are required to the post-termination restrictions contained in the Employment Contract to make them more appropriate for an employee of your seniority within the business.

As a result, the following amendments will be made to your Employment Contract:

Non-Compete Restriction:

 

  1.

New clause 18.1(d) is inserted in your Employment Contract as follows:

“in the event the Employee’s employment is terminated within 18 months following the occurrence of a Change of Control, for 12 months following Termination, the Employee will not directly or indirectly Participate in the business or affairs of any Restricted Competitor unless:

 

  (i)

the Restricted Competitor also engages in business activities which are not a Competitive Business;

 

  (ii)

the Employee does not occupy, with or at the Restricted Competitor, a corporate executive position with the Restricted Competitor that provides oversight of or support to such Restricted Competitor’s activities in a Competitive Business; and

 

  (iii)

the Employee does not participate in the Competitive Business-related activities of the Restricted Competitor (and instead engages solely in activities that do not concern a Competitive Business).”

Non solicitation restriction

The definition of “Group Employee” in clause 1.1 of your Employment Contract is deleted in its entirety and replaced with the following:

“any person who is at the date of Termination or was at any time during the Relevant Period employed in an executive or managerial capacity together with their direct reports or engaged as a consultant in the Company and in each case with whom the Employee or any person reporting to the Employee has had dealings in the course of employment other than in a minimal way at any time during the Relevant Period.”

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

Definitions

The definitions which are set out in Schedule 1 of this letter will be inserted into clause 1.1 of your Employment Contract.

In addition, the definitions of “Control” and “Change of Control” contained in clause 1.1 of your Employment Contract will be deleted in their entirety and replaced by a new definition titled “Change of Control” as follows:

means (a) the acquisition by any “person” (as defined in Section 3(a)(9) and 13(d) of the Exchange Act), other than a stockholder of WisdomTree, Inc. that, as at the date of the deed of variation relating to this agreement entered into between the Company and the Employee on 21 April 2023 , is the beneficial owner (as defined in Rule 13d-3 promulgated under the Exchange Act) of 15% or more of the outstanding voting securities of WisdomTree, Inc., of more than 50% of the combined voting power of the then outstanding voting securities of WisdomTree, Inc.;(b) the sale of all or substantially all of the Company’s assets at that time; or (c) any occurrence of a Sale Event or Change in Control Event, as defined in WisdomTree, Inc.’s 2022 Equity Plan”

General

If the Employee’s employment with the Company is terminated for any reason other than death, Disability or termination by the Company in accordance with clause 15.3, each of the Company and the Employee agree to discuss and in good faith seek to agree on the substance and wording of any internal and external communications regarding the circumstances of the Employee’s termination.

If the Employee initiates or otherwise participates in any arbitration proceeding against the Company to enforce the rights and entitlements granted pursuant to clauses 19 or 21 and the Employee substantially prevails in such a proceeding, the Employee shall be entitled to recover from the Company all of the Employee’s costs of enforcement, including reasonable attorney’s fees and expenses.

This letter and the rights and obligations of the parties shall be governed by and construed in accordance with the laws of England. In the event of any claim, dispute or difference arising out of or in connection with this letter the parties irrevocably agree and submit to the non-exclusive jurisdiction of the Courts of England.

No variation of this letter shall be effective unless made in writing and signed by or on behalf of you and the Company.

To confirm your agreement to the changes set out in this letter, please sign this letter, in the presence of a witness. I will arrange for the letter to be countersigned on behalf of the Company and will send you a fully executed copy.

If you have any questions or issues that you want to discuss, please do not hesitate to contact us.

Yours sincerely

/s/ Beena Joseph

Beena Joseph

Head of HR

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

EXECUTED as a DEED and DELIVERED by the parties on the date set out in this letter deed.

 

EXECUTED as a DEED and DELIVERED by

   )
ALEXIS MARINOF   )
 

  /s/ Alexis Marinof

  Alexis Marinof

in the presence of:

  

Witness’ signature:  /s/ Celine Wolff                

  

Name: /s/ Celine Wolff                                     

  

Address: [Address of Witness]

  

 

 

Occupation:    Osteopath                                  

  

EXECUTED as a DEED

  

)

By WISDOMTREE EUROPE LTD acting by:

  

)

 

  /s/ Peter Ziemba

in the presence of:

  
 

Peter Ziemba

 

Director

Witness’ signature: /s/ Terry Siegel                

  

Name: /s/ Terry Siegel                                    

  

Address: [Address of Witness]

  

Occupation:     Retired                                

  

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

SCHEDULE 1

The following definitions will be inserted into clause 1.1 of your Employment Contract:

“Annual Base Salary” means the higher of the Employee’s annual base salary in effect immediately prior to (i) the Employee’s date of Termination or (ii) the Change of Control.

“AUM” means assets under management of an ETF Sponsor or ETP Sponsor as calculated and reported by Bloomberg or its successor, or if not so reported, then calculated by reference to shares outstanding and net asset value of its ETFs or ETPs, as the case may be, as reported by a Bloomberg terminal.

“Average Cash Incentive Compensation” means an amount equal to 50% of the Employee’s Target Incentive Compensation for the Termination Year.

“Awards” means all Time-Based Award(s) and Performance-Based Award(s).

“Committee” means the Compensation Committee of the Board of Directors of WisdomTree, Inc.

“Competing ETF Sponsor” means an ETF Sponsor that is one of the top ten ETF Sponsors in the United States based upon the AUM of its United States-listed ETFs, as of the end of the fiscal quarter immediately preceding the date of Termination.

“Competing ETP Sponsor” means an ETP Sponsor that is one of the top ten ETP Sponsors in the European Union and the United Kingdom combined based upon the AUM of its European Union- and United Kingdom-listed ETPs, as of the end of the fiscal quarter immediately preceding the date of Termination.

“Competitive Business” means (i) the business of being an ETP Sponsor, (ii) the business of being an ETP sponsor or (iii) a business that competes with the WisdomTree Digital Business.

“Continuing Obligations” means the Employee’s obligations to the Company pursuant to this agreement and any other agreement containing confidentiality, assignment of intellectual property, or other restrictive covenants including post termination restrictions, as the same may be amended or supplemented from time to time.

“Disability” means the earlier to occur of either of the following events:

 

  (i)

The Employee, because of physical or mental disability or incapacity, is unable to perform his obligations to, or duties for, the Company on a full-time basis for 90 consecutive days or a period in excess of 150 days out of any period of 360 consecutive days; or

 

  (ii)

the determination by a physician selected by the Company, duly licensed in the United Kingdom with a medical specialty appropriate for such determination (which determination shall be binding and conclusive for the purpose of this agreement), that the Employee is either physically or mentally, permanently disabled or incapacitated or otherwise so disabled or incapacitated that the Employee will be unable to perform his obligations to, or duties for, the Company for 90 consecutive days or a period in excess of 150 days out of any period of 360 consecutive days. The Employee’s failure to submit to an examination of a physician hereunder shall automatically result in a determination of Disability hereunder.

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

“ETF” means:

 

  a.

Any open-end management investment company or unit investment trust registered under the Investment Company Act of 1940, as amended (the “1940 Act”) that issues and redeems any series of redeemable securities in compliance with the conditions of an exemptive order or regulation issued or promulgated by the U.S. Securities and Exchange Commission permitting, among other things, (I) the shares to be issued and redeemed only in large aggregations, and (II) secondary market transactions in the shares to occur at negotiated prices on national securities exchanges, as defined in Section 2(a)(26) of the 1940 Act (an “Exchange”), and lists such redeemable securities for trading on an Exchange; and

 

  b.

Any exchange traded product, such as a grantor trust or other entity registered under the Securities Act of 1933, as amended (the “1933 Act”) (I) that is not registered as an investment company under the 1940 Act, (II) that is typically treated as a pass through entity under the Internal Revenue Code of 1986, as amended, (III) that issues and redeems a series of redeemable securities in large aggregations, and (IV) whose redeemable securities are listed for trading on one or more Exchanges and trade through secondary market transactions at negotiated prices on such Exchanges; or any exchange traded note registered under the 1933 Act that (x) provides for payments based on the performance of an index or pool of assets, (y) trades through secondary market transactions at negotiated prices on one or more Exchanges, and (z) is listed for trading on one or more Exchanges.

“ETF Sponsor” means an entity that is, or as a result of the Employee’s engagement or participation would become, a sponsor or promoter of an ETF or the investment advisor or investment manager to an ETF.

“ETP” means an entity or any exchange traded product that issues securities that represent an entitlement by the holder to an investment return obtained by the entity or exchange traded product by investing in securities, notes, commodities, cryptocurrencies or swaps to seek to achieve a stated investment purpose.

“ETP Sponsor” means an entity that is, or as a result of the Employee’s engagement or participation would become, a sponsor or promoter of an ETP or the advisor or manager to an ETP.

“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

“Good Reason” means that the Employee has complied with the “Good Reason Process” following the occurrence of any of the following events: (i) a material diminution in the Employee’s responsibilities, authority or duties (except for a reasonable diminution in connection with Disability); (ii) a material diminution in the Employee’s Annual Base Salary except for across-the-board salary reductions based on the Company’s financial performance similarly affecting all or substantially all senior management employees of the Company; (iii) a material change in the geographic location of the principal place at which the Employee provides services to the Company, not including work-related travel or short-term assignments; or (iv) the material breach by the Company of this Agreement.

“Good Reason Process” means that (i) the Employee reasonably determines in good faith that a “Good Reason” condition has occurred; (ii) the Employee notifies the Company in writing of the first occurrence of the Good Reason condition within 60 days of the first occurrence of such condition; (iii) the Employee cooperates in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) the Employee terminates his or her employment within 60 days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.

“Involuntary Termination” means (i) the Employee’s termination of employment by the Company other than due to: (A) death, (B) Disability or (C) termination by the Company in accordance with clause 15.3 (ii) the Employee’s resignation from his employment for Good Reason.

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

“Participate” means to directly or indirectly engage or participate, directly or indirectly (whether as an officer, director, employee partner, consultant, holder of an equity or debt investment, lender, or in any other manner or capacity) but excluding a Permitted Investment.

“Performance-Based Award” means all then-outstanding stock-based awards of the WisdomTree, Inc. that are subject to performance-based vesting and for which achievement of the performance metrics has not been determined as of the date of Termination.

“Permitted Investment” means a holding (directly or through nominees) by way of bona fide personal investment of any units of any authorised unit trust and less than one per cent. in aggregate of the issued shares, debentures or other securities of any class of any company with revenues in excess of $100,000,000 whose shares are listed on a recognised investment exchange, a recognised overseas investment exchange, or a designated investment exchange as recorded on the Financial Services Register by the FCA from time to time or any such other exchange as may be specified by the Board of Directors of WisdomTree, Inc. from time to time.

“Post-Change of Control Termination” means either (a) termination of the Employee’s employment by the Company in circumstances other than if the Employee’s employment was terminated under clause 15.3 of this agreement; (b) if the Employee resigns with Good Reason, in either case within 18 months after a Change of Control.

“Post-Employment Period” means the 12-month period immediately following the date of Termination less any time spent by the Employee on Garden Leave.

“Relevant Period” the period of 12 months immediately prior to the date of Termination (or the period since the start of the Employee’s employment, if shorter than 12 months) or, where the Executive has not been provided with work pursuant to clause 16 of this agreement after either party has served notice of termination, the period of 12 months immediately prior to the start of any period during which the Executive has not been provided with work pursuant to clause 16 of this agreement.

“Restricted Competitor” means any entity that (i) is a Competing ETF Sponsor, (ii) is a Competing ETP Sponsor or (iii) competes with the WisdomTree Digital Business in any jurisdiction where the Digital Wallet is offered to customers.

“Settlement Agreement” means a settlement agreement on terms satisfactory to the Company which is entered into between the Employee and the Company and/or with any Group Companies.

“Severance Terms” means the enhanced severance payments set out in clauses 19, 20 and 21 of the Employment Contract.

“Target Incentive Compensation” means the average of the Employee’s actual incentive compensation (including both cash and the fair value of Awards at the time of grant):

(i) for the three most recent full fiscal years for which the Employee has been paid incentive compensation; or

(ii) for such lesser number of full or partial fiscal years for which the Employee has been paid incentive compensation (with any partial fiscal year weighted proportionally less than any full fiscal year in determining the Employee’s average incentive compensation;

and in the event the Employee never has been paid any incentive compensation for a full or partial fiscal year, the Target Incentive Compensation shall be the target annual incentive compensation for the Termination Year as may be set forth in the annual budget for WisdomTree, Inc. as initially approved by the Board of Directors of WisdomTree, Inc. for the Termination Year or this Agreement, or if no such amount is set forth therein, 100% of the Employee’s Annual Base Salary).

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

“Termination Year” means the fiscal year in which the date of Termination occurs.

“Termination Year Cash Incentive Compensation” means the product of: (i) the Committee’s aggregate percentage funding of the WisdomTree Inc.’s budgeted incentive compensation pool for the Termination Year, multiplied by (ii) 50% of the Employee’s Target Incentive Compensation for the Termination Year. If the Employee was not employed by the Company for the entirety of the Termination Year, the foregoing amount shall be multiplied by the fraction obtained by dividing the number of days the Employee was employed by the Company during the Termination Year by 365.

“Time-Based Awards” means all then-outstanding stock-based awards of WisdomTree, Inc. that are subject solely to time-based vesting.

“Twelve Month Restrictive Covenant” means the post termination restriction contained in clause 18.1(d) of this agreement.

“WisdomTree Digital Business” means the business of developing and/or operating a platform for the purchase, sale and exchange of blockchain-based digital assets, the issuance of tokens representing such assets, and/or the development and operation of a digital wallet via a mobile telephone application that provides services related thereto to facilitate such activity (“Digital Wallet”).

 

WisdomTree Europe Ltd is incorporated in England and Wales, with its registered office at 1 King William Street, London, EC4N 7AF

Company registration no. 08985846 | VAT registration no: GB185352787

EX-10.2 3 d452823dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

LOGO

April 21, 2023

[Name]

Dear [Name]:

Reference is made to the letter agreement, dated [DATE], and amended on [DATE] [and [DATE]]1 (the “Letter”), between you and WisdomTree Asset Management, Inc. (“WTAM”), relating to your employment with WTAM. Capitalized terms used and not defined in this amendment to the Letter (“Amendment”) have the respective meanings assigned to them in the Letter.

The terms of this Amendment are as follows:

 

1.

Paragraph 3 ([Stock Options and]2 Restricted Stock) of the Letter shall be amended by adding the following subparagraph[s] [[(d),] (e) [and (f)]] after subparagraph [(c)/(d)]3 therein:

[(d) As used in this letter, “Date of Termination” means the date that your employment with WTAM (or any successor) ends. Notwithstanding the foregoing, your employment shall not be deemed to have been terminated solely as a result of you becoming an employee of a subsidiary of WTI or any direct or indirect successor to the business or the assets of WTI.

(e) As used in this letter, “Post-Employment Period” means the 12-month period immediately following the Date of Termination.]4

[(e)/(f)] Notwithstanding anything to the contrary in this letter or in any [Stock Option Agreement,]5 Restricted Stock Agreement or other equity-based awards of the Company held by you that are outstanding as of the Date of Termination, no accelerated vesting pursuant to Paragraph[s] 3(a), [3(b)]6 or the provisions of the agreements representing such equity-based awards specifically relating to Involuntary Termination will occur unless you enter into, do not revoke, and comply with a fully effective Release as set forth in Paragraph 7.

 

2.

Paragraph 4 (Protection of Confidential Information and Intellectual Property) of the Letter shall be deleted in its entirety and replaced with the following:

 

  4.

Protection of Confidential Information and Intellectual Property; Associated Noncompetition and Nonsolicitation Obligations.

(a)         You agree that your services hereunder are of a special, unique and extraordinary character, and that your position with the Company places you in a position of confidence and trust. You further acknowledge that in the course of rendering services to the Company and WT Advised Issuers (as defined below), as applicable, you have obtained and will obtain Confidential Information (as defined below) of the Company and WT Advised Issuers and gain access to customer goodwill. Accordingly, you agree that during your employment by the Company and for a one-year period thereafter (the “Restricted Period”) with respect to clause (i) below, and at all times both during and after your employment with respect to clause (ii) below, you shall not, directly or indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise:

 

1 Form Note: To reference date of amendment(s), as applicable.

2 Form Note: Heading name referencing Stock Options for Messrs. Steinberg and Ziemba only.

3 Form Note: Subsection herein “(e)/(f)” to be added to Messrs. Steinberg and Ziemba’s agreements as subsection (e) and to Mr. Lilien and Ms. Frankenthaler’s agreements as subsection (f).

4 Form Note: Subsections to be included for Mr. Lilien and Ms. Frankenthaler only, where Date of Termination and Post-Employment Period is used but previously undefined.

5 Form Note: Reference to historical stock option agreements relevant for Messrs. Steinberg and Ziemba only.

6 Form Note: Paragraph reference for Messrs. Steinberg and Ziemba only (relating to inclusion of historical stock options agreements).

(i)         solicit, entice, or attempt to persuade any officer, director, employee, or agent of the Company to become an officer, director, employee, or agent of or perform services in any other capacity on behalf of yourself or any other person or entity; or

(ii)         disparage the reputation of the Company or the respective directors, trustees, officers or employees of the Company, or the product and service offerings of the Company, including, without limitation, through written or spoken communication relating to the Company, its personnel or its products and services; provided, that nothing in the foregoing subparagraph (ii) shall affect or impede any of your rights under the National Labor Relations Act, including your right to engage in concerted group activity and to communicate with colleagues and/or third parties (such as labor unions and their representatives) including regarding working conditions.

(b)         For three (3) months following the Date of Termination in the event of either (i) an Involuntary Termination (as defined below) or (ii) if the Company makes a Three-Month Restrictive Covenant Election under Paragraph 8, you shall not directly or indirectly engage or participate, directly or indirectly (whether as an officer, director, employee, partner, consultant, holder of an equity or debt investment, lender, or in any other manner or capacity) (collectively, “Participate”), in the business or affairs of any Competitor (as defined below), unless (A) the Competitor also engages in activities other than in a Competitive Business (as defined below), (B) you do not occupy, with or at the Competitor, a corporate executive position that provides oversight of or support to such Competitor’s activities in a Competitive Business and (C) you do not Participate in the Competitive Business-related activities of the Competitor (and instead you engage solely in activities that do not concern a Competitive Business) (this Paragraph 4(b), the “Three-Month Restrictive Covenant”).

(c)         For twelve (12) months following the date of your Post-Change of Control Termination (as defined below), you shall not directly or indirectly Participate in the business or affairs of any Restricted Competitor (as defined below), unless (i) the Restricted Competitor also engages in activities other than in a Competitive Business, (ii) you do not occupy, with or at the Restricted Competitor, a corporate executive position with the Restricted Competitor, that provides oversight of or support to such Restricted Competitor’s activities in a Competitive Business and (iii) you do not Participate in the Competitive Business-related activities of the Restricted Competitor (and instead you engage solely in activities that do not concern a Competitive Business) (this Paragraph 4(c), the “Twelve-Month Restrictive Covenant”).

(d)         To the extent you are an attorney admitted to practice in the State of New York, or any other state that limits the applicability of noncompetition provisions with respect to attorneys, the restrictions set forth in Paragraphs 4(b) and 4(c) shall be binding on you only to the extent permissible under Rule 5.6 of the New York Rules of Professional Conduct (or the corresponding rule in such other state, if applicable). By way of explanation, if you are an attorney admitted to practice in the State of New York (or any other state that limits the applicability of noncompetition provisions with respect to attorneys) the restrictions contained in the aforementioned paragraphs shall be enforceable to the extent they seek to prohibit you from Participating in the affairs of a Competitor in a position that is non-legal in nature and does not require admittance to practice law as a pre-requisite to holding such position.

(e)         Definitions.

(i)         “AUM” means assets under management of an ETF Sponsor or ETP Sponsor as calculated and reported by Bloomberg or its successor, or if not so reported, then calculated by reference to shares outstanding and net asset value of its ETFs or ETPs, as the case may be, as reported by a Bloomberg terminal.

(ii)         “Competing ETF Sponsor” means an ETF Sponsor that is one of the top ten (10) ETF Sponsors in the United States based upon the AUM of its United States-listed ETFs, as of the end of the fiscal quarter immediately preceding the Date of Termination.

(iii)         “Competing ETP Sponsor” means an ETP Sponsor that is one of the top ten (10) ETP Sponsors in the European Union and the United Kingdom combined based upon the AUM of its European Union- and United Kingdom-listed ETPs, as of the end of the fiscal quarter immediately preceding the Date of Termination.

 

2

(iv)         “Competitive Business” means (i) the business of being an ETF Sponsor, (ii) the business of being an ETP sponsor or (iii) a business that competes with the WisdomTree Digital Business.

(v)         “Competitor” means any entity that (i) is an ETF Sponsor in the United States, (ii) is an ETP Sponsor in the European Union and/or the United Kingdom or (iii) competes with the WisdomTree Digital Business.

(vi)         “ETF” means:

(A)         any open-end management investment company or unit investment trust registered under the Investment Company Act of 1940, as amended (the “1940 Act”) that issues and redeems any series of redeemable securities in compliance with the conditions of an exemptive order or regulation issued or promulgated by the U.S. Securities and Exchange Commission permitting, among other things, (I) the shares to be issued and redeemed only in large aggregations, and (II) secondary market transactions in the shares to occur at negotiated prices on national securities exchanges, as defined in Section 2(a)(26) of the 1940 Act (an “Exchange”), and lists such redeemable securities for trading on an Exchange; and

(B)         any exchange traded product, such as a grantor trust or other entity registered under the Securities Act of 1933, as amended (the “1933 Act”), (I) that is not registered as an investment company under the 1940 Act, (II) that is typically treated as a pass through entity under the Internal Revenue Code of 1986, as amended (the “Code”), (III) that issues and redeems a series of redeemable securities in large aggregations, and (IV) whose redeemable securities are listed for trading on one or more Exchanges and trade through secondary market transactions at negotiated prices on such Exchanges; or any exchange traded note registered under the 1933 Act that (x) provides for payments based on the performance of an index or pool of assets, (y) trades through secondary market transactions at negotiated prices on one or more Exchanges, and (z) is listed for trading on one or more Exchanges.

(vii)         “ETF Sponsor” means an entity that is, or as a result of your engagement or participation would become, a sponsor or promoter of an ETF or the investment advisor or investment manager to an ETF.

(viii)         “ETP” means an entity, or any exchange traded product, that issues securities that represent an entitlement by the holder to an investment return obtained by the entity by investing in securities, notes, commodities, cryptocurrencies or swaps to seek to achieve a stated investment purpose.

(ix)         “ETP Sponsor” means an entity that is, or as a result of your engagement or participation would become, a sponsor or promoter of an ETP or the advisor or manager to an ETP.

(x)         “Restricted Competitor” means any entity that (i) is a Competing ETF Sponsor, (ii) is a Competing ETP Sponsor or (iii) competes with the WisdomTree Digital Business in any jurisdiction where the Digital Wallet (as defined below) is offered to customers.

(xi)         “WisdomTree Digital Business” means the business of developing and/or operating a platform for the purchase, sale and exchange of blockchain-based digital assets, the issuance of tokens representing such assets, and/or the development and operation of a digital wallet via a mobile telephone application that provides services related thereto to facilitate such activity (“Digital Wallet”).

(f)         Your ownership, in the aggregate, of less than 1% of the outstanding shares of capital stock of any corporation with revenues in excess of $100,000,000 and one or more classes of its capital stock listed on an Exchange shall not constitute a violation of the restrictions contained in clauses (b) or (c) above.

(g)         You agree that all information, whether or not in writing, concerning the business, technology, business relationships or financial affairs of the Company or any investment company to which the Company serves, has served or may in the future serve, as an investment advisor or manager (each such investment company, a “WT Advised Issuer,” and collectively, the “WT Advised Issuers”) and that the Company and the WT Advised Issuers (as applicable) have not released to the general public (collectively, “Confidential Information”) and

 

3

all tangible embodiments thereof are and will be the exclusive property of the Company or WT Advised Issuer, as applicable. By way of illustration, Confidential Information may include information or material that has not been made generally available to the public, such as: (a) corporate information, including plans, strategies, methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer or business partner identities or other information about customers, business partners, prospect identities or other information about prospects, or market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists, financial forecasts, pricing methodologies, market share data; (d) operational or technological information, including plans, specifications, manuals, forms, templates, software codes and designs, algorithms, technical data and strategies, research and development strategies, hardware configuration information, designs, methods, procedures or modalities, formulae, data, reports, discoveries, inventions, materials, improvements, concepts, ideas, models, processes, know-how and trade secrets, and other Intellectual Property (as defined below), agreements with third parties; and (e) personnel information, including personnel lists, reporting or organizational structure, resumes, personnel data, performance evaluations and termination arrangements or documents. Confidential Information also includes information received in confidence by the Company or the WT Advised Issuers from their respective customers, suppliers, business partners or other third parties. You will not, at any time, without WTI’s prior written permission, either during or after your employment, disclose any Confidential Information to anyone outside of the Company, or use or permit to be used any Confidential Information for any purpose other than the performance of your duties as an employee of WTAM. You will cooperate with the Company and use your best efforts to prevent the unauthorized disclosure or use of all Confidential Information. You will deliver to the Chief Legal Officer of WTI all copies and other tangible embodiments of Confidential Information in your possession or control upon the earlier of a request by the Company or termination of your employment. You understand that the Company and WT Advised Issuers are now and may hereafter be subject to nondisclosure or confidentiality agreements with third persons that require the Company and WT Advised Issuers to protect or refrain from use or disclosure of proprietary information. You agree to be bound by the terms of such agreements in the event you have access to such proprietary information. You understand that the Company and WT Advised Issuers strictly prohibit you from using or disclosing confidential or proprietary information belonging to any other person or entity (including any employer or former employer) in connection with your employment. In addition, you agree not to bring any confidential information belonging to any other person or entity onto Company premises, property or into Company workspaces or transfer onto any Company device, database or technology systems any such information belonging to any such person or entity.

You will keep and maintain adequate and current records of all Confidential Information and Intellectual Property (as defined below) developed by you during your employment, which records will be available to and remain the sole property of the Company at all times. Subject to Paragraph 4(h), all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes, or other written, photographic or other tangible or electronic material containing Confidential Information, whether created by you or others, which come into your custody or possession, are the exclusive property of the Company to be used by you only in the performance of your duties for the Company and WT Advised Issuers, as applicable. Any property situated on the Company’s premises or saved on the Company’s technology systems and databases and owned by the Company, including without limitation desktop or laptop computers, tablets, disks and other storage media, filing cabinets or other work areas or on the Company’s networks or servers, is subject to inspection by the Company at any time with or without notice. In the event of the termination of your employment for any reason, you will deliver to the Company all property and equipment of the Company in your possession, custody or control, including all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes, or other written, photographic or other tangible or electronic material containing Confidential Information, and other materials of any nature pertaining to the Confidential Information of the Company and WT Advised Issuers and to your work, and will not take or keep in your possession any of the foregoing or any copies.

(h)         During your employment, you will disclose to the Company all artwork, articles, materials, memoranda, reports, writings, research, software, programs, promotions, compilations, designs, drawings, layouts, models, patterns, know-how, inventions, ideas, formulas, procedures, processes, concepts, discoveries, technology, algorithms, designs, methods, improvements or other works of any nature

 

4

whatsoever, that are created, prepared, produced, authored, edited, amended, conceived, or reduced practice by me individually or jointly with others, including but not limited to market indices, research procedures and models, which relate directly or indirectly to the business of the Company or arise out of your employment with WTAM or your service as an officer of the other entities comprising the Company or the use of the Company’s property or resources including, without limitation, any market indices, research procedures, models, ideas, proposals and plans which may be copyrighted, trademarked, patented or otherwise protected (collectively, “Intellectual Property”). It is understood and agreed that Intellectual Property does not include ideas, proposals or plans of a legal nature that are commonly known among attorneys counseling companies in the exchange traded products industry or digital assets industry. To preclude any possible uncertainty, if there is any Intellectual Property that you have, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of your employment with WTAM that you consider to be your property or the property of third parties and that you wish to have excluded from the scope of this Agreement (“Prior Inventions”), you have set forth on Exhibit B attached hereto a complete list of those Prior Inventions. If disclosure of any such Prior Invention would cause you to violate any prior confidentiality agreement, you understand that you are not to list such Prior Inventions in Exhibit B but you are only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. If, in the course of your employment with WTAM, you incorporate a Prior Invention into a product, process or machine, research or development program, or other work done for the Company, you hereby grant to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, worldwide license (with the full right to sublicense directly and indirectly through multiple tiers) to make, have made, modify, use, sell, offer for sale and import such Prior Invention.

You agree that, as between you and the Company, all such Intellectual Property will be the sole property of the Company. You expressly understand and agree that any and all Intellectual Property constitutes a “work for hire” under applicable law, including the U.S. Copyright Law. In the event any Intellectual Property is not regarded as a “work for hire,” you hereby assign to the Employing Company (as defined below) the sole and exclusive right to all Intellectual Property and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, sui generis database rights and other intellectual property rights in all countries and territories worldwide and under any international conventions (collectively, “Intellectual Property Rights”). You agree that you will promptly disclose to the Company any and all Intellectual Property, and that, upon request of the Company, you will execute and deliver any and all documents or instruments and take any other action that the Company will deem necessary to assign to and vest completely in the Employing Company, to perfect trademark, copyright and patent protection with respect to, or to otherwise protect the Company’s trade secrets and proprietary interest in the Intellectual Property. With respect to any Intellectual Property and Intellectual Property Rights assigned hereunder to the Company, during your employment and at any time thereafter, you will, at the request and expense of the Company, sign, execute, make and do all such deeds, documents, acts and things as the Company and its duly authorized agents may reasonably require: (i) to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) trademarks, copyrights or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same; and (ii) to defend any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for revocation of such trademarks, copyrights, patents or other analogous protection. In the event you do not, within five (5) days after delivery to me, execute and deliver such documents reasonably necessary to vest in the Company all right, title and interest in such Intellectual Property, you hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as your agent and attorney-in-fact, to act for and on your behalf and stead to execute and file any such application or applications and to do all other lawfully permitted acts to further the prosecution and issuance of trademarks, copyright or other analogous protection thereon with the same legal force and effect as if executed by you. The obligations of this Paragraph will continue after the termination of your employment with respect to such Intellectual Property conceived of or developed by you while employed by the Employing Company. The Company agrees to pay any and all copyright, trademark and patent fees and expenses or the costs incurred by you at the Company’s request for any assistance rendered to the Company pursuant to this Paragraph 4(h). You understand that to the extent this letter is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made

 

5

by an employee, this Paragraph 4(h) will be interpreted not to apply to any invention that a court rules and/or the Company agrees falls within such classes.

For the purposes of this Paragraph 4(h), the term “Employing Company” means the entity employing you at the time that the applicable Intellectual Property is created, made, conceived or reduced to practice. If you are jointly employed by two or more entities at such time, the Employing Company means the entity that is the primary employer.

(i)         If you commit a material breach, or if there are facts that indicate that you intend or you are about to commit a material breach, of any of the provisions of this Paragraph 4, the Company will have all legal and equitable rights available to it, including, without limitation, the right and remedy:

(i)         to have the provisions of this letter specifically enforced by any court having equity jurisdiction, including, but not limited to, granting the Company an injunction against you, it being acknowledged and agreed by you that the services being rendered hereunder to the Company are of a special, unique, and extraordinary character and that any such breach or threatened breach will cause irreparable injury to the Company and that money damages will not provide an adequate remedy to the Company; and

(ii)         (x) to the fullest extent permitted by applicable law, to require you to account for and pay over to the Company all compensation, profits, monies, accruals, increments, or benefits (collectively “Benefits”) derived or received by you as the result of any transactions constituting a breach of any of the provisions of Paragraph 4 and you hereby agree to account for and pay over such Benefits to the Company, and (y) to cease any severance payments that would otherwise be payable to you.

If the Company shall initiate any legal proceeding to enforce the rights granted to it pursuant to this Paragraph 4(i), the substantially prevailing party in such a proceeding shall be entitled to recover from the non-prevailing party all of its costs of enforcement or defense (as the case may be), including reasonable attorney’s fees and expenses.

If you commit a material breach of any of your obligations under Paragraph 4, the time period for which the obligation at issue shall run shall be tolled during the time such material breach is ongoing until the first date on which you cease to be in material breach of such obligation.

Each of the rights and remedies enumerated in this Paragraph 4(i) will be independent of the other, and will be severally enforceable, and such rights and remedies will be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or equity. If any provision of Paragraph 4 is held to be unenforceable because of the scope, duration, or area of its applicability, the tribunal making such determination will have the power to modify such scope, duration, or area, or all of them, and such provision or provisions will then be applicable in such modified form.

(j)         Nothing in this letter shall be interpreted or applied to prohibit you from making any good faith report to any governmental agency or other governmental entity concerning any acts or omissions that you may believe to constitute a possible violation of federal or state law or making other disclosures that are protected under the whistleblower provisions of applicable federal or state law or regulation. In addition, for the avoidance of doubt, you understand that pursuant to the federal Defend Trade Secrets Act of 2016, you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Lastly, notwithstanding anything herein to the contrary, nothing in this letter shall limit or restrict your right to initiate a legal proceeding in a court of law or equity to seek indemnification from the Company pursuant to your Indemnification Agreement with WTI dated as of the date set forth on Appendix A and your right to have WTI reimburse you for your expenses, including reasonable attorney’s fees, in connection with enforcing your claim for indemnification thereunder.

 

3.

Paragraph 9 (Change of Control Severance) of the Letter shall be amended by adding the following proviso at the end of subparagraph (ii) thereunder immediately before the words “; and”:

 

6

provided, that in order to effectuate the accelerated vesting contemplated by this subsection, the unvested portion of such time-based equity awards that would otherwise be forfeited on the Date of Termination will be delayed until the earlier of (x) the effective date of the Release (at which time acceleration will occur) or (y) the date that the Release can no longer become fully effective (at which time the unvested portion of such time-based equity awards will be forfeited)

 

4.

Paragraph 9 (Change of Control Severance) ) of the Letter shall be amended by adding the following paragraph immediately following subparagraph (iii) thereof:

For purposes of clarity, notwithstanding anything to the contrary in this letter or in any time-based equity awards of the Company held by you that are outstanding as of the Date of Termination, no accelerated vesting pursuant to Paragraph 9(ii) above will occur unless you enter into, do not revoke, and comply with the Release as set forth in this Paragraph 9.

 

5.

Paragraph 10(b) (Definitions) of the Letter shall be deleted in its entirety and replaced with the following:

 

  (b)

“Change of Control” shall mean (i) the acquisition by any “person” (as defined in Section 3(a)(9) and 13(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”)), other than a stockholder of the Company that, as of the date of this Letter, is the beneficial owner (as defined in Rule 13d-3 promulgated under the Exchange Act) of 15% or more of the outstanding voting securities of the Company, of more than 50% of the combined voting power of the then outstanding voting securities of the Company; (ii) the sale by the Company of all, or substantially all, of the assets of the Company to one or more purchasers, in one or a series of related transactions, where the transaction or transactions require approval pursuant to Delaware law by the stockholders of the Company; or (iii) any occurrence of a Sale Event or Change in Control Event as defined in the WisdomTree Investments, Inc. 2022 Equity Plan, as amended from time to time.

 

6.

Except as expressly provided in this Amendment, all the terms and provisions of the Letter are and will remain in full force and effect and are hereby ratified and confirmed by the parties. On and after the date hereof, each reference in the Letter to “this letter, “this letter agreement,” “hereunder,” “hereof,” “herein” or words of like import will mean and be a reference to the Letter as amended by this Amendment.

 

7.

This Amendment shall be governed by, and construed in accordance with, the internal laws of New York, without regard to principles of conflicts of law. This Amendment may not be amended or modified unless memorialized in writing and signed by both you and WTAM. This Amendment may be executed in counterparts, each of which is deemed an original, but all of which together constitutes one and the same agreement. Each party agrees that electronic signatures of the parties included in this Amendment will have the same force and effect as manual signatures. Delivery of an executed counterpart of this Amendment electronically shall be effective as delivery of an original executed counterpart of this Amendment.

Please confirm your acceptance of this Amendment by signing below and returning a copy to me.

 

Sincerely,

WISDOMTREE ASSET MANAGEMENT, INC.

 

By:    

Name:

  

Title:

  

I agree to the terms and conditions set forth in the above Amendment to the Letter.

 

 

    

 

[Name]

     Date

 

7

EXHIBIT B

 

To:    COMPANY   
From:                                           
Date:                                           

SUBJECT:             Prior Inventions

The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company:

 

 

☐       No inventions or improvements

 

☐       See below:

 

                                                                                                                                                                       

 

                                                                                                                                                                       

 

                                                                                                                                                                       

 

☐       Additional sheets attached.

 

The following is a list of all patents and patent applications in which I have been named as an inventor:

 

☐       None

 

☐       See below:

 

                                                                                                                                                                       

 

                                                                                                                                                                       

 

                                                                                                                                                                       

 

8

EX-10.3 4 d452823dex103.htm EX-10.3 EX-10.3

Exhibit 10.3

Approved by the Compensation Committee of the

Board of Directors on February 23, 2023

WISDOMTREE, INC.

EXECUTIVE SEVERANCE PLAN

WisdomTree, Inc. (the “Company”) considers it essential to the best interests of its stockholders to foster the continuous employment of key management personnel. The Compensation Committee (the “Committee”) of the Board of Directors of the Company (the “Board”) recognizes, however, that, as is the case with many publicly held corporations, the possibility of an involuntary termination of employment, either before or after a Change of Control (as defined in Section 1 hereof), exists and that such possibility, and the uncertainty and questions that it may raise among management, may result in the departure or distraction of management personnel to the detriment of the Company and its stockholders. Therefore, the Committee has determined that the WisdomTree, Inc. Executive Severance Plan (this “Plan”) should be adopted to reinforce and encourage the continued attention and dedication of the Company’s Eligible Participants (as defined in Section 1 hereof) to their assigned duties without distraction. Nothing in this Plan shall be construed as creating an express or implied contract of employment and nothing shall alter the “at will” nature of the US Eligible Participants’ (as defined in Section 1 hereof) employment with the Company. For purposes of this Plan, the employment of an Eligible Participant by the Company refers to the employment of the Eligible Participant by the applicable current or future, direct or indirect subsidiary of the Company (each a “WT Sub” and collectively, the “WT Subs”) since the Company has no direct employees. In addition, certain WT Subs serve, have served or may in the future serve, as an investment advisor or manager to investment companies (each such investment company, a “WT Advised Issuer” and collectively, the “WT Advised Issuers”). Accordingly, as the context may require, the word “Company” refers to either (i) the Company, the WT Subs and the WT Advised Issuers collectively, (ii) any one or more of such entities, or (iii) the applicable WT Sub that employs such Eligible Participant.

1.    Definitions.

(a)    “Administrator” means the Committee.

(b)    “Annual Base Salary” means the higher of the Eligible Participant’s annual base salary in effect immediately prior to (i) the Eligible Participant’s Date of Termination or (ii) the Change of Control.

(c)    “Average Cash Incentive Compensation” means an amount equal to 50% of the Eligible Participant’s Target Incentive Compensation for the Termination Year.

(d)    “Award(s)” means all Time-Based Award(s) and Performance-Based Award(s).

(e)    “Cause” means any one or more of the following acts or omissions by the Eligible Participant: (i) the willful and continued failure of the Eligible Participant to (A) materially perform the Eligible Participant’s duties and obligations to the Company or (B) carry out specific legal and lawful directions of a senior officer or the Board (in each case other than by reason of Disability); (ii) the material breach of any Continuing Obligations (including a breach of the representations and warranties made by the Eligible Participant in such Eligible Participant’s employment agreement or offer letter and/or the Restrictive Covenant Agreement); (iii) the material failure to comply with the written policies or rules of the Company; (iv) the commission of an act or failure to act that involves willful misconduct, bad faith or gross negligence; (v) the commission of any act of fraud, misappropriation, embezzlement or similar willful and malicious conduct against the Company; or (vi) the Eligible Participant’s conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state thereof. Notwithstanding the foregoing, “Cause” shall not be deemed to exist for a reason specified in clauses (i)(A) or (ii) above unless the Eligible Participant has been given written notice setting forth in reasonable detail the act, omission or failure of, or breach by, the Eligible Participant and a period of at least 10 days after such notice to cure all of such acts, omissions, failures or breaches, and the same shall not have been cured within such 10-day period; provided, further, that the Company shall not be required to give notice and an opportunity to cure

for a reason specified in clauses (i)(A) or (ii) if an Eligible Participant has committed the same or substantially similar acts, omissions, failures or breaches and the Company has previously given the Eligible Participant notice of and an opportunity to cure the same.

(f)    “Change of Control” means (i) the acquisition by any “person” (as defined in Section 3(a)(9) and 13(d) of the Exchange Act), other than a stockholder of the Company that, as of the date the Eligible Participant becomes an Eligible Participant, is the beneficial owner (as defined in Rule 13d-3 promulgated under the Exchange Act) of 15% or more of the outstanding voting securities of the Company, of more than 50% of the combined voting power of the then outstanding voting securities of the Company; (ii) the sale by the Company of all, or substantially all, of the assets of the Company to one or more purchasers, in one or a series of related transactions, where the transaction or transactions require approval pursuant to Delaware law by the stockholders of the Company; or (iii) any occurrence of a Sale Event or Change in Control Event, as defined in the Company’s 2022 Equity Plan, as amended from time to time.

(g)    “Code” means the U.S. Internal Revenue Code of 1986, as amended.

(h)    “Continuing Obligations” means the Eligible Participant’s obligations to the Company pursuant to any agreement containing confidentiality, assignment of inventions, or other restrictive covenants, including the Restrictive Covenant Agreement and the Eligible Participant’s offer letter of employment, as the same may be amended or supplemented from time to time.

(i)    “Date of Termination” means the date that an Eligible Participant’s employment with the Company (or any successor) ends. Notwithstanding the foregoing, an Eligible Participant’s employment shall not be deemed to have been terminated solely as a result of the Eligible Participant becoming an employee of any subsidiary of the Company or any direct or indirect successor to the business or assets of the Company.

(j)    “Disability” means the earlier to occur of either of the following events:

(i)    the Eligible Participant, because of physical or mental disability or incapacity, is unable to perform the Eligible Participant’s obligations to, or duties for, the Company on a full-time basis for 90 consecutive days or a period in excess of 150 days out of any period of 360 consecutive days; or

(ii)    the determination by a physician selected by the Company, duly licensed in New York for US Eligible Participants and in the United Kingdom for UK Eligible Participants with a medical specialty appropriate for such determination (which determination shall be binding and conclusive for the purpose of this Plan), that the Eligible Participant is either physically or mentally, permanently disabled or incapacitated or otherwise so disabled or incapacitated that the Eligible Participant will be unable to perform the Eligible Participant’s obligations to, or duties for, the Company for 90 consecutive days or a period in excess of 150 days out of any period of 360 consecutive days. The Eligible Participant’s failure to submit to an examination of a physician hereunder shall automatically result in a determination of Disability hereunder.

(k)    “Eligible Participants” means those Executive Officers or other employees designated by the Administrator by written resolution in its sole discretion, and who meet the eligibility requirements set forth in Section 3 of this Plan.

(l)    “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.

(m)    “Executive Officer” means an employee of the Company designated by written resolution of the Board as (i) an executive officer of the Company as that term is defined under Rule 3b-7 of the Exchange Act and (ii) an officer of the Company for purposes of Section 16 of the Exchange Act.

 

2

(n)    “Good Reason” means that the Eligible Participant has complied with the “Good Reason Process” following the occurrence of any of the following events: (i) a material diminution in the Eligible Participant’s responsibilities, authority or duties (except for a reasonable diminution in connection with Disability); (ii) a material diminution in the Eligible Participant’s Annual Base Salary, except for across-the-board salary reductions based on the Company’s financial performance similarly affecting all or substantially all senior management employees of the Company; (iii) a material change in the geographic location of the principal place at which the Eligible Participant provides services to the Company, not including work-related travel or short-term assignments; or (iv) the material breach by the Company of a written employment agreement or offer letter between the Company and the Eligible Participant.

(o)    “Good Reason Process” means that (i) the Eligible Participant reasonably determines in good faith that a “Good Reason” condition has occurred; (ii) the Eligible Participant notifies the Company in writing of the first occurrence of the Good Reason condition within 60 days of the first occurrence of such condition; (iii) the Eligible Participant cooperates in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) the Eligible Participant terminates the Eligible Participant’s employment within 60 days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.

(p)    “Involuntary Termination” means (i) the Eligible Participant’s termination of employment by the Company other than due to: (A) death, (B) Disability or (C) termination by the Company for Cause or (ii) the Eligible Participant’s resignation from the Eligible Participant’s employment for Good Reason.

(q)    “Participation Agreement” means an agreement between an Eligible Participant and the Company that acknowledges the Eligible Participant’s participation in this Plan.

(r)    “Performance-Based Awards” means all then-outstanding stock-based awards of the Company that are subject to performance-based vesting and for which achievement of the performance metrics has not been determined as of the Date of Termination.

(s)    “Post-Change of Control Termination” means termination of the Eligible Participant’s employment by the Company without Cause or the Eligible Participant’s resignation of the Eligible Participant’s employment for Good Reason, in either case within 18 months after a Change of Control.

(t)    “Post-Employment Period” means the 12-month period immediately following the Date of Termination.

(u)    “Prior Year” means the fiscal year immediately preceding the Termination Year.

(v)    “Prior Year Cash Incentive Compensation” means the product of: (i) the Committee’s aggregate percentage funding of the Company’s budgeted incentive compensation pool for the Prior Year, multiplied by (ii) 50% of the Eligible Participant’s Target Incentive Compensation for the Prior Year.

(w)    “Reimbursement” means reimbursement for reasonable business expenses incurred by the Eligible Participant in performing services for the Company prior to the Date of Termination, in accordance with the policies and procedures then in effect and established by the Company for its Executive Officers.

(x)    “Restrictive Covenant Agreement” means the Employee Confidentiality, Assignment and Restrictive Covenant Agreement between the Eligible Participant and the Company, as may be amended from time to time.

(y)    “Target Incentive Compensation” means the average of the Eligible Participant’s actual incentive compensation (including both cash and the fair value of Awards at the time of grant) (i) for the three most recent full fiscal years for which the Eligible Participant has been paid incentive compensation or (ii) for such lesser number of full or partial fiscal years for which the Eligible Participant has been paid incentive compensation (with

 

3

any partial fiscal year weighted proportionally less than any full fiscal year in determining the Eligible Participant’s average incentive compensation; and, in the event the Eligible Participant never has been paid any incentive compensation for a full or partial fiscal year, the Target Incentive Compensation shall be the target annual incentive compensation for the Termination Year as may be set forth in the annual budget for WisdomTree, Inc. as initially approved by the Board of Directors of WisdomTree, Inc. for the Termination Year or the Eligible Participant’s employment agreement or offer letter, or if no such amount is set forth therein, 100% of the Eligible Participant’s Annual Base Salary).

(z)    “Termination Year” means the fiscal year in which the Date of Termination occurs.

(aa)    “Termination Year Cash Incentive Compensation” means the product of: (i) the Committee’s aggregate percentage funding of the Company’s budgeted incentive compensation pool for the Termination Year, multiplied by (ii) 50% of the Eligible Participant’s Target Incentive Compensation for the Termination Year. If the Eligible Participant was not employed by the Company for the entirety of the Termination Year, the foregoing amount shall be multiplied by the fraction obtained by dividing the number of days the Eligible Participant was employed by the Company during the Termination Year by 365.

(bb)    “Time-Based Awards” means all then-outstanding stock-based awards of the Company that are subject solely to time-based vesting.

(cc)    “UK Eligible Participant” means any Eligible Participant employed in the United Kingdom.

(dd)    “US Eligible Participant” means any Eligible Participant employed in the United States or, for purposes of Section 8(b) and 8(c), otherwise subject to the federal tax laws of the United States.

2.    Administration of this Plan.

(a)    Administrator. This Plan shall be administered by the Administrator.

(b)    Powers of Administrator. The Administrator shall have all powers necessary to enable it to properly carry out its duties with respect to the complete control of the administration of this Plan. Not in limitation, but in amplification of the foregoing, the Administrator shall have the power and authority in its discretion to:

(i)    construe this Plan to determine all questions that shall arise as to interpretations of this Plan’s provisions;

(ii)    determine which individuals are and are not Eligible Participants, determine the benefits to which any Eligible Participant may be entitled, the eligibility requirements for participation in this Plan and all other matters pertaining to this Plan;

(iii)    adopt amendments to this Plan that are deemed necessary or desirable to comply with all applicable laws and regulations, including, but not limited to, Section 409A of the Code and the guidance thereunder;

(iv)    make all determinations it deems advisable for the administration of this Plan, including the authority and ability to delegate administrative functions to a third party;

(v)    decide all disputes arising in connection with this Plan; and

(vi)    otherwise supervise the administration of this Plan.

All decisions and interpretations of the Administrator shall be final, conclusive and binding on all parties, including the Company and Eligible Participants.

 

4

3.    Eligibility. All Eligible Participants who have (i) served for at least 12 months as an Executive Officer or in another senior executive role of the Company as determined by the Administrator by written resolution in its sole discretion, (ii) executed and submitted to the Company a Participation Agreement and (iii) satisfied such other requirements as may be determined by the Administrator from time to time, are eligible to participate in this Plan. Notwithstanding the foregoing, the Administrator may determine at any time that an Eligible Participant should no longer be designated as such as a result of a material change in such Eligible Participant’s role, and such individual shall cease to be eligible to participate in this Plan on the date that is the first anniversary of the effective date of the Eligible Participant’s change in status.

4.    Termination Generally. If the Eligible Participant’s employment with the Company is terminated for any reason other than death, Disability or for Cause, each of the Company and the Eligible Participant agree to discuss and in good faith seek to agree on the substance and wording of any internal and external communications regarding the circumstances of the Eligible Participant’s termination.

If the Eligible Participant’s employment with the Company is terminated for any reason (including without limitation death or Disability), the Company shall pay or provide to the Eligible Participant (or to the Eligible Participant’s authorized representative or estate), on or before the time required by law but in any event (i) within 10 business days following the Date of Termination with respect to the amount set forth in clause (a) below, (ii) upon payment of the annual incentive compensation for the Prior Year to the Company’s other senior executives with respect to the amount set forth in clause (b) below, provided, however, that the Eligible Participant shall not receive any payment pursuant to clause (b) below if (A) the Eligible Participant resigns the Eligible Participant’s employment without Good Reason, (B) the Eligible Participant’s employment is terminated by the Company for Cause, or (C) the Eligible Participant received payment, prior to the Date of Termination, of the Eligible Participant’s incentive compensation for the Prior Year, and (iii) promptly after submission of a request for Reimbursement, with appropriate documentation in accordance with the Company’s policies and procedures then in effect, with respect to the amount set forth in clause (c) below:

(a)    all accrued but unpaid Annual Base Salary, and accrued but unused vacation or paid time off, if applicable, through the Date of Termination;

(b)    the Prior Year Cash Incentive Compensation. If the Eligible Participant was not employed by the Company for the entirety of the Prior Year, the foregoing amount shall be multiplied by the fraction obtained by dividing the number of days the Eligible Participant was employed by the Company during the Prior Year by 365; and

(c)    the Reimbursement.

5.    Involuntary Termination.

(a)    Upon the Eligible Participant’s Involuntary Termination and provided the Eligible Participant (i) enters into a fully effective Release Agreement in substantially the form attached as Exhibit A hereto (the “Release”) within 60 days after the Date of Termination (or such shorter period as set forth in the Release) and complies with such Release, and (ii) complies with the Restrictive Covenant Agreement, the Company will pay, in the manner set forth below, as severance to the Eligible Participant (or in the case of the Eligible Participant’s subsequent death, the legal representative of the Eligible Participant’s estate or such other person or persons as the Eligible Participant shall have designated by written notice to the Company) an amount equal to the sum of:

(i)    the Annual Base Salary;

(ii)    the Termination Year Cash Incentive Compensation; and

(iii)    the Average Cash Incentive Compensation.

 

5

(b)    Notwithstanding anything to the contrary in any applicable Award agreement, (i) any Awards held by the Participant that would have vested during the Post-Employment Period shall immediately accelerate and become fully vested and exercisable or nonforfeitable, as applicable, as of the later of (A) the Date of Termination or (B) the effective date of the Release (such date, the “Accelerated Vesting Date”), provided that in order to effectuate the accelerated vesting contemplated by this subsection, the unvested portion of an Eligible Participant’s Awards that would otherwise be forfeited on the Date of Termination will be delayed until the earlier of (x) the effective date of the Release (at which time the acceleration contemplated by this subclause (b)(i) will occur) or (y) the date that the Release can no longer become fully effective (at which time the entire unvested portion of such Awards will be forfeited), (ii) vesting of the Eligible Participant’s Awards shall otherwise cease as of the Date of Termination, but the Eligible Participant’s Awards that remain unvested as of the Accelerated Vesting Date and that were not forfeited pursuant to clause (b)(i) (y) above will remain outstanding until the last day of the Post-Employment Period, and (iii) if a Change of Control occurs during the Post-Employment Period, the Eligible Participant shall be entitled to any accelerated vesting with respect to the Awards that the Eligible Participant would have been entitled to if the Eligible Participant had remained employed through the date of the Change of Control. For the avoidance of doubt, no accelerated vesting pursuant to this Section 5(b) will occur unless the Eligible Participant enters into a fully effective Release within 60 days after the Date of Termination (or such shorter period as set forth in the Release) and complies with such Release.

(c)    If the Eligible Participant elects COBRA insurance coverage, the Company will reimburse the Eligible Participant on a monthly basis for 100% of the amount of such premiums (the “COBRA Premiums”) for such insurance for 12 months following the Date of Termination; provided that the Company’s payment obligation shall cease upon the expiration of the Eligible Participant’s rights under COBRA or if the Eligible Participant becomes reemployed and eligible for group health benefits; provided further, however, that if the Company determines that it cannot pay such amounts without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then the Company will convert such payments to payroll payments directly to the Eligible Participant for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings and paid on the Company’s regular payroll dates. For the avoidance of doubt, the taxable payments described above may be used for any purpose, including, but not limited to, continuation coverage under COBRA.

(d)    The Termination Year Cash Incentive Compensation shall be paid when the Company pays to non-terminated senior executives their year-end incentive compensation for the Termination Year, but in no event later than March 15 of the calendar year following the Eligible Participant’s Date of Termination. The Annual Base Salary and Average Cash Incentive Compensation shall be paid out in substantially equal bi-monthly or semi-weekly installments in accordance with the Company’s payroll practice over 12 months commencing within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, those amounts, to the extent they qualify as “non-qualified deferred compensation” within the meaning of Section 409A of the Code, shall begin to be paid in the second calendar year by the last day of such 60-day period; provided, further, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination. Notwithstanding the foregoing, if the Eligible Participant breaches any of the Continuing Obligations, all payments under this Section 5 shall immediately cease, but the Eligible Participant shall be entitled to retain any payments made to the Eligible Participant prior to any breach by the Eligible Participant of the Continuing Obligations.

6.    Voluntary Resignation Without Good Reason or Termination for Cause.

(a)    If the Eligible Participant resigns the Eligible Participant’s employment without Good Reason, the Eligible Participant shall provide the Company with at least 10 business days’ written notice before the effective Date of Termination (the “Notice Period”). At any time during the Notice Period, or in the event the Company terminates the Eligible Participant’s employment for Cause, the Company may (but shall not be obligated to) elect to invoke the Three-Month Restrictive Covenant as provided in the Restrictive Covenant Agreement (the “Three-Month Restrictive Covenant Election”). In the event the Company provides the Eligible Participant with a timely Three-Month Restrictive Covenant Election following the Eligible Participant’s resignation without Good Reason or the termination of the Eligible Participant’s employment by the Company for Cause, then provided the Eligible Participant (I) enters into a fully effective Release within 60 days after the Date of Termination (or such shorter period as set forth in the Release) and complies with such Release, and (II) complies with the Three-Month Restrictive Covenant (the “Three-Month Restrictive Covenant

 

6

Requirements”), the Company will pay the Eligible Participant the sum of:

(i)    25% of the Annual Base Salary;

(ii)    an amount equal to 12.5% of the Target Incentive Compensation for the Termination Year; and

(iii)    an amount equal to 25% of the value (determined based on the closing price of a share of the underlying stock on the Date of Termination multiplied by the number of shares subject to the Time-Based Award) of any Time-Based Awards that would have vested in the Post-Employment Period if no termination had occurred (assuming for the purpose of this calculation that during the Post-Employment Period no event (such as a Change of Control) would occur that would provide for the acceleration of vesting under any such Time-Based Award).

(b)    This amount shall be paid out in substantially equal bi-monthly or semi-weekly installments in accordance with the Company’s payroll practice over three months commencing within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, those amounts, to the extent they qualify as “non-qualified deferred compensation” within the meaning of Section 409A of the Code, shall begin to be paid in the second calendar year by the last day of such 60-day period; provided, further, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination. In addition, if the Three-Month Restrictive Covenant Requirements are complied with and the Eligible Participant elects COBRA insurance coverage, the Company will reimburse the Eligible Participant for COBRA Premiums for three months following the Date of Termination; provided that the Company’s payment obligation shall cease upon the expiration of the Eligible Participant’s rights under COBRA or if the Eligible Participant becomes reemployed and eligible for group health benefits; provided further, however, that if the Company determines that it cannot pay such amounts without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then the Company will convert such payments to payroll payments directly to the Eligible Participant for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings and paid on the Company’s regular payroll dates. For the avoidance of doubt, the taxable payments described above may be used for any purpose, including, but not limited to, continuation coverage under COBRA.

(c)    Notwithstanding the foregoing, if the Eligible Participant breaches any of the Continuing Obligations, all payments under this Section 6 shall immediately cease, but the Eligible Participant shall be entitled to retain any payments made to the Eligible Participant prior to any breach by the Eligible Participant of the Continuing Obligations.

7.    Termination Upon a Change of Control.

(a)    The provisions of this Section 7 shall apply in lieu of, and expressly supersede, the provisions of Section 5 regarding severance pay and benefits upon a termination of employment, if such termination of employment occurs within 18 months after the occurrence of a Change of Control. Upon a Post-Change of Control Termination, and provided the Eligible Participant (I) enters into a fully effective Release within 60 days after the Date of Termination (or such shorter period as set forth in the Release) and complies with such Release, and (II) the Eligible Participant complies with the Twelve-Month Restrictive Covenant set forth in the Restrictive Covenant Agreement (provided that the Eligible Participant shall not be obligated to comply with the Twelve-Month Restrictive Covenant following the one year anniversary of the Date of Termination), the Company will pay, in the manner set forth below, as severance to the Eligible Participant (or in the case of the Eligible Participant’s subsequent death, the legal representative of the Eligible Participant’s estate or such other person or persons as the Eligible Participant shall have designated by written notice to the Company):

(i)    the sum of (A) 1.75 times the Annual Base Salary; (B) an amount determined by multiplying the Average Cash Incentive Compensation by the fraction obtained by dividing the number of days the Eligible Participant was employed by the Company during the Termination Year by 365; and (C) 1.75 times the Average Cash Incentive Compensation. The amount in

 

7

this Section 7(a) shall be paid in a lump sum within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, such payments to the extent they qualify as “non-qualified deferred compensation” within the meaning of Section 409A of the Code, shall be paid in the second calendar year by the last day of such 60-day period;

(ii)    (A) notwithstanding anything to the contrary in any applicable Time-Based Award agreement, Time-Based Awards held by the Eligible Participant that would have vested in the 21-month period following the Date of Termination shall immediately accelerate and become fully vested and exercisable or nonforfeitable, as applicable, as of the Accelerated Vesting Date, provided that in order to effectuate the accelerated vesting contemplated by this subsection, the unvested portion of an Eligible Participant’s Time-Based Awards that would otherwise be forfeited on the Date of Termination will be delayed until the earlier of (x) the effective date of the Release (at which time acceleration will occur) or (y) the date that the Release can no longer become fully effective (at which time the unvested portion of such Time-Based Awards will be forfeited), and (B) Performance-Based Awards will vest in accordance with the terms of the applicable Performance-Based Award agreement; and

(iii)    if the Eligible Participant elects COBRA insurance coverage, the Company will reimburse the Eligible Participant for COBRA Premiums for 21 months following the Date of Termination; provided that the Company’s payment obligation shall cease upon the expiration of the Eligible Participant’s rights under COBRA or if the Eligible Participant became reemployed and eligible for group health benefits; provided further, however, that if the Company determines that it cannot pay such amounts without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then the Company will convert such payments to payroll payments directly to the Eligible Participant for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings and paid on the Company’s regular payroll dates. For the avoidance of doubt, the taxable payments described above may be used for any purpose, including, but not limited to, continuation coverage under COBRA.

(b)    The Company agrees to maintain, for a period of at least six (6) years after the Eligible Participant’s Date of Termination, directors’ and officers’ liability insurance insuring the Eligible Participant (in the Eligible Participant’s capacity as an officer and/or director) and other officers and directors, with a limit of liability not less than the aggregate of the respective amounts set forth in the policy or policies maintained by the Company immediately prior to the Change of Control.

(c)    Notwithstanding the foregoing, if the Eligible Participant breaches any Continuing Obligations, all payments under this Section 7 shall immediately cease, but the Eligible Participant shall be entitled to retain any payments made to the Eligible Participant prior to any breach by the Eligible Participant of the Continuing Obligations. However, if the Eligible Participant breaches the Twelve-Month Restrictive Covenant, the Company shall be entitled to recover from the Eligible Participant a pro-rata portion of the payments made to the Eligible Participant under this Section 7 that correspond to the proportionate period of time that the Eligible Participant was in breach of the Twelve-Month Restrictive Covenant.

8.    General Terms and Conditions.

(a)    Tax Withholding. All payments made by the Company under this Plan shall be subject to any tax or other amounts required to be withheld by the Company under applicable law.

(b)    Section 409A (US Eligible Participants only).

(i)    Anything in this Plan to the contrary notwithstanding, if at the time of the Eligible Participant’s “separation from service” within the meaning of Section 409A of the Code, the Company determines that the Eligible Participant is a “specified

 

8

employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Eligible Participant becomes entitled to under this Plan would be considered deferred compensation subject to the 20% additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided, as applicable, until the date that is the earlier of (A) six months and one day after the Eligible Participant’s separation from service, or (B) the Eligible Participant’s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule.

(ii)    The Company and each Eligible Participant intend that this Plan will be administered in accordance with Section 409A of the Code and that all amounts payable hereunder shall be exempt from the requirements of such section to the greatest extent possible. To the extent that any provision of this Plan is not exempt from Section 409A of the Code or ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner to comply with Section 409A of the Code. Each payment pursuant to this Plan is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). Each Eligible Participant acknowledges that this Plan may be amended as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to the Company or the Eligible Participant.

(iii)    To the extent that any payment or benefit described in this Plan constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Eligible Participant’s termination of employment, then such payments or benefits shall be payable only upon the Eligible Participant’s “separation from service.” The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h).

(iv)    All in-kind benefits provided and expenses eligible for reimbursement under this Plan shall be provided by the Company or incurred by the Eligible Participant during the time periods set forth in this Plan. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

(v)    The Company makes no representation or warranty and shall have no liability to any Eligible Participant or any other person if any provisions of this Plan are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.

(c)    Additional Limitation (US Eligible Participants only).

(i)    Anything in this Plan to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution by the Company to or for the benefit of any Eligible Participant, whether paid or payable or distributed or distributable pursuant to the terms of this Plan or otherwise, calculated in a manner consistent with Section 280G of the Code and the applicable regulations thereunder (the “Aggregate Payments”), would be subject to the excise tax imposed by Section 4999 of the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the Eligible Participant becomes subject to the excise tax

 

9

imposed by Section 4999 of the Code; provided that such reduction shall only occur if it would result in the Eligible Participant receiving a higher After Tax Amount (as defined below) than the Eligible Participant would receive if the Aggregate Payments were not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following order, in each case, in reverse chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from consummation of the transaction that is subject to Section 280G of the Code: (1) cash payments not subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits; provided that, in the case of all the foregoing Aggregate Payments, all amounts or payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c) shall be reduced before any amounts that are subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c).

(ii)    For purposes of this Section 8(c), the “After Tax Amount” means the amount of the Aggregate Payments less all federal, state, and local income, excise and employment taxes imposed on the Eligible Participant as a result of the Eligible Participant’s receipt of the Aggregate Payments. For purposes of determining the After Tax Amount, the Eligible Participant shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes.

(iii)    The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section 8(c)(i) shall be made by a nationally recognized accounting firm selected by the Company (the “Accounting Firm”), which shall provide detailed supporting calculations both to the Company and the Eligible Participant within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or the Eligible Participant. Any determination by the Accounting Firm shall be binding upon the Company and the Eligible Participant.

(d)    Unfunded Plan. This Plan shall be unfunded and shall not create (or be construed to create) a trust or separate fund. Likewise, this Plan shall not establish any fiduciary relationship between the Company or any of its subsidiaries or affiliates and any Eligible Participant.

(e)    Notice and Communication of Date of Termination.

(i)    Notice of Termination. A termination of the Eligible Participant’s employment shall be communicated by a Notice of Termination from the Company to the Eligible Participant or vice versa in accordance with this Section 8(e). For purposes of this Plan, a “Notice of Termination” shall mean a notice which shall indicate the specific termination provision in this Plan relied upon.

(ii)    Delivery of Notice. Any notices, requests, demands, and other communications provided for by this Plan shall be sufficient if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to an Eligible Participant at the last address the Eligible Participant has filed in writing with the Company, or to the Company at the following physical or email address:

WisdomTree, Inc.

250 West 34th Street, 3rd Floor

New York, NY 10119

Attention: Chief Legal Officer

Email: legalnotice@wisdomtree.com

 

10

(f)    No Mitigation. Eligible Participants are not required to seek other employment or to attempt in any way to reduce any amounts payable to an Eligible Participant under this Plan.

(g)    Benefits and Burdens. This Plan shall inure to the benefit of and be binding upon the Company and the Eligible Participants, their respective successors, executors, administrators, heirs and permitted assigns. In the event of an Eligible Participant’s death after a termination of employment but prior to the completion of all payments due to the Eligible Participant under this Plan, the Company (or its successor) shall continue such payments to the Eligible Participant’s beneficiary designated in writing to the Company prior to the Eligible Participant’s death (or to the Eligible Participant’s estate, if the Eligible Participant fails to make such designation).

(h)    Enforceability. If any portion or provision of this Plan shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Plan, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Plan shall be valid and enforceable to the fullest extent permitted by law.

(i)    Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance of any term or obligation of this Plan, or the waiver by any party of any breach of this Plan, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

(j)    Non-Duplication of Benefits and Effect on Other Plans. Notwithstanding any other provision in this Plan to the contrary, the benefits provided hereunder shall be in lieu of any other severance payments and/or benefits provided by the Company, including, without limitation, any such severance payments, notice pay and/or benefits pursuant to an employment agreement or offer letter between the Company and the Eligible Participant. For UK Eligible Participants, the benefits provided in this Plan shall be inclusive of any statutory redundancy payment.

(k)    Contract of Employment. Nothing in this Plan shall be construed as giving any Eligible Participant any right to be retained in the employ of the Company or shall affect the terms and conditions of an Eligible Participant’s employment with the Company.

(l)    Amendment or Termination of Plan. The Company may amend or terminate this Plan at any time or from time to time, but no such action shall adversely affect the rights of any Eligible Participant without providing the Eligible Participant with 12 months’ prior notice of such action.

(m)    Obligations of Successors. In addition to any obligations imposed by law upon any successor to the Company, any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company shall expressly assume and agree to perform this Plan in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.

(n)    Attorney’s Fees. If the Eligible Participant initiates or otherwise participates in any arbitration proceeding against the Company to enforce the rights and entitlements granted to the Eligible Participant pursuant to Sections 4, 5, 6, or 7 and the Eligible Participant substantially prevails in such a proceeding, the Eligible Participant shall be entitled to recover from the Company all of the Eligible Participant’s costs of enforcement, including reasonable attorney’s fees and expenses.

(o)    Governing Law. This Plan shall be construed in accordance with and governed by the laws of the State of New York, without regard to principles of conflict of laws of such state.

(p)    Effective Date. This Plan is effective as of February 23, 2023.

 

11

Exhibit A to Executive Severance Plan

FORM OF RELEASE AGREEMENT

In consideration for the agreement by _________ (“Employer”) to provide ____________ (“Employee”) with the severance payments (the “Severance”) set forth in the Executive Severance Plan (the “Plan”), and for other good and valuable consideration as set forth therein, which Employee hereby acknowledges:

 

1.

Employee, on behalf of Employee and Employee’s heirs, representatives and assigns, hereby releases and discharges Employer, WisdomTree, Inc. (the “Company”), any direct or indirect subsidiary of the Company, including Employer (each a “WT Sub” and collectively, the “WT Subs”) and any investment company to which Employer, the Company or any WT Sub serves or has served as investment advisor or manager (each a “WT Advised Issuer” and collectively, the “WT Advised Issuers”) and all of their respective subsidiaries, divisions and affiliated or related companies (collectively, the “Primary Releasees”), and all of the respective current and former directors, officers, stockholders, successors, assigns, agents, representatives and employees of each, and their members, trustees and attorneys (collectively, the “Secondary Releasees,” and, together with the Primary Releasees, the “Releasees”), of and from (i) any and all claims Employee ever had, now has, or may have in the future against one or more of the Primary Releasees regarding any matter arising on or before the Effective Date of this Release, and (ii) any and all claims Employee ever had, now has, or may have in the future against one or more the Secondary Releasees regarding any matter arising on or before the Effective Date of this Release (but, with respect to this clause (ii), only to the extent that the matter relates to Employee’s employment by Employer), including, without limitation, all claims regarding Employee’s employment with Employer or the termination thereof, any claim for equitable relief or recovery of monies or damages, claims of breach of contract, wrongful termination, unjust dismissal, defamation, libel or slander, or under any federal, state or local law dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability or sexual preference, any tort, any claim for wages, any claim for breach of a fair employment practice law, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Older Workers Benefit Protection Act, the Civil Rights Act of 1991, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act, the Family and Medical Leave Act, the New York State Human Rights Law, the New York City Humans Rights Law, the New York Labor Law, workers compensation laws and any violation of any other local, state or federal law, ordinance or regulation, the common law and any other purported restriction on an employer’s right to terminate the employment of employees. It is the understanding and agreement of the parties that the release provided by this sub-paragraph shall be a general release in all respects. Notwithstanding the foregoing, this Release does not extend to: (a) those rights that cannot be waived as a matter of law; (b) Employee’s right to claim entitlement to the Severance as set forth in the Plan; or (c) Employee’s right to indemnification protections as an officer and/or director of the Company and/or any of the Releasees as arising under contract, statute, regulation, certificates of incorporation or comparable documents of formation, or by-laws or comparable documents of organization.1

 

2.

Pursuant to and as a part of Employee’s complete, total release and discharge of the Primary Releasees as set forth in Paragraph 1 above, and as part of Employee’s limited release and discharge of the Secondary Releasees as set forth in Paragraph 1, Employee expressly agrees, to the fullest extent permitted by law, not to (a) sue, file a charge, claim, complaint, grievance or demand for arbitration in any forum or (b) assist or otherwise participate willingly or voluntarily in any claim, arbitration, suit, action, charge, complaint, investigation or other proceeding of any kind, in each case, which relates to (i) any matter that involves the Primary Releasees and that occurred on or before the Effective Date of this Release or (ii) any matter that involves the Secondary Releasees and relates to Employee’s employment by the Company and that occurred on or before the Effective Date of this Release. Employee represents that Employee has not filed or initiated any such proceedings against any of the Releasees as of the Effective Date. Nothing in this Release shall be interpreted or applied to prohibit Employee from making any good faith report to any governmental agency or other governmental entity concerning any acts or omissions that Employee may believe to constitute a possible violation of federal or

 

1 

WisdomTree reserves the right to update this Form of Release Agreement to account for the law of the state in which the Employee is located.

 

12

  state law or making other disclosures that are protected under the whistleblower provisions of applicable federal or state law or regulation. Nothing in this Release shall be construed to prohibit Employee from filing a charge with or participating in any investigation or proceeding conducted by the Equal Employment Opportunity Commission (“EEOC”) or a comparable state or local agency. Notwithstanding the foregoing, Employee agrees to waive the right to recover monetary damages in any charge, complaint, or lawsuit filed by Employee or by anyone else on Employee’s behalf with the EEOC or a comparable state or local agency. For the avoidance of doubt, this Release does not limit Employee’s right to receive an award for information provided to any government agency or entity other than the EEOC or a comparable state or local agency. Except as otherwise provided in this paragraph, Employee will not voluntarily participate in any judicial proceeding of any nature or description against any of the Releasees that in any way involves the allegations and facts that Employee could have raised against any of the Releasees as of the date of this Release.

 

3.

If forty (40) years of age or older, Employee specifically releases all claims under the Age Discrimination in Employment Act (the “ADEA”), including without limitation claims relating to Employee’s employment and its termination.

 

4.

Employee acknowledges that Employee fully understands and agrees that this Release shall operate as a complete defense to any claim or entitlement which hereafter may be asserted by Employee against any and all of the Releasees for or on account of any matter or thing whatsoever arising out of or in any way based upon the circumstances, facts and events relating to Employee’s employment and separation from employment, or to any claim made by Employee against any of the Releasees arising from such circumstances, facts and events.

 

5.

Employee is specifically agreeing to the terms of this Release because Employer has agreed to pay Employee money to which Employee was not otherwise entitled under Employer’s policies, and has provided such other good and valuable consideration as specified herein. Employer has agreed to provide this money and other benefits because of Employee’s agreement to accept it in full settlement of all possible claims Employee might have or ever had against the Primary Releasees (and the Secondary Releasees as provided in Paragraph 1), and because of Employee’s execution of this Release.

 

6.

Employee acknowledges and agrees that in the event Employee breaches any Continuing Obligations (as defined in the Plan), Employer may discontinue further severance payments. For the avoidance of any doubt, even in such an event, Employee understands and agrees that this Release would remain in full force and effect. The Continuing Obligations are incorporated herein and remain in full effect.

 

7.

Employee acknowledges that Employee has read this Release in its entirety, fully understands its meaning and is executing this Release voluntarily and of Employee’s own free will with full knowledge of its significance. Employee acknowledges and warrants that Employee has had ample opportunity to consider the terms and provisions of this Release for at least twenty-one (21) days and that Employer advised Employee to consult with an attorney prior to executing this Release. If forty (40) years old or older, Employee further acknowledges and agrees that Employee has seven (7) days after executing this Release to revoke Employee’s signature on this Release, and that this Release does not become valid until the eighth (8th) day after Employee signs this Release without revocation. If Employee wishes to revoke this Release, such revocation must be in a signed writing and must arrive at Employer to the attention of the Head of Human Resources at 250 West 34th Street, 3rd Floor, New York, NY 10119, within the seven (7) day revocation period.

Printed Name:                                                           

Signature:                                                                  

Date:                                                                          

 

13

EX-10.4 5 d452823dex104.htm EX-10.4 EX-10.4

Exhibit 10.4

EXECUTION VERSION

Employee Confidentiality, Assignment and Restrictive Covenant Agreement

In consideration and as a condition of (i) my employment or continued employment by [NAME OF EMPLOYING ENTITY] (the “Employer,” and together with its ultimate parent WisdomTree, Inc. (“WisdomTree”) and each of their subsidiaries (whether or not wholly owned), other affiliates, successors and assigns, the “Company Entities”), (ii) my eligibility for the compensation and benefits from the Employer, (iii) the Confidential Information to which I will have access to in the course of my employment with the Employer, and (iv) the opportunity to participate in WisdomTree’s Executive Severance Plan (the “Plan”), I enter into this Employee Confidentiality, Assignment and Restrictive Covenant Agreement (this “Agreement”) and I agree to the terms and conditions in this Agreement.

1.        Confidential Information. I agree that all information, whether or not in writing, concerning the business, technology, business relationships or financial affairs of any of the Company Entities or any investment company to which any of the Company Entities serve, have served or may in the future serve, as an investment advisor or manager (each such investment company, a “WT Advised Issuer,” and collectively, the “WT Advised Issuers”) and that the Company Entities and the WT Advised Issuers (as applicable) have not released to the general public (collectively, “Confidential Information”) and all tangible embodiments thereof are and will be the exclusive property of the respective Company Entity or WT Advised Issuer, as applicable. By way of illustration, Confidential Information may include information or material that has not been made generally available to the public, such as: (a) corporate information, including plans, strategies, methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer or business partner identities or other information about customers, business partners, prospect identities or other information about prospects, or market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists, financial forecasts, pricing methodologies, market share data; (d) operational or technological information, including plans, specifications, manuals, forms, templates, software codes and designs, algorithms, technical data and strategies, research and development strategies, hardware configuration information, designs, methods, procedures or modalities, formulae, data, reports, discoveries, inventions, materials, improvements, concepts, ideas, models, processes, know-how and trade secrets, and other Intellectual Property (as defined below), agreements with third parties; and (e) personnel information, including personnel lists, reporting or organizational structure, resumes, personnel data, performance evaluations and termination arrangements or documents. Confidential Information also includes information received in confidence by the Company Entities or the WT Advised Issuers from their respective customers, suppliers, business partners or other third parties.

2.        Recognition of Company’s Rights. I will not, at any time, without the Employer’s prior written permission, either during or after my employment, disclose any Confidential Information to anyone outside of the Company Entities, or use or permit to be used any Confidential Information for any purpose other than the performance of my duties as an employee of the Employer. I will cooperate with the Company Entities and use my best efforts to prevent the unauthorized disclosure or use of all Confidential Information. I will deliver to the Chief Legal Officer of WisdomTree all copies and other tangible embodiments of Confidential Information in my possession or control upon the earlier of a request by the Company Entities or termination of my employment.

3.        Rights of Others. I understand that the Company Entities and WT Advised Issuers are now and may hereafter be subject to nondisclosure or confidentiality agreements with third persons that require the Company Entities and WT Advised Issuers to protect or refrain from use or disclosure of proprietary information. I agree to be bound by the terms of such agreements in the event I have access to such proprietary information. I understand that the Company Entities and WT Advised Issuers strictly prohibit me from using or disclosing confidential or proprietary information belonging to any other person or entity (including any employer or former employer) in connection with my employment. In addition, I agree not to bring any confidential information belonging to any other person or entity onto the Company Entities’ premises, property or into the Company Entities’ workspaces or transfer onto any device, database or technology systems of the Company Entities any such information belonging to any such person or entity.

4.        Commitment to Company Entities; Avoidance of Conflict of Interest. While an employee of the Employer, I will not, directly or indirectly, engage in (a) any business activity that is competitive with, or conflicts with, the business activities of the Company Entities or (b) without the prior written approval of the Chief Legal Officer of WisdomTree, any other outside business activity. I will advise the Chief Legal Officer of WisdomTree or

such person’s designee at such time as any activity of either the Company Entities or another business presents me with a conflict of interest or the appearance of a conflict of interest as an employee of the Employer. I will take whatever action is requested of me by WisdomTree to resolve any conflict or appearance of conflict which it or any other Company Entity finds to exist.

5.        Developments. During my employment, I will disclose to the Company Entities all artwork, articles, materials, memoranda, reports, writings, research, software, programs, promotions, compilations, designs, drawings, layouts, models, patterns, know-how, inventions, ideas, formulas, procedures, processes, concepts, discoveries, technology, algorithms, designs, methods, improvements or other works of any nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived, or reduced to practice by me individually or jointly with others, including but not limited to market indices, research procedures and models, which relate directly or indirectly to the business of the Company Entities or arise out of my employment with the Employer or my service as an officer of the other entities comprising the Company Entities or the use of the Company Entities’ property or resources including, without limitation, any market indices, research procedures, models, ideas, proposals and plans which may be copyrighted, trademarked, patented or otherwise protected (collectively, “Intellectual Property”). It is understood and agreed that Intellectual Property does not include ideas, proposals or plans of a legal nature that are commonly known among attorneys counseling companies in the exchange traded products industry or digital assets industry. To preclude any possible uncertainty, if there is any Intellectual Property that I have, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of my employment with the Employer that I consider to be my property or the property of third parties and that I wish to have excluded from the scope of this Agreement (“Prior Inventions”), I have set forth on Exhibit A attached hereto a complete list of those Prior Inventions. If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in Exhibit A but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. If, in the course of my employment with the Employer, I incorporate a Prior Invention into a product, process or machine, research or development program, or other work done for the Company Entities, I hereby grant to the Company Entities a nonexclusive, royalty-free, fully paid-up, irrevocable, worldwide license (with the full right to sublicense directly and indirectly through multiple tiers) to make, have made, modify, use, sell, offer for sale and import such Prior Invention.

I agree that, as between me and the Company Entities, all such Intellectual Property will be the sole property of the Company Entities. I expressly understand and agree that any and all Intellectual Property constitutes a “work for hire” under applicable law, including the U.S. Copyright Law. In the event any Intellectual Property is not regarded as a “work for hire,” I hereby assign to Employing Company (as defined below) the sole and exclusive right to all Intellectual Property and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, sui generis database rights and other intellectual property rights in all countries and territories worldwide and under any international conventions (collectively, “Intellectual Property Rights”). I agree that I will promptly disclose to the Company Entities any and all Intellectual Property, and that, upon request of the Company Entities, I will execute and deliver any and all documents or instruments and take any other action that the Company Entities will deem necessary to assign to and vest completely in the Employing Company, to perfect trademark, copyright and patent protection with respect to, or to otherwise protect the Company Entities’ trade secrets and proprietary interest in the Intellectual Property. With respect to any Intellectual Property and Intellectual Property Rights assigned hereunder to the Company Entities, during my employment and at any time thereafter, I will, at the request and expense of the Company Entities, sign, execute, make and do all such deeds, documents, acts and things as the Company Entities and their duly authorized agents may reasonably require: (i) to apply for, obtain and vest in the name of the Company Entities alone (unless the Company Entities otherwise directs) trademarks, copyrights or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same; and (ii) to defend any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for revocation of such trademarks, copyrights, patents or other analogous protection. In the event I do not, within five (5) days after delivery to me, execute and deliver such documents reasonably necessary to vest in the Company Entities all right, title and interest in such Intellectual Property, I hereby irrevocably designate and appoint the Company Entities and their duly authorized officers and agents as my agent and attorney-in-fact, to act for and on my behalf and stead to execute and file any such application or applications and to do all other lawfully permitted acts to further the prosecution and issuance of trademarks, copyright or other analogous protection thereon with the same legal force and effect as if executed by me. The obligations of this Section will continue after the termination of my employment with respect to such Intellectual Property conceived of or developed by me while employed by the Employing Company. The Company Entities agree to pay any and all copyright, trademark and

 

2

patent fees and expenses or the costs incurred by me at the Company Entities’ request for any assistance rendered to the Company Entities pursuant to this Section 5. I understand that to the extent this Agreement is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this Section 5 will be interpreted not to apply to any invention that a court rules and/or the Company Entities agree falls within such classes.

For the purposes of this Section 5, the term “Employing Company” means the entity employing me at the time that the applicable Intellectual Property is created, made, conceived or reduced to practice. If I am jointly employed by two or more entities at such time, the Employing Company means the entity that is the primary employer.

6.        Documents and Other Materials. I will keep and maintain adequate and current records of all Confidential Information and Intellectual Property developed by me during my employment, which records will be available to and remain the sole property of the Company Entities at all times.

Subject to Section 5, all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes, or other written, photographic or other tangible or electronic material containing Confidential Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company Entities to be used by me only in the performance of my duties for the Employer, other Company Entities and WT Advised Issuers, as applicable. Any property situated on the Company Entities’ premises or saved on the Company Entities’ technology systems and databases and owned by the Company Entities, including without limitation desktop or laptop computers, tablets, disks and other storage media, filing cabinets or other work areas or on the Company Entities’ networks or servers, is subject to inspection by the Company Entities at any time with or without notice. In the event of the termination of my employment for any reason, I will deliver to the Company Entities all property and equipment of the Company Entities in my possession, custody or control, including all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes, or other written, photographic or other tangible or electronic material containing Confidential Information, and other materials of any nature pertaining to the Confidential Information of the Company Entities and WT Advised Issuers and to my work, and will not take or keep in my possession any of the foregoing or any copies.

7.        Protection of Confidential Information and Intellectual Property; Associated Noncompetition and Nonsolicitation Obligations.

(a)        I agree that my services hereunder are of a special, unique and extraordinary character, and that my position with the Employer places me in a position of confidence and trust. I further acknowledge that in the course of rendering services to the Employer, other Company Entities and WT Advised Issuers, as applicable, I have obtained and will obtain Confidential Information of the Company Entities and WT Advised Issuers and gain access to customer goodwill. Accordingly, I agree that during my employment by the Employer and for a one-year period thereafter (the “Restricted Period”) with respect to clause (i) below, and at all times both during and after my employment with respect to clause (ii) below, I shall not, directly or indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise:

(i)        solicit, entice, or attempt to persuade any officer, director, employee, or agent of the Company Entities to become an officer, director, employee, or agent of, or perform services in any other capacity on behalf of, myself or any other person or entity; or

(ii)        disparage the reputation of the Company Entities or the respective directors, trustees, officers or employees of the Company Entities, or the product and service offerings of the Company Entities, including, without limitation, through written or spoken communication relating to the Company Entities, its personnel or its products and services; provided, that nothing in the foregoing subsection (ii) shall affect or impede any of my rights under the National Labor Relations Act, including my right to engage in concerted group activity and to communicate with colleagues and/or third parties (such as labor unions and their representatives) including regarding working conditions.

 

3

(b)        For three (3) months following the Date of Termination (as defined in the Plan) in the event of either (i) an Involuntary Termination (as defined in the Plan) or (ii) if the Employer or WisdomTree makes a Three-Month Restrictive Covenant Election under the Plan, I shall not directly or indirectly engage or participate, directly or indirectly (whether as an officer, director, employee, partner, consultant, holder of an equity or debt investment, lender, or in any other manner or capacity) (collectively, “Participate”), in the business or affairs of any Competitor (as defined below) unless (A) the Competitor also engages in activities other than in a Competitive Business (as defined below), (B) I do not occupy, with or at the Competitor, a corporate executive position that provides oversight of or support to such Competitor’s activities in a Competitive Business and (C) I do not Participate in the Competitive Business-related activities of the Competitor (and instead I engage solely in activities that do not concern a Competitive Business) (this Section 7(b), the “Three-Month Restrictive Covenant”).

(c)        For twelve (12) months following the date of my Post-Change of Control Termination (as defined in the Plan), I shall not directly or indirectly Participate in the business or affairs of any Restricted Competitor (as defined below) unless (i) the Restricted Competitor also engages in activities other than in a Competitive Business, (ii) I do not occupy, with or at the Restricted Competitor, a corporate executive position with the Restricted Competitor that provides oversight of or support to such Restricted Competitor’s activities in a Competitive Business and (iii) I do not Participate in the Competitive Business-related activities of the Restricted Competitor (and instead I engage solely in activities that do not concern a Competitive Business) (this Section 7(c), the “Twelve-Month Restrictive Covenant”).

(d)        To the extent I am an attorney admitted to practice in the State of New York, or any other state that limits the applicability of noncompetition provisions with respect to attorneys, the restrictions set forth in Sections 7(b) and 7(c) shall be binding on me only to the extent permissible under Rule 5.6 of the New York Rules of Professional Conduct (or the corresponding rule in such other state, if applicable). By way of explanation, if I am an attorney admitted to practice in the State of New York (or any other state that limits the applicability of noncompetition provisions with respect to attorneys) the restrictions contained in the aforementioned paragraphs shall be enforceable to the extent they seek to prohibit me from Participating in the affairs of a Competitor in a position that is non-legal in nature and does not require admittance to practice law as a pre-requisite to holding such position.

(e)        Definitions.

(i)        “AUM” means assets under management of an ETF Sponsor or ETP Sponsor as calculated and reported by Bloomberg or its successor, or if not so reported, then calculated by reference to shares outstanding and net asset value of its ETFs or ETPs, as the case may be, as reported by a Bloomberg terminal.

(ii)        “Competing ETF Sponsor” means an ETF Sponsor that is one of the top ten (10) ETF Sponsors in the United States based upon the AUM of its United States-listed ETFs, as of the end of the fiscal quarter immediately preceding the Date of Termination.

(iii)        “Competing ETP Sponsor” means an ETP Sponsor that is one of the top ten (10) ETP Sponsors in the European Union and the United Kingdom combined based upon the AUM of its European Union- and United Kingdom-listed ETPs, as of the end of the fiscal quarter immediately preceding the Date of Termination.

(iv)        “Competitive Business” means (i) the business of being an ETF Sponsor, (ii) the business of being an ETP sponsor or (iii) a business that competes with the WisdomTree Digital Business.

(v)        “Competitor” means any entity that (i) is an ETF Sponsor in the United States, (ii) is an ETP Sponsor in the European Union and/or the United Kingdom or (iii) competes with the WisdomTree Digital Business.

(vi)        “ETF” means:

(A)        any open-end management investment company or unit investment trust registered under the Investment Company Act of 1940, as amended (the “1940 Act”) that issues and redeems any series of redeemable securities in compliance with the conditions of an exemptive order or regulation issued or promulgated by the U.S. Securities and Exchange Commission permitting, among other things, (I) the shares to be issued and redeemed only in large

 

4

aggregations, and (II) secondary market transactions in the shares to occur at negotiated prices on national securities exchanges, as defined in Section 2(a)(26) of the 1940 Act (an “Exchange”), and lists such redeemable securities for trading on an Exchange; and

(B)        any exchange traded product, such as a grantor trust or other entity registered under the Securities Act of 1933, as amended (the “1933 Act”), (I) that is not registered as an investment company under the 1940 Act, (II) that is typically treated as a pass through entity under the Internal Revenue Code of 1986, as amended, (III) that issues and redeems a series of redeemable securities in large aggregations, and (IV) whose redeemable securities are listed for trading on one or more Exchanges and trade through secondary market transactions at negotiated prices on such Exchanges; or any exchange traded note registered under the 1933 Act that (x) provides for payments based on the performance of an index or pool of assets, (y) trades through secondary market transactions at negotiated prices on one or more Exchanges, and (z) is listed for trading on one or more Exchanges.

(vii)        “ETF Sponsor” means an entity that is, or as a result of my engagement or participation would become, a sponsor or promoter of an ETF or the investment advisor or investment manager to an ETF.

(viii)        “ETP” means an entity, or any exchange traded product, that issues securities that represent an entitlement by the holder to an investment return obtained by the entity by investing in securities, notes, commodities, cryptocurrencies or swaps to seek to achieve a stated investment purpose.

(ix)        “ETP Sponsor” means an entity that is, or as a result of my engagement or participation would become, a sponsor or promoter of an ETP or the advisor or manager to an ETP.

(x)        “Restricted Competitor” means any entity that (i) is a Competing ETF Sponsor, (ii) is a Competing ETP Sponsor or (iii) competes with the WisdomTree Digital Business in any jurisdiction where the Digital Wallet (as defined below) is offered to customers.

(xi)        “WisdomTree Digital Business” means the business of developing and/or operating a platform for the purchase, sale and exchange of blockchain-based digital assets, the issuance of tokens representing such assets, and/or the development and operation of a digital wallet via a mobile telephone application that provides services related thereto to facilitate such activity (“Digital Wallet”).

(f)        My ownership, in the aggregate, of less than 1% of the outstanding shares of capital stock of any corporation with revenues in excess of $100,000,000 and one or more classes of its capital stock listed on an Exchange shall not constitute a violation of the restrictions contained in clauses (b) or (c) above.

8.        Government Contracts. I acknowledge that the Company Entities may have, from time to time, agreements with other persons or with the United States government or its agencies that impose obligations or restrictions on the Company Entities regarding inventions made during the course of work under such agreements or regarding the confidential nature of such work. I agree to comply with any such obligations or restrictions upon the direction of the Company Entities. In addition to the rights assigned under Section 5, I also assign to the applicable Company Entity (or any of its nominees) all rights that I have or acquired in any Intellectual Property, full title to which is required to be in the United States under any contract between any such Company Entity and the United States or any of its agencies.

9.        Prior Agreements. I hereby represent that, except as I have fully disclosed previously in writing to the Employer or WisdomTree, I am not bound by the terms of any agreement with any previous or current employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of my employment with the Employer or to refrain from competing, directly or indirectly, with the business of such employer or any other party. I further represent that my performance of all of the terms of this Agreement as an employee of the Employer does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or in trust prior to my employment with the Employer. I will not disclose to the Company Entities or the WT Advised Issuers, as applicable, or induce the Company Entities or the WT Advised Issuers, as applicable, to use any confidential or proprietary information or material belonging to any previous employer or others.

 

5

10.        Remedies Upon Breach. If I commit a material breach, or if there are facts that indicate that I intend or I am about to commit a material breach, of any of the provisions of this Agreement, the Company Entities will have all legal and equitable rights available to it, including, without limitation, the right and remedy:

(a)        to have the provisions of this Agreement specifically enforced by any court having equity jurisdiction, including, but not limited to, granting the Company Entities an injunction against me, it being acknowledged and agreed by me that the services being rendered hereunder to the Company Entities are of a special, unique, and extraordinary character and that any such breach or threatened breach will cause irreparable injury to the Company Entities and that money damages will not provide an adequate remedy to the Company Entities; and

(b)        (x) to the fullest extent permitted by applicable law, to require me to account for and pay over to the Company Entities all compensation, profits, monies, accruals, increments or benefits (collectively “Benefits”) derived or received by me as the result of any transactions constituting a breach of any of the provisions of this Agreement, and I hereby agree to account for and pay over such Benefits to the Company Entities, and (y) to cease any severance payments that would otherwise be payable to me.

If any of the Company Entities shall initiate any legal proceeding to enforce the rights granted to it pursuant to this Agreement, the substantially prevailing party in such a proceeding shall be entitled to recover from the non-prevailing party all of its costs of enforcement or defense (as the case may be), including reasonable attorney’s fees and expenses.

If I commit a material breach of any of my obligations under this Agreement, the time period for which the obligation at issue shall run shall be tolled during the time such material breach is ongoing until the first date on which I cease to be in material breach of such obligation.

Each of the rights and remedies enumerated in this Section 10 will be independent of the other, and will be severally enforceable, and such rights and remedies will be in addition to, and not in lieu of, any other rights and remedies available to the Company Entities under law or equity. If any provision of Section 7 is held to be unenforceable because of the scope, duration, or area of its applicability, the tribunal making such determination will have the power to modify such scope, duration, or area, or all of them, and such provision or provisions will then be applicable in such modified form.

11.        Use of Voice, Image and Likeness. I give the Company Entities permission to use any and all of my voice, image and likeness, with or without using my name, in connection with the products and/or services of the Company Entities, for the purposes of advertising and promoting such products and/or services and/or the Company Entities, and/or for other purposes deemed appropriate by the Company Entities in its reasonable discretion, except to the extent prohibited by law.

12.        No Employment Obligation. I understand that this Agreement does not create an obligation on any of the Company Entities or any other person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement signed on behalf of the Employer by an authorized officer, my employment with the Employer is at will and therefore may be terminated by the Employer or me at any time and for any reason, with or without cause.

13.        Survival and Assignment by the Company. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment. I further understand that my obligations under this Agreement will continue following the termination of my employment regardless of the manner of such termination and will be binding upon my heirs, executors and administrators. The Company Entities will have the right to assign this Agreement to their affiliates, successors and assigns. I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company Entities or any parent, subsidiary or affiliate to whose employ I may be transferred without the necessity that this Agreement be re-signed at the time of such transfer. Further to the foregoing, for purposes of this Agreement, if my employment is transferred from the Employer to another member of the Company Entities, references herein to “Employer” shall be read to be such new employing entity, as applicable.

 

6

14.        Notice of Resignation. If I elect to resign from my employment with the Employer, I agree to provide the Employer with written notification of my resignation at least ten (10) business days prior to my intended resignation date. Such notice shall include information in reasonable detail about my post-employment job duties and other business activities, including the name and address of any subsequent employer and/or person or entity with whom or which I intend to engage in business activities during the Restricted Period and the nature of my job duties and other business activities. The Employer may elect to waive all or part of the 10-business day notice period in its sole discretion, and such waiver shall not result in a termination by the Employer for purposes of this Agreement or any other agreement to which any of the Company Entities and I are party.

15.        Post-Employment Notifications. During the Restricted Period, I will notify the Employer of any change in my address and of each subsequent employment or business activity, including the name and address of my employer or other post-employment plans and the nature of my activities.

16.        Disclosures During Restricted Period. I will provide a copy of this Agreement to any person or entity with whom I may enter into a business relationship, whether as an employee, consultant, partner, coventurer or otherwise, prior to entering into such business relationship during any restricted period.

17.        Waiver. I acknowledge and agree that no waiver of any of my obligations under this Agreement shall be effective unless made in writing by the Employer or WisdomTree. The failure of the Company Entities to require my performance of any term or obligation of this Agreement, or the waiver of any breach of this Agreement, shall not prevent the Company Entities’ subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

18.        Severability. If any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the maximum extent compatible with the applicable law as it shall then appear. In case any provisions (or portions thereof) contained in this Agreement shall, for any reason, be held invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein. To the extent applicable law requires additional consideration for this Agreement, any equity, cash incentive, or severance compensation for which the Company Entities may (in their sole discretion) make me eligible shall (in each case and independent of the other) constitute such consideration.

19.        Choice of Law and Jurisdiction. This Agreement will be deemed to be made and entered into in the State of New York (the “State”), and will in all respects be interpreted, enforced and governed under the laws of the State. I hereby consent to the exclusive jurisdiction of the state and federal courts situated within the State for purposes of enforcing this Agreement or for any other lawsuit relating to or arising under this Agreement, and I hereby waive any objection that I might have to personal jurisdiction or venue in those courts.

20.        Independence of Obligations. My obligations under this Agreement are independent of any obligation, contractual or otherwise, the Company Entities have to me. The Company Entities’ breach of any such obligation shall not be a defense against the enforcement of this Agreement or otherwise limit my obligations under this Agreement.

21.        Protected Disclosures. I understand that nothing contained in this Agreement limits my ability to communicate with any federal, state or local governmental agency or commission, including to provide documents or other information, without notice to the Company Entities. I also understand that nothing in this Agreement limits my ability to share compensation information concerning myself or others, except that this does not permit me to disclose compensation information concerning others that I obtain because my job responsibilities require or allow access to such information.

22.        Defend Trade Secrets Act of 2016; Other Legal Disclosures. I understand that nothing in this Agreement shall be interpreted or applied to prohibit me from making any good faith report to any governmental agency or other governmental entity concerning any acts or omissions that I may believe to constitute a possible violation of federal or state law or making other disclosures that are protected under the whistleblower provisions of applicable federal or state law or regulation. In addition, for the avoidance of doubt, I understand that pursuant to the federal Defend Trade Secrets Act of 2016, I shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or

 

7

investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

23.        Other Agreements; Amendment. This Agreement supplements and does not supersede any other confidentiality, assignment of inventions or restrictive covenant agreement between any of the Company Entities and me, including the provisions contained in my offer letter with the Employer. To the extent that this Agreement addresses similar subject matters, this Agreement supersedes any other agreements between any of the Company Entities and me with respect to such subject matters. Notwithstanding anything herein to the contrary, nothing in this Agreement shall limit or restrict my right to initiate a legal proceeding in a court of law or equity to seek indemnification from any Company Entity pursuant to any written indemnification agreement with such Company Entity and my right to have such Company Entity reimburse me for my expenses, including reasonable attorney’s fees, under such written agreement in connection with enforcing my claim for indemnification thereunder, as applicable. This Agreement may be amended only in a written agreement executed by a duly authorized officer of the Employer and WisdomTree and me.

24.        Counterparts. This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together constitutes one and the same agreement. Each party agrees that electronic signatures of the parties included in this Agreement will have the same force and effect as manual signatures. Delivery of an executed counterpart of this Agreement electronically shall be effective as delivery of an original executed counterpart of this Agreement.

[Remainder of Page Intentionally Left Blank]

 

8

I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING BELOW, I CERTIFY THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I UNDERSTAND IT COMPLETELY.

I ACKNOWLEDGE AND AGREE THAT THE TERMS OF THIS AGREEMENT WILL APPLY TO MY ENTIRE SERVICE RELATIONSHIP WITH THE EMPLOYER, INCLUDING WITHOUT LIMITATION ANY PERIOD OF SERVICE PRIOR TO THE DATE OF MY SIGNATURE BELOW.

IN WITNESS WHEREOF, the undersigned has executed this Agreement and it shall become effective when it is fully executed by all parties.

 

EMPLOYEE
Signed:                                                                                                   
Type or print name:                                                                               
Date:                                 
EMPLOYER
[NAME OF EMPLOYER]
By:                                                                                                         
Name:
Title:
Date:                                 
WISDOMTREE, INC.
By:                                                                                                         
Name:
Title:
Date:                                 

 

9

EXHIBIT A

To:        COMPANY ENTITIES

From:                                             

Date:                                              

SUBJECT:         Prior Inventions

            The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Employer that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Employer:

 

            ☐             No inventions or improvements

            ☐             See below:

                                                                                                                                                                                                                 

                                                                                                                                                                                                                 

                                                                                                                                                                                                                 

            ☐             Additional sheets attached

            The following is a list of all patents and patent applications in which I have been named as an inventor:

            ☐             None

            ☐             See below:

                                                                                                                                                                                                                 

                                                                                                                                                                                                                 

                                                                                                                                                                                                                 

 

10

EX-31.1 6 d452823dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification

I, Jonathan Steinberg, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of WisdomTree, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By:  

/s/ Jonathan Steinberg

  Jonathan Steinberg
 

Chief Executive Officer

(Principal Executive Officer)

Date: May 9, 2023

EX-31.2 7 d452823dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification

I, Bryan Edmiston, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of WisdomTree, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By:  

/s/ Bryan Edmiston

  Bryan Edmiston
 

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

Date: May 9, 2023

EX-32.1 8 d452823dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of WisdomTree, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission (the “SEC”) on the date hereof (the “Report”), we, Jonathan Steinberg, Chief Executive Officer of the Company, and Bryan Edmiston, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to our knowledge, that:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act, as amended; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification is being furnished and not filed, and shall not be incorporated into any documents for any purpose, under the Exchange Act, as amended. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

 

By:  

/s/ Jonathan Steinberg

  Jonathan Steinberg
 

Chief Executive Officer

(Principal Executive Officer)

By:  

/s/ Bryan Edmiston

  Bryan Edmiston
 

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

May 9, 2023

EX-101.SCH 9 wt-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Comprehensive Income/(Loss) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Organization and Description of Business link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Cash and Cash Equivalents link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Financial instruments owned link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Securities Held-to-Maturity link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Investments link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Fixed Assets, net link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Deferred Consideration link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Convertible Notes link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Series A Preferred Stock link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Contingencies link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Variable Interest Entities link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Revenues from Contracts with Customers link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Stock-Based Awards link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Stockholder Rights Plan link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Earnings/(Loss) Per Share link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Shares Repurchased link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Contingent Payments link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Financial instruments owned (Tables) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Securities Held-to-Maturity (Tables) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Fixed Assets, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Deferred Consideration (Tables) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Convertible Notes (Tables) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Series A Preferred Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Variable Interest Entities (Tables) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Revenues from Contracts with Customers (Tables) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Stock-Based Awards (Tables) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Earnings/(Loss) Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Lives of Related Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Cash and Cash Equivalents - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Fair Value Measurements - Summary of Categorization of Assets and Liabilities Measured at Fair Value (Detail) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Recurring Fair Value Measurements (Detail) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Financial instruments owned - Debt Securities, Trading, and Equity Securities, FV-NI (Detail) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Financial instruments owned - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Securities Held-to-Maturity - Schedule of Securities Held-to-Maturity (Detail) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Securities Held-to-Maturity - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity (Detail) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Securities Held-to-Maturity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Securities Held-to-Maturity - Schedule of Maturity Profile of Securities Held-to-Maturity (Detail) link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Investments - Details of Investments Carried at Cost (Detail) link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Investments - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Investments - Summary of Inputs Used in PWERM Approach of Investment (Detail) link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Fixed Assets, net - Schedule of Fixed Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Deferred Consideration - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - Deferred Consideration - Summary of valuation of deferred consideration (Detail) link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Deferred Consideration - Schedule of Deferred Consideration (Detail) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Convertible Notes - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Convertible Notes - Schedule of key terms of convertible notes (Detail) link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Convertible Notes - Summary of the carrying value of the convertible notes (Detail) link:presentationLink link:definitionLink link:calculationLink 1072 - Disclosure - Series A Preferred Stock - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1073 - Disclosure - Series A Preferred Stock - Summary of Series A Preferred Stock Balance (Detail) link:presentationLink link:definitionLink link:calculationLink 1074 - Disclosure - Leases - Summary of additional information regarding Company's Leases (Detail) link:presentationLink link:definitionLink link:calculationLink 1075 - Disclosure - Leases - Summary of future minimum lease payments (Detail) link:presentationLink link:definitionLink link:calculationLink 1076 - Disclosure - Leases - Summary of Reconciles future minimum lease payments (Detail) link:presentationLink link:definitionLink link:calculationLink 1077 - Disclosure - Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1078 - Disclosure - Variable Interest Entities - Summary of Information about Variable Interests (Detail) link:presentationLink link:definitionLink link:calculationLink 1079 - Disclosure - Revenues from Contracts with Customers - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1080 - Disclosure - Revenues from Contracts with Customers - Summary of Revenues from Contracts with Customers (Detail) link:presentationLink link:definitionLink link:calculationLink 1081 - Disclosure - Revenues from Contracts with Customers - Summary of Geographic Distribution of Revenue (Detail) link:presentationLink link:definitionLink link:calculationLink 1082 - Disclosure - Related Party Transactions - Summary of Accounts Receivable from Related Parties (Detail) link:presentationLink link:definitionLink link:calculationLink 1083 - Disclosure - Related Party Transactions - Summary of Revenues from Advisory Services Provided to Related Parties (Detail) link:presentationLink link:definitionLink link:calculationLink 1084 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1085 - Disclosure - Stock-Based Awards - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1086 - Disclosure - Stock-Based Awards - Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period (Detail) link:presentationLink link:definitionLink link:calculationLink 1087 - Disclosure - Stock-Based Awards - Summary of Restricted Stock Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1088 - Disclosure - Stock-Based Awards - Summary of Restricted Stock Activity (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1089 - Disclosure - Stockholder Rights Plan - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1090 - Disclosure - Earnings/(Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1091 - Disclosure - Earnings/(Loss) Per Share - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1092 - Disclosure - Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Detail) link:presentationLink link:definitionLink link:calculationLink 1093 - Disclosure - Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1094 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1095 - Disclosure - Income Taxes - Summary of Deferred Tax Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1096 - Disclosure - Income Taxes - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits (Detail) link:presentationLink link:definitionLink link:calculationLink 1097 - Disclosure - Shares Repurchased - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1098 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill by Reporting Unit (Detail) link:presentationLink link:definitionLink link:calculationLink 1099 - Disclosure - Goodwill and Intangible Assets - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1100 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1101 - Disclosure - Goodwill and Intangible Assets - Summary of Unamortized Finite-lived Intangible Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1102 - Disclosure - Contingent Payments - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 wt-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 wt-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 wt-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 wt-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 14 g452823g00v53.jpg GRAPHIC begin 644 g452823g00v53.jpg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end GRAPHIC 15 g452823g0508223256518.jpg GRAPHIC begin 644 g452823g0508223256518.jpg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end GRAPHIC 16 g452823sp036.jpg GRAPHIC begin 644 g452823sp036.jpg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g452823sp037.jpg GRAPHIC begin 644 g452823sp037.jpg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end GRAPHIC 18 g452823sp038.jpg GRAPHIC begin 644 g452823sp038.jpg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˄A0 4 =[X<_Y -M_P "_P#0C7GUOC9V4O@1 MJ5D:!0 4 % %74_^05>?]<7_ /035P^)$R^%GG%>D<(4 % %K3/^0K9_]=D_ M]"%1/X65'XD>CUYIW!0 4 % &#_S/_\ W#/_ &K0!O4 % !0!EZAJFE[9[&Z MN'3ES_OC^5<>(W1TT=F='7,; MA0 4 4-'_P"/*3_KYN/_ $<] !H__'E)_P!?-Q_Z.>@"_0 4 % &7XC_ .0# M<_\ ?\ T(5K1^-&=7X&<%7H'&% !0!J>'/^0];?\"_]!-8UO@9I2^-'>UP' M8% !0 4 % '&>+?^0K%_UQ'_ *$U=N'^$Y:WQ˄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end GRAPHIC 19 g452823sp038a.jpg GRAPHIC begin 644 g452823sp038a.jpg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˄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˄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end GRAPHIC 20 g452823sp060.jpg GRAPHIC begin 644 g452823sp060.jpg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end GRAPHIC 21 g452823sp068.jpg GRAPHIC begin 644 g452823sp068.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2023
May 04, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Period End Date Mar. 31, 2023  
Trading Symbol WT  
Document Fiscal Period Focus Q1  
Entity Registrant Name WisdomTree, Inc.  
Entity Central Index Key 0000880631  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   149,263,168
Document Transition Report false  
Document Quarterly Report true  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common Stock  
Security Exchange Name NYSE  
Entity File Number 001-10932  
Entity Address, Address Line One 250 West 34th Street  
Entity Address, Address Line Two 3rd Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10119  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 13-3487784  
City Area Code 212  
Local Phone Number 801-2080  
Preferred Stock [Member]    
Document Information [Line Items]    
Title of 12(b) Security Preferred Stock Purchase Rights  
Security Exchange Name NYSE  
No Trading Symbol Flag true  

XML 23 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents (Note 3) $ 119,099 $ 132,101
Financial instruments owned, at fair value (including $45,214 and $25,283 invested in WisdomTree products at March 31, 2023 and December 31, 2022, respectively) (Note 5) 130,180 126,239
Accounts receivable (including $32,446 and $24,139 due from related parties at March 31, 2023 and December 31, 2022, respectively) 35,496 30,549
Prepaid expenses 5,877 4,684
Income taxes receivable 1,799 0
Other current assets 291 390
Total current assets 292,742 293,963
Fixed assets, net 515 544
Indemnification receivable (Note 20) 0 1,353
Securities held-to-maturity 253 259
Deferred tax assets, net (Note 20) 5,871 10,536
Investments (Note 7) 26,902 35,721
Right of use assets—operating leases (Note 12) 1,153 1,449
Goodwill (Note 22) 85,856 85,856
Intangible assets, net (Note 22) 603,968 603,567
Other noncurrent assets 507 571
Total assets 1,017,767 1,033,819
Current liabilities:    
Convertible notes—current (Note 10) 59,884 59,197
Fund management and administration payable 27,830 36,521
Deferred consideration—gold payments (Note 9) 17,984 16,796
Compensation and benefits payable 9,341 24,121
Income taxes payable 0 1,599
Operating lease liabilities (Note 12) 1,041 1,125
Accounts payable and other liabilities 14,846 9,075
Total current liabilities 130,926 148,434
Convertible notes (Note 10) 273,767 262,019
Deferred consideration—gold payments (Note 9) 161,847 183,494
Operating lease liabilities (Note 12) 120 339
Other noncurrent liabilities (Note 20) 0 1,353
Total liabilities 566,660 595,639
Preferred stock—Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $86,638 and $77,969 at March 31, 2023 and December 31, 2022, respectively) (Note 11) 132,569 132,569
Contingencies (Note 13)
Stockholders' equity    
Preferred stock, par value $0.01; 2,000 shares authorized: 0 0
Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 149,291 and 146,517 at March 31, 2023 and December 31, 2022, respectively 1,493 1,465
Additional paid-in capital 292,971 291,847
Accumulated other comprehensive loss (954) (1,420)
Retained earnings 25,028 13,719
Total stockholders' equity 318,538 305,611
Total liabilities and stockholders' equity $ 1,017,767 $ 1,033,819
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 2,000,000 2,000,000
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 400,000,000 400,000,000
Common stock, shares issued 149,291,000 146,517,000
Common stock, shares outstanding 149,291,000 146,517,000
Accounts receivable from related parties $ 32,446 $ 24,139
Series A Redeemable Convertible Preferred Stock [Member]    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 14,750 14,750
Preferred stock, shares issued 14,750 14,750
Preferred stock, shares outstanding 14,750 14,750
Preferred Stock Redemption Value $ 86,638 $ 77,969
WisdomTree ETF [Member]    
Securities owned, at fair value $ 45,214 $ 25,283
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Revenues:    
Total revenues $ 82,044 $ 78,368
Operating Expenses:    
Compensation and benefits 27,398 24,787
Fund management and administration 17,153 15,494
Marketing and advertising 4,007 4,023
Sales and business development 2,994 2,609
Contractual gold payments (Note 9) 4,486 4,450
Professional fees 3,715 4,459
Occupancy, communications and equipment 1,101 753
Depreciation and amortization 109 47
Third-party distribution fees 2,253 2,212
Other 2,257 1,845
Total operating expenses 65,473 60,679
Operating income 16,571 17,689
Other Income/(Expenses):    
Interest expense (4,002) (3,732)
Gain/(loss) on revaluation of deferred consideration—gold payments (Note 9) [1] 20,592 (17,018)
Interest income 1,083 794
Impairments (Note 7) (4,900) 0
Loss on extinguishment of convertible notes (Note 10) (9,721) 0
Other losses, net (2,007) (24,707)
Income/(loss) before income taxes 17,616 (26,974)
Income tax expense/(benefit) 1,383 (16,713)
Net income/(loss) $ 16,233 $ (10,261)
Earnings/(loss) per share—basic $ 0.1 $ (0.08)
Earnings/(loss) per share—diluted $ 0.1 $ (0.08)
Weighted-average common shares—basic 143,862 142,782
Weighted-average common shares—diluted 159,887 142,782 [2]
Cash dividends declared per common share $ 0.03 $ 0.03
Advisory Fees [Member]    
Operating Revenues:    
Total revenues $ 77,637 $ 76,517
Other Income [Member]    
Operating Revenues:    
Total revenues $ 4,407 $ 1,851
[1] Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.
[2] Excludes 15,521 participating securities and 31 potentially dilutive non-participating common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands).
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Comprehensive Income/(Loss) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Net income/(loss) $ 16,233 $ (10,261)
Other comprehensive income/(loss)    
Foreign currency translation adjustment, net of income taxes 466 (486)
Other comprehensive income/(loss) 466 (486)
Comprehensive income/(loss) $ 16,699 $ (10,747)
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
As Adjusted [Member]
Retained Earnings/ (Accumulated Deficit)
Balance at Dec. 31, 2021 $ 269,424 $ 1,451 $ 289,736   $ 682 $ (22,445)
Balance, shares at Dec. 31, 2021   145,107,000        
Restricted stock issued and vesting of restricted stock units, net 0 $ 21 (21) $ 0   0
Restricted stock issued and vesting of restricted stock units net, shares   2,042,000        
Shares repurchased (3,394) $ (6) (3,388) 0   0
Shares repurchased, shares   (589,000)        
Stock-based compensation 2,936 $ 0 2,936 0   0
Other comprehensive income/(loss) (486) 0 0 (486)   0
Dividends (4,842) 0 (4,842) 0   0
Net income (loss) (10,261) 0 0 0   (10,261)
Balance at Mar. 31, 2022 253,377 $ 1,466 284,421 196   (32,706)
Balance, shares at Mar. 31, 2022   146,560,000        
Balance at Dec. 31, 2022 $ 305,611 $ 1,465 291,847 (1,420)   13,719
Balance, shares at Dec. 31, 2022 146,517,000 146,517,000        
Restricted stock issued and vesting of restricted stock units, net $ 0 $ 34 (34) 0   0
Restricted stock issued and vesting of restricted stock units net, shares   3,379,000        
Shares repurchased (3,384) $ (6) (3,378) 0   0
Shares repurchased, shares   (605,000)        
Stock-based compensation 4,536 $ 0 4,536 0   0
Other comprehensive income/(loss) 466 0 0 466   0
Dividends (4,924) 0 0 0   (4,924)
Net income (loss) 16,233 0 0 0   16,233
Balance at Mar. 31, 2023 $ 318,538 $ 1,493 $ 292,971 $ (954)   $ 25,028
Balance, shares at Mar. 31, 2023 149,291,000 149,291,000        
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income/(loss) $ 16,233 $ (10,261)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
(Gain)/loss on revaluation of deferred consideration—gold payments [1] (20,592) 17,018
Advisory and license fees paid in gold, other precious metals and cryptocurrency (12,760) (16,052)
Loss on extinguishment of convertible notes 9,721 0
Impairments 4,900 0
Deferred income taxes 4,783 5,273
Stock-based compensation 4,536 2,936
Contractual gold payments 4,486 4,450
Losses on investments 3,919 163
(Gains)/losses on financial instruments owned, at fair value (1,954) 5,142
Amortization of issuance costs—convertible notes 579 645
Amortization of right of use asset 319 89
Depreciation and amortization 109 47
Changes in operating assets and liabilities:    
Accounts receivable (4,791) (3,710)
Prepaid expenses (1,161) (2,264)
Gold and other precious metals 8,332 11,959
Other assets 167 (52)
Intangibles—software development (452) 0
Fund management and administration payable 3,638 3,199
Compensation and benefits payable (27,271) (23,690)
Income taxes payable (3,418) (4,228)
Operating lease liabilities (326) (97)
Accounts payable and other liabilities 5,606 6,741
Net cash used in operating activities (5,397) (2,692)
Cash flows from investing activities:    
Purchase of financial instruments owned, at fair value (20,278) (25,461)
Purchase of investments 0 (6,863)
Purchase of fixed assets (26) (54)
Proceeds from the sale of financial instruments owned, at fair value 18,290 13,639
Proceeds from held-to-maturity securities maturing or called prior to maturity 6 18
Net cash used in investing activities (2,008) (18,721)
Cash flows from financing activities:    
Repurchase of convertible notes (See Note 10) (124,317) 0
Dividends paid (4,821) (4,842)
Shares repurchased (3,384) (3,394)
Convertible notes issuance costs (3,548) 0
Proceeds from the issuance of convertible notes (Note 10) 130,000 0
Net cash used in financing activities (6,070) (8,236)
Increase/(decrease) in cash flow due to changes in foreign exchange rate 473 (665)
Net decrease in cash and cash equivalents (13,002) (30,314)
Cash and cash equivalents—beginning of year 132,101 140,709
Cash and cash equivalents—end of period 119,099 110,395
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 1,422 2,123
Cash paid for interest $ 801 $ 0
[1] Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Organization and Description of Business
1. Organization and Description of Business
WisdomTree, Inc., through its global subsidiaries (collectively, “WisdomTree” or the “Company”), is a global financial innovator, offering a well-diversified suite of exchange-traded products (“ETPs”), models and solutions. Building on its heritage of innovation, the Company is also developing next-generation digital products and structures, including digital or blockchain-enabled mutual funds (“Digital Funds”) and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime
™
. The Company has the following wholly-owned operating subsidiaries:
 
  •  
WisdomTree Asset Management, Inc.
is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (“WTT”) and WisdomTree exchange-traded funds (“ETFs”). The WisdomTree ETFs are issued in the U.S. by WTT. WTT is a
non-consolidated
Delaware statutory trust registered with the SEC as an
open-end
management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.
 
  •  
WisdomTree Management Jersey Limited
(“ManJer”) is a Jersey based management company providing management services to seven issuers (the “ManJer Issuers”) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and
leveraged-and-inverse
strategies.
 
  •  
WisdomTree Multi Asset Management Limited
(“WTMAML”) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (“WMAI”) in respect of the ETPs issued by WMAI. WMAI is a
non-consolidated
public limited company domiciled in Ireland.
 
  •  
WisdomTree Management Limited
(“WML”) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (“WTICAV”) in respect of the WisdomTree UCITS ETFs issued by WTICAV. WTICAV is a
non-consolidated
public limited company domiciled in Ireland.
 
  •  
WisdomTree UK Limited
(“WTUK”) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.
 
  •  
WisdomTree Europe Limited
is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK. WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.
 
  •  
WisdomTree Ireland Limited
is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.
 
  •  
WisdomTree Digital Commodity Services, LLC
is a New York based company that has been formed to serve as the sponsor of the WisdomTree Bitcoin Trust and WisdomTree Ethereum Trust, each an ETF currently under review with the SEC.
 
  •  
WisdomTree Digital Management, Inc. (“WT Digital Management”) is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (“WTDT”) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S. by WTDT. WTDT is a Delaware statutory trust registered with the SEC as an open-end management investment company. Each Digital Fund will use blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but will not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies. 
 
  •  
WisdomTree Digital Movement, Inc
. is a New York based company operating as a money services business registered with the Financial Crimes Enforcement Network (“FinCEN”) and seeking state money transmitter licenses to operate a platform for the purchase, sale and exchange of digital assets, while also providing digital wallet services through WisdomTree Prime
™
to facilitate such activity.
 
  •  
WisdomTree Securities, Inc
. is a New York based limited purpose broker-dealer (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds.
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies
2. Significant Accounting Policies
Basis of Presentation
These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of financial condition, results of operations, and cash flows for the periods presented. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Consolidation
The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.
The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.
Segment and Geographic Information
The Company, through its subsidiaries in the U.S. and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company’s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.
Foreign Currency Translation
Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income/(Loss) as a component of other comprehensive (loss)/income.
Use of Estimates
The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.
Revenue Recognition
The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
Contractual Gold Payments
Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note 9).
Marketing and Advertising
Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.
Depreciation and Amortization
Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows:
 
Equipment
      3 to 5 years  
Internally-developed software
      3 years  
The assets listed above are recorded at cost less accumulated depreciation and amortization.
 
Stock-Based Awards
Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.
Third-Party Distribution Fees
The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETFs and for including WisdomTree ETFs on third-party customer platforms and recognizes these expenses as incurred.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.
Accounts Receivable
Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.
Impairment of Long-Lived Assets
The Company performs a review for the impairment of long-lived assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.
Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)
Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or
available-for-sale
(“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.
Securities
Held-to-Maturity
The Company accounts for certain of its securities as
held-to-maturity
on a trade date basis, which are recorded at amortized cost. For
held-to-maturity
securities, the Company has the intent and ability to hold these securities to maturity and it is not
more-likely-than-not
that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity.
Held-to-maturity
securities are placed on
non-accrual
status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on
held-to-maturity
securities placed on
non-accrual
status is recognized on a cash basis as interest income if and when received.
The Company reviews its portfolio of
held-to-maturity
securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.
Investments in pass-through government-sponsored enterprises (“GSEs”) are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.
 
Investments
The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321,
Investments – Equity Securities
(“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.
Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).
Goodwill
Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring
re-evaluation,
if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.
Goodwill is allocated to the Company’s U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.
Goodwill is assessed for impairment annually on November 30
th
. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.
Intangible Assets
Indefinite-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values.
Finite-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.
The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30
th
.
Software Development Costs
Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.
Leases
The Company accounts for its lease obligations in accordance with ASC Topic 842,
Leases
(“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting
right-of-use
asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement,
right-of-use
assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term.
ASC 842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and
non-lease
components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.
 
Deferred Consideration—Gold Payments
Deferred consideration represents the present value of an obligation to pay gold to a third party into perpetuity and is measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note 9). Changes in the fair value of this obligation are reported as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.
Convertible Notes
Convertible notes are carried at amortized cost, net of issuance costs. In accordance with Accounting Standards Update (“ASU”)
2020-06,
Debt – Debt with Conversion and Other Options
, the Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.
Contingencies
The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.
Contingent Payments
The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.
Earnings per Share
Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series A
non-voting
convertible preferred stock (Note 11) and unvested share-based payment awards that contain
non-forfeitable
rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the
two-class
method. Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).
Diluted EPS is calculated under the treasury stock method and the
two-class
method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards, the Series A
non-voting
convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series A
non-voting
convertible preferred stock and the convertible notes are computed under the
if-converted
method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price.
Income Taxes
The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is
more-likely-than-not
that some portion or all the deferred tax assets will not be realized.
Tax positions are evaluated utilizing a
two-step
process. The Company first determines whether any of its tax positions are
more-likely-than-not
to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.
The Global Intangible
Low-Taxed
Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.
Non-income
based taxes are recorded as part of other liabilities and other expenses.
XML 31 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Cash and Cash Equivalents
 3 Months Ended
Mar. 31, 2023
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents
3. Cash and Cash Equivalents
Of the total cash and cash equivalents of $119,099 and $132,101 at March 31, 2023 and December 31, 2022, $118,306 and $131,104, respectively, were held at two financial institutions. At March 31, 2023 and December 31, 2022, cash equivalents were approximately $336 and $930, respectively.
Certain of the Company’s subsidiaries are required to maintain a minimum level of regulatory capital, which was $28,726 and $25,988 at March 31, 2023 and December 31, 2022, respectively. These requirements are generally satisfied by cash on hand.
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
4. Fair Value Measurements
The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. ASC 820,
Fair Value Measurement
, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:
 
Level 1   –   Quoted prices for identical instruments in active markets.
     
Level 2   –   Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
     
Level 3   –   Instruments whose significant drivers are unobservable.
The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2023 and 2022, there were no transfers between Levels 2 and 3.
 
                                                                                                     
    
March 31, 2023
  
    
Total
     
Level 1
     
Level 2
  
Level 3
  
Assets:
                                   
Recurring fair value measurements:
                                   
Cash equivalents
   
  $
336
 
   
  $
336
 
   
  $
—
 
  
  $
—  
 
Financial instruments owned, at fair value
                             
 
  
 
ETFs
   
 
33,728
 
   
 
33,728
 
   
 
—
 
  
 
—  
 
U.S. treasuries
   
 
2,993
 
   
 
2,993
 
   
 
—
 
  
 
—  
 
Pass-through GSEs
   
 
81,046
 
   
 
23,352
 
   
 
  57,694
 
  
 
—  
 
Other assets—seed capital (WisdomTree blockchain-enabled funds)
                             
 
  
 
U.S. treasuries
   
 
4,901
 
   
 
4,901
 
   
 
—
 
  
 
—  
 
Equities
   
 
4,937
 
   
 
4,937
 
   
 
—
 
  
 
—  
 
Fixed income
   
 
1,915
 
   
 
—
 
   
 
1,915
 
  
 
—  
 
Other
   
 
660
 
   
 
—
 
   
 
660
 
  
 
—  
 
Investments in Convertible Notes
                                   
Securrency, Inc.—convertible note (Note 7)
   
 
10,051
 
   
 
—
 
   
 
—
 
  
 
10,051  
 
Fnality International Limited—convertible note (Note 7)
   
 
7,451
 
   
 
—
 
   
 
—
 
  
 
7,451  
 
    
 
 
     
 
 
     
 
 
 
  
 
 
  
Total
   
  $
    148,018
 
   
  $
    70,247
 
   
  $
    60,269
   
  
  $
      17,502  
 
    
 
 
     
 
 
     
 
 
 
  
 
 
  
 
                                                                                                     
    
March 31, 2023
  
    
Total
     
Level 1
     
Level 2
     
Level 3
  
Non-recurring
fair value measurements:
                                    
Securrency, Inc.—Series A convertible preferred stock
(1)
   
  $
    3,588
 
   
  $
—
 
   
  $
—
 
   
  $
3,588  
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Liabilities:
                                    
Recurring fair value measurements:
                                    
Deferred consideration (Note 9)
   
  $
    179,831
 
   
  $
            —
 
   
  $
        —
 
   
  $
    179,831  
 
    
 
 
     
 
 
     
 
 
     
 
 
  
   
    
December 31, 2022
  
    
Total
     
Level 1
     
Level 2
     
Level 3
  
Assets:
                                    
Recurring fair value measurements:
                                    
Cash equivalents
   
  $
930 
 
   
  $
930 
 
   
  $
— 
 
   
  $
—
 
Financial instruments owned, at fair value
                                    
ETFs
   
 
23,772 
 
   
 
23,772 
 
   
 
— 
 
   
 
—
 
U.S. treasuries
   
 
2,980 
 
   
 
2,980 
 
   
 
— 
 
   
 
—
 
Pass-through GSEs
   
 
96,837 
 
   
 
23,290 
 
   
 
73,547 
 
   
 
—
 
Corporate bonds
   
 
885 
 
   
 
— 
 
   
 
885 
 
   
 
—
 
Other assets—seed capital (WisdomTree blockchain-enabled funds)
   
 
1,765 
 
   
 
— 
 
   
 
1,765 
 
   
 
—
 
Investments in Convertible Notes
            
 
 
 
                  
Securrency, Inc.—convertible note (Note 7)
   
 
14,500 
 
   
 
— 
 
   
 
— 
 
   
 
14,500
 
Fnality International Limited—convertible note (Note 7)
   
 
6,921 
 
   
 
— 
 
   
 
— 
 
   
 
6,921
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
  $
  148,590 
 
   
  $
  50,972 
 
   
  $
  76,197 
 
   
  $
21,421
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Non-recurring
fair value measurements:
                                    
Other investments
(2)
   
  $
312 
 
   
  $
— 
 
   
  $
— 
 
   
  $
312
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Liabilities:
                                    
Recurring fair value measurements:
                                    
Deferred consideration (Note 9)
   
  $
200,290 
 
   
  $
— 
 
   
  $
— 
 
   
  $
   200,290
 
    
 
 
     
 
 
     
 
 
     
 
 
  
 
(1)
Fair value determined on March 31, 2023.
(2)
Fair value determined on May 10, 2022.
Recurring Fair Value Measurements—Methodology
Cash Equivalents (Note 3)
– These financial assets represent cash invested in highly liquid investments with original maturities of less than 90 days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.
Financial instruments owned (Note 5)
– Financial instruments owned are investments in ETFs, U.S. treasuries, pass-through GSEs, corporate bonds, equities, fixed income and other assets. ETFs, U.S. treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass-through GSEs, corporate bonds and fixed income include consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level 2. Pass-through GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1.
 
Fair Value Measurements classified as Level
 3
– The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:
 
        
Three Months Ended,

March 31,
  
        
2023
    
2022
  
   
Investments in Convertible Notes (Note 7)
                 
   
Beginning balance
      $ 21,421       $ —  
    
  
Purchases
      —       6,863  
   
Net unrealized losses
(1)
      (3,919 )      (163 ) 
        
 
 
    
 
 
  
   
Ending balance
      $ 17,502       $ 6,700  
        
 
 
    
 
 
  
   
Deferred Consideration (Note 9)
                 
   
Beginning balance
      $     200,290       $ 228,062  
   
Net realized losses
(2)
      4,486       4,450  
   
Net unrealized (gains)/losses
(3)
      (20,592 )      17,018  
   
Settlements
      (4,353 )      (4,353 ) 
        
 
 
    
 
 
  
   
Ending balance
      $ 179,831        $     245,177    
        
 
 
    
 
 
  
 
(1)
Recorded in other losses, net in the Consolidated Statements of Operations.
(2)
Recorded as contractual gold payments expense in the Consolidated Statements of Operations.
(3)
Recorded as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments owned
 3 Months Ended
Mar. 31, 2023
Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract]  
Financial instruments owned
5.  Financial instruments owned
These instruments consist of the following:
 
        
    March 31,    

2023
    
    December 31,    
2022
  
          
  
Financial instruments owned
                 
   
Trading securities
      $ 117,767       $ 124,474  
   
Other assets—seed capital (WisdomTree blockchain-enabled funds)
      12,413       1,765  
        
 
 
    
 
 
  
           $     130,180         $     126,239   
        
 
 
    
 
 
  
The Company recognized net trading gains/(losses) on financial instruments owned that were still held at the reporting dates of $4,722 and ($4,316) during the three months ended March 31, 2023 and 2022, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations.
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Securities Held-to-Maturity
 3 Months Ended
Mar. 31, 2023
Text Block [Abstract]  
Securities Held-to-Maturity
6.  Securities
Held-to-Maturity
The following table is a summary of the Company’s securities
held-to-maturity:
 
                                            
       
    March 31,    

2023
   
    December 31,    

2022
 
Debt instruments: Pass-through GSEs (amortized cost)
      $           253          $           259    
      
 
 
 
   
 
 
 
During the three months ended March 31, 2023 and 2022, the Company received proceeds of $6 and $18, respectively, from
held-to-maturity
securities maturing or being called prior to maturity.
The following table summarizes unrealized losses, gains and fair value (classified as Level 2 within the fair value hierarchy) of securities
held-to-maturity:
 
                                            
       
    March 31,    

2023
   
    December 31,    
2022
 
Cost/amortized cost
      $ 253      $ 259  
 
Gross unrealized losses
      (17 )       (20 ) 
 
Gross unrealized gains
      —        —  
      
 
 
 
   
 
 
 
 
Fair value
      $           236        $           239    
      
 
 
 
   
 
 
 
An allowance for credit losses was not provided on the Company’s
held-to-maturity
securities as all securities are investments in pass-through GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.
 
The following table sets forth the maturity profile of the securities
held-to-maturity;
however, these securities may be called prior to the maturity date:
 
                                
       
    March 31,    

2023
   
    December 31,    

2022
 
Due within one year
      $ —        $ —  
 
Due one year through five years
      —        —  
 
Due five years through ten years
      26        27  
 
Due over ten years
      227        232  
      
 
 
 
   
 
 
 
 
Total
      $           253          $           259    
      
 
 
 
   
 
 
 
XML 35 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Investments
 3 Months Ended
Mar. 31, 2023
Schedule of Investments [Abstract]  
Investments
7. Investments
The following table sets forth the Company’s investments:
 
      
       
        March 31, 2023        
     
        December 31, 2022        
  
      
Carrying

Value
     
Cost
     
Carrying

Value
     
Cost
  
 
Securrency, Inc.—Series A convertible preferred stock
      $ 3,588          $ 8,112          $ 8,488          $ 8,112    
 
Securrency, Inc.—Series B convertible preferred stock
      5,500          5,500          5,500          5,500    
 
Securrency, Inc.—convertible note
      10,051          15,000          14,500          15,000    
      
 
 
     
 
 
     
 
 
     
 
 
  
 
Subtotal—Securrency, Inc.
      $ 19,139          $ 28,612          $ 28,488          $ 28,612    
 
Fnality International Limited—convertible note
      7,451          6,863          6,921          6,863    
 
Other investments
      312          250          312          250    
      
 
 
     
 
 
     
 
 
     
 
 
  
         $     26,902          $     35,725          $  35,721          $     35,725    
      
 
 
     
 
 
     
 
 
     
 
 
  
Securrency, Inc. – Preferred Stock
The Company owns approximately 22% (or 17 % on a fully-diluted basis) of the capital stock of Securrency, Inc. (“Securrency”), a developer of institutional-grade blockchain-based financial and regulatory technology, issued as a result of strategic investments totaling $13,612. In consideration of such investments, the Company received 5,178,488
shares of Series A convertible preferred stock (“Securrency Series A Shares”) in December
 2019 and 2,004,665
shares of Series B convertible preferred stock (“Securrency Series B Shares”) in March 2021. The Securrency Series B Shares contain a liquidation preference that is pari passu with shares of Series
B-1
convertible preferred stock (which are substantially the same as the Securrency Series B Shares except that they have limited voting rights) and senior to that of the holders of the Securrency Series A Shares, which are senior to the holders of common stock. Otherwise, the Securrency Series A Shares and Securrency Series B Shares have substantially the same terms, are convertible into common stock at the option of the Company and contain various rights and protections including a
non-cumulative
 
6.0
%
dividend, payable if and when declared by the board of directors of Securrency. In addition, the Securrency Series A Shares and Securrency Series B Shares (together with the Securrency Series
B-1
convertible preferred stock) are separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at
least
60
% of the
Securrency 
Series A Shares (at any time on or after December 31, 2029) and
90
%
of the Securrency Series B Shares (at any time on or after March 31, 2031).
These investments are accounted for under the measurement alternative prescribed in ASC 321, as they do not have a readily determinable fair value and are not considered to be
in-substance
common stock. The investments are assessed for impairment and similar observable transactions on a quarterly basis. During the three months ending March, 31, 2023, the Company recognized an impairment of $4,900
on its Securrency Series A Shares to reduce the carrying value of its investment to fair value. Fair value was determined using the probability-weighted expected return method (“PWERM”), a valuation approach that estimates fair value assuming various outcomes.
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy):
 
    
March 31,

2023
  
Conversion of Securrency Series A Shares upon a future equity financing
      33.3%  
Redemption of Securrency Series A Shares upon a corporate transaction
      33.3%  
Default
      33.4%  
There was no impairment recognized during the three months ended March 31, 2022 based upon a qualitative assessment.
 
Securrency – Convertible Note
In April and November 2022, the Company participated in a convertible note financing, making an aggregate investment of $15,000 in convertible notes of Securrency. In consideration for its investment, the Company was issued a 7% Convertible Promissory Note maturing on
October 20, 2023.
The notes are convertible into either common stock or a class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency’s common stock that is issued in the event of a future equity financing of Securrency. The notes will convert at a conversion price equal to a discount of 25% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round.
The notes are redeemable upon the occurrence of a corporate transaction for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted, in accordance with the terms of the notes, to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion may occur upon the election by the holders of a
majority-in-interest
of the aggregate principal amount of outstanding notes. If no such election is made, Securrency may elect to pay or convert the notes in its sole discretion.
The notes are accounted for at fair value. Fair value is determined by the Company using PWERM. During the three months ended March 31, 2023, the Company recognized an unrealized loss of $4,449 when
re-measuring
the notes to fair value.
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 
    
  March 31,  

2023
   
  December 31,  

2022
Conversion of note upon a future equity financing
        33.3%          60%
Redemption of note upon a corporate transaction
        33.3%          25%
Default
        33.4%          15%
Time to potential outcome (in years)
          0.56          0.33
Fnality International Limited – Convertible Note
In February 2022, the Company participated in a convertible note financing, making an investment of £5,000 ($6,863) in convertible notes of Fnality International Limited (“Fnality”), a company incorporated in England and Wales and focused on creating a
peer-to-peer
digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross-border payments from a single pool of liquidity. In consideration for its investment, the Company was issued a 5% Convertible Unsecured Loan Note maturing on December 31, 2023.
The note is convertible into equity shares in the event of a future equity financing of Fnality. The note will convert at a conversion price equal to the lower of (i) a discount of 20% to lowest price paid per equity share issued pursuant to such future financing round and (ii) an amount paid per share subject to a
pre-money
valuation cap. Mandatory conversion may occur on or after the maturity date or, if earlier, in the event a future financing round has not been completed within a specified time from an initial closing of such financing round (“Long Stop Date”), upon the approval of holders of at least 75% of the outstanding notes. The note is also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date.
The note is redeemable upon the occurrence of a change of control for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption may also occur on or after maturity or prior to maturity upon approval by holders of at least 50% and 75%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events.
The note is accounted for at fair value. Fair value is determined by the Company using the PWERM and is also remeasured for changes in the British pound and U.S. dollar exchange rate. During the three months ended March 31, 2023, the Company recognized a gain of $530 when
re-measuring
the notes to fair value.
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 
    
  March 31,  

2023
  
  December 31,  

2022
Conversion of note upon a future financing round
          85%         85%
Redemption of note upon a change of control
          10%         10%
Default
            5%           5%
Time to potential outcome (in years)
          0.08         0.25
XML 36 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets, net
 3 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
Fixed Assets, net
8. Fixed Assets, net
The following table summarizes fixed assets:
 
    
March 31,

2023
     
December 31,
2022
  
Equipment
     $             997          $             962    
Less: accumulated depreciation
      (482)          (418)   
    
 
 
     
 
 
  
Total
     $ 515          $ 544    
    
 
 
     
 
 
  
XML 37 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Consideration
 3 Months Ended
Mar. 31, 2023
Text Block [Abstract]  
Deferred Consideration
9. Deferred Consideration
Deferred consideration represents an obligation the Company assumed in connection with its acquisition of the European exchange-traded commodity, currency and
leveraged-and-inverse
business of ETFS Capital Limited (“ETFS Capital”) which occurred on April 11, 2018 (“ETFS Acquisition”). The obligation is for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March 31, 2058 and then subsequently reduced to 6,333 ounces of gold per year continuing into perpetuity (“Contractual Gold Payments”).
The Contractual Gold Payments are paid from advisory fee income generated by any Company-sponsored financial product backed by physical gold and are subject to adjustment and reduction for declines in advisory fee income generated by such products, with any reduction remaining due and payable until paid in full. ETFS Capital’s recourse is limited to such advisory fee income and it has no recourse back to the Company for any unpaid amounts that exceed advisory fees earned. ETFS Capital ultimately has the right to claw back Gold Bullion Securities Ltd. (a physically backed gold ETP issuer) if the Company fails to remit any amounts due.
The Company determined the present value of the deferred consideration of $179,831 and $200,290 at March 31, 2023 and December 31, 2022 using the following assumptions:
 
    
March 31,
2023
    
December 31,
2022
  
Forward-looking gold price (low)—per ounce
      $ 1,999        $ 1,858  
Forward-looking gold price (high)—per ounce
      $ 3,567        $ 3,126  
Forward-looking gold price (weighted average)—per ounce
      $ 2,401        $         2,237  
Discount rate
              13.3%        11.0%  
Perpetual growth rate
      1.5%        1.3%  
Fair value as of March 31, 2023 was determined using an equal weighting of a discounted cash flow approach and market approach. The forward-looking gold prices at March 31, 2023 were extrapolated from the last observable CMX exchange price (beyond 2028) and the weighted-average price per ounce was derived from the relative present values of the annual payment obligations. The perpetual growth rate at March 31, 2023 was determined based upon the increase in observable forward-looking gold prices through 2028. This obligation is classified as Level 3 as the discount rate, the extrapolated forward-looking gold prices and perpetual growth rate are significant unobservable inputs. An increase in spot gold prices, forward-looking gold prices and the perpetual growth rate would result in an increase in deferred consideration, whereas an increase in the discount rate would reduce the fair value.
Current amounts payable were $17,984 and $16,796 and long-term amounts payable were $161,847 and $183,494 at March 31, 2023 and December 31, 2022, respectively.
During the three months ended March 31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:
 
    
Three Months Ended

March 31,
  
    
2023
     
2022
  
Contractual Gold Payments
     $ 4,486        $ 4,450    
Contractual Gold Payments—gold ounces paid
      2,375          2,375    
Gain/(loss) on revaluation of deferred consideration—gold payments
(1)
     $     20,592        $     (17,018)   
 
(1)
 
Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.
XML 38 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Convertible Notes
10. Convertible Notes
On February 14, 2023, the Company issued and sold $130,000 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2023 Notes”) pursuant to an indenture dated February 14, 2023, between the Company and U.S. Bank Trust Company, National Association, as trustee (or its successor in interest, the “Trustee”), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Rule 144A”).
On June 14, 2021, the Company issued and sold $150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2021 Notes”) pursuant to an indenture dated June 14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A.
On June 16, 2020, the Company issued and sold $150,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the “June 2020 Notes”) pursuant to an indenture dated June 16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. On August 13, 2020, the Company issued and sold $25,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June 16, 2020, and constitute a further issuance of, and form a single series with, the Company’s June 2020 Notes (the “August 2020 Notes” and together with the June 2020 Notes, the “2020 Notes”).
In connection with the issuance of the 2023 Notes, the Company repurchased $115,000 in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $9,721 during the three months ended March 31, 2023.
After the issuance of the 2023 Notes (and together with the remaining 2020 Notes and the 2021 Notes, the “Convertible Notes”), the Company had $340,000 in aggregate principal amount of Convertible Notes outstanding.
Key terms of the Convertible Notes are as follows:
 
    
  2023 Notes  
     
  2021 Notes  
     
  2020 Notes  
  
Principal outstanding
      $130.0        $150.0        $60.0    
Maturity date (unless earlier converted, repurchased or redeemed)
      August 15, 2028        June 15, 2026        June 15, 2023    
Interest rate
      5.75%        3.25%        4.25%    
Conversion price
      $9.54        $11.04        $5.92    
Conversion rate
      104.8658        90.5797        168.9189    
Redemption price
      $12.40        $14.35        $7.70    
 
  •  
Interest rate:
Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and June 15 and December 15 of each year for the 2020 Notes and the 2021 Notes.
 
  •  
Conversion price:
Convertible at an initial conversion rate into shares of the Company’s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.
 
  •  
Conversion:
Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.
 
  •  
Cash settlement of principal amount:
Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.
 
  •  
Redemption price:
The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective
 
 
Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.
 
  •  
Limited investor put rights:
Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.
 
  •  
Conversion rate increase in certain customary circumstances:
In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853 shares, 144.9275 shares and 270.2702 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2021 Notes and 2020 Notes, respectively (the equivalent of 59,767,426 shares of the Company’s common stock), subject to adjustment.
 
  •  
Seniority and Security:
The Convertible Notes rank equal in right of payment, and are the Company’s senior unsecured obligations, but are subordinated in right of payment to the Company’s obligations to make certain redemption payments (if and when due) in respect of its Series A
Non-Voting
Convertible Preferred Stock (Note 11).
The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Convertible Notes outstanding may declare the entire principal amount of all the Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.
The following table provides a summary of the carrying value of the Convertible Notes at March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
  
December 31, 2022
    
2023
Notes
  
2021
Notes
  
2020 Notes
  
Total
  
2021 Notes
  
2020 Notes
  
Total
Principal amount
     $  130,000      $  150,000      $  60,000      $   340,000      $   150,000      $   175,000      $   325,000  
Plus: Premium
      —       —       250       250       —       250       250  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Gross proceeds
      130,000       150,000       60,250       340,250       150,000       175,250       325,250  
Less: Unamortized issuance costs
      (3,465)       (2,768)       (366)
    (6,599)       (2,981)       (1,053)       (4,034)  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Carrying amount
      126,535      $ 147,232      $ 59,884      $ 333,651      $ 147,019      $ 174,197      $ 321,216  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Effective interest rate
(1)
      6.25%       3.83%       5.18%       5.00%       3.83%       5.26%       4.60%  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
        
                                                                                                   
(1)
Includes amortization of the issuance costs and premium.
Interest expense on the Convertible Notes during the three months ended March 31, 2023 and 2022 was $4,002 and $3,732, respectively. Interest payable of $3,243 and $621 at March 31, 2023 and December 31, 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.
The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $331,766 and $320,513 at March 31, 2023 and December 31, 2022, respectively. The
if-converted
value of the Convertible Notes did not exceed the principal amount at March 31, 2023 and December 31, 2022.
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Series A Preferred Stock
 3 Months Ended
Mar. 31, 2023
Series A Preferred Stock [Member]  
Preferred Shares
11. Series A Preferred Stock
On April 10, 2018, the Company filed a Certificate of Designations of Series A
Non-Voting
Convertible Preferred Stock (the “Series A Certificate of Designations”) with the Delaware Secretary of State establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series A Preferred Stock (defined below). The Series A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company’s common stock on an
as-converted
basis. The Series A Preferred Stock has no voting rights, is not transferable and has the same priority with regard to dividends, distributions and payments as the common stock.
As described in the Series A Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attribution parties) would beneficially own more than 9.99% of the Company’s outstanding common stock immediately after giving effect to such conversion.
 
In connection with the completion of the ETFS Acquisition, the Company issued 14,750 shares of Series A
Non-Voting
Convertible Preferred Stock (the “Series A Preferred Stock”), which are convertible into an aggregate of 14,750,000 shares of common stock. The fair value of this consideration was $132,750, based on the closing price of the Company’s common stock on April 10, 2018 of $9.00 per share, the trading day prior to the closing of the acquisition.
The following is a summary of the Series A Preferred Stock balance:
 
    
March 31,

2023
  
December 31,
2022
Issuance of Series A Preferred Stock
    $     132,750     $     132,750  
Less: Issuance costs
      (181 )      (181 ) 
    
 
 
 
  
 
 
 
Series A Preferred Stock—carrying value
    $ 132,569     $ 132,569  
    
 
 
 
  
 
 
 
Cash dividends declared per share (quarterly)
    $ 0.03     $ 0.03  
    
 
 
 
  
 
 
 
Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer’s control. ETFS Capital has the right to redeem all the Series A Preferred Stock specified to be converted during the period of time specified in the Series A Certificate of Designations in the event that: (a) the number of shares of the Company’s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series A Preferred Stock requested by ETFS Capital to be converted; or (b) ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per Series A Preferred Stock as it would have received had each outstanding Series A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law.
Any such redemption will be at a price per Series A Preferred Stock equal to the dollar volume-weighted average price for a share of common stock for the
30-trading
day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. Such redemption payment will be made in one payment no later than 10 business days following the last day of the Company’s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series A Preferred Stock was $86,638 and $77,969 at March 31, 2023 and December 31, 2022, respectively.
The carrying amount of the Series A Preferred Stock was not adjusted as it was not probable that the Series A Preferred Stock would become redeemable.
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Leases
 3 Months Ended
Mar. 31, 2023
Lessee Disclosure [Abstract]  
Leases
12. Leases
The Company has entered into operating leases for its office facilities (including its corporate headquarters) and equipment. The Company has no finance leases.
The following table provides additional information regarding the Company’s leases:
 
    
Three Months Ended

March 31,
  
    
        2023        
     
        2022        
  
Lease cost:
                  
Operating lease cost
    $ 319          $ 89      
Short-term lease cost
      56            276      
    
 
 
     
 
 
  
Total lease cost
    $ 375          $             365      
    
 
 
     
 
 
  
Other information:
                  
Cash paid for amounts included in the measurement of operating liabilities (operating leases)
    $             326          $ 97      
    
 
 
     
 
 
  
Right-of-use
assets obtained in exchange for new operating lease liabilities
      n/a            n/a      
    
 
 
     
 
 
  
Weighted-average remaining lease term (in years)—operating leases
      1.0            1.3      
    
 
 
     
 
 
  
Weighted-average discount rate—operating leases
      6.5%         4.4%   
    
 
 
     
 
 
  
None of the Company’s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company’s ability to pay dividends or incur additional financing obligations.
 
The following table discloses future minimum lease payments at March 31, 2023 with respect to the Company’s operating lease liabilities:
            
 
Remainder of 2023
     $ 803    
 
2024
      397    
 
2025
      —    
 
2026
      —    
 
2027
      —    
 
2028 and thereafter
      —    
      
 
 
  
 
Total future minimum lease payments (undiscounted)
     $         1,200    
      
 
 
  
The following table reconciles the future minimum lease payments (disclosed above) at March 31, 2023 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets:
 
            
 
Amounts recognized in the Company’s Consolidated Balance     Sheets
         
 
Lease liability—short term
    $ 1,041    
 
Lease liability—long term
      120    
      
 
 
  
 
Subtotal
      1,161    
 
Difference between undiscounted and discounted cash flows
      39    
      
 
 
  
 
Total future minimum lease payments (undiscounted)
      $       1,200    
      
 
 
  
XML 41 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Contingencies
 3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
13. Contingencies
The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.
Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP
In December 2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (“WT Ireland”) were served with a writ of summons to appear before the Court of Milan, Italy. In January 2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (“3OIL”) in March 2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures’ closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.
In February 2022, the Court of Udine ruled in the Company’s favor. Also in February 2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL.
In March 2022, WMAI and WTUK were served with writs of summons to appear before the Court of Turin and the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers.
Total damages sought by all investors are approximately €15,800 ($17,186) at March 31, 2023.
The Company is currently assessing these claims with its external counsel. An accrual has not been made with respect to these matters at March 31, 2023 and December 31, 2022.
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Variable Interest Entities
 3 Months Ended
Mar. 31, 2023
Variable Interest Entities
14. Variable Interest Entities
VIEs are entities with any of the following characteristics: (i) the entity does not have enough equity to finance its activities without additional financial support; (ii) the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii) the entity is structured with
non-substantive
voting rights.
Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities’ economic performance. Such power is conveyed through the entities’ boards of directors and the Company does not have control over the boards.
 
The following table presents information about the Company’s variable interests in
non-consolidated
VIEs:
 
    
      March 31,      

2023
     
      December 31,      

2022
     
                                                    
Carrying Amount—Assets (Securrency):
                  
Preferred stock—Series A Shares
    $ 3,588         $ 8,488    
Preferred stock—Series B Shares
      5,500          5,500    
Convertible note
      10,051          14,500    
    
 
 
     
 
 
  
Subtotal—Securrency
    $ 19,139         $ 28,488    
Carrying Amount—Assets (Fnality):
                    
Convertible note
      7,451          6,921    
Carrying Amount—Assets (Other investments):
      312          312    
    
 
 
     
 
 
  
Total (Note 7)
    $ 26,902         $ 35,721    
    
 
 
     
 
 
  
 
Maximum exposure to loss
    $         26,902         $         35,721    
    
 
 
     
 
 
  
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues from Contracts with Customers
 3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer
15. Revenues from Contracts with Customers
The following table presents the Company’s total revenues from contracts with customers:
 
    
Three Months Ended March 31,
  
    
2023
     
2022
  
Revenues from contracts with customers:
                  
Advisory fees
     $ 77,637         $ 76,517    
Other
      4,407          1,851    
    
 
 
     
 
 
  
Total operating revenues
     $       82,044         $       78,368    
    
 
 
     
 
 
  
The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity’s performance in transferring control of services to the customer.
Substantially all the Company’s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note 16). These advisory fees are recognized over time, are earned from the Company’s ETPs and are calculated based on a percentage of the ETPs’ average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.
Other income includes revenues
the Company earns
from swap providers associated with certain of the Company’s European-listed ETPs, the nature of which are either based on a percentage of the ETPs’ average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due
,
which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
Geographic Distribution of Revenue
The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside:
 
    
Three Months Ended March 31,
  
    
2023
     
2022
  
Revenues from contracts with customers:
                  
United States
     $ 49,681         $ 46,229    
Jersey
      29,053          28,598    
Ireland
      3,310          3,541    
    
 
 
     
 
 
  
Total operating revenues
     $     82,044         $     78,368    
    
 
 
     
 
 
  
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
 3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
16. Related Party Transactions
The Company’s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S. WisdomTree ETFs and WisdomTree UCITS ETFs. The Board of Trustees and Board of Directors (including certain officers of the Company) of the related parties are primarily responsible for overseeing the management and affairs of the entities for the benefit of their stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other
non-distribution
services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs’ average daily net assets. A majority of the independent members of the Board of Trustees are required to annually approve the advisory agreements of the U.S. WisdomTree ETFs and these agreements may be terminated by the Board of Trustees upon notice.
The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:
 
    
March 31,

2023
     
December 31,

2022
     
            
Receivable from WTT
     $ 17,124         $ 16,399    
Receivable from ManJer Issuers
      12,790          4,485    
Receivable from WMAI and WTICAV
      2,532          3,255    
    
 
 
     
 
 
  
Total
     $       32,446         $       24,139    
    
 
 
     
 
 
  
The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30 days aged and are collected shortly after the applicable reporting period.
The following table summarizes revenues from advisory services provided to related parties:
 
    
Three Months Ended March 31,
     
            
    
2023
     
2022
  
Advisory services provided to WTT
     $ 49,487         $ 46,070    
Advisory services provided to ManJer Issuers
      24,840          26,905    
Advisory services provided to WMAI and WTICAV
      3,310          3,542    
    
 
 
     
 
 
  
Total
     $       77,637         $       76,517    
    
 
 
     
 
 
  
The Company also has investments in certain WisdomTree products of approximately $45,214 and $25,283 at March 31, 2023 and December 31, 2022, respectively. This includes $12,413 and $1,765,
respectively, of investments in certain consolidated affiliated blockchain-enabled funds advised by WT Digital Management, referred to herein as “other assets–seed capital.” Net unrealized and realized gains/(losses) related to trading WisdomTree products during the three months ended March 31, 2023 and 2022
were $422 and ($806), respectively, which are recorded in other losses, net on the Consolidated Statements of Operations.
XML 45 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Awards
 3 Months Ended
Mar. 31, 2023
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Awards
17. Stock-Based Awards
On July 15, 2022, the Company’s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000 shares of common stock (less one share for every share granted under the 2016 Equity Plan since March 31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March 31, 2022) in the form of stock options and other stock-based awards.
The Company grants equity awards to employees and directors which include restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and stock options. Certain awards described below are subject to acceleration under certain conditions.
 
Stock options:
   
Generally issued for terms of ten years and may vest after at least one year of service and have an exercise price equal to the Company’s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black-Scholes option pricing model.
   
RSAs/RSUs:
   
Awards are valued based on the Company’s stock price on grant date and generally vest ratably, on an annual basis, over three years.
PRSUs:    These awards cliff vest three years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company’s total shareholder return (“TSR”) compares to a peer group of other publicly traded asset managers over the three-year period. A Monte Carlo simulation is used to value these awards.
   
    
The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:
 
•   If the relative TSR is below the 25
th
percentile, then 0% of the target number of PRSUs granted will vest;
 
•   If the relative TSR is at the 25th percentile, then 50% of the target number of PRSUs granted will vest;
 
•   If the relative TSR is above the 25th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50th percentile and capped at 200% of the target number of PRSUs granted for performance at the 85th percentile (or 100th percentile for grants made in 2020); and
 
•   If the Company’s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.
Stock-based compensation expense during the three months ended March 31, 2023 and 2022 was $4,536 and $2,936, respectively.
A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows:
 
       
March 31, 2023
     
Unrecognized Stock-
Based

Compensation
   
Weighted-Average

Remaining
  Vesting Period (Years)  
 
Employees and directors
    $             30,415                  2.10
A summary of stock-based compensation award activity (shares) during the three months ended March 31, 2023 is as follows:
 
    
RSA
  
RSU
  
PRSU
Balance at January 1, 2023
      3,391,082       141,963       668,188  
Granted
      3,273,263       73,855       576,240
(1)
 
Vested
      (1,498,171 )      (26,837 )      (83,158 )
(2)
 
Forfeited
      (11,885 )       (233 )       (24,955 )
(2)
 
    
 
 
 
  
 
 
 
  
 
 
 
Balance at March 31, 2023
          5,154,289           188,748             1,136,315  
    
 
 
 
  
 
 
 
  
 
 
 
 
                                                                                
 
 
 
(1)
Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. A Monte-Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning
90-day
average stock prices; (ii) valuation date stock prices; (iii) historical stock price volatilities ranging from 37% to 56% (average 47%); (iv) correlation coefficients based upon the price data used to calculate the historical volatilities; (v) a risk free interest rate of 3.8%; and (vi) an expected dividend yield of 0%.
 
 
(2)
The payout on PRSUs vesting in January 2023 was 77%. The remainder of the awards were forfeited.
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholder Rights Plan
 3 Months Ended
Mar. 31, 2023
Stockholder Rights Plan [Abstract]  
Stockholder Rights Plan
18. Stockholder Rights Plan
On March 17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March 17, 2023, between the Company and Continental Stock Transfer & Trust Company, as Rights Agent (the “Stockholder Rights Agreement”).
Pursuant to the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i) one Right (as defined below) for each outstanding share of common stock, par value $0.01 per share, of the Company’s common stock and (ii) 1,000 Rights for each outstanding share of Series A Preferred Stock”, to stockholders of record as of the close of business on March 28, 2023 (the “Record Date”). In addition, one Right will automatically attach to each share of common stock and 1,000 Rights will automatically attach to each share of Series A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each “Right” entitles the registered holder thereof to purchase from the Company a unit consisting of one
ten-thousandth
of a share (a “Unit”) of Series B Junior Participating Cumulative Preferred Stock, par value $0.01 per share, of the Company (the “Series B Preferred Stock”) at a cash exercise price of $32.00 per Unit (the “Exercise Price”), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below.
 
Initially, the Rights are not exercisable and are attached to and trade with all shares of common stock and Series A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series A Preferred Stock and will become exercisable upon the earlier of (i) the close of business on the tenth calendar day following the first public announcement that a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired beneficial ownership of 10% (or 20% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than 20% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule 13G pursuant to Rule
13d-1(b)
or Rule
13d-1(c)
of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the “Stock Acquisition Date”), or (ii) the close of business on the tenth business day (or such later day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the “Distribution Date”). A person or group who beneficially owned 10% or more (or 20% or more in the case of passive stockholders) of the Company’s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own 10% or more (or 20% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement.
For purposes of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership.
In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of
Series B 
Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units of
Series B 
Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the “Subscription Right”). In the event that, at any time following the Stock Acquisition Date, (i) the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii) any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii) 50% or more of the Company’s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the “Merger Right”). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void.
The Rights may be redeemed in whole, but not in part, at a price of $0.01 per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i) the time at which any person becomes an Acquiring Person or (ii) the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.
The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).
Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company.
The Rights are not exercisable until the Distribution Date and will expire at the close of business on March 16, 2024; provided that if the Company’s stockholders have not ratified the Stockholder Rights Agreement by the close of business on the first day after the Company’s 2023 annual meeting of stockholders (including any adjournments or postponements thereof), the Rights will expire at such time, in each case, unless previously redeemed or exchanged by the Company.
 
The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a “Qualifying Offer” (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i) a fully financed
all-cash
tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii) an offer that is otherwise in the best interests of the Company’s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a “Qualifying Offer,” including if the consideration offered in a proposed transaction is stock of the acquiror.
Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board
of Directors
 
has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the “Special Meeting”) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90th business day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10th business day thereafter.
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings/(Loss) Per Share
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Earnings/(Loss) Per Share
19. Earnings/(Loss) Per Share
The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented:
 
      
Three Months Ended

March 31,
Basic Earnings/(Loss) per Share
     
          2023          
   
          2022          
Net income/(loss)
       $ 16,233       $ (10,261 ) 
Less: Income distributed to participating securities
        (498 )       (549 ) 
Less: Undistributed income allocable to participating securities
        (1,206 )         —    
      
 
 
 
   
 
 
 
Net income/(loss) available to common stockholders—Basic EPS
       $ 14,529       $ (10,810 ) 
     
Weighted average common shares (in thousands)
        143,862          142,782  
      
 
 
 
   
 
 
 
Basic earnings/(loss) per share
       $         0.10       $ (0.08 )     
      
 
 
 
   
 
 
 
 
      
Three Months Ended

March 31,
Diluted Earnings/(Loss) per Share
     
          2023          
   
          2022          
Net earnings/(loss) available to common stockholders
       $ 14,529       $ (10,810 ) 
Add back: Undistributed income allocable to participating securities
        1,206        —    
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive
        (1,202 )         —    
      
 
 
 
   
 
 
 
Net income/(loss) available to common stockholders—Diluted EPS
       $ 14,533       $ (10,810 )     
      
 
 
 
   
 
 
 
Weighted Average Diluted Shares (in thousands)
:
                    
Weighted average common shares
        143,862        142,782  
Dilutive effect of common stock equivalents, excluding participating securities
        569        —    
      
 
 
 
   
 
 
 
Weighted average diluted shares, excluding participating securities (in thousands)
        144,431        142,782  
      
 
 
 
   
 
 
 
Diluted earnings/(loss) per share
       $ 0.10       $ (0.08 ) 
      
 
 
 
   
 
 
 
Diluted earnings/(loss) per share presented above is calculated using the
two-class
method as this method results in the lowest diluted earnings per share amount for common stock. During the three months ended March 31, 2022, there were no dilutive common stock equivalents as the Company reported a net loss for the period. Total antidilutive
non-participating
common stock equivalents were 695 and 509 for the three months ended March 31, 2023 and 2022, respectively.
 
There were no potential common shares associated with the conversion options embedded in the Convertible Notes included in weighted average diluted shares for the three months ended March 31, 2023 and 2022 as the Company’s average stock price was lower than the conversion price.
The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:
 
      
Three Months Ended

March 31,
Reconciliation of Weighted Average Diluted Shares (in thousands)
     
2023
   
2022
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations
        159,887        142,782
(1)
 
Less: Participating securities:
                    
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11)
        (14,750 )       —    
Potentially dilutive restricted stock awards
        (706 )       —    
      
 
 
 
   
 
 
 
Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above
              144,431            142,782  
      
 
 
 
   
 
 
 
 
(1)
 
Excludes 15,521 participating securities and 31 potentially dilutive
non-participating
common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands).
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
 3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
20. Income Taxes
Effective Income Tax Rate – Three Months Ended March 31, 2023 and March 31, 2022
The Company’s effective income tax rate during the three months ended March 31, 2023 was 7.9% resulting in income tax expense of $1,383. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a
non-taxable
gain on revaluation of deferred consideration and a $1,353 reduction in unrecognized tax benefits (including interest and penalties). These items were partly offset by a
non-deductible
loss on extinguishment of our convertible notes and an increase in the deferred tax asset valuation allowance on losses recognized on the Company’s investments.
The Company’s effective income tax rate during the three months ended March 31, 2022 of 62.0% resulted in an income tax benefit of $16,713. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a $19,897 reduction in unrecognized tax benefits (including interest and penalties), a lower tax rate on foreign earnings and tax windfalls associated with the vesting of stock-based compensation awards. These items were partly offset by a
non-taxable
loss on revaluation of deferred consideration and an increase in the deferred tax asset valuation allowance on losses recognized on securities owned.
Deferred Tax Assets
A summary of the components of the Company’s deferred tax assets at March 31, 2023 and December 31, 2022 is as follows:
 
        
March 31,

2023
     
December 31,

2022
  
 
Deferred tax assets:
                  
 
Capital losses
      $         17,740             $         17,541       
 
Unrealized losses
      4,781             3,821       
 
NOLs—Foreign
      1,625             1,609       
 
Accrued expenses
      1,527             6,030       
 
Goodwill and intangible assets
      1,038             1,085       
 
Stock-based compensation
      865             1,526       
 
Interest carryforwards
      476             —       
 
Operating lease liabilities
      260             313       
 
Foreign currency translation adjustment
      254             173       
 
NOLs—U.S.
      127             255       
 
Outside basis differences
      122             122       
 
        
March 31,

2023
     
December 31,
2022
  
 
Other
      355             341       
      
 
 
     
 
 
  
 
Deferred tax assets
      29,170             32,816       
      
 
 
     
 
 
  
 
Deferred tax liabilities:
                  
 
Fixed assets and prepaid assets
      150             278       
 
Unremitted earnings—European subsidiaries
      246             205       
 
Right of use assets—operating leases
      260             313       
      
 
 
     
 
 
  
 
Deferred tax liabilities
      656             796       
      
 
 
     
 
 
  
 
Total deferred tax assets less deferred tax liabilities
      28,514             32,020       
 
Less: Valuation allowance
      (22,643)            (21,484)      
      
 
 
     
 
 
  
 
Deferred tax assets, net
      $ 5,871             $ 10,536       
      
 
 
     
 
 
  
Net Operating and Capital Losses—U.S.
The Company’s tax effected net operating losses (“NOLs”) at March 31, 2023 were $127, which expire in 2024. The net operating loss carryforwards have been reduced by the impact of annual limitations described in the Internal Revenue Code Section 382 that arose as a result of an ownership change.
The Company’s tax effected capital losses at March 31, 2023 were $17,740. These capital losses expire between the years 2023 and 2028.
Net Operating Losses—Europe
One of the Company’s European subsidiaries generated NOLs outside the U.S. These tax effected NOLs, all of which are carried forward indefinitely, were $1,625 at March 31, 2023.
Valuation Allowance
The Company’s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is
more-likely-than-not
that these deferred tax assets will not be realized.
Uncertain Tax Positions
Tax positions are evaluated utilizing a
two-step
process. The Company first determines whether any of its tax positions are
more-likely-than-not
to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.
In connection with the ETFS Acquisition, the Company accrued a liability for uncertain tax positions and interest and penalties at the acquisition date. The Company also recorded an offsetting indemnification asset provided by ETFS Capital as part of its agreement to indemnify the Company for any potential claims. The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:
 
      
Total
   
Unrecognized
Tax Benefits
   
Interest and
Penalties
Balance at January 1, 2023
        $         1,353      $         957      $         396  
Decrease—Lapse of statute of limitations
        (1,353 )         (957 )         (396 )   
      
 
 
 
   
 
 
 
   
 
 
 
Balance at March 31, 2023
        $ —        $ —        $ —    
      
 
 
 
   
 
 
 
   
 
 
 
 
 
(1)
The gross unrecognized tax benefits were accrued in British pounds.
Income Tax Examinations
The Company is subject to U.S. federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions. As of March 31, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the years before 2018.
Undistributed Earnings of Foreign Subsidiaries
ASC
740-30
Income Taxes provides guidance that US companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $246 and $205 at March 31, 2023 and December 31, 2022, respectively.
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Shares Repurchased
 3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Shares Repurchased
21. Shares Repurchased
On February 22, 2022, the Company’s Board of Directors approved an increase of $85,709 to the Company’s share repurchase program to $100,000 and extended the term for three years through April 27, 2025. Included under the Company’s share repurchase program are purchases to offset future equity grants made under the Company’s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company’s books and records.
During the three months ended March 31, 2023 and 2022, the Company repurchased 604,505 and 588,694 shares of its common stock, respectively, under this program for an aggregate cost of $3,384 and $3,394, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company’s books and records.
As of March 31, 2023, $96,591,597 remained under this program for future purchases.
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets
 3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
22. Goodwill and Intangible Assets
Goodwill
The table below sets forth goodwill which is tested annually for impairment on November 30
th
:
 
    
Total
  
Balance at January 1, 2023
    $               85,856      
Changes
      —      
    
 
 
  
Balance at March 31, 2023
    $ 85,856      
    
 
 
  
Goodwill arising from the ETFS Acquisition of $84,057 is not deductible for tax purposes as the acquisition was structured as a stock acquisition occurring in the U.K. The remainder of the goodwill is deductible for U.S. tax purposes.
Intangible Assets
The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30
th
:
 
Balance at March 31, 2023
  
Item
   
Gross Asset
     
Accumulated
Amortization
     
Net Asset
  
ETFS acquisition
     $     601,247        $         —           $     601,247   
Software development
      2,822         (101)           2,721   
    
 
 
     
 
 
     
 
 
  
Balance at March 31, 2023
     $ 604,069        $ (101)          $ 603,968   
    
 
 
     
 
 
     
 
 
  
 
Balance at December 31, 2022
  
Item
   
Gross Asset
     
Accumulated
Amortization
     
Net Asset
  
ETFS acquisition
     $     601,247        $         —           $     601,247   
Software development
      2,370         (50)           2,320   
    
 
 
     
 
 
     
 
 
  
Balance at December 31, 2022
     $ 603,617        $ (50)          $ 603,567   
    
 
 
     
 
 
     
 
 
  
ETFS Acquisition (Indefinite-Lived)
In connection with the ETFS Acquisition, which was completed on April 11, 2018, the Company identified intangible assets valued at $601,247 related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.
Software Development (Finite-Lived)
Internally-developed software is amortized over a useful life of three years. During the three-month period ended March 31, 2023, the Company recognized amortization expense on internally-developed software of $51.
 
As of March 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows:
 
Remained of 2023
     $ 656      
2024
      940      
2025
      891      
2026
      234      
2027
      —      
2028 and thereafter
      —      
    
 
 
  
Total expected amortization expense
     $       2,721      
    
 
 
  
The weighted-average remaining useful life of the finite-lived intangible assets is 2.9 years.
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Contingent Payments
 3 Months Ended
Mar. 31, 2023
Contingent Payments [Abstract]  
Contingent Payments
23. Contingent Payments
Sale of Canadian ETF Business
On February 19, 2020, the Company completed the sale of all the outstanding shares of
WisdomTree Asset Management Canada, Inc.
to CI Financial Corp. The Company received CDN $3,720 (USD $2,774) in cash at closing and was paid CDN $3,000 (USD $2,360) and CDN $2,000 (USD $1,477) of additional cash consideration based upon the achievement of certain AUM growth targets as determined on the
18-month
and the
36-month
anniversaries of the closing date, respectively.
A gain of $1,477 was recognized during the three months ended March 31, 2023, from remeasuring the contingent payment to its realizable value. These gains were recorded in other losses, net.
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
 3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events
24. Subsequent Events
The Company evaluated subsequent events through the date of issuance of the accompanying consolidated financial statements.
There were no events requiring disclosure. 
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of financial condition, results of operations, and cash flows for the periods presented. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Consolidation
Consolidation
The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.
The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.
Segment and Geographic Information
Segment and Geographic Information
The Company, through its subsidiaries in the U.S. and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company’s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.
Foreign Currency Translation
Foreign Currency Translation
Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income/(Loss) as a component of other comprehensive (loss)/income.
Use of Estimates
Use of Estimates
The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.
Revenue Recognition
Revenue Recognition
The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.
Contractual Gold Payments
Contractual Gold Payments
Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note 9).
Marketing and Advertising
Marketing and Advertising
Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.
Depreciation and Amortization
Depreciation and Amortization
Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows:
 
Equipment
      3 to 5 years  
Internally-developed software
      3 years  
The assets listed above are recorded at cost less accumulated depreciation and amortization.
Stock-Based Awards
Stock-Based Awards
Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.
Third-Party Distribution Fees
Third-Party Distribution Fees
The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETFs and for including WisdomTree ETFs on third-party customer platforms and recognizes these expenses as incurred.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.
Accounts Receivable
Accounts Receivable
Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
The Company performs a review for the impairment of long-lived assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.
Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)
Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)
Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or
available-for-sale
(“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.
Securities Held-to-Maturity
Securities
Held-to-Maturity
The Company accounts for certain of its securities as
held-to-maturity
on a trade date basis, which are recorded at amortized cost. For
held-to-maturity
securities, the Company has the intent and ability to hold these securities to maturity and it is not
more-likely-than-not
that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity.
Held-to-maturity
securities are placed on
non-accrual
status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on
held-to-maturity
securities placed on
non-accrual
status is recognized on a cash basis as interest income if and when received.
The Company reviews its portfolio of
held-to-maturity
securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.
Investments in pass-through government-sponsored enterprises (“GSEs”) are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee.
Investments
Investments
The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321,
Investments – Equity Securities
(“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.
Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).
Goodwill
Goodwill
Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring
re-evaluation,
if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.
Goodwill is allocated to the Company’s U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.
Goodwill is assessed for impairment annually on November 30
th
. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.
Intangible Assets
Intangible Assets
Indefinite-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values.
Finite-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.
The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30
th
.
Software Development Costs
Software Development Costs
Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.
Leases
Leases
The Company accounts for its lease obligations in accordance with ASC Topic 842,
Leases
(“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting
right-of-use
asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement,
right-of-use
assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term.
ASC 842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and
non-lease
components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.
Deferred Consideration—Gold Payments
Deferred Consideration—Gold Payments
Deferred consideration represents the present value of an obligation to pay gold to a third party into perpetuity and is measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note 9). Changes in the fair value of this obligation are reported as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.
Convertible Notes
Convertible Notes
Convertible notes are carried at amortized cost, net of issuance costs. In accordance with Accounting Standards Update (“ASU”)
2020-06,
Debt – Debt with Conversion and Other Options
, the Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.
Contingencies
Contingencies
The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.
Contingent Payments
Contingent Payments
The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.
Earnings per Share
Earnings per Share
Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series A
non-voting
convertible preferred stock (Note 11) and unvested share-based payment awards that contain
non-forfeitable
rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the
two-class
method. Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).
Diluted EPS is calculated under the treasury stock method and the
two-class
method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards, the Series A
non-voting
convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series A
non-voting
convertible preferred stock and the convertible notes are computed under the
if-converted
method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price.
Income Taxes
Income Taxes
The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is
more-likely-than-not
that some portion or all the deferred tax assets will not be realized.
Tax positions are evaluated utilizing a
two-step
process. The Company first determines whether any of its tax positions are
more-likely-than-not
to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.
The Global Intangible
Low-Taxed
Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.
Non-income
based taxes are recorded as part of other liabilities and other expenses.
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Estimated Useful Lives of Related Assets
Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows:
 
Equipment
      3 to 5 years  
Internally-developed software
      3 years  
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Summary of Categorization of Assets and Liabilities Measured at Fair Value
The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2023 and 2022, there were no transfers between Levels 2 and 3.
 
                                                                                                     
    
March 31, 2023
  
    
Total
     
Level 1
     
Level 2
  
Level 3
  
Assets:
                                   
Recurring fair value measurements:
                                   
Cash equivalents
   
  $
336
 
   
  $
336
 
   
  $
—
 
  
  $
—  
 
Financial instruments owned, at fair value
                             
 
  
 
ETFs
   
 
33,728
 
   
 
33,728
 
   
 
—
 
  
 
—  
 
U.S. treasuries
   
 
2,993
 
   
 
2,993
 
   
 
—
 
  
 
—  
 
Pass-through GSEs
   
 
81,046
 
   
 
23,352
 
   
 
  57,694
 
  
 
—  
 
Other assets—seed capital (WisdomTree blockchain-enabled funds)
                             
 
  
 
U.S. treasuries
   
 
4,901
 
   
 
4,901
 
   
 
—
 
  
 
—  
 
Equities
   
 
4,937
 
   
 
4,937
 
   
 
—
 
  
 
—  
 
Fixed income
   
 
1,915
 
   
 
—
 
   
 
1,915
 
  
 
—  
 
Other
   
 
660
 
   
 
—
 
   
 
660
 
  
 
—  
 
Investments in Convertible Notes
                                   
Securrency, Inc.—convertible note (Note 7)
   
 
10,051
 
   
 
—
 
   
 
—
 
  
 
10,051  
 
Fnality International Limited—convertible note (Note 7)
   
 
7,451
 
   
 
—
 
   
 
—
 
  
 
7,451  
 
    
 
 
     
 
 
     
 
 
 
  
 
 
  
Total
   
  $
    148,018
 
   
  $
    70,247
 
   
  $
    60,269
   
  
  $
      17,502  
 
    
 
 
     
 
 
     
 
 
 
  
 
 
  
 
                                                                                                     
    
March 31, 2023
  
    
Total
     
Level 1
     
Level 2
     
Level 3
  
Non-recurring
fair value measurements:
                                    
Securrency, Inc.—Series A convertible preferred stock
(1)
   
  $
    3,588
 
   
  $
—
 
   
  $
—
 
   
  $
3,588  
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Liabilities:
                                    
Recurring fair value measurements:
                                    
Deferred consideration (Note 9)
   
  $
    179,831
 
   
  $
            —
 
   
  $
        —
 
   
  $
    179,831  
 
    
 
 
     
 
 
     
 
 
     
 
 
  
   
    
December 31, 2022
  
    
Total
     
Level 1
     
Level 2
     
Level 3
  
Assets:
                                    
Recurring fair value measurements:
                                    
Cash equivalents
   
  $
930 
 
   
  $
930 
 
   
  $
— 
 
   
  $
—
 
Financial instruments owned, at fair value
                                    
ETFs
   
 
23,772 
 
   
 
23,772 
 
   
 
— 
 
   
 
—
 
U.S. treasuries
   
 
2,980 
 
   
 
2,980 
 
   
 
— 
 
   
 
—
 
Pass-through GSEs
   
 
96,837 
 
   
 
23,290 
 
   
 
73,547 
 
   
 
—
 
Corporate bonds
   
 
885 
 
   
 
— 
 
   
 
885 
 
   
 
—
 
Other assets—seed capital (WisdomTree blockchain-enabled funds)
   
 
1,765 
 
   
 
— 
 
   
 
1,765 
 
   
 
—
 
Investments in Convertible Notes
            
 
 
 
                  
Securrency, Inc.—convertible note (Note 7)
   
 
14,500 
 
   
 
— 
 
   
 
— 
 
   
 
14,500
 
Fnality International Limited—convertible note (Note 7)
   
 
6,921 
 
   
 
— 
 
   
 
— 
 
   
 
6,921
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
   
  $
  148,590 
 
   
  $
  50,972 
 
   
  $
  76,197 
 
   
  $
21,421
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Non-recurring
fair value measurements:
                                    
Other investments
(2)
   
  $
312 
 
   
  $
— 
 
   
  $
— 
 
   
  $
312
 
    
 
 
     
 
 
     
 
 
     
 
 
  
Liabilities:
                                    
Recurring fair value measurements:
                                    
Deferred consideration (Note 9)
   
  $
200,290 
 
   
  $
— 
 
   
  $
— 
 
   
  $
   200,290
 
    
 
 
     
 
 
     
 
 
     
 
 
  
 
(1)
Fair value determined on March 31, 2023.
(2)
Fair value determined on May 10, 2022.
Summary of Reconciliation of Recurring Fair Value Measurements The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:
 
        
Three Months Ended,

March 31,
  
        
2023
    
2022
  
   
Investments in Convertible Notes (Note 7)
                 
   
Beginning balance
      $ 21,421       $ —  
    
  
Purchases
      —       6,863  
   
Net unrealized losses
(1)
      (3,919 )      (163 ) 
        
 
 
    
 
 
  
   
Ending balance
      $ 17,502       $ 6,700  
        
 
 
    
 
 
  
   
Deferred Consideration (Note 9)
                 
   
Beginning balance
      $     200,290       $ 228,062  
   
Net realized losses
(2)
      4,486       4,450  
   
Net unrealized (gains)/losses
(3)
      (20,592 )      17,018  
   
Settlements
      (4,353 )      (4,353 ) 
        
 
 
    
 
 
  
   
Ending balance
      $ 179,831        $     245,177    
        
 
 
    
 
 
  
 
(1)
Recorded in other losses, net in the Consolidated Statements of Operations.
(2)
Recorded as contractual gold payments expense in the Consolidated Statements of Operations.
(3)
Recorded as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations.
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments owned (Tables)
 3 Months Ended
Mar. 31, 2023
Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract]  
Schedule Of Trading Securities And Other Trading Assets
These instruments consist of the following:
 
        
    March 31,    

2023
    
    December 31,    
2022
  
          
  
Financial instruments owned
                 
   
Trading securities
      $ 117,767       $ 124,474  
   
Other assets—seed capital (WisdomTree blockchain-enabled funds)
      12,413       1,765  
        
 
 
    
 
 
  
           $     130,180         $     126,239   
        
 
 
    
 
 
  
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Securities Held-to-Maturity (Tables)
 3 Months Ended
Mar. 31, 2023
Text Block [Abstract]  
Schedule of Securities Held-to-Maturity
The following table is a summary of the Company’s securities
held-to-maturity:
 
                                            
       
    March 31,    

2023
   
    December 31,    

2022
 
Debt instruments: Pass-through GSEs (amortized cost)
      $           253          $           259    
      
 
 
 
   
 
 
 
Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity
The following table summarizes unrealized losses, gains and fair value (classified as Level 2 within the fair value hierarchy) of securities
held-to-maturity:
 
                                            
       
    March 31,    

2023
   
    December 31,    
2022
 
Cost/amortized cost
      $ 253      $ 259  
 
Gross unrealized losses
      (17 )       (20 ) 
 
Gross unrealized gains
      —        —  
      
 
 
 
   
 
 
 
 
Fair value
      $           236        $           239    
      
 
 
 
   
 
 
 
Schedule of Maturity Profile of Securities Held-to-Maturity
The following table sets forth the maturity profile of the securities
held-to-maturity;
however, these securities may be called prior to the maturity date:
 
                                
       
    March 31,    

2023
   
    December 31,    

2022
 
Due within one year
      $ —        $ —  
 
Due one year through five years
      —        —  
 
Due five years through ten years
      26        27  
 
Due over ten years
      227        232  
      
 
 
 
   
 
 
 
 
Total
      $           253          $           259    
      
 
 
 
   
 
 
 
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Tables)
 3 Months Ended
Mar. 31, 2023
Investment [Line Items]  
Investments
The following table sets forth the Company’s investments:
 
      
       
        March 31, 2023        
     
        December 31, 2022        
  
      
Carrying

Value
     
Cost
     
Carrying

Value
     
Cost
  
 
Securrency, Inc.—Series A convertible preferred stock
      $ 3,588          $ 8,112          $ 8,488          $ 8,112    
 
Securrency, Inc.—Series B convertible preferred stock
      5,500          5,500          5,500          5,500    
 
Securrency, Inc.—convertible note
      10,051          15,000          14,500          15,000    
      
 
 
     
 
 
     
 
 
     
 
 
  
 
Subtotal—Securrency, Inc.
      $ 19,139          $ 28,612          $ 28,488          $ 28,612    
 
Fnality International Limited—convertible note
      7,451          6,863          6,921          6,863    
 
Other investments
      312          250          312          250    
      
 
 
     
 
 
     
 
 
     
 
 
  
         $     26,902          $     35,725          $  35,721          $     35,725    
      
 
 
     
 
 
     
 
 
     
 
 
  
Securrency Inc [Member]  
Investment [Line Items]  
Summary of Inputs Used in PWERM Approach of Investment
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy):
 
    
March 31,

2023
  
Conversion of Securrency Series A Shares upon a future equity financing
      33.3%  
Redemption of Securrency Series A Shares upon a corporate transaction
      33.3%  
Default
      33.4%  
Securrency Convertible Note [Member]  
Investment [Line Items]  
Summary of Inputs Used in PWERM Approach of Investment
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 
    
  March 31,  

2023
   
  December 31,  

2022
Conversion of note upon a future equity financing
        33.3%          60%
Redemption of note upon a corporate transaction
        33.3%          25%
Default
        33.4%          15%
Time to potential outcome (in years)
          0.56          0.33
Fnality Convertible Note [Member]  
Investment [Line Items]  
Summary of Inputs Used in PWERM Approach of Investment
The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:
 
    
  March 31,  

2023
  
  December 31,  

2022
Conversion of note upon a future financing round
          85%         85%
Redemption of note upon a change of control
          10%         10%
Default
            5%           5%
Time to potential outcome (in years)
          0.08         0.25
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets, net (Tables)
 3 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Fixed Assets
The following table summarizes fixed assets:
 
    
March 31,

2023
     
December 31,
2022
  
Equipment
     $             997          $             962    
Less: accumulated depreciation
      (482)          (418)   
    
 
 
     
 
 
  
Total
     $ 515          $ 544    
    
 
 
     
 
 
  
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Consideration (Tables)
 3 Months Ended
Mar. 31, 2023
Text Block [Abstract]  
Summary of valuation of deferred consideration
The Company determined the present value of the deferred consideration of $179,831 and $200,290 at March 31, 2023 and December 31, 2022 using the following assumptions:
 
    
March 31,
2023
    
December 31,
2022
  
Forward-looking gold price (low)—per ounce
      $ 1,999        $ 1,858  
Forward-looking gold price (high)—per ounce
      $ 3,567        $ 3,126  
Forward-looking gold price (weighted average)—per ounce
      $ 2,401        $         2,237  
Discount rate
              13.3%        11.0%  
Perpetual growth rate
      1.5%        1.3%  
Schedule of Deferred Consideration
During the three months ended March 31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:
 
    
Three Months Ended

March 31,
  
    
2023
     
2022
  
Contractual Gold Payments
     $ 4,486        $ 4,450    
Contractual Gold Payments—gold ounces paid
      2,375          2,375    
Gain/(loss) on revaluation of deferred consideration—gold payments
(1)
     $     20,592        $     (17,018)   
 
(1)
 
Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes (Tables)
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of key terms of convertible notes
Key terms of the Convertible Notes are as follows:
 
    
  2023 Notes  
     
  2021 Notes  
     
  2020 Notes  
  
Principal outstanding
      $130.0        $150.0        $60.0    
Maturity date (unless earlier converted, repurchased or redeemed)
      August 15, 2028        June 15, 2026        June 15, 2023    
Interest rate
      5.75%        3.25%        4.25%    
Conversion price
      $9.54        $11.04        $5.92    
Conversion rate
      104.8658        90.5797        168.9189    
Redemption price
      $12.40        $14.35        $7.70    
Summary of the carrying value of the convertible notes
The following table provides a summary of the carrying value of the Convertible Notes at March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
  
December 31, 2022
    
2023
Notes
  
2021
Notes
  
2020 Notes
  
Total
  
2021 Notes
  
2020 Notes
  
Total
Principal amount
     $  130,000      $  150,000      $  60,000      $   340,000      $   150,000      $   175,000      $   325,000  
Plus: Premium
      —       —       250       250       —       250       250  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Gross proceeds
      130,000       150,000       60,250       340,250       150,000       175,250       325,250  
Less: Unamortized issuance costs
      (3,465)       (2,768)       (366)
    (6,599)       (2,981)       (1,053)       (4,034)  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Carrying amount
      126,535      $ 147,232      $ 59,884      $ 333,651      $ 147,019      $ 174,197      $ 321,216  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Effective interest rate
(1)
      6.25%       3.83%       5.18%       5.00%       3.83%       5.26%       4.60%  
    
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
        
                                                                                                   
(1)
Includes amortization of the issuance costs and premium.
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Series A Preferred Stock (Tables)
 3 Months Ended
Mar. 31, 2023
Series A Preferred Stock [Member]  
Summary of Series A Preferred Stock Balance
The following is a summary of the Series A Preferred Stock balance:
 
    
March 31,

2023
  
December 31,
2022
Issuance of Series A Preferred Stock
    $     132,750     $     132,750  
Less: Issuance costs
      (181 )      (181 ) 
    
 
 
 
  
 
 
 
Series A Preferred Stock—carrying value
    $ 132,569     $ 132,569  
    
 
 
 
  
 
 
 
Cash dividends declared per share (quarterly)
    $ 0.03     $ 0.03  
    
 
 
 
  
 
 
 
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2023
Lessee Disclosure [Abstract]  
Schedule for Summary of Additional Information Related to Operating Lease
The following table provides additional information regarding the Company’s leases:
 
    
Three Months Ended

March 31,
  
    
        2023        
     
        2022        
  
Lease cost:
                  
Operating lease cost
    $ 319          $ 89      
Short-term lease cost
      56            276      
    
 
 
     
 
 
  
Total lease cost
    $ 375          $             365      
    
 
 
     
 
 
  
Other information:
                  
Cash paid for amounts included in the measurement of operating liabilities (operating leases)
    $             326          $ 97      
    
 
 
     
 
 
  
Right-of-use
assets obtained in exchange for new operating lease liabilities
      n/a            n/a      
    
 
 
     
 
 
  
Weighted-average remaining lease term (in years)—operating leases
      1.0            1.3      
    
 
 
     
 
 
  
Weighted-average discount rate—operating leases
      6.5%         4.4%   
    
 
 
     
 
 
  
Schedule of Future Minimum Lease Payments
The following table discloses future minimum lease payments at March 31, 2023 with respect to the Company’s operating lease liabilities:
            
 
Remainder of 2023
     $ 803    
 
2024
      397    
 
2025
      —    
 
2026
      —    
 
2027
      —    
 
2028 and thereafter
      —    
      
 
 
  
 
Total future minimum lease payments (undiscounted)
     $         1,200    
      
 
 
  
Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet
The following table reconciles the future minimum lease payments (disclosed above) at March 31, 2023 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets:
 
            
 
Amounts recognized in the Company’s Consolidated Balance     Sheets
         
 
Lease liability—short term
    $ 1,041    
 
Lease liability—long term
      120    
      
 
 
  
 
Subtotal
      1,161    
 
Difference between undiscounted and discounted cash flows
      39    
      
 
 
  
 
Total future minimum lease payments (undiscounted)
      $       1,200    
      
 
 
  
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Variable Interest Entities (Tables)
 3 Months Ended
Mar. 31, 2023
Summary of Variable Interests in Non-consolidated VIEs
The following table presents information about the Company’s variable interests in
non-consolidated
VIEs:
 
    
      March 31,      

2023
     
      December 31,      

2022
     
                                                    
Carrying Amount—Assets (Securrency):
                  
Preferred stock—Series A Shares
    $ 3,588         $ 8,488    
Preferred stock—Series B Shares
      5,500          5,500    
Convertible note
      10,051          14,500    
    
 
 
     
 
 
  
Subtotal—Securrency
    $ 19,139         $ 28,488    
Carrying Amount—Assets (Fnality):
                    
Convertible note
      7,451          6,921    
Carrying Amount—Assets (Other investments):
      312          312    
    
 
 
     
 
 
  
Total (Note 7)
    $ 26,902         $ 35,721    
    
 
 
     
 
 
  
 
Maximum exposure to loss
    $         26,902         $         35,721    
    
 
 
     
 
 
  
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues from Contracts with Customers (Tables)
 3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Summary of Revenues from Contracts with Customers
The following table presents the Company’s total revenues from contracts with customers:
 
    
Three Months Ended March 31,
  
    
2023
     
2022
  
Revenues from contracts with customers:
                  
Advisory fees
     $ 77,637         $ 76,517    
Other
      4,407          1,851    
    
 
 
     
 
 
  
Total operating revenues
     $       82,044         $       78,368    
    
 
 
     
 
 
  
Summary of Geographic Distribution of Revenue
The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside:
 
    
Three Months Ended March 31,
  
    
2023
     
2022
  
Revenues from contracts with customers:
                  
United States
     $ 49,681         $ 46,229    
Jersey
      29,053          28,598    
Ireland
      3,310          3,541    
    
 
 
     
 
 
  
Total operating revenues
     $     82,044         $     78,368    
    
 
 
     
 
 
  
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions (Tables)
 3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Summary of Accounts Receivable from Related Parties
The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:
 
    
March 31,

2023
     
December 31,

2022
     
            
Receivable from WTT
     $ 17,124         $ 16,399    
Receivable from ManJer Issuers
      12,790          4,485    
Receivable from WMAI and WTICAV
      2,532          3,255    
    
 
 
     
 
 
  
Total
     $       32,446         $       24,139    
    
 
 
     
 
 
  
Summary of Revenues from Advisory Services Provided to Related Parties
The following table summarizes revenues from advisory services provided to related parties:
 
    
Three Months Ended March 31,
     
            
    
2023
     
2022
  
Advisory services provided to WTT
     $ 49,487         $ 46,070    
Advisory services provided to ManJer Issuers
      24,840          26,905    
Advisory services provided to WMAI and WTICAV
      3,310          3,542    
    
 
 
     
 
 
  
Total
     $       77,637         $       76,517    
    
 
 
     
 
 
  
XML 67 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Awards (Tables)
 3 Months Ended
Mar. 31, 2023
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period
A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows:
 
       
March 31, 2023
     
Unrecognized Stock-
Based

Compensation
   
Weighted-Average

Remaining
  Vesting Period (Years)  
 
Employees and directors
    $             30,415                  2.10
Summary of Restricted Stock Activity
A summary of stock-based compensation award activity (shares) during the three months ended March 31, 2023 is as follows:
 
    
RSA
  
RSU
  
PRSU
Balance at January 1, 2023
      3,391,082       141,963       668,188  
Granted
      3,273,263       73,855       576,240
(1)
 
Vested
      (1,498,171 )      (26,837 )      (83,158 )
(2)
 
Forfeited
      (11,885 )       (233 )       (24,955 )
(2)
 
    
 
 
 
  
 
 
 
  
 
 
 
Balance at March 31, 2023
          5,154,289           188,748             1,136,315  
    
 
 
 
  
 
 
 
  
 
 
 
 
                                                                                
 
 
 
(1)
Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. A Monte-Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning
90-day
average stock prices; (ii) valuation date stock prices; (iii) historical stock price volatilities ranging from 37% to 56% (average 47%); (iv) correlation coefficients based upon the price data used to calculate the historical volatilities; (v) a risk free interest rate of 3.8%; and (vi) an expected dividend yield of 0%.
 
 
(2)
The payout on PRSUs vesting in January 2023 was 77%. The remainder of the awards were forfeited.
XML 68 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings/(Loss) Per Share (Tables)
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Reconciliation of Basic and Diluted Earnings Per Share
The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented:
 
      
Three Months Ended

March 31,
Basic Earnings/(Loss) per Share
     
          2023          
   
          2022          
Net income/(loss)
       $ 16,233       $ (10,261 ) 
Less: Income distributed to participating securities
        (498 )       (549 ) 
Less: Undistributed income allocable to participating securities
        (1,206 )         —    
      
 
 
 
   
 
 
 
Net income/(loss) available to common stockholders—Basic EPS
       $ 14,529       $ (10,810 ) 
     
Weighted average common shares (in thousands)
        143,862          142,782  
      
 
 
 
   
 
 
 
Basic earnings/(loss) per share
       $         0.10       $ (0.08 )     
      
 
 
 
   
 
 
 
 
      
Three Months Ended

March 31,
Diluted Earnings/(Loss) per Share
     
          2023          
   
          2022          
Net earnings/(loss) available to common stockholders
       $ 14,529       $ (10,810 ) 
Add back: Undistributed income allocable to participating securities
        1,206        —    
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive
        (1,202 )         —    
      
 
 
 
   
 
 
 
Net income/(loss) available to common stockholders—Diluted EPS
       $ 14,533       $ (10,810 )     
      
 
 
 
   
 
 
 
Weighted Average Diluted Shares (in thousands)
:
                    
Weighted average common shares
        143,862        142,782  
Dilutive effect of common stock equivalents, excluding participating securities
        569        —    
      
 
 
 
   
 
 
 
Weighted average diluted shares, excluding participating securities (in thousands)
        144,431        142,782  
      
 
 
 
   
 
 
 
Diluted earnings/(loss) per share
       $ 0.10       $ (0.08 ) 
      
 
 
 
   
 
 
 
Schedule of Weighted Average Number of Shares
The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:
 
      
Three Months Ended

March 31,
Reconciliation of Weighted Average Diluted Shares (in thousands)
     
2023
   
2022
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations
        159,887        142,782
(1)
 
Less: Participating securities:
                    
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11)
        (14,750 )       —    
Potentially dilutive restricted stock awards
        (706 )       —    
      
 
 
 
   
 
 
 
Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above
              144,431            142,782  
      
 
 
 
   
 
 
 
 
(1)
 
Excludes 15,521 participating securities and 31 potentially dilutive
non-participating
common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands).
XML 69 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
 3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Summary of Deferred Tax Asset Recorded
Deferred Tax Assets
A summary of the components of the Company’s deferred tax assets at March 31, 2023 and December 31, 2022 is as follows:
 
        
March 31,

2023
     
December 31,

2022
  
 
Deferred tax assets:
                  
 
Capital losses
      $         17,740             $         17,541       
 
Unrealized losses
      4,781             3,821       
 
NOLs—Foreign
      1,625             1,609       
 
Accrued expenses
      1,527             6,030       
 
Goodwill and intangible assets
      1,038             1,085       
 
Stock-based compensation
      865             1,526       
 
Interest carryforwards
      476             —       
 
Operating lease liabilities
      260             313       
 
Foreign currency translation adjustment
      254             173       
 
NOLs—U.S.
      127             255       
 
Outside basis differences
      122             122       
 
        
March 31,

2023
     
December 31,
2022
  
 
Other
      355             341       
      
 
 
     
 
 
  
 
Deferred tax assets
      29,170             32,816       
      
 
 
     
 
 
  
 
Deferred tax liabilities:
                  
 
Fixed assets and prepaid assets
      150             278       
 
Unremitted earnings—European subsidiaries
      246             205       
 
Right of use assets—operating leases
      260             313       
      
 
 
     
 
 
  
 
Deferred tax liabilities
      656             796       
      
 
 
     
 
 
  
 
Total deferred tax assets less deferred tax liabilities
      28,514             32,020       
 
Less: Valuation allowance
      (22,643)            (21,484)      
      
 
 
     
 
 
  
 
Deferred tax assets, net
      $ 5,871             $ 10,536       
      
 
 
     
 
 
  
Schedule of Changes in Balance of Gross Unrecognized Tax Benefits The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:
 
      
Total
   
Unrecognized
Tax Benefits
   
Interest and
Penalties
Balance at January 1, 2023
        $         1,353      $         957      $         396  
Decrease—Lapse of statute of limitations
        (1,353 )         (957 )         (396 )   
      
 
 
 
   
 
 
 
   
 
 
 
Balance at March 31, 2023
        $ —        $ —        $ —    
      
 
 
 
   
 
 
 
   
 
 
 
 
 
(1)
The gross unrecognized tax benefits were accrued in British pounds.
XML 70 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Goodwill
The table below sets forth goodwill which is tested annually for impairment on November 30
th
:
 
    
Total
  
Balance at January 1, 2023
    $               85,856      
Changes
      —      
    
 
 
  
Balance at March 31, 2023
    $ 85,856      
    
 
 
  
Summary of Intangible Assets
The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30
th
:
 
Balance at March 31, 2023
  
Item
   
Gross Asset
     
Accumulated
Amortization
     
Net Asset
  
ETFS acquisition
     $     601,247        $         —           $     601,247   
Software development
      2,822         (101)           2,721   
    
 
 
     
 
 
     
 
 
  
Balance at March 31, 2023
     $ 604,069        $ (101)          $ 603,968   
    
 
 
     
 
 
     
 
 
  
 
Balance at December 31, 2022
  
Item
   
Gross Asset
     
Accumulated
Amortization
     
Net Asset
  
ETFS acquisition
     $     601,247        $         —           $     601,247   
Software development
      2,370         (50)           2,320   
    
 
 
     
 
 
     
 
 
  
Balance at December 31, 2022
     $ 603,617        $ (50)          $ 603,567   
    
 
 
     
 
 
     
 
 
  
Summary of Unamortized Finite-lived Intangible Assets
As of March 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows:
 
Remained of 2023
     $ 656      
2024
      940      
2025
      891      
2026
      234      
2027
      —      
2028 and thereafter
      —      
    
 
 
  
Total expected amortization expense
     $       2,721      
    
 
 
  
XML 71 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies - Schedule of Estimated Useful Lives of Related Assets (Detail)
 3 Months Ended
Mar. 31, 2023
Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 years
Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years
Internally-developed software  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 3 years
XML 72 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies - Additional Information (Detail)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Cash and cash equivalents maturity period, maximum 90 days  
Short-term lease exception - Lease term 12 months 12 months
XML 73 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Cash and Cash Equivalents - Additional Information (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Cash equivalents $ 336 $ 930
Total cash and cash equivalents 119,099 132,101
Two Financial Institutions [Member]    
Cash and cash equivalents 118,306 131,104
European Business Segment [Member]    
Minimum level of regulatory net capital $ 28,726 $ 25,988
XML 74 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Additional Information (Detail)
 3 Months Ended
Mar. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Liquid investments, original maturities 90 days
XML 75 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Summary of Categorization of Assets and Liabilities Measured at Fair Value (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Liabilities:    
Deferred consideration (Note 10) $ 179,831 $ 200,290
Fair Value, Measurements, Recurring [Member]    
Assets:    
Cash equivalents 336 930
Total 148,018 148,590
Liabilities:    
Deferred consideration (Note 10) 179,831 200,290
Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Other assets fair value disclosure 4,901  
Fair Value, Measurements, Recurring [Member] | Equity Securities [Member]    
Assets:    
Other assets fair value disclosure 4,937  
Fair Value, Measurements, Recurring [Member] | Fixed Income Investments [Member]    
Assets:    
Other assets fair value disclosure 1,915  
Fair Value, Measurements, Recurring [Member] | Other Investment Companies [Member]    
Assets:    
Other assets fair value disclosure 660  
Fair Value, Measurements, Recurring [Member] | Securrency Convertible Note [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 10,051 14,500
Fair Value, Measurements, Recurring [Member] | ETFs [Member]    
Assets:    
Financial instruments owned, at fair value 33,728 23,772
Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Financial instruments owned, at fair value 2,993 2,980
Fair Value, Measurements, Recurring [Member] | Pass-through GSEs [Member]    
Assets:    
Financial instruments owned, at fair value 81,046 96,837
Fair Value, Measurements, Recurring [Member] | Other assets—seed capital (WisdomTree blockchain-enabled funds) [Member]    
Assets:    
Financial instruments owned, at fair value   1,765
Fair Value, Measurements, Recurring [Member] | Corporate Bonds [Member]    
Assets:    
Financial instruments owned, at fair value   885
Fair Value, Measurements, Nonrecurring [Member] | Other Investments [Member]    
Assets:    
Investment owned, at fair value   312
Securrency - Series A convertible preferred stock | Fair Value, Measurements, Nonrecurring [Member]    
Assets:    
Investment owned, at fair value 3,588  
Fnality Convertible Note [Member] | Fair Value, Measurements, Recurring [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 7,451 6,921
Level 1 [Member] | Fair Value, Measurements, Recurring [Member]    
Assets:    
Cash equivalents 336 930
Total 70,247 50,972
Liabilities:    
Deferred consideration (Note 10) 0 0
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Other assets fair value disclosure 4,901  
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Equity Securities [Member]    
Assets:    
Other assets fair value disclosure 4,937  
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Fixed Income Investments [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Other Investment Companies [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Securrency Convertible Note [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 0 0
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | ETFs [Member]    
Assets:    
Financial instruments owned, at fair value 33,728 23,772
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Financial instruments owned, at fair value 2,993 2,980
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Pass-through GSEs [Member]    
Assets:    
Financial instruments owned, at fair value 23,352 23,290
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Other assets—seed capital (WisdomTree blockchain-enabled funds) [Member]    
Assets:    
Financial instruments owned, at fair value   0
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | Corporate Bonds [Member]    
Assets:    
Financial instruments owned, at fair value   0
Level 1 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Other Investments [Member]    
Assets:    
Investment owned, at fair value   0
Level 1 [Member] | Securrency - Series A convertible preferred stock | Fair Value, Measurements, Nonrecurring [Member]    
Assets:    
Investment owned, at fair value 0  
Level 1 [Member] | Fnality Convertible Note [Member] | Fair Value, Measurements, Recurring [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 0 0
Level 2 [Member] | Fair Value, Measurements, Recurring [Member]    
Assets:    
Cash equivalents 0 0
Total 60,269 76,197
Liabilities:    
Deferred consideration (Note 10) 0 0
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Equity Securities [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Fixed Income Investments [Member]    
Assets:    
Other assets fair value disclosure 1,915  
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Other Investment Companies [Member]    
Assets:    
Other assets fair value disclosure 660  
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Securrency Convertible Note [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 0 0
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | ETFs [Member]    
Assets:    
Financial instruments owned, at fair value 0 0
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Financial instruments owned, at fair value 0 0
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Pass-through GSEs [Member]    
Assets:    
Financial instruments owned, at fair value 57,694 73,547
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Other assets—seed capital (WisdomTree blockchain-enabled funds) [Member]    
Assets:    
Financial instruments owned, at fair value   1,765
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | Corporate Bonds [Member]    
Assets:    
Financial instruments owned, at fair value   885
Level 2 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Other Investments [Member]    
Assets:    
Investment owned, at fair value   0
Level 2 [Member] | Securrency - Series A convertible preferred stock | Fair Value, Measurements, Nonrecurring [Member]    
Assets:    
Investment owned, at fair value 0  
Level 2 [Member] | Fnality Convertible Note [Member] | Fair Value, Measurements, Recurring [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 0 0
Level 3 [Member] | Fair Value, Measurements, Recurring [Member]    
Assets:    
Cash equivalents 0 0
Total 17,502 21,421
Liabilities:    
Deferred consideration (Note 10) 179,831 200,290
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Equity Securities [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Fixed Income Investments [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Other Investment Companies [Member]    
Assets:    
Other assets fair value disclosure 0  
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Securrency Convertible Note [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure 10,051 14,500
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | ETFs [Member]    
Assets:    
Financial instruments owned, at fair value 0 0
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | US Treasury Securities [Member]    
Assets:    
Financial instruments owned, at fair value 0 0
Other assets fair value disclosure 0  
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Pass-through GSEs [Member]    
Assets:    
Financial instruments owned, at fair value 0 0
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Other assets—seed capital (WisdomTree blockchain-enabled funds) [Member]    
Assets:    
Financial instruments owned, at fair value   0
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | Corporate Bonds [Member]    
Assets:    
Financial instruments owned, at fair value   0
Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Other Investments [Member]    
Assets:    
Investment owned, at fair value   312
Level 3 [Member] | Securrency - Series A convertible preferred stock | Fair Value, Measurements, Nonrecurring [Member]    
Assets:    
Investment owned, at fair value 3,588  
Level 3 [Member] | Fnality Convertible Note [Member] | Fair Value, Measurements, Recurring [Member]    
Investments in Convertible Notes    
Investments, Fair value disclosure $ 7,451 $ 6,921
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Summary of Reconciliation of Recurring Fair Value Measurements (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Deferred consideration (Note XX)    
Beginning balance $ 21,421 $ 0
Purchases 0 6,863
Net unrealized (gains)/losses (3,919) (163)
Ending balance 17,502 6,700
Deferred Consideration Obligation [Member]    
Deferred consideration (Note XX)    
Beginning balance 200,290 228,062
Net realized losses 4,486 4,450
Net unrealized (gains)/losses (20,592) 17,018
Settlements (4,353) (4,353)
Ending balance $ 179,831 $ 245,177
XML 77 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments owned - Debt Securities, Trading, and Equity Securities, FV-NI (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Debt and Equity Securities, FV-NI [Line Items]    
Financial Instruments, Owned, at Fair Value $ 130,180 $ 126,239
WETF Trading Securities [Member]    
Debt and Equity Securities, FV-NI [Line Items]    
Financial Instruments, Owned, at Fair Value 117,767 124,474
Other assets—seed capital (WisdomTree blockchain-enabled funds) [Member]    
Debt and Equity Securities, FV-NI [Line Items]    
Financial Instruments, Owned, at Fair Value $ 12,413 $ 1,765
XML 78 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Financial instruments owned - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Financial Instruments Owned at Fair Value [Member]    
Debt and Equity Securities, FV-NI [Line Items]    
Debt and Equity Securities, Gain (Loss) $ 4,722 $ 4,316
XML 79 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Securities Held-to-Maturity - Schedule of Securities Held-to-Maturity (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Schedule of Held-to-maturity Securities [Line Items]    
Debt instruments: Pass-through GSEs (amortized cost) $ 253 $ 259
Pass-through GSEs [Member]    
Schedule of Held-to-maturity Securities [Line Items]    
Debt instruments: Pass-through GSEs (amortized cost) $ 253 $ 259
XML 80 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Securities Held-to-Maturity - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]    
Held-to-maturity cost or amortized cost $ 253 $ 259
Held-to-maturity gross unrealized losses (17) (20)
Held-to-maturity gross unrealized gains 0 0
Held-to-maturity fair value $ 236 $ 239
XML 81 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Securities Held-to-Maturity - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]    
Proceeds from Sale and Maturity of Held-to-maturity Securities $ 6 $ 18
XML 82 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Securities Held-to-Maturity - Schedule of Maturity Profile of Securities Held-to-Maturity (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]    
Held-to-maturity due within one year $ 0 $ 0
Held-to-maturity due one year through five years 0 0
Held-to-maturity due five years through ten years 26 27
Held-to-maturity due over ten years 227 232
Held-to-maturity cost or amortized cost $ 253 $ 259
XML 83 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Investments - Details of Investments Carried at Cost (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Investment [Line Items]    
Investments $ 26,902 $ 35,721
Other InvestmentsCarrying Value [Member]    
Investment [Line Items]    
Investments 26,902 35,721
Other Investments Cost [Member]    
Investment [Line Items]    
Investments 35,725 35,725
Securrency Inc. - Series A Convertible Preferred Stock - Carrying Value [Member]    
Investment [Line Items]    
Investments 3,588 8,488
Securrency Inc. - Series A Convertible Preferred Stock - Cost [Member]    
Investment [Line Items]    
Investments 8,112 8,112
Securrency Inc. - Series B Convertible Preferred Stock - Carrying Value [Member]    
Investment [Line Items]    
Investments 5,500 5,500
Securrency Inc. - Series B Convertible Preferred Stock - Cost [Member]    
Investment [Line Items]    
Investments 5,500 5,500
Securrency Inc - Convertible Note - Carrying Value [Member]    
Investment [Line Items]    
Investments 10,051 14,500
Securrency Inc - Convertible Note - Cost [Member]    
Investment [Line Items]    
Investments 15,000 15,000
Subtotal – Securrency, Inc. - Carrying Value [Member]    
Investment [Line Items]    
Investments 19,139 28,488
Subtotal – Securrency, Inc. - Cost [Member]    
Investment [Line Items]    
Investments 28,612 28,612
Fnality International Limited Convertible Note Carrying Value [Member]    
Investment [Line Items]    
Investments 7,451 6,921
Fnality International Limited Convertible Note Cost [Member]    
Investment [Line Items]    
Investments 6,863 6,863
Onramp Invest Inc Series A-4 Preferred Stock - Carrying Value [Member]    
Investment [Line Items]    
Investments 312 312
Onramp Invest Inc - Series A-4 Preferred Stock - Cost [Member]    
Investment [Line Items]    
Investments $ 250 $ 250
XML 84 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Investments - Additional Information (Detail)
£ in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2031
Dec. 31, 2029
Mar. 31, 2023
GBP (£)
Dec. 31, 2022
USD ($)
Mar. 31, 2021
shares
Dec. 31, 2019
shares
Investment [Line Items]                
Cost of Investments $ 26,902         $ 35,721    
Unrealized gain (loss) on investments $ 1,954 $ (5,142)            
Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes At Maturity 50.00%              
Percentage of voting approval required to redeem all of the outstanding notes before maturity 75.00%              
Percentage of outstanding convertible note 75              
Subsequent Event [Member]                
Investment [Line Items]                
Percentage of voting approval required to redeem all of the outstanding series a shares       60.00%        
Percentage of voting approval required to redeem all of the outstanding series B shares     90.00%          
Securrency Inc [Member]                
Investment [Line Items]                
Cost of Investments $ 13,612              
Ownership interest percentage 22.00%       22.00%      
Original fully diluted ownership interest percentage 17.00%       17.00%      
Impairment Of Investments $ 0              
Securrency - Series A Preferred Stock [Member]                
Investment [Line Items]                
Number of shares purchased | shares               5,178,488
Non-cumulative dividend 6.00%              
Impairment Of Investments $ 4,900              
Securrency - Series B Convertible Preferred Stock [Member]                
Investment [Line Items]                
Number of shares purchased | shares             2,004,665  
Fnality International Limited Convertible Note | Accounting Standards Update 2016-01 [Member]                
Investment [Line Items]                
Fair value $ 6,863       £ 5,000      
Fnality International Limited [Member]                
Investment [Line Items]                
Ownership interest percentage 5.00%       5.00%      
Percentage of discount on future equity financing for preferred stock 20.00%       20.00%      
Unrealized gain (loss) on investments $ 530              
Debt Instrument Maturity Date Dec. 31, 2023              
Securrency Convertible Note [Member]                
Investment [Line Items]                
Ownership interest percentage 7.00%       7.00%      
Percentage of discount on future equity financing for preferred stock 25.00%       25.00%      
Unrealized gain (loss) on investments $ 4,449              
Debt Instrument Maturity Date Oct. 20, 2023              
Securrency Convertible Note [Member] | Accounting Standards Update 2016-01 [Member]                
Investment [Line Items]                
Fair value $ 15,000              
XML 85 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Investments - Summary of Inputs Used in PWERM Approach of Investment (Detail) - Fair Value, Inputs, Level 3 [Member] - yr
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Securrency Inc [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Conversion of Series A Shares upon a future equity financing 33.30%  
Redemption of Series A Shares upon a corporate transaction 33.30%  
Default 33.40%  
Securrency Convertible Note [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Default 33.40% 15.00%
Conversion of note upon a future equity financing 33.30% 60.00%
Redemption of note upon a corporate transaction 33.30% 25.00%
Time to potential outcome (in years) 0.56 0.33
Fnality Convertible Note [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Conversion of note upon a future financing round 85.00% 85.00%
Redemption of note upon a change of control 10.00% 10.00%
Default 5.00% 5.00%
Time to potential outcome (in years) 0.08 0.25
XML 86 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Fixed Assets, net - Schedule of Fixed Assets (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Less: accumulated depreciation $ (482) $ (418)
Total 515 544
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, Gross $ 997 $ 962
XML 87 R66.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Consideration - Additional Information (Detail)
$ in Thousands
Mar. 31, 2023
USD ($)
oz
Dec. 31, 2022
USD ($)
Business Acquisition [Line Items]    
Deferred consideration $ 179,831 $ 200,290
Deferred consideration, current 17,984 16,796
Deferred consideration, non-current $ 161,847 $ 183,494
April 1, 2018 through March 31, 2058 [Member]    
Business Acquisition [Line Items]    
Fixed payment ounces of gold | oz 9,500  
April 1, 2058 and Thereafter [Member]    
Business Acquisition [Line Items]    
Fixed payment ounces of gold | oz 6,333  
XML 88 R67.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Consideration - Summary of valuation of deferred consideration (Detail) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Disclosure Of Valuation Of Deferred Consideration [Line Item]    
Discount rate 13.30% 11.00%
Perpetual growth rate 1.50% 1.30%
Minimum [Member]    
Disclosure Of Valuation Of Deferred Consideration [Line Item]    
Forward-looking gold price $ 1,999 $ 1,858
Maximum [Member]    
Disclosure Of Valuation Of Deferred Consideration [Line Item]    
Forward-looking gold price 3,567 3,126
Weighted Average [Member]    
Disclosure Of Valuation Of Deferred Consideration [Line Item]    
Forward-looking gold price $ 2,401 $ 2,237
XML 89 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Consideration - Schedule of Deferred Consideration (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Contractual Gold Payments $ 4,486 $ 4,450
Contractual Gold Payments – gold ounces paid 2,375 2,375
Gain/(loss) on revaluation of deferred consideration - gold payments [1] $ 20,592 $ (17,018)
[1] Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations.
XML 90 R69.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes - Additional Information (Detail)
 3 Months Ended
Feb. 14, 2023
USD ($)
Day
$ / shares
shares
Jun. 14, 2021
USD ($)
Day
$ / shares
shares
Aug. 13, 2020
USD ($)
Day
$ / shares
Jun. 16, 2020
USD ($)
Day
$ / shares
shares
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2020
USD ($)
$ / shares
Convertible Senior Notes [Line Items]                
Convertible senior notes face value         $ 340,000,000   $ 325,000,000  
Loss on extinguishment of debt (Note 11)         (9,721,000) $ 0    
Accounts Payable and Accrued Liabilities [Member]                
Convertible Senior Notes [Line Items]                
Interest payable         3,243,000   621,000  
Convertible Senior Notes Due Two Thousand And Twenty Three [Member]                
Convertible Senior Notes [Line Items]                
Interest expense         4,002,000 $ 3,732,000    
Convertible senior notes face value     $ 25,000,000 $ 150,000,000 340,000,000      
Convertible senior notes stated rate of interest     4.25% 4.25%        
Covertible senior notes year of maturity     2023 2023        
Redemption provisions - Convertible notes, threshold consecutive trading days | Day 30 30 30 30        
Minimum percentage of lenders required to have entire principal amount of convertible notes repurchased by the Company upon certain events of default       25.00%        
Convertible Senior Notes Due Two Thousand And Twenty Three [Member] | Fair Value, Inputs, Level 2 [Member]                
Convertible Senior Notes [Line Items]                
Fair Value Of Convertible Notes         $ 331,766,000   320,513,000  
Convertible Senior Notes [Member]                
Convertible Senior Notes [Line Items]                
Convertible debt instrument terms of interest payment           •   Interest rate: Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and June 15 and December 15 of each year for the 2020 Notes and the 2021 Notes.      
Convertible debt instrument conversion price | $ / shares $ 1,000 $ 1,000 $ 1,000 $ 1,000        
Convertible debt instrument terms of conversion   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.        
Redemption provisions - Convertible notes   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.        
Redemption provisions - Convertible notes, threshold trading days | Day 20 20 20 20        
Redemption provisions - Convertible notes, threshold consecutive trading days | Day 30 30 30 30        
Redemption provisions - Convertible notes redemption price as a percentage of principal amount accrued interest and unpaid interest 100.00% 100.00% 100.00% 100.00%        
Maximum number of shares issuable upon conversion | shares 59,767,426 59,767,426   59,767,426        
Number Of Threshold Trading Days For Determining The Share Price 5 days 5 days 5 days 5 days        
Measurement period for determining share price 10 days 10 days 10 days 10 days        
Share price as a percentage of last reported price and conversion rate 98.00% 98.00% 98.00% 98.00%        
Convertible Senior Notes Due Two Thousand And Twenty Six [Member]                
Convertible Senior Notes [Line Items]                
Convertible senior notes face value $ 130,000,000 $ 150,000,000            
Convertible senior notes stated rate of interest 5.75% 3.25%            
Covertible senior notes year of maturity 2028 2026            
Maximum Conversion Rate 167.7853 144.9275 270.2702 270.2702        
Two Thousand And Twenty Notes [Member]                
Convertible Senior Notes [Line Items]                
Convertible senior notes face value $ 115,000,000       $ 60,000,000   $ 175,000,000 $ 60,000
Convertible debt instrument conversion price | $ / shares               $ 5.92
Loss on extinguishment of debt (Note 11)         $ 9,721,000      
XML 91 R70.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes - Schedule of key terms of convertible notes (Detail) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2021
Dec. 31, 2020
May 31, 2023
Feb. 14, 2023
Dec. 31, 2022
Debt Instrument [Line Items]            
Principal outstanding $ 340,000,000         $ 325,000,000
Two Thousand And Twenty One Notes [Member]            
Debt Instrument [Line Items]            
Principal outstanding 150,000,000 $ 150,000       150,000,000
Maturity date (unless earlier converted, repurchased or redeemed)   Jun. 15, 2026        
Interest rate   3.25%        
Conversion price   $ 11.04        
Conversion rate   90.5797        
Redemption price   $ 14.35        
Two Thousand And Twenty Notes [Member]            
Debt Instrument [Line Items]            
Principal outstanding 60,000,000   $ 60,000   $ 115,000,000 $ 175,000,000
Maturity date (unless earlier converted, repurchased or redeemed)     Jun. 15, 2023      
Interest rate     4.25%      
Conversion price     $ 5.92      
Conversion rate     168.9189      
Redemption price     $ 7.7      
Two Thousand And Twenty Three Notes [Member]            
Debt Instrument [Line Items]            
Principal outstanding $ 130,000,000     $ 130,000    
Maturity date (unless earlier converted, repurchased or redeemed) Aug. 15, 2028          
Interest rate 5.75%          
Conversion price $ 9.54          
Conversion rate 104.8658          
Redemption price $ 12.4          
XML 92 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes - Summary of the carrying value of the convertible notes (Detail) - USD ($)
May 31, 2023
Mar. 31, 2023
Feb. 14, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]            
Principal amount   $ 340,000,000   $ 325,000,000    
Plus: Premium   250,000   250,000    
Gross proceeds   340,250,000   325,250,000    
Less: Unamortized issuance costs   (6,599,000)   (4,034,000)    
Carrying amount   $ 333,651,000   $ 321,216,000    
Effective interest rate   5.00%   4.60%    
Two Thousand And Twenty Three Notes [Member]            
Debt Instrument [Line Items]            
Principal amount $ 130,000 $ 130,000,000        
Plus: Premium   0        
Gross proceeds   130,000,000        
Less: Unamortized issuance costs   (3,465,000)        
Carrying amount   $ 126,535,000        
Effective interest rate   6.25%        
Two Thousand And Twenty One Notes [Member]            
Debt Instrument [Line Items]            
Principal amount   $ 150,000,000   $ 150,000,000 $ 150,000  
Plus: Premium   0   0    
Gross proceeds   150,000,000   150,000,000    
Less: Unamortized issuance costs   (2,768,000)   (2,981,000)    
Carrying amount   $ 147,232,000   $ 147,019,000    
Effective interest rate   3.83%   3.83%    
Two Thousand And Twenty Notes [Member]            
Debt Instrument [Line Items]            
Principal amount   $ 60,000,000 $ 115,000,000 $ 175,000,000   $ 60,000
Plus: Premium   250,000   250,000    
Gross proceeds   60,250,000   175,250,000    
Less: Unamortized issuance costs   (366,000)   (1,053,000)    
Carrying amount   $ 59,884,000   $ 174,197,000    
Effective interest rate   5.18%   5.26%    
XML 93 R72.htm IDEA: XBRL DOCUMENT v3.23.1
Series A Preferred Stock - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Apr. 11, 2018
Mar. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]      
Fair value of preferred stock consideration $ 132,750    
Series A Preferred Stock [Member]      
Class of Stock [Line Items]      
Other redemption rights unrelated to stockholder approval   Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer’s control. ETFS Capital has the right to redeem all the Series A Preferred Stock specified to be converted during the period of time specified in the Series A Certificate of Designations in the event that: (a) the number of shares of the Company’s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series A Preferred Stock requested by ETFS Capital to be converted; or (b) ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per Series A Preferred Stock as it would have received had each outstanding Series A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law.  
Preferred stock redemption value   $ 86,638 $ 77,969
Acquisition of ETFS Business [Member] | Preferred Stock [Member] | Series A Preferred Stock [Member]      
Class of Stock [Line Items]      
Shares issued in business acquisition 14,750    
Acquisition of ETFS Business [Member] | Common Stock [Member]      
Class of Stock [Line Items]      
Common stock equivalents 14,750,000    
Series of Individually Immaterial Business Acquisitions [Member]      
Class of Stock [Line Items]      
Acquisition price per share $ 9    
XML 94 R73.htm IDEA: XBRL DOCUMENT v3.23.1
Series A Preferred Stock - Summary of Series A Preferred Stock Balance (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Preferred Units [Line Items]    
Preferred Stock—carrying value $ 132,569 $ 132,569
Series A Preferred Stock [Member]    
Preferred Units [Line Items]    
Issuance of Preferred Stock 132,750 132,750
Less: Issuance costs (181) (181)
Preferred Stock—carrying value $ 132,569 $ 132,569
Cash dividends declared per share (quarterly) $ 0.03 $ 0.03
XML 95 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Summary of additional information regarding Company's Leases (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Lease cost:    
Operating lease cost $ 319 $ 89
Short-term lease cost 56 276
Total lease cost 375 365
Other information:    
Cash paid for amounts included in the measurement of operating liabilities (operating leases) $ 326 $ 97
Weighted-average remaining lease term (in years)—operating leases 1 year 1 year 3 months 18 days
Weighted-average discount rate—operating leases 6.50% 4.40%
XML 96 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Summary of future minimum lease payments (Detail)
$ in Thousands
Mar. 31, 2023
USD ($)
Lessee Disclosure [Abstract]  
Remainder of 2023 $ 803
2024 397
2025 0
2026 0
2027 0
2028 and thereafter 0
Total future minimum lease payments (undiscounted) $ 1,200
XML 97 R76.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Summary of Reconciles future minimum lease payments (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Amounts recognized in the Company's Consolidated Balance Sheets    
Lease liability—short term $ 1,041 $ 1,125
Lease liability—long term 120 $ 339
Subtotal 1,161  
Difference between undiscounted and discounted cash flows 39  
Total future minimum lease payments (undiscounted) $ 1,200  
XML 98 R77.htm IDEA: XBRL DOCUMENT v3.23.1
Contingencies - Additional Information (Detail) - Mar. 31, 2023
€ in Thousands, $ in Thousands
EUR (€)
USD ($)
Court Of Turin And Court Of Milan [Member]    
Loss contingency acrual € 15,800 $ 17,186
XML 99 R78.htm IDEA: XBRL DOCUMENT v3.23.1
Variable Interest Entities - Summary of Information about Variable Interests (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Carrying Amount - Assets    
Total assets $ 1,017,767 $ 1,033,819
Other Investments [Member]    
Carrying Amount - Assets    
Preferred stock—Series A Shares 312 312
Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]    
Carrying Amount - Assets    
Total assets 19,139 28,488
Securrency Inc [Member]    
Carrying Amount - Assets    
Preferred stock—Series A Shares 3,588 8,488
Preferred stock—Series B Shares 5,500 5,500
Convertible note 10,051 14,500
Fnality International Limited [Member]    
Carrying Amount - Assets    
Equity Method Investments 7,451 6,921
Variable Interest Entity, Not Primary Beneficiary [Member]    
Carrying Amount - Assets    
Total assets 26,902 35,721
Maximum exposure to loss $ 26,902 $ 35,721
XML 100 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues from Contracts with Customers - Additional Information (Detail) - Advisory Fees [Member]
$ in Thousands
Mar. 31, 2023
USD ($)
Revenue from Contracts with Customers [Line Items]  
Contract assets $ 0
Contract liabilities 0
Costs incurred to obtain or fulfill contracts with customers $ 0
XML 101 R80.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues from Contracts with Customers - Summary of Revenues from Contracts with Customers (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues Categorized as Revenues from Contracts with Customers and Other Sources of Revenues [Line Items]    
Total operating revenues $ 82,044 $ 78,368
Advisory Fees [Member]    
Revenues Categorized as Revenues from Contracts with Customers and Other Sources of Revenues [Line Items]    
Total operating revenues 77,637 76,517
Other Income [Member]    
Revenues Categorized as Revenues from Contracts with Customers and Other Sources of Revenues [Line Items]    
Total operating revenues $ 4,407 $ 1,851
XML 102 R81.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues from Contracts with Customers - Summary of Geographic Distribution of Revenue (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues $ 82,044 $ 78,368
UNITED STATES    
Revenues 49,681 46,229
JERSEY    
Revenues 29,053 28,598
IRELAND    
Revenues $ 3,310 $ 3,541
XML 103 R82.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions - Summary of Accounts Receivable from Related Parties (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Related Party Transaction [Line Items]    
Accounts receivable from related parties $ 32,446 $ 24,139
WisdomTree Trust [Member]    
Related Party Transaction [Line Items]    
Accounts receivable from related parties 17,124 16,399
Manjer Issuers [Member]    
Related Party Transaction [Line Items]    
Accounts receivable from related parties 12,790 4,485
Wisdomtree Multi Asset Issuer plc And Wisdomtree issuer icav [Member]    
Related Party Transaction [Line Items]    
Accounts receivable from related parties $ 2,532 $ 3,255
XML 104 R83.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions - Summary of Revenues from Advisory Services Provided to Related Parties (Detail) - Advisory Services [Member] - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Related Party Transaction [Line Items]    
Revenues from advisory services $ 77,637 $ 76,517
WisdomTree Trust [Member]    
Related Party Transaction [Line Items]    
Revenues from advisory services 49,487 46,070
Manjer Issuers [Member]    
Related Party Transaction [Line Items]    
Revenues from advisory services 24,840 26,905
WisdomTree Multi Asset Issuer PLC And WisdomTree Issuer PLC [Member]    
Related Party Transaction [Line Items]    
Revenues from advisory services $ 3,310 $ 3,542
XML 105 R84.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]      
Net gains (losses) related to certain WisdomTree ETFs $ (422) $ 806  
WisdomTree ETF [Member]      
Related Party Transaction [Line Items]      
Investments 45,214   $ 25,283
WisdomTree ETF [Member] | Affiliated Blockchain Enabled Funds [Member]      
Related Party Transaction [Line Items]      
Investments $ 12,413   $ 1,765
XML 106 R85.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Awards - Additional Information (Detail) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended
Jul. 15, 2022
Mar. 31, 2023
Mar. 31, 2022
Share-based Payment Award      
Stock option issuance period   10 years  
Option vested period   1 year  
Shares of common stock authorized to issue under equity award plan 16,000,000    
Stock-based compensation expense   $ 4,536 $ 2,936
Below 25th Percentile [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   0.00%  
At 25th Percentile [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   50.00%  
At 50th Percentile [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   100.00%  
At 100th Percentile for grants made in 2019 and 2020 [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   200.00%  
At 85th Percentile for grants made in 2021 [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   200.00%  
Vesting Capped If TsrIs Negative [Member]      
Share-based Payment Award      
Vesting cap if TSR is negative   100.00%  
Performance Based Restricted Stock Unit [Member] | Maximum [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   200.00%  
Performance Based Restricted Stock Unit [Member] | Minimum [Member]      
Share-based Payment Award      
Shares granted and outstanding, Vesting percentage   0.00%  
XML 107 R86.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Awards - Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period (Detail) - Employees and Directors [Member]
$ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Stock-Based Compensation $ 30,415
Weighted Average Remaining Vesting Period 2 years 1 month 6 days
XML 108 R87.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Awards - Summary of Restricted Stock Activity (Detail)
 3 Months Ended
Mar. 31, 2023
shares
Restricted Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Beginning Balance, Shares 3,391,082
Granted, Shares 3,273,263
Vested, Shares (1,498,171)
Forfeited, Shares (11,885)
Ending Balance, Shares 5,154,289
Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Beginning Balance, Shares 141,963
Granted, Shares 73,855
Vested, Shares (26,837)
Forfeited, Shares (233)
Ending Balance, Shares 188,748
Performance Based Restricted Stock Unites (PRSUs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Beginning Balance, Shares 668,188
Granted, Shares 576,240
Vested, Shares (83,158)
Forfeited, Shares (24,955)
Ending Balance, Shares 1,136,315
XML 109 R88.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Awards - Summary of Restricted Stock Activity (Parenthetical) (Detail) - Performance Based Restricted Stock Unit [Member]
 1 Months Ended 3 Months Ended
Jan. 31, 2023
Mar. 31, 2023
PRSUs - Monte Carlo Inputs    
Historical stock price volatility (low)   37.00%
Historical stock price volatility (high)   56.00%
Historical stock price volatility (average)   47.00%
Risk free interest rate   3.80%
Percentage of vesting payout 77.00%  
Expected dividend yield   0.00%
Maximum [Member]    
PRSUs - Monte Carlo Inputs    
Shares granted and outstanding, Vesting percentage   200.00%
Minimum [Member]    
PRSUs - Monte Carlo Inputs    
Shares granted and outstanding, Vesting percentage   0.00%
XML 110 R89.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholder Rights Plan - Additional Information (Detail) - $ / shares
Mar. 17, 2023
Mar. 31, 2023
Dec. 31, 2022
Disclosure Of Stockholder Rights Plan [Line Items]      
Number of preferred stock purchase right issued for outstanding stock 1,000    
Common stock, par or stated value per share   $ 0.01 $ 0.01
Preferred stock, par or stated value per share   $ 0.01 $ 0.01
Percentage of assets sold 50.00%    
Stockholder Right Agreement [Member]      
Disclosure Of Stockholder Rights Plan [Line Items]      
Number of preferred stock purchase right issued for outstanding stock 1,000,000    
Number of shares issued per unit 0.1    
Exercise price per unit $ 32    
Percentage of beneficial equity interest acquired on rights issued 10.00%    
Percentage of equity interest acquired with affiliates and joint ventures 20.00%    
Percentage of common stock acquired 20.00%    
Percentage of beneficial interest acquired on rights issued 10.00%    
Stockholder Right Agreement [Member] | Series A Non Voting Convertible Preferred Stock [Member]      
Disclosure Of Stockholder Rights Plan [Line Items]      
Preferred stock, par or stated value per share $ 0.01    
Stockholder Right Agreement [Member] | Common Stock [Member]      
Disclosure Of Stockholder Rights Plan [Line Items]      
Common stock, par or stated value per share $ 0.01    
XML 111 R90.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings/(Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings Per Share [Abstract]    
Net income/(loss) $ 16,233 $ (10,261)
Less: Income distributed to participating securities (498) (549)
Less: Undistributed income allocable to participating securities (1,206) 0
Net income/(loss) available to common stockholders—Basic EPS $ 14,529 $ (10,810)
Weighted average common shares (in thousands) 143,862 142,782
Basic earnings/(loss) per share $ 0.1 $ (0.08)
Net earnings/(loss) available to common stockholders $ 14,529 $ (10,810)
Add back: Undistributed income allocable to participating securities 1,206 0
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive (1,202) 0
Net income/(loss) available to common stockholders – Diluted EPS $ 14,533 $ (10,810)
Weighted average common shares 143,862 142,782
Dilutive effect of common stock equivalents, excluding participating securities 569 0
Weighted average diluted shares 144,431 142,782
Diluted earnings/(loss) per share $ 0.1 $ (0.08)
XML 112 R91.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings/(Loss) Per Share - Additional Information (Detail) - shares
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings Per Share [Line Items]    
Anti-dilutive non-participating common stock equivalents excluded from the calculation of diluted earnings per share 695,000 509,000
XML 113 R92.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Detail) - shares
shares in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings Per Share [Abstract]    
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations 159,887 142,782 [1]
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (14,750) 0
Potentially dilutive restricted stock awards (706) 0
Weighted average diluted shares 144,431 142,782
[1] Excludes 15,521 participating securities and 31 potentially dilutive non-participating common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands).
XML 114 R93.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Parenthetical) (Detail)
shares in Thousands
 3 Months Ended
Mar. 31, 2022
shares
Earnings Per Share [Abstract]  
Participating Securities 15,521
Potentially Dilutive common stock equivalents 31
XML 115 R94.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Schedule Of Income Tax [Line Items]      
Tax effected NOLs - US $ 127    
NOL expiration date 2024    
Tax effected NOLs - International $ 1,625    
Federal statutory rate 21.00% 21.00%  
Tax effected capital loss $ 17,740   $ 17,541
Estimated effective rate 7.90% 62.00%  
Income tax expense/(benefit) $ 1,383 $ (16,713)  
Reduction in unrecognised tax benefits 1,353    
Deferred tax liabilities undistributed earnings of foreign subsidaries $ 246   $ 205
Unrecognized Tax Benefits Including Interest And Penalties [Member]      
Schedule Of Income Tax [Line Items]      
Unrecognized tax benefits   $ 19,897  
XML 116 R95.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes - Summary of Deferred Tax Assets (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Deferred tax assets:    
Capital losses $ 17,740 $ 17,541
Unrealized losses 4,781 3,821
NOLs—Foreign 1,625 1,609
Accrued expenses 1,527 6,030
Goodwill and intangible assets 1,038 1,085
Stock-based compensation 865 1,526
Interest carryforwards 476 0
Operating lease liabilities 260 313
Foreign currency translation adjustment 254 173
NOLs—U.S. 127 255
Outside basis difference 122 122
Other 355 341
Deferred tax assets 29,170 32,816
Deferred tax liabilities:    
Fixed assets and prepaid assets 150 278
Unremitted earnings—European subsidiaries 246 205
Right of use assets—operating leases 260 313
Deferred tax liabilities 656 796
Total deferred tax assets less deferred tax liabilities 28,514 32,020
Less: Valuation allowance (22,643) (21,484)
Deferred tax assets, net $ 5,871 $ 10,536
XML 117 R96.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits (Detail)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
Income Tax Contingency [Line Items]  
Beginning balance $ 1,353
Decrease—Lapse of statute of limitations (1,353)
Ending balance 0
Unrecognized Tax Benefits [Member]  
Income Tax Contingency [Line Items]  
Beginning balance 957
Decrease—Lapse of statute of limitations (957)
Ending balance 0
Interest And Penalties [Member]  
Income Tax Contingency [Line Items]  
Beginning balance 396
Decrease—Lapse of statute of limitations (396)
Ending balance $ 0
XML 118 R97.htm IDEA: XBRL DOCUMENT v3.23.1
Shares Repurchased - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Feb. 22, 2022
Mar. 31, 2023
Mar. 31, 2022
Class of Stock [Line Items]      
Repurchased common stock, value   $ 3,384 $ 3,394
Maximum [Member]      
Class of Stock [Line Items]      
Common stock purchase authorized amount $ 100,000    
Three-Year Share Repurchase Program [Member]      
Class of Stock [Line Items]      
Common stock purchase authorized amount $ 85,709    
Repurchased common stock, shares   604,505 588,694
Repurchased common stock, value   $ 3,384 $ 3,394
Dollar amount remaining available for future share repurchases   $ 96,591,597  
Stock repurchase program, period in force 3 years    
Share repurchase program, extended term date Apr. 27, 2025    
XML 119 R98.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets - Summary of Goodwill by Reporting Unit (Detail)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
Goodwill [Line Items]  
Beginning balance $ 85,856
Ending balance 85,856
Reportable Subsegments [Member]  
Goodwill [Line Items]  
Beginning balance 85,856
Changes 0
Ending balance $ 85,856
XML 120 R99.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Apr. 11, 2018
Indefinite-lived Intangible Assets [Line Items]      
Goodwill $ 85,856 $ 85,856  
Intangible asset related to its customary advisory agreement 603,968 603,567  
Accumulated Amortization $ 101 $ 50  
Software Development [Member]      
Indefinite-lived Intangible Assets [Line Items]      
Finite lived intangible assets useful lives 3 years    
Accumulated Amortization $ 51    
Finite lived intangible assets remaining useful lives 2 years 10 months 24 days    
Acquisition of ETFS Business [Member]      
Indefinite-lived Intangible Assets [Line Items]      
Goodwill     $ 84,057
Intangible asset related to its customary advisory agreement     $ 601,247
Series of Individually Immaterial Business Acquisitions [Member]      
Indefinite-lived Intangible Assets [Line Items]      
Acquisition completion date Apr. 11, 2018    
XML 121 R100.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets - Summary of Intangible Assets (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Intangible Assets And Goodwill [Line Items]    
Gross Asset $ 604,069 $ 603,617
Accumulated Amortization (101) (50)
Net Asset 603,968 603,567
Software Development [Member]    
Intangible Assets And Goodwill [Line Items]    
Gross Asset 2,822 2,370
Accumulated Amortization (101) (50)
Net Asset 2,721 2,320
ETFS acquisition {Member}    
Intangible Assets And Goodwill [Line Items]    
Gross Asset 601,247 601,247
Accumulated Amortization 0 0
Net Asset $ 601,247 $ 601,247
XML 122 R101.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets - Summary of Unamortized Finite-lived Intangible Assets (Detail) - Software Development [Member]
$ in Thousands
Mar. 31, 2023
USD ($)
Schedule Of Finite Lived Intangible Assets Future Amortization Expense [Line Items]  
Remained of 2023 $ 656
2024 940
2025 891
2026 234
2027 0
2028 and thereafter 0
Total expected amortization expense $ 2,721
XML 123 R102.htm IDEA: XBRL DOCUMENT v3.23.1
Contingent Payments - Additional Information (Detail) - WisdomTree Asset Management Canada, Inc [Member]
$ in Thousands, $ in Thousands
 3 Months Ended
Feb. 19, 2020
CAD ($)
Feb. 19, 2020
USD ($)
Mar. 31, 2023
USD ($)
Feb. 19, 2020
USD ($)
Proceeds from divestiture of businesses $ 3,720 $ 2,774    
Recognized gain loss on sale of business     $ 1,477  
Maximum [Member]        
Additional consideration payable 3,000     $ 2,360
Minimum [Member]        
Additional consideration payable $ 2,000     $ 1,477
XML 124 d452823d10q_htm.xml IDEA: XBRL DOCUMENT 0000880631 2023-01-01 2023-03-31 0000880631 2022-01-01 2022-03-31 0000880631 2023-03-31 0000880631 2022-12-31 0000880631 2022-06-16 2022-07-15 0000880631 2018-04-11 0000880631 2022-03-31 0000880631 2023-05-04 0000880631 2022-01-01 2022-12-31 0000880631 2023-03-17 2023-03-17 0000880631 2021-12-31 0000880631 wt:FederalAgencyMember 2022-12-31 0000880631 us-gaap:EquipmentMember 2022-12-31 0000880631 wt:WisdomTreeTrustMember 2022-12-31 0000880631 wt:WisdomtreeManagementJerseyLimitedMember 2022-12-31 0000880631 wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2022-12-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcostMember 2022-12-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcostMember 2022-12-31 0000880631 wt:SecurrencyincconvertiblenotecarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincconvertiblenotecostMember 2022-12-31 0000880631 wt:SecurrencyincsubtotalcarryingvalueMember 2022-12-31 0000880631 wt:SecurrencyincsubtotalcostMember 2022-12-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecarryingvalueMember 2022-12-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecostMember 2022-12-31 0000880631 wt:OnrampinvestincseriesafourpreferredstockcarryingvalueMember 2022-12-31 0000880631 wt:OnrampinvestincpreferredstockcostMember 2022-12-31 0000880631 wt:OtherInvestmentscarryingValueMember 2022-12-31 0000880631 wt:OtherInvestmentsCostMember 2022-12-31 0000880631 wt:SecurrencyIncMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember 2022-12-31 0000880631 wt:SeriesARedeemableConvertiblePreferredStockMember 2022-12-31 0000880631 wt:WisdomtreeETFMember 2022-12-31 0000880631 wt:AffiliatedBlockchainEnabledFundsMember wt:WisdomtreeETFMember 2022-12-31 0000880631 us-gaap:SeriesAPreferredStockMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AllOtherCorporateBondsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AllOtherCorporateBondsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:AllOtherCorporateBondsMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AllOtherCorporateBondsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2022-12-31 0000880631 wt:EuropeanBusinessSegmentMember 2022-12-31 0000880631 wt:WisdomtreeETFMember 2022-12-31 0000880631 srt:MinimumMember 2022-12-31 0000880631 srt:MaximumMember 2022-12-31 0000880631 srt:WeightedAverageMember 2022-12-31 0000880631 wt:TwothousandandtwentyonenotesMember 2022-12-31 0000880631 wt:TwothousandandtwentynotesMember 2022-12-31 0000880631 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-12-31 0000880631 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2022-12-31 0000880631 wt:TwoFinancialInstitutionsMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0000880631 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2022-12-31 0000880631 wt:FnalityInternationalLimitedMember 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2022-12-31 0000880631 wt:RighttomanageassetundermanagementMember 2022-12-31 0000880631 us-gaap:SoftwareDevelopmentMember 2022-12-31 0000880631 wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2022-12-31 0000880631 wt:WetfTradingSecuritiesMember 2022-12-31 0000880631 wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000880631 wt:FederalAgencyMember 2023-03-31 0000880631 wt:SecurrencyIncMember 2023-03-31 0000880631 wt:EmployeesAndDirectorsMember 2023-03-31 0000880631 us-gaap:EquipmentMember 2023-03-31 0000880631 wt:WisdomTreeTrustMember 2023-03-31 0000880631 wt:WisdomtreeManagementJerseyLimitedMember 2023-03-31 0000880631 wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2023-03-31 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2023-03-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincseriesaconvertiblepreferredstockcostMember 2023-03-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincseriesbconvertiblepreferredstockcostMember 2023-03-31 0000880631 wt:SecurrencyincconvertiblenotecarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincconvertiblenotecostMember 2023-03-31 0000880631 wt:SecurrencyincsubtotalcarryingvalueMember 2023-03-31 0000880631 wt:SecurrencyincsubtotalcostMember 2023-03-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecarryingvalueMember 2023-03-31 0000880631 wt:FnalityinternationallimitedconvertiblenotecostMember 2023-03-31 0000880631 wt:OnrampinvestincseriesafourpreferredstockcarryingvalueMember 2023-03-31 0000880631 wt:OnrampinvestincpreferredstockcostMember 2023-03-31 0000880631 wt:OtherInvestmentscarryingValueMember 2023-03-31 0000880631 wt:OtherInvestmentsCostMember 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember 2023-03-31 0000880631 wt:FnalityInternationalLimitedMember 2023-03-31 0000880631 us-gaap:OtherInvestmentsMember 2023-03-31 0000880631 wt:SeriesARedeemableConvertiblePreferredStockMember 2023-03-31 0000880631 wt:WisdomtreeETFMember 2023-03-31 0000880631 wt:AffiliatedBlockchainEnabledFundsMember wt:WisdomtreeETFMember 2023-03-31 0000880631 wt:AdvisoryFeesMember 2023-03-31 0000880631 wt:ThroughMarchThirtyFirstTwoThousandFiftyEightMember 2023-03-31 0000880631 wt:AprilOneTwoThousandFiftyEightAndThereafterMember 2023-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FederalAgencyMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentCompaniesMember 2023-03-31 0000880631 wt:EuropeanBusinessSegmentMember 2023-03-31 0000880631 wt:WisdomtreeETFMember 2023-03-31 0000880631 srt:MinimumMember 2023-03-31 0000880631 srt:MaximumMember 2023-03-31 0000880631 srt:WeightedAverageMember 2023-03-31 0000880631 wt:TwoThousandAndTwentyThreeNotesMember 2023-03-31 0000880631 wt:TwothousandandtwentyonenotesMember 2023-03-31 0000880631 wt:TwothousandandtwentynotesMember 2023-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-03-31 0000880631 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2023-03-31 0000880631 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2023-03-31 0000880631 wt:TwoFinancialInstitutionsMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember wt:SecurrencyseriesaconvertiblepreferredstockMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember wt:SecurrencyseriesaconvertiblepreferredstockMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember wt:SecurrencyseriesaconvertiblepreferredstockMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsNonrecurringMember wt:SecurrencyseriesaconvertiblepreferredstockMember 2023-03-31 0000880631 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2023-03-31 0000880631 wt:CourtofturinandcourtofmilanMember 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2023-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:FnalityConvertibleNoteMember 2023-03-31 0000880631 wt:RighttomanageassetundermanagementMember 2023-03-31 0000880631 wt:OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember 2023-03-31 0000880631 wt:WetfTradingSecuritiesMember 2023-03-31 0000880631 wt:FnalityInternationalLimitedConvertibleNoteMember us-gaap:AccountingStandardsUpdate201601Member 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:AccountingStandardsUpdate201601Member 2023-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2023-03-31 0000880631 wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2022-01-01 2022-03-31 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2022-01-01 2022-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomTreeTrustMember 2022-01-01 2022-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomtreeManagementJerseyLimitedMember 2022-01-01 2022-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2022-01-01 2022-03-31 0000880631 wt:AdvisoryServicesMember 2022-01-01 2022-03-31 0000880631 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000880631 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000880631 wt:OtherServicesIncomeMember 2022-01-01 2022-03-31 0000880631 us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember 2022-01-01 2022-03-31 0000880631 wt:DeferredConsiderationObligationMember 2022-01-01 2022-03-31 0000880631 country:US 2022-01-01 2022-03-31 0000880631 country:JE 2022-01-01 2022-03-31 0000880631 country:IE 2022-01-01 2022-03-31 0000880631 wt:FinancialInstrumentsOwnedAtFairValueMember 2022-01-01 2022-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-01-01 2023-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0000880631 us-gaap:ReportableSubsegmentsMember 2023-01-01 2023-03-31 0000880631 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitsMember 2023-01-01 2023-03-31 0000880631 wt:EmployeesAndDirectorsMember 2023-01-01 2023-03-31 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2023-01-01 2023-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2023-01-01 2023-03-31 0000880631 srt:MaximumMember us-gaap:EquipmentMember 2023-01-01 2023-03-31 0000880631 srt:MinimumMember us-gaap:EquipmentMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyseriesapreferredstockMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomTreeTrustMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomtreeManagementJerseyLimitedMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2023-01-01 2023-03-31 0000880631 wt:AdvisoryServicesMember 2023-01-01 2023-03-31 0000880631 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000880631 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000880631 wt:OtherServicesIncomeMember 2023-01-01 2023-03-31 0000880631 us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember 2023-01-01 2023-03-31 0000880631 wt:UnrecognizedTaxBenefitsMember 2023-01-01 2023-03-31 0000880631 wt:InterestAndPenaltiesMember 2023-01-01 2023-03-31 0000880631 wt:DeferredConsiderationObligationMember 2023-01-01 2023-03-31 0000880631 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-01-01 2023-03-31 0000880631 wt:AtTwentyFifthPercentileMember 2023-01-01 2023-03-31 0000880631 wt:BelowTwentyFifthPercentileMember 2023-01-01 2023-03-31 0000880631 srt:MaximumMember wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-03-31 0000880631 srt:MinimumMember wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-03-31 0000880631 wt:At85thPercentileForGrantsMadeIn2021Member 2023-01-01 2023-03-31 0000880631 wt:At100thPercentileForGrantsMadeIn2019And2020Member 2023-01-01 2023-03-31 0000880631 wt:AtFiftyPercentileMember 2023-01-01 2023-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-03-31 0000880631 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000880631 country:US 2023-01-01 2023-03-31 0000880631 country:JE 2023-01-01 2023-03-31 0000880631 country:IE 2023-01-01 2023-03-31 0000880631 wt:ConvertibleSeniorNotesMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember 2023-01-01 2023-03-31 0000880631 wt:FnalityInternationalLimitedMember 2023-01-01 2023-03-31 0000880631 wt:TwoThousandAndTwentyThreeNotesMember 2023-01-01 2023-03-31 0000880631 wt:WisdomtreeAssetManagementCanadaIncMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyIncMember 2023-01-01 2023-03-31 0000880631 wt:FnalityConvertibleNoteMember 2023-01-01 2023-03-31 0000880631 wt:TwothousandandtwentynotesMember 2023-01-01 2023-03-31 0000880631 wt:VestingCappedIfTsrisNegativeMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000880631 wt:FinancialInstrumentsOwnedAtFairValueMember 2023-01-01 2023-03-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000880631 wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000880631 wt:SecurrencyseriesapreferredstockMember 2019-12-31 0000880631 wt:SecurrencyseriesbconvertiblepreferredstockMember 2021-03-31 0000880631 us-gaap:SubsequentEventMember 2029-12-31 0000880631 us-gaap:SubsequentEventMember 2031-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0000880631 wt:SecurrencyConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0000880631 wt:FnalityConvertibleNoteMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2023-02-14 2023-02-14 0000880631 wt:ConvertibleSeniorNotesMember 2023-02-14 2023-02-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2023-02-14 2023-02-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2023-02-14 0000880631 wt:TwothousandandtwentynotesMember 2023-02-14 0000880631 wt:ConvertibleSeniorNotesMember 2023-02-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2021-06-14 2021-06-14 0000880631 wt:ConvertibleSeniorNotesMember 2021-06-14 2021-06-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2021-06-14 2021-06-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2021-06-14 0000880631 wt:ConvertibleSeniorNotesMember 2021-06-14 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-06-16 2020-06-16 0000880631 wt:ConvertibleSeniorNotesMember 2020-06-16 2020-06-16 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2020-06-16 2020-06-16 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-06-16 0000880631 wt:ConvertibleSeniorNotesMember 2020-06-16 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-08-13 2020-08-13 0000880631 wt:ConvertibleSeniorNotesMember 2020-08-13 2020-08-13 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2020-08-13 2020-08-13 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2020-08-13 0000880631 wt:ConvertibleSeniorNotesMember 2020-08-13 0000880631 wt:TwothousandandtwentynotesMember 2020-01-01 2020-12-31 0000880631 wt:TwothousandandtwentynotesMember 2020-12-31 0000880631 wt:TwothousandandtwentyonenotesMember 2021-01-01 2021-12-31 0000880631 wt:TwothousandandtwentyonenotesMember 2021-12-31 0000880631 wt:TwoThousandAndTwentyThreeNotesMember 2023-05-31 0000880631 wt:AcquisitionOfEtfsBusinessMember us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2018-04-01 2018-04-11 0000880631 wt:AcquisitionOfEtfsBusinessMember 2018-04-11 0000880631 wt:AcquisitionOfEtfsBusinessMember us-gaap:CommonStockMember 2018-04-11 0000880631 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-04-11 0000880631 wt:UnrecognizedTaxBenefitsIncludingInterestAndPenaltiesMember 2022-03-31 0000880631 wt:StockholderRightAgreementMember 2023-03-17 2023-03-17 0000880631 us-gaap:CommonStockMember wt:StockholderRightAgreementMember 2023-03-17 0000880631 wt:SeriesANonVotingConvertiblePreferredStockMember wt:StockholderRightAgreementMember 2023-03-17 0000880631 wt:StockholderRightAgreementMember 2023-03-17 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2022-02-22 0000880631 srt:MaximumMember 2022-02-22 0000880631 wt:WisdomtreeAssetManagementCanadaIncMember 2020-02-19 2020-02-19 0000880631 srt:MaximumMember wt:WisdomtreeAssetManagementCanadaIncMember 2020-02-19 0000880631 srt:MinimumMember wt:WisdomtreeAssetManagementCanadaIncMember 2020-02-19 0000880631 wt:ThreeYearShareRepurchaseProgramMember 2022-02-22 2022-02-22 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2023-01-01 2023-01-31 0000880631 us-gaap:RetainedEarningsMember 2021-12-31 0000880631 srt:RestatementAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000880631 us-gaap:CommonStockMember 2021-12-31 0000880631 wt:DeferredConsiderationObligationMember 2021-12-31 0000880631 us-gaap:RetainedEarningsMember 2022-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000880631 us-gaap:CommonStockMember 2022-03-31 0000880631 wt:DeferredConsiderationObligationMember 2022-03-31 0000880631 us-gaap:RestrictedStockMember 2022-12-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000880631 wt:PerformanceBasedRestrictedStockUnitsMember 2022-12-31 0000880631 us-gaap:ReportableSubsegmentsMember 2022-12-31 0000880631 us-gaap:ReportableSubsegmentsMember 2023-03-31 0000880631 us-gaap:RestrictedStockMember 2023-03-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitsMember 2023-03-31 0000880631 us-gaap:RetainedEarningsMember 2022-12-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000880631 us-gaap:CommonStockMember 2022-12-31 0000880631 wt:InterestAndPenaltiesMember 2022-12-31 0000880631 wt:UnrecognizedTaxBenefitsMember 2022-12-31 0000880631 wt:DeferredConsiderationObligationMember 2022-12-31 0000880631 wt:InterestAndPenaltiesMember 2023-03-31 0000880631 wt:UnrecognizedTaxBenefitsMember 2023-03-31 0000880631 us-gaap:RetainedEarningsMember 2023-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000880631 us-gaap:CommonStockMember 2023-03-31 0000880631 wt:DeferredConsiderationObligationMember 2023-03-31 iso4217:USD utr:Year shares utr:Day pure utr:Month iso4217:CAD iso4217:EUR iso4217:GBP iso4217:USD shares utr:oz utr:Y false Q1 0000880631 --12-31 Large Accelerated Filer true 10-Q true 2023-03-31 2023 false 001-10932 WisdomTree, Inc. DE 13-3487784 250 West 34th Street 3rd Floor New York NY 10119 212 801-2080 Common Stock Preferred Stock Purchase Rights WT NYSE NYSE Yes Yes false false false 149263168 P5D P5D P5D P5D P10D P10D P10D P10D 0.1 119099000 132101000 45214000 25283000 130180000 126239000 32446000 24139000 35496000 30549000 5877000 4684000 1799000 0 291000 390000 292742000 293963000 515000 544000 0 1353000 253000 259000 5871000 10536000 26902000 35721000 1153000 1449000 85856000 85856000 603968000 603567000 507000 571000 1017767000 1033819000 59884000 59197000 27830000 36521000 17984000 16796000 9341000 24121000 0 1599000 1041000 1125000 14846000 9075000 130926000 148434000 273767000 262019000 161847000 183494000 120000 339000 0 1353000 566660000 595639000 0.01 0.01 14750 14750 14750 14750 14750 14750 86638000 77969000 132569000 132569000 0.01 0.01 2000000 2000000 0 0 0.01 0.01 400000000 400000000 149291000 149291000 146517000 146517000 1493000 1465000 292971000 291847000 -954000 -1420000 25028000 13719000 318538000 305611000 1017767000 1033819000 77637000 76517000 4407000 1851000 82044000 78368000 27398000 24787000 17153000 15494000 4007000 4023000 2994000 2609000 4486000 4450000 3715000 4459000 1101000 753000 109000 47000 2253000 2212000 2257000 1845000 65473000 60679000 16571000 17689000 4002000 3732000 20592000 -17018000 1083000 794000 4900000 0 -9721000 0 -2007000 -24707000 17616000 -26974000 1383000 -16713000 16233000 -10261000 0.1 -0.08 0.1 -0.08 143862000 142782000 159887000 142782000 0.03 0.03 16233000 -10261000 466000 -486000 466000 -486000 16699000 -10747000 146517000 1465000 291847000 -1420000 13719000 305611000 3379000 34000 -34000 0 0 0 605000 6000 3378000 0 0 3384000 0 4536000 0 0 4536000 0 0 466000 0 466000 0 0 0 4924000 4924000 0 0 0 16233000 16233000 149291000 1493000 292971000 -954000 25028000 318538000 145107000 1451000 289736000 682000 -22445000 269424000 2042000 21000 -21000 0 0 0 589000 6000 3388000 0 0 3394000 0 2936000 0 0 2936000 0 0 -486000 0 -486000 0 4842000 0 0 4842000 0 0 0 -10261000 -10261000 146560000 1466000 284421000 196000 -32706000 253377000 16233000 -10261000 20592000 -17018000 12760000 16052000 -9721000 0 4900000 0 4783000 5273000 4536000 2936000 4486000 4450000 -3919000 -163000 1954000 -5142000 579000 645000 319000 89000 109000 47000 4791000 3710000 1161000 2264000 -8332000 -11959000 -167000 52000 -452000 0 3638000 3199000 -27271000 -23690000 -3418000 -4228000 326000 97000 5606000 6741000 -5397000 -2692000 20278000 25461000 0 6863000 26000 54000 18290000 13639000 6000 18000 -2008000 -18721000 124317000 0 4821000 4842000 3384000 3394000 3548000 0 130000000 0 -6070000 -8236000 473000 -665000 -13002000 -30314000 132101000 140709000 119099000 110395000 1422000 2123000 801000 0 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. Organization and Description of Business </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">WisdomTree, Inc., through its global subsidiaries (collectively, “WisdomTree” or the “Company”), is a global financial innovator, offering a well-diversified suite of exchange-traded products (“ETPs”), models and solutions. Building on its heritage of innovation, the Company is also developing next-generation digital products and structures, including digital or blockchain-enabled mutual funds (“Digital Funds”) and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">™</div>. The Company has the following wholly-owned operating subsidiaries: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Asset Management, Inc.</div></div> is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (“WTT”) and WisdomTree exchange-traded funds (“ETFs”). The WisdomTree ETFs are issued in the U.S. by WTT. WTT is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-consolidated</div> Delaware statutory trust registered with the SEC as an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">open-end</div> management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Management Jersey Limited </div></div>(“ManJer”) is a Jersey based management company providing management services to seven issuers (the “ManJer Issuers”) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">leveraged-and-inverse</div></div> strategies. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Multi Asset Management Limited</div></div> (“WTMAML”) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (“WMAI”) in respect of the ETPs issued by WMAI. WMAI is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-consolidated</div> public limited company domiciled in Ireland. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Management Limited</div></div> (“WML”) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (“WTICAV”) in respect of the WisdomTree UCITS ETFs issued by WTICAV. WTICAV is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-consolidated</div> public limited company domiciled in Ireland. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree UK Limited</div></div> (“WTUK”) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Europe Limited</div></div> is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK. WisdomTree Europe Limited is no longer regulated and does not provide any regulated services. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Ireland Limited</div></div> is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Digital Commodity Services, LLC</div></div> is a New York based company that has been formed to serve as the sponsor of the WisdomTree Bitcoin Trust and WisdomTree Ethereum Trust, each an ETF currently under review with the SEC. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="null;text-indent: 0px;;font-style:italic;display:inline;"><div style="display:inline;">WisdomTree Digital Management, Inc. (“WT Digital Management”) is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (“WTDT”) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S. by WTDT. WTDT is a Delaware statutory trust registered with the SEC as an open-end management investment company. Each Digital Fund will use blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but will not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies. <br/></div></div></div></div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Digital Movement, Inc</div></div>. is a New York based company operating as a money services business registered with the Financial Crimes Enforcement Network (“FinCEN”) and seeking state money transmitter licenses to operate a platform for the purchase, sale and exchange of digital assets, while also providing digital wallet services through WisdomTree Prime<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">™</div> to facilitate such activity. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:7%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">WisdomTree Securities, Inc</div></div>. is a New York based limited purpose broker-dealer (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds. </div> </td> </tr> </table> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">2. Significant Accounting Policies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of financial condition, results of operations, and cash flows for the periods presented. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment and Geographic Information </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company, through its subsidiaries in the U.S. and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company’s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Foreign Currency Translation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income/(Loss) as a component of other comprehensive (loss)/income. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Contractual Gold Payments </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note 9). </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketing and Advertising </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Marketing and advertising costs, including media advertising and production costs, are expensed when incurred. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Depreciation and Amortization </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3 to 5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Internally-developed software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The assets listed above are recorded at cost less accumulated depreciation and amortization. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Awards </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Third-Party Distribution Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETFs and for including WisdomTree ETFs on third-party customer platforms and recognizes these expenses as incurred. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Receivable </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company performs a review for the impairment of long-lived assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> (“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-Maturity</div></div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for certain of its securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> on a trade date basis, which are recorded at amortized cost. For <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities, the Company has the intent and ability to hold these securities to maturity and it is not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> securities are placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status is recognized on a cash basis as interest income if and when received. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company reviews its portfolio of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Investments in pass-through government-sponsored enterprises (“GSEs”) are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Investments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments – Equity Securities </div></div>(“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses). </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-evaluation,</div> if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill is allocated to the Company’s U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill is assessed for impairment annually on November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Indefinite-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Finite-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Software Development Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for its lease obligations in accordance with ASC Topic 842, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases </div></div>(“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">ASC 842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Company has elected to apply this practical expedient to all lease contracts, where applicable. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Consideration—Gold Payments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Deferred consideration represents the present value of an obligation to pay gold to a third party into perpetuity and is measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note 9). Changes in the fair value of this obligation are reported as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Convertible notes are carried at amortized cost, net of issuance costs. In accordance with Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt – Debt with Conversion and Other Options</div></div>, the Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Contingencies </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Contingent Payments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Earnings per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> convertible preferred stock (Note 11) and unvested share-based payment awards that contain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-forfeitable</div> rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method. Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive). </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Diluted EPS is calculated under the treasury stock method and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards, the Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> convertible preferred stock and the convertible notes are computed under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> that some portion or all the deferred tax assets will not be realized. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Tax positions are evaluated utilizing a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> process. The Company first determines whether any of its tax positions are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Global Intangible <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Low-Taxed</div> Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-income</div> based taxes are recorded as part of other liabilities and other expenses. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of financial condition, results of operations, and cash flows for the periods presented. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment and Geographic Information </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company, through its subsidiaries in the U.S. and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company’s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Foreign Currency Translation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income/(Loss) as a component of other comprehensive (loss)/income. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Contractual Gold Payments </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note 9). </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Marketing and Advertising </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Marketing and advertising costs, including media advertising and production costs, are expensed when incurred. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Depreciation and Amortization </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3 to 5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Internally-developed software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The assets listed above are recorded at cost less accumulated depreciation and amortization. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3 to 5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Internally-developed software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> P3Y P5Y P3Y <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Awards </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Third-Party Distribution Fees </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETFs and for including WisdomTree ETFs on third-party customer platforms and recognizes these expenses as incurred. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits. </div> P90D <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Receivable </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company performs a review for the impairment of long-lived assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> (“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-Maturity</div></div> </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for certain of its securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> on a trade date basis, which are recorded at amortized cost. For <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities, the Company has the intent and ability to hold these securities to maturity and it is not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-maturity</div></div> securities are placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status is recognized on a cash basis as interest income if and when received. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company reviews its portfolio of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Investments in pass-through government-sponsored enterprises (“GSEs”) are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Investments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments – Equity Securities </div></div>(“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses). </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-evaluation,</div> if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill is allocated to the Company’s U.S. business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill is assessed for impairment annually on November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Indefinite-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Finite-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Software Development Costs </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for its lease obligations in accordance with ASC Topic 842, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases </div></div>(“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">ASC 842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Company has elected to apply this practical expedient to all lease contracts, where applicable. </div> P12M P12M <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Consideration—Gold Payments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Deferred consideration represents the present value of an obligation to pay gold to a third party into perpetuity and is measured using forward-looking gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note 9). Changes in the fair value of this obligation are reported as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Convertible notes are carried at amortized cost, net of issuance costs. In accordance with Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt – Debt with Conversion and Other Options</div></div>, the Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Contingencies </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Contingent Payments </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Earnings per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> convertible preferred stock (Note 11) and unvested share-based payment awards that contain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-forfeitable</div> rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method. Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive). </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Diluted EPS is calculated under the treasury stock method and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards, the Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> convertible preferred stock and the convertible notes are computed under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> that some portion or all the deferred tax assets will not be realized. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Tax positions are evaluated utilizing a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> process. The Company first determines whether any of its tax positions are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Global Intangible <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Low-Taxed</div> Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-income</div> based taxes are recorded as part of other liabilities and other expenses. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. Cash and Cash Equivalents </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Of the total cash and cash equivalents of $119,099 and $132,101 at March 31, 2023 and December 31, 2022, $118,306 and $131,104, respectively, were held at two financial institutions. At March 31, 2023 and December 31, 2022, cash equivalents were approximately $336 and $930, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Certain of the Company’s subsidiaries are required to maintain a minimum level of regulatory capital, which was $28,726 and $25,988 at March 31, 2023 and December 31, 2022, respectively. These requirements are generally satisfied by cash on hand. </div> 119099000 132101000 118306000 131104000 336000 930000 28726000 25988000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">4. Fair Value Measurements </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement</div></div>, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:95%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:6%"/> <td style="vertical-align:bottom;width:1%"/> <td style="width:1%"/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Level 1</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">–</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Quoted prices for identical instruments in active markets.</td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Level 2</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">–</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">Level 3</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">–</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top">Instruments whose significant drivers are unobservable.</td></tr></table></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2023 and 2022, there were no transfers between Levels 2 and 3. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-TimesNewRomanPS; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:87%"> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">336</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">336</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial instruments owned, at fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">33,728</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">33,728</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S. treasuries</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,993</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,993</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pass-through GSEs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">81,046</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,352</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  57,694</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets—seed capital (WisdomTree blockchain-enabled funds)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S. treasuries</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,901</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,901</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,937</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,937</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,915</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,915</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">660</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">660</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments in Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">10,051</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">10,051  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fnality International Limited—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">7,451</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">7,451  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    148,018</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    70,247</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    60,269</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">   </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">      17,502  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-TimesNewRomanPS; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:88%"> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-recurring</div> fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—Series A convertible preferred stock <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    3,588</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">3,588  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred consideration (Note 9)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    179,831</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">            —</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">        —</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    179,831  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="16" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">930 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">930 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial instruments owned, at fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,772 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,772 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S. treasuries</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,980 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,980 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pass-through GSEs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">96,837 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,290 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">73,547 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate bonds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">885 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">885 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets—seed capital (WisdomTree blockchain-enabled funds)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,765 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,765 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments in Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">14,500 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">14,500</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fnality International Limited—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">6,921 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">6,921</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  148,590 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  50,972 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  76,197 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">21,421</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-recurring</div> fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other investments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">312 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">312</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred consideration (Note 9)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">200,290 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">   200,290</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:31%"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> Fair value determined on March 31, 2023. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> Fair value determined on May 10, 2022. </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recurring Fair Value Measurements—Methodology </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash Equivalents (Note 3) </div></div>– These financial assets represent cash invested in highly liquid investments with original maturities of less than 90 days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial instruments owned (Note 5) </div></div>– Financial instruments owned are investments in ETFs, U.S. treasuries, pass-through GSEs, corporate bonds, equities, fixed income and other assets. ETFs, U.S. treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass-through GSEs, corporate bonds and fixed income include consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level 2. Pass-through GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div/><div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measurements classified as Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 3</div></div> – The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0"> <tr style="font-size: 0px;"> <td style="width:2%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:78%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments in Convertible Notes (Note 7)</div></div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">    </div></td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchases</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net unrealized losses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,919</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(163</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">17,502</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">6,700</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Deferred Consideration (Note 9)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">    200,290</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">228,062</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized losses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,450</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net unrealized (gains)/losses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">(20,592</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">) </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">17,018</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,353</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,353</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">179,831</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">    245,177</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">   </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:31%"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> Recorded in other losses, net in the Consolidated Statements of Operations. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> Recorded as contractual gold payments expense in the Consolidated Statements of Operations. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> Recorded as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2023 and 2022, there were no transfers between Levels 2 and 3. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-TimesNewRomanPS; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:87%"> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">336</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">336</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial instruments owned, at fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">33,728</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">33,728</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S. treasuries</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,993</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,993</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pass-through GSEs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">81,046</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,352</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  57,694</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets—seed capital (WisdomTree blockchain-enabled funds)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S. treasuries</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,901</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,901</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,937</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">4,937</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,915</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,915</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">660</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">660</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments in Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">10,051</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">10,051  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fnality International Limited—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">7,451</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">7,451  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    148,018</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    70,247</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    60,269</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">   </div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">      17,502  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-TimesNewRomanPS; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:88%"> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td> <td style="vertical-align:bottom;width:1%"> </td> <td> </td> <td style="white-space:nowrap">                  </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-recurring</div> fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—Series A convertible preferred stock <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    3,588</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">3,588  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred consideration (Note 9)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    179,831</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">            —</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">        —</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    179,831  </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="16" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">930 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">930 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial instruments owned, at fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,772 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,772 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S. treasuries</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,980 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">2,980 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pass-through GSEs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">96,837 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">23,290 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">73,547 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate bonds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">885 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">885 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets—seed capital (WisdomTree blockchain-enabled funds)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,765 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">1,765 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments in Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">14,500 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">14,500</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fnality International Limited—convertible note (Note 7)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">6,921 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">6,921</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  148,590 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  50,972 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  76,197 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">21,421</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-recurring</div> fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other investments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">312 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">312</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recurring fair value measurements:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-TimesNewRomanPS; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred consideration (Note 9)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">200,290 </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">— </div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">  $</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">   200,290</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:31%"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> Fair value determined on March 31, 2023. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> Fair value determined on May 10, 2022. </div> 336000 336000 0 0 33728000 33728000 0 0 2993000 2993000 0 0 81046000 23352000 57694000 0 4901000 4901000 0 0 4937000 4937000 0 0 1915000 0 1915000 0 660000 0 660000 0 10051000 0 0 10051000 7451000 0 0 7451000 148018000 70247000 60269000 17502000 3588000 0 0 3588000 179831000 0 0 179831000 930000 930000 0 0 23772000 23772000 0 0 2980000 2980000 0 0 96837000 23290000 73547000 0 885000 0 885000 0 1765000 0 1765000 0 14500000 0 0 14500000 6921000 0 0 6921000 148590000 50972000 76197000 21421000 312000 0 0 312000 200290000 0 0 200290000 P90D The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0"> <tr style="font-size: 0px;"> <td style="width:2%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:78%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments in Convertible Notes (Note 7)</div></div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">    </div></td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchases</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net unrealized losses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,919</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(163</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">17,502</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">6,700</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Deferred Consideration (Note 9)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">    200,290</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">228,062</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized losses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,450</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net unrealized (gains)/losses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">(20,592</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">) </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">17,018</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,353</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,353</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">179,831</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">  $</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">    245,177</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff">   </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:31%"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> Recorded in other losses, net in the Consolidated Statements of Operations. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> Recorded as contractual gold payments expense in the Consolidated Statements of Operations. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> Recorded as gain/(loss) on revaluation of deferred consideration—gold payments in the Consolidated Statements of Operations. </div> 21421000 0 0 6863000 -3919000 -163000 17502000 6700000 200290000 228062000 4486000 4450000 -20592000 17018000 4353000 4353000 179831000 245177000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5.  Financial instruments owned </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">These instruments consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0"> <tr style="font-size: 0px;"> <td style="width:5%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:75%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    <br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">          </div></div></td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;white-space:nowrap;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial instruments owned</div></div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,474</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets—seed capital (WisdomTree blockchain-enabled funds)</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">12,413</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">1,765</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    130,180</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    126,239</td> <td style="white-space:nowrap;vertical-align:bottom">  </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company recognized net trading gains/(losses) on financial instruments owned that were still held at the reporting dates of $4,722 and ($4,316) during the three months ended March 31, 2023 and 2022, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">These instruments consist of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0"> <tr style="font-size: 0px;"> <td style="width:5%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:75%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    <br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">          </div></div></td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;white-space:nowrap;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial instruments owned</div></div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,474</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:top;background-color:#cceeff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets—seed capital (WisdomTree blockchain-enabled funds)</div></td> <td style="vertical-align:bottom;background-color:#cceeff">  </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">12,413</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff;text-align:right;">1,765</td> <td style="white-space:nowrap;vertical-align:bottom;background-color:#cceeff"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    130,180</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    126,239</td> <td style="white-space:nowrap;vertical-align:bottom">  </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 117767000 124474000 12413000 1765000 130180000 126239000 4722000 4316000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">6.  Securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Held-to-Maturity</div></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table is a summary of the Company’s securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity:</div></div> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                                            </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt instruments: Pass-through GSEs (amortized cost)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          253</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          259</td> <td style="white-space:nowrap;vertical-align:bottom">   </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">During the three months ended March 31, 2023 and 2022, the Company received proceeds of $6 and $18, respectively, from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities maturing or being called prior to maturity. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes unrealized losses, gains and fair value (classified as Level 2 within the fair value hierarchy) of securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity:</div></div> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:88%;border:0"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="7" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                                            </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    <br/> 2022</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost/amortized cost</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">253</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross unrealized losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross unrealized gains</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          236</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          239</td> <td style="white-space:nowrap;vertical-align:bottom">   </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">An allowance for credit losses was not provided on the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> securities as all securities are investments in pass-through GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S. government guarantee. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table sets forth the maturity profile of the securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity;</div></div> however, these securities may be called prior to the maturity date: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="8" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                                </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due within one year</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due one year through five years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due five years through ten years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due over ten years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">227</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          253</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          259</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table is a summary of the Company’s securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity:</div></div> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                                            </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt instruments: Pass-through GSEs (amortized cost)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          253</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          259</td> <td style="white-space:nowrap;vertical-align:bottom">   </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 253000 259000 6000 18000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes unrealized losses, gains and fair value (classified as Level 2 within the fair value hierarchy) of securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity:</div></div> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:88%;border:0"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="7" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                                            </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    <br/> 2022</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost/amortized cost</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">253</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross unrealized losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross unrealized gains</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          236</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          239</td> <td style="white-space:nowrap;vertical-align:bottom">   </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 253000 259000 17000 20000 0 0 236000 239000 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table sets forth the maturity profile of the securities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity;</div></div> however, these securities may be called prior to the maturity date: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="8" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">                                </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    March 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    December 31,    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due within one year</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due one year through five years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due five years through ten years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due over ten years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">227</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          253</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">          259</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> 0 0 0 0 26000 27000 227000 232000 253000 259000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">7. Investments </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table sets forth the Company’s investments: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:87%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="12" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        March 31, 2023        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        December 31, 2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—Series A convertible preferred stock</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,588  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,112  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,112  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—Series B convertible preferred stock</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,051  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,000  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,000  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subtotal—Securrency, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,139  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,612  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,612  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fnality International Limited—convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,451  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,921  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    26,902  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    35,725  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 35,721  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    35,725  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securrency, Inc. – Preferred Stock </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company owns approximately 22% (or 17 % on a fully-diluted basis) of the capital stock of Securrency, Inc. (“Securrency”), a developer of institutional-grade blockchain-based financial and regulatory technology, issued as a result of strategic investments totaling $13,612. In consideration of such investments, the Company received 5,178,488 <div style="null;text-indent: 0px;;display:inline;">shares of Series A convertible preferred stock (“Securrency Series A Shares”) in December</div> 2019 and 2,004,665 <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">shares of Series B convertible preferred stock (“Securrency Series B Shares”) in March 2021. The Securrency Series B Shares contain a liquidation preference that is pari passu with shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1</div> convertible preferred stock (which are substantially the same as the Securrency Series B Shares except that they have limited voting rights) and senior to that of the holders of the Securrency Series A Shares, which are senior to the holders of common stock. Otherwise, the Securrency Series A Shares and Securrency Series B Shares have substantially the same terms, are convertible into common stock at the option of the Company and contain various rights and protections including a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cumulative<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div>6.0<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">% </div><div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">dividend, payable if and when declared by the board of directors of Securrency. In addition, the Securrency Series A Shares and Securrency Series B Shares (together with the Securrency Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1</div> convertible preferred stock) are separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">least </div>60<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">% of the <div style="display:inline;">Securrency </div>Series A Shares (at any time on or after December 31, 2029) and </div>90<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">% </div><div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">of the Securrency Series B Shares (at any time on or after March 31, 2031). </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">These investments are accounted for under the measurement alternative prescribed in ASC 321, as they do not have a readily determinable fair value and are not considered to be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-substance</div> common stock. The investments are assessed for impairment and similar observable transactions on a quarterly basis. During the three months ending March, 31, 2023, the Company recognized an impairment of $4,900 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">on its Securrency Series A Shares to reduce the carrying value of its investment to fair value. Fair value was determined using the probability-weighted expected return method (“PWERM”), a valuation approach that estimates fair value assuming various outcomes. </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:88%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Conversion of Securrency Series A Shares upon a future equity financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redemption of Securrency Series A Shares upon a corporate transaction</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Default</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33.4%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">There was no impairment recognized during the three months ended March 31, 2022 based upon a qualitative assessment. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securrency – Convertible Note </div></div></div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">In April and November 2022, the Company participated in a convertible note financing, making an aggregate investment of $15,000 in convertible notes of Securrency. In consideration for its investment, the Company was issued a 7% Convertible Promissory Note maturing on<br/>October 20, 2023. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The notes are convertible into either common stock or a class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency’s common stock that is issued in the event of a future equity financing of Securrency. The notes will convert at a conversion price equal to a discount of 25% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The notes are redeemable upon the occurrence of a corporate transaction for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted, in accordance with the terms of the notes, to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion may occur upon the election by the holders of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">majority-in-interest</div></div> of the aggregate principal amount of outstanding notes. If no such election is made, Securrency may elect to pay or convert the notes in its sole discretion. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The notes are accounted for at fair value. Fair value is determined by the Company using PWERM. During the three months ended March 31, 2023, the Company recognized an unrealized loss of $4,449 when <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measuring</div> the notes to fair value. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0"> <tr style="font-size: 0px;"> <td style="width:81%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  March 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  December 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of note upon a future equity financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">    33.3%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      60%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption of note upon a corporate transaction</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">    33.3%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      25%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Default</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">    33.4%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      15%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Time to potential outcome (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.56</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.33</td> </tr> </table> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fnality International Limited – Convertible Note </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In February 2022, the Company participated in a convertible note financing, making an investment of £5,000 ($6,863) in convertible notes of Fnality International Limited (“Fnality”), a company incorporated in England and Wales and focused on creating a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">peer-to-peer</div></div> digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross-border payments from a single pool of liquidity. In consideration for its investment, the Company was issued a 5% Convertible Unsecured Loan Note maturing on December 31, 2023. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The note is convertible into equity shares in the event of a future equity financing of Fnality. The note will convert at a conversion price equal to the lower of (i) a discount of 20% to lowest price paid per equity share issued pursuant to such future financing round and (ii) an amount paid per share subject to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-money</div> valuation cap. Mandatory conversion may occur on or after the maturity date or, if earlier, in the event a future financing round has not been completed within a specified time from an initial closing of such financing round (“Long Stop Date”), upon the approval of holders of at least 75% of the outstanding notes. The note is also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The note is redeemable upon the occurrence of a change of control for an amount which is the greater of (i) the principal amount and all accrued interest and (ii) the amount that would be received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption may also occur on or after maturity or prior to maturity upon approval by holders of at least 50% and 75%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The note is accounted for at fair value. Fair value is determined by the Company using the PWERM and is also remeasured for changes in the British pound and U.S. dollar exchange rate. During the three months ended March 31, 2023, the Company recognized a gain of $530 when <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measuring</div> the notes to fair value. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  March 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  December 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of note upon a future financing round</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      85%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      85%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption of note upon a change of control</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      10%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      10%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Default</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">        5%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">        5%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Time to potential outcome (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.08</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.25</td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table sets forth the Company’s investments: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:87%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="12" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        March 31, 2023        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        December 31, 2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—Series A convertible preferred stock</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,588  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,112  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,112  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—Series B convertible preferred stock</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Securrency, Inc.—convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,051  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,000  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,000  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subtotal—Securrency, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,139  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,612  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,612  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fnality International Limited—convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,451  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,921  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    26,902  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    35,725  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 35,721  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    35,725  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 3588000 8112000 8488000 8112000 5500000 5500000 5500000 5500000 10051000 15000000 14500000 15000000 19139000 28612000 28488000 28612000 7451000 6863000 6921000 6863000 312000 250000 312000 250000 26902000 35725000 35721000 35725000 0.22 0.17 13612000 5178488 2004665 0.06 0.60 0.90 4900000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy): </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:88%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Conversion of Securrency Series A Shares upon a future equity financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Redemption of Securrency Series A Shares upon a corporate transaction</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Default</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33.4%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> 0.333 0.333 0.334 0 15000000 0.07 2023-10-20 0.25 4449000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0"> <tr style="font-size: 0px;"> <td style="width:81%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  March 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  December 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of note upon a future equity financing</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">    33.3%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      60%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption of note upon a corporate transaction</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">    33.3%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      25%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Default</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">    33.4%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      15%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Time to potential outcome (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.56</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.33</td> </tr> </table> 0.333 0.60 0.333 0.25 0.334 0.15 0.56 0.33 5000000 6863000 0.05 2023-12-31 0.20 75 0.50 0.75 530000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  March 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  December 31,  </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of note upon a future financing round</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      85%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      85%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption of note upon a change of control</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      10%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      10%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Default</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">        5%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">        5%</td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Time to potential outcome (in years)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.08</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">      0.25</td> </tr> </table> 0.85 0.85 0.10 0.10 0.05 0.05 0.08 0.25 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. Fixed Assets, net </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes fixed assets: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">            997   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">            962  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: accumulated depreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(482)  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(418) </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">515   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">544  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes fixed assets: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">            997   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">            962  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: accumulated depreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(482)  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(418) </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">515   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">544  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 997000 962000 482000 418000 515000 544000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">9. Deferred Consideration </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Deferred consideration represents an obligation the Company assumed in connection with its acquisition of the European exchange-traded commodity, currency and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">leveraged-and-inverse</div></div> business of ETFS Capital Limited (“ETFS Capital”) which occurred on April 11, 2018 (“ETFS Acquisition”). The obligation is for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March 31, 2058 and then subsequently reduced to 6,333 ounces of gold per year continuing into perpetuity (“Contractual Gold Payments”). </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Contractual Gold Payments are paid from advisory fee income generated by any Company-sponsored financial product backed by physical gold and are subject to adjustment and reduction for declines in advisory fee income generated by such products, with any reduction remaining due and payable until paid in full. ETFS Capital’s recourse is limited to such advisory fee income and it has no recourse back to the Company for any unpaid amounts that exceed advisory fees earned. ETFS Capital ultimately has the right to claw back Gold Bullion Securities Ltd. (a physically backed gold ETP issuer) if the Company fails to remit any amounts due. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company determined the present value of the deferred consideration of $179,831 and $200,290 at March 31, 2023 and December 31, 2022 using the following assumptions: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:74%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding: 0px;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward-looking gold price (low)—per ounce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,999</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward-looking gold price (high)—per ounce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward-looking gold price (weighted average)—per ounce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,401</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        2,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        13.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.0%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Perpetual growth rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="text-indent: 5%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Fair value as of March 31, 2023 was determined using an equal weighting of a discounted cash flow approach and market approach. The forward-looking gold prices at March 31, 2023 were extrapolated from the last observable CMX exchange price (beyond 2028) and the weighted-average price per ounce was derived from the relative present values of the annual payment obligations. The perpetual growth rate at March 31, 2023 was determined based upon the increase in observable forward-looking gold prices through 2028. This obligation is classified as Level 3 as the discount rate, the extrapolated forward-looking gold prices and perpetual growth rate are significant unobservable inputs. An increase in spot gold prices, forward-looking gold prices and the perpetual growth rate would result in an increase in deferred consideration, whereas an increase in the discount rate would reduce the fair value. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Current amounts payable were $17,984 and $16,796 and long-term amounts payable were $161,847 and $183,494 at March 31, 2023 and December 31, 2022, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">During the three months ended March 31, 2023 and 2022, the Company recognized the following in respect of deferred consideration: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:98%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual Gold Payments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,486  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,450  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual Gold Payments—gold ounces paid</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,375  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,375  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain/(loss) on revaluation of deferred consideration—gold payments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    20,592  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    (17,018) </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 31%;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:3%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations. </div></td></tr></table> 9500 6333 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company determined the present value of the deferred consideration of $179,831 and $200,290 at March 31, 2023 and December 31, 2022 using the following assumptions: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:74%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding: 0px;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward-looking gold price (low)—per ounce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,999</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward-looking gold price (high)—per ounce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,567</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward-looking gold price (weighted average)—per ounce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,401</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        2,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        13.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.0%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Perpetual growth rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.3%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 179831000 200290000 1999000 1858000 3567000 3126000 2401000 2237000 0.133 0.11 0.015 0.013 17984000 16796000 161847000 183494000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">During the three months ended March 31, 2023 and 2022, the Company recognized the following in respect of deferred consideration: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:98%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual Gold Payments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,486  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,450  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual Gold Payments—gold ounces paid</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,375  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,375  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain/(loss) on revaluation of deferred consideration—gold payments<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    20,592  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    (17,018) </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="line-height: 8pt; margin-top: 0px; margin-bottom: 0px; border-bottom: 1px solid rgb(0, 0, 0); width: 31%;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:3%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations. </div></td></tr></table> 4486000 4450000 2375000 2375000 20592000 -17018000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">10. Convertible Notes </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On February 14, 2023, the Company issued and sold $130,000 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2023 Notes”) pursuant to an indenture dated February 14, 2023, between the Company and U.S. Bank Trust Company, National Association, as trustee (or its successor in interest, the “Trustee”), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (“Rule 144A”). </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On June 14, 2021, the Company issued and sold $150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2021 Notes”) pursuant to an indenture dated June 14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On June 16, 2020, the Company issued and sold $150,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the “June 2020 Notes”) pursuant to an indenture dated June 16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A. On August 13, 2020, the Company issued and sold $25,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June 16, 2020, and constitute a further issuance of, and form a single series with, the Company’s June 2020 Notes (the “August 2020 Notes” and together with the June 2020 Notes, the “2020 Notes”). </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In connection with the issuance of the 2023 Notes, the Company repurchased $115,000 in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $9,721 during the three months ended March 31, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">After the issuance of the 2023 Notes (and together with the remaining 2020 Notes and the 2021 Notes, the “Convertible Notes”), the Company had $340,000 in aggregate principal amount of Convertible Notes outstanding. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Key terms of the Convertible Notes are as follows: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:64%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2023 Notes  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021 Notes  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2020 Notes  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$130.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$150.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$60.0  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maturity date (unless earlier converted, repurchased or redeemed)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">August 15, 2028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 15, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 15, 2023  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.75%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.25%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.25%  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">$9.54</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">$11.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">$5.92  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">104.8658</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">90.5797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">168.9189  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$12.40</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$14.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$7.70  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Interest rate:</div></div> Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and June 15 and December 15 of each year for the 2020 Notes and the 2021 Notes. </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Conversion price:</div></div> Convertible at an initial conversion rate into shares of the Company’s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment. </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Conversion:</div></div> Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the <span style="-sec-ix-hidden:hidden78766212"><span style="-sec-ix-hidden:hidden78766211">five</span><span style="-sec-ix-hidden:hidden78766210"> business </span><span style="-sec-ix-hidden:hidden78766111">day</span></span> period after any <span style="-sec-ix-hidden:hidden78766109">ten</span><span style="-sec-ix-hidden:hidden78766107"> consecutive </span><span style="-sec-ix-hidden:hidden78766106">trading </span><span style="-sec-ix-hidden:hidden78766104">day</span> period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances. </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash settlement of principal amount:</div></div> Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock. </div></td></tr></table><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption price: </div></div>The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective </div></td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div/><div><div style="background-color:white;display: inline;"/></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:8%"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; line-height: normal;">Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Limited investor put rights:</div></div> Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Conversion rate increase in certain customary circumstances:</div></div> In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853 shares, 144.9275 shares and 270.2702 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2021 Notes and 2020 Notes, respectively (the equivalent of 59,767,426 shares of the Company’s common stock), subject to adjustment. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:6%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Seniority and Security:</div></div> The Convertible Notes rank equal in right of payment, and are the Company’s senior unsecured obligations, but are subordinated in right of payment to the Company’s obligations to make certain redemption payments (if and when due) in respect of its Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Voting</div> Convertible Preferred Stock (Note 11). </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Convertible Notes outstanding may declare the entire principal amount of all the Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the carrying value of the Convertible Notes at March 31, 2023 and December 31, 2022: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:45%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="15" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023<br/> Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021<br/> Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020 Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021 Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020 Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal amount</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"> 130,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"> 150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"> 60,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  340,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  175,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  325,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus: Premium</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">130,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">60,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">340,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">175,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">325,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Unamortized issuance costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(3,465)</td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(2,768)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(366)</td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(6,599)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(2,981)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(1,053)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(4,034)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying amount</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">126,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">147,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">59,884</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">333,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">147,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">174,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">321,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effective interest rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:7.5px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">6.25%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.83%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.18%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.00%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.83%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.26%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.60%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">        <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">                                                                                                   </div> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> Includes amortization of the issuance costs and premium. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Interest expense on the Convertible Notes during the three months ended March 31, 2023 and 2022 was $4,002 and $3,732, respectively. Interest payable of $3,243 and $621 at March 31, 2023 and December 31, 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $331,766 and $320,513 at March 31, 2023 and December 31, 2022, respectively. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> value of the Convertible Notes did not exceed the principal amount at March 31, 2023 and December 31, 2022. </div> 130000000 0.0575 2028 150000000 0.0325 2026 150000000 0.0425 2023 25000000 0.0425 2023 115000000 9721000 340000000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Key terms of the Convertible Notes are as follows: </div><div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:64%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2023 Notes  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021 Notes  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2020 Notes  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$130.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$150.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$60.0  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maturity date (unless earlier converted, repurchased or redeemed)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">August 15, 2028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 15, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 15, 2023  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.75%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.25%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.25%  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion price</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">$9.54</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">$11.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">$5.92  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">104.8658</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">90.5797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">168.9189  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redemption price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$12.40</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$14.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">$7.70  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 130000 150000 60000 2028-08-15 2026-06-15 2023-06-15 0.0575 0.0325 0.0425 9.54 11.04 5.92 104.8658 90.5797 168.9189 12.4 14.35 7.7   •   Interest rate: Payable semiannually in arrears on February 15 and August 15 of each year for the 2023 Notes (beginning on August 15, 2023) and June 15 and December 15 of each year for the 2020 Notes and the 2021 Notes. 1000 1000 1000 1000   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.   •   Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2028, March 15, 2026 and March 15, 2023 for the 2023 Notes, 2021 Notes and 2020 Notes, respectively, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2028, March 15, 2026 and March 15, 2023 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances. 20 20 20 20 30 30 30 30 0.98 0.98 0.98 0.98   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.   •   Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2025, June 20, 2023 and June 20, 2021 in respect of the 2023 Notes, 2021 Notes and 2020 Notes, respectively, and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective     Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes. 20 20 20 20 30 30 30 30 1 1 1 1 1 1 1 1 167.7853 144.9275 270.2702 270.2702 59767426 59767426 59767426 0.25 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the carrying value of the Convertible Notes at March 31, 2023 and December 31, 2022: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:45%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="15" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023<br/> Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021<br/> Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020 Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021 Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020 Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal amount</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"> 130,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"> 150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"> 60,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  340,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  175,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">  325,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus: Premium</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">130,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">60,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">340,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">175,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">325,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Unamortized issuance costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(3,465)</td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(2,768)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(366)</td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(6,599)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(2,981)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(1,053)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">(4,034)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying amount</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">126,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">147,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">59,884</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">333,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">147,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">174,197</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">321,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effective interest rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:7.5px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">6.25%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.83%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.18%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.00%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.83%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5.26%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.60%</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">        <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">                                                                                                   </div> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> Includes amortization of the issuance costs and premium. </div> 130000000 150000000 60000000 340000000 150000000 175000000 325000000 0 0 250000 250000 0 250000 250000 130000000 150000000 60250000 340250000 150000000 175250000 325250000 3465000 2768000 366000 6599000 2981000 1053000 4034000 126535000 147232000 59884000 333651000 147019000 174197000 321216000 0.0625 0.0383 0.0518 0.05 0.0383 0.0526 0.046 4002000 3732000 3243000 621000 331766000 320513000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. Series A Preferred Stock </div></div> <div style="text-indent: 5%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On April 10, 2018, the Company filed a Certificate of Designations of Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Voting</div> Convertible Preferred Stock (the “Series A Certificate of Designations”) with the Delaware Secretary of State establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series A Preferred Stock (defined below). The Series A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company’s common stock on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis. The Series A Preferred Stock has no voting rights, is not transferable and has the same priority with regard to dividends, distributions and payments as the common stock. </div></div> <div style="text-indent: 5%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As described in the Series A Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attribution parties) would beneficially own more than 9.99% of the Company’s outstanding common stock immediately after giving effect to such conversion. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In connection with the completion of the ETFS Acquisition, the Company issued 14,750 shares of Series A <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Voting</div> Convertible Preferred Stock (the “Series A Preferred Stock”), which are convertible into an aggregate of 14,750,000 shares of common stock. The fair value of this consideration was $132,750, based on the closing price of the Company’s common stock on April 10, 2018 of $9.00 per share, the trading day prior to the closing of the acquisition. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following is a summary of the Series A Preferred Stock balance: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:74%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A Preferred Stock</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    132,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    132,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Issuance costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(181</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(181</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A Preferred Stock—carrying value</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">132,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">132,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash dividends declared per share (quarterly)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer’s control. ETFS Capital has the right to redeem all the Series A Preferred Stock specified to be converted during the period of time specified in the Series A Certificate of Designations in the event that: (a) the number of shares of the Company’s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series A Preferred Stock requested by ETFS Capital to be converted; or (b) ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per Series A Preferred Stock as it would have received had each outstanding Series A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Any such redemption will be at a price per Series A Preferred Stock equal to the dollar volume-weighted average price for a share of common stock for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. Such redemption payment will be made in one payment no later than 10 business days following the last day of the Company’s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series A Preferred Stock was $86,638 and $77,969 at March 31, 2023 and December 31, 2022, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The carrying amount of the Series A Preferred Stock was not adjusted as it was not probable that the Series A Preferred Stock would become redeemable.</div> 14750 14750000 132750000 9 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following is a summary of the Series A Preferred Stock balance: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:74%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series A Preferred Stock</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    132,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    132,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Issuance costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(181</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(181</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Series A Preferred Stock—carrying value</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">132,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">132,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash dividends declared per share (quarterly)</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">0.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> 132750000 132750000 181000 181000 132569000 132569000 0.03 0.03 Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer’s control. ETFS Capital has the right to redeem all the Series A Preferred Stock specified to be converted during the period of time specified in the Series A Certificate of Designations in the event that: (a) the number of shares of the Company’s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series A Preferred Stock requested by ETFS Capital to be converted; or (b) ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per Series A Preferred Stock as it would have received had each outstanding Series A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law. 86638000 77969000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. Leases </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company has entered into operating leases for its office facilities (including its corporate headquarters) and equipment. The Company has no finance leases. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table provides additional information regarding the Company’s leases: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:86%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2023        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Lease cost:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease cost</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term lease cost</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">276    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease cost</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">375    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">            365    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Other information:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">            326    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets obtained in exchange for new operating lease liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">n/a    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">n/a    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average remaining lease term (in years)—operating leases</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.3    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average discount rate—operating leases</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5% </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.4% </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">None of the Company’s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company’s ability to pay dividends or incur additional financing obligations. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table discloses future minimum lease payments at March 31, 2023 with respect to the Company’s operating lease liabilities: </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:66%;border:0"> <tr style="font-size: 0px;"> <td style="width:21%"/> <td style="vertical-align:bottom;width:1%"/> <td style="width:64%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="10" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remainder of 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">803  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">397  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2028 and thereafter</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total future minimum lease payments (undiscounted)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        1,200  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table reconciles the future minimum lease payments (disclosed above) at March 31, 2023 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:66%;border:0"> <tr style="font-size: 0px;"> <td style="width:21%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:64%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="10" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts recognized in the Company’s Consolidated Balance     Sheets</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lease liability—short term</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,041  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lease liability—long term</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subtotal</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,161  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Difference between undiscounted and discounted cash flows</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total future minimum lease payments (undiscounted)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      1,200  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table provides additional information regarding the Company’s leases: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:86%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2023        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Lease cost:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease cost</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term lease cost</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">276    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease cost</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">375    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">            365    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Other information:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">            326    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets obtained in exchange for new operating lease liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">n/a    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">n/a    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average remaining lease term (in years)—operating leases</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.3    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average discount rate—operating leases</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5% </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.4% </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 319000 89000 56000 276000 375000 365000 326000 97000 P1Y P1Y3M18D 0.065 0.044 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table discloses future minimum lease payments at March 31, 2023 with respect to the Company’s operating lease liabilities: </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:66%;border:0"> <tr style="font-size: 0px;"> <td style="width:21%"/> <td style="vertical-align:bottom;width:1%"/> <td style="width:64%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="10" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remainder of 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">803  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">397  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2028 and thereafter</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total future minimum lease payments (undiscounted)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        1,200  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 803000 397000 0 0 0 0 1200000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table reconciles the future minimum lease payments (disclosed above) at March 31, 2023 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:66%;border:0"> <tr style="font-size: 0px;"> <td style="width:21%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:64%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="10" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts recognized in the Company’s Consolidated Balance     Sheets</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lease liability—short term</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,041  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lease liability—long term</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subtotal</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,161  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Difference between undiscounted and discounted cash flows</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.4em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total future minimum lease payments (undiscounted)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      1,200  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 1041000 120000 1161000 39000 1200000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">13. Contingencies </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In December 2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (“WT Ireland”) were served with a writ of summons to appear before the Court of Milan, Italy. In January 2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (“3OIL”) in March 2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures’ closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In February 2022, the Court of Udine ruled in the Company’s favor. Also in February 2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In March 2022, WMAI and WTUK were served with writs of summons to appear before the Court of Turin and the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Total damages sought by all investors are approximately €15,800 ($17,186) at March 31, 2023. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company is currently assessing these claims with its external counsel. An accrual has not been made with respect to these matters at March 31, 2023 and December 31, 2022. </div> 15800000 17186000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. Variable Interest Entities </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">VIEs are entities with any of the following characteristics: (i) the entity does not have enough equity to finance its activities without additional financial support; (ii) the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii) the entity is structured with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-substantive</div> voting rights. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities’ economic performance. Such power is conveyed through the entities’ boards of directors and the Company does not have control over the boards. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s variable interests in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-consolidated</div> VIEs: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:87%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      March 31,      </div></div></div><br/> <div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      December 31,      </div></div></div><br/> <div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td rowspan="15" style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td rowspan="15" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"/> <div style="margin-top: 0px; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">                                                    </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying Amount—Assets (Securrency):</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock—Series A Shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,588  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock—Series B Shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,051  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subtotal—Securrency</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,139  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying Amount—Assets (Fnality):</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,451  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,921  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying Amount—Assets (Other investments):</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total (Note 7)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,902  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,721  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="font-size: 4pt; margin-top: 0px; margin-bottom: 0px; line-height: normal;"> </div> <div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maximum exposure to loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        26,902  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        35,721  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company’s variable interests in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-consolidated</div> VIEs: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:87%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      March 31,      </div></div></div><br/> <div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      December 31,      </div></div></div><br/> <div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td rowspan="15" style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td rowspan="15" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"/> <div style="margin-top: 0px; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">                                                    </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying Amount—Assets (Securrency):</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock—Series A Shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,588  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock—Series B Shares</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,051  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,500  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subtotal—Securrency</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,139  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,488  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying Amount—Assets (Fnality):</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,451  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,921  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carrying Amount—Assets (Other investments):</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">312  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total (Note 7)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,902  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,721  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="font-size: 4pt; margin-top: 0px; margin-bottom: 0px; line-height: normal;"> </div> <div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maximum exposure to loss</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        26,902  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        35,721  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 3588000 8488000 5500000 5500000 10051000 14500000 19139000 28488000 7451000 6921000 312000 312000 26902000 35721000 26902000 35721000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">15. Revenues from Contracts with Customers </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table presents the Company’s total revenues from contracts with customers: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:73%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues from contracts with customers:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory fees</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,637  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,517  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,407  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,851  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating revenues</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      82,044  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      78,368  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity’s performance in transferring control of services to the customer. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Substantially all the Company’s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note 16). These advisory fees are recognized over time, are earned from the Company’s ETPs and are calculated based on a percentage of the ETPs’ average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Other income includes revenues <div style="null;text-indent: 0px;;display:inline;">the Company earns</div> from swap providers associated with certain of the Company’s European-listed ETPs, the nature of which are either based on a percentage of the ETPs’ average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due<div style="null;text-indent: 0px;;display:inline;">,</div> which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Geographic Distribution of Revenue </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues from contracts with customers:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,681  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,229  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Jersey</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,053  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,598  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ireland</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,310  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,541  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating revenues</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">    82,044  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">    78,368  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table presents the Company’s total revenues from contracts with customers: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:73%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues from contracts with customers:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory fees</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,637  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,517  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,407  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,851  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating revenues</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      82,044  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      78,368  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 77637000 76517000 4407000 1851000 82044000 78368000 0 0 0 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues from contracts with customers:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,681  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,229  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Jersey</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,053  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,598  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ireland</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,310  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,541  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating revenues</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">    82,044  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">    78,368  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 49681000 46229000 29053000 28598000 3310000 3541000 82044000 78368000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">16. Related Party Transactions </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company’s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S. WisdomTree ETFs and WisdomTree UCITS ETFs. The Board of Trustees and Board of Directors (including certain officers of the Company) of the related parties are primarily responsible for overseeing the management and affairs of the entities for the benefit of their stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-distribution</div> services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs’ average daily net assets. A majority of the independent members of the Board of Trustees are required to annually approve the advisory agreements of the U.S. WisdomTree ETFs and these agreements may be terminated by the Board of Trustees upon notice. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:99%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:93%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td rowspan="7" style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td rowspan="7" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">            </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Receivable from WTT</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,124  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,399  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Receivable from ManJer Issuers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,790  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,485  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Receivable from WMAI and WTICAV</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,532  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,255  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      32,446  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      24,139  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30 days aged and are collected shortly after the applicable reporting period. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes revenues from advisory services provided to related parties: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div/> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:99%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:93%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td rowspan="8" style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td rowspan="8" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">            </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory services provided to WTT</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,487  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,070  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory services provided to ManJer Issuers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,840  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,905  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory services provided to WMAI and WTICAV</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,310  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,542  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      77,637  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      76,517  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company also has investments in certain WisdomTree products of approximately $45,214 and $25,283 at March 31, 2023 and December 31, 2022, respectively. This includes $12,413 and $1,765, <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">respectively, of investments in certain consolidated affiliated blockchain-enabled funds advised by WT Digital Management, referred to herein as “other assets–seed capital.” Net unrealized and realized gains/(losses) related to trading WisdomTree products during the three months ended March 31, 2023 and 2022 </div></div> were $422 and ($806), respectively, which are recorded in other losses, net on the Consolidated Statements of Operations. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:99%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:93%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td rowspan="7" style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td rowspan="7" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">            </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Receivable from WTT</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,124  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,399  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Receivable from ManJer Issuers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,790  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,485  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Receivable from WMAI and WTICAV</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,532  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,255  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      32,446  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      24,139  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 17124000 16399000 12790000 4485000 2532000 3255000 32446000 24139000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table summarizes revenues from advisory services provided to related parties: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:99%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:93%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td rowspan="8" style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td rowspan="8" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">            </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory services provided to WTT</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,487  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,070  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory services provided to ManJer Issuers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,840  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,905  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Advisory services provided to WMAI and WTICAV</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,310  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,542  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      77,637  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      76,517  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 49487000 46070000 24840000 26905000 3310000 3542000 77637000 76517000 45214000 25283000 12413000 1765000 -422000 806000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. Stock-Based Awards </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On July 15, 2022, the Company’s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000 shares of common stock (less one share for every share granted under the 2016 Equity Plan since March 31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March 31, 2022) in the form of stock options and other stock-based awards. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company grants equity awards to employees and directors which include restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and stock options. Certain awards described below are subject to acceleration under certain conditions. </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:95%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:12%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:86%"/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-right: 1.8em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Generally issued for terms of ten years and may vest after at least one year of service and have an exercise price equal to the Company’s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black-Scholes option pricing model.</div> </td> </tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSAs/RSUs:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-right: 1.8em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Awards are valued based on the Company’s stock price on grant date and generally vest ratably, on an annual basis, over three years.</div> </td> </tr> </table> </div> <div/> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:95%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:12%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:86%"/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top">PRSUs:</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top">These awards cliff vest three years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company’s total shareholder return (“TSR”) compares to a peer group of other publicly traded asset managers over the three-year period. A Monte Carlo simulation is used to value these awards.</td> </tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:</div> <div style="font-size: 3pt; margin-top: 0px; margin-bottom: 0px; line-height: normal;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">•   If the relative TSR is below the 25<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div> percentile, then 0% of the target number of PRSUs granted will vest;</div> <div style="font-size: 3pt; margin-top: 0px; margin-bottom: 0px; line-height: normal;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">•   If the relative TSR is at the 25th percentile, then 50% of the target number of PRSUs granted will vest;</div> <div style="font-size: 3pt; margin-top: 0px; margin-bottom: 0px; line-height: normal;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">•   If the relative TSR is above the 25th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50th percentile and capped at 200% of the target number of PRSUs granted for performance at the 85th percentile (or 100th percentile for grants made in 2020); and</div> <div style="font-size: 3pt; margin-top: 0px; margin-bottom: 0px; line-height: normal;"> </div> <div style="margin-top: 0pt; margin-bottom: 1pt; margin-left: 2em; text-indent: -2em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">•   If the Company’s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.</div> </td> </tr> </table> </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense during the three months ended March 31, 2023 and 2022 was $4,536 and $2,936, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:73%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:3%"/> <td style="vertical-align:bottom;width:6%"/> <td style="width:52%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="5" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unrecognized Stock-<br/> Based</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-Average</div><br/> Remaining<br/>   Vesting Period (Years)  </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employees and directors</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">            30,415            </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">2.10</td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A summary of stock-based compensation award activity (shares) during the three months ended March 31, 2023 is as follows: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:70%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSA</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSU</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PRSU</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at January 1, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,391,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">668,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,273,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">576,240</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,498,171</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,837</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(83,158</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,885</td> <td style="white-space:nowrap;vertical-align:bottom">)  </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(233</td> <td style="white-space:nowrap;vertical-align:bottom">)  </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(24,955</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    5,154,289</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    188,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      1,136,315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="break-inside: avoid; font-size: 0px;"> <td colspan="12" style="vertical-align:bottom"/> <td style="vertical-align:bottom"/> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:15%"> </td> <td style="width:3%;vertical-align:top;text-align:left;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">                                                                                </div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"> </div> </td> </tr> </table> <div style="font-size: 2pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:15%"> </td> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. A Monte-Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">90-day</div> average stock prices; (ii) valuation date stock prices; (iii) historical stock price volatilities ranging from 37% to 56% (average 47%); (iv) correlation coefficients based upon the price data used to calculate the historical volatilities; (v) a risk free interest rate of 3.8%; and (vi) an expected dividend yield of 0%. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:15%"> </td> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The payout on PRSUs vesting in January 2023 was 77%. The remainder of the awards were forfeited. </div> </td> </tr> </table> 16000000 P10Y P1Y 0 2 0 0.50 1 2 2 1 4536000 2936000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:73%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:3%"/> <td style="vertical-align:bottom;width:6%"/> <td style="width:52%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="5" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unrecognized Stock-<br/> Based</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Compensation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-Average</div><br/> Remaining<br/>   Vesting Period (Years)  </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employees and directors</div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">            30,415            </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">2.10</td> </tr> </table> 30415000 P2Y1M6D <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A summary of stock-based compensation award activity (shares) during the three months ended March 31, 2023 is as follows: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:70%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSA</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSU</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">PRSU</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at January 1, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,391,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">668,188</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,273,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">576,240</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,498,171</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,837</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(83,158</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,885</td> <td style="white-space:nowrap;vertical-align:bottom">)  </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(233</td> <td style="white-space:nowrap;vertical-align:bottom">)  </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(24,955</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    5,154,289</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    188,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      1,136,315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="break-inside: avoid; font-size: 0px;"> <td colspan="12" style="vertical-align:bottom"/> <td style="vertical-align:bottom"/> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:15%"> </td> <td style="width:3%;vertical-align:top;text-align:left;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">                                                                                </div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"> </div> </td> </tr> </table> <div style="font-size: 2pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:15%"> </td> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. A Monte-Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">90-day</div> average stock prices; (ii) valuation date stock prices; (iii) historical stock price volatilities ranging from 37% to 56% (average 47%); (iv) correlation coefficients based upon the price data used to calculate the historical volatilities; (v) a risk free interest rate of 3.8%; and (vi) an expected dividend yield of 0%. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:15%"> </td> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The payout on PRSUs vesting in January 2023 was 77%. The remainder of the awards were forfeited. </div> </td> </tr> </table> 3391082 141963 668188 3273263 73855 576240 1498171 26837 83158 11885 233 24955 5154289 188748 1136315 0 2 0.37 0.56 0.47 0.038 0 0.77 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. Stockholder Rights Plan </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On March 17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March 17, 2023, between the Company and Continental Stock Transfer &amp; Trust Company, as Rights Agent (the “Stockholder Rights Agreement”). </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i) one Right (as defined below) for each outstanding share of common stock, par value $0.01 per share, of the Company’s common stock and (ii) 1,000 Rights for each outstanding share of Series A Preferred Stock”, to stockholders of record as of the close of business on March 28, 2023 (the “Record Date”). In addition, one Right will automatically attach to each share of common stock and 1,000 Rights will automatically attach to each share of Series A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each “Right” entitles the registered holder thereof to purchase from the Company a unit consisting of <span style="-sec-ix-hidden:hidden78766108">one</span> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ten-thousandth</div> of a share (a “Unit”) of Series B Junior Participating Cumulative Preferred Stock, par value $0.01 per share, of the Company (the “Series B Preferred Stock”) at a cash exercise price of $32.00 per Unit (the “Exercise Price”), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Initially, the Rights are not exercisable and are attached to and trade with all shares of common stock and Series A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series A Preferred Stock and will become exercisable upon the earlier of (i) the close of business on the tenth calendar day following the first public announcement that a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired beneficial ownership of 10% (or 20% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than 20% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule 13G pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13d-1(b)</div> or Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13d-1(c)</div> of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the “Stock Acquisition Date”), or (ii) the close of business on the tenth business day (or such later day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the “Distribution Date”). A person or group who beneficially owned 10% or more (or 20% or more in the case of passive stockholders) of the Company’s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own 10% or more (or 20% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">For purposes of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of <div style="display:inline;">Series B </div>Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units of <div style="display:inline;">Series B </div>Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the “Subscription Right”). In the event that, at any time following the Stock Acquisition Date, (i) the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii) any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii) 50% or more of the Company’s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the “Merger Right”). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Rights may be redeemed in whole, but not in part, at a price of $0.01 per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i) the time at which any person becomes an Acquiring Person or (ii) the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates). </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Rights are not exercisable until the Distribution Date and will expire at the close of business on March 16, 2024; provided that if the Company’s stockholders have not ratified the Stockholder Rights Agreement by the close of business on the first day after the Company’s 2023 annual meeting of stockholders (including any adjournments or postponements thereof), the Rights will expire at such time, in each case, unless previously redeemed or exchanged by the Company. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a “Qualifying Offer” (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i) a fully financed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">all-cash</div> tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii) an offer that is otherwise in the best interests of the Company’s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a “Qualifying Offer,” including if the consideration offered in a proposed transaction is stock of the acquiror. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board <div style="null;text-indent: 0px;;display:inline;">of Directors<div style="display:inline;"> </div></div>has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the “Special Meeting”) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90th business day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10th business day thereafter. </div> 1000 0.01 1000000 0.01 32 0.10 0.20 0.20 0.10 0.20 0.10 0.20 0.50 0.01 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">19. Earnings/(Loss) Per Share </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:92%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basic Earnings/(Loss) per Share</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2023          </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2022          </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income/(loss)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,233</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,261</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Income distributed to participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(498</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(549</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Undistributed income allocable to participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,206</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income/(loss) available to common stockholders—Basic EPS</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,810</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1pt"> <td style="height:3pt"> </td> <td colspan="4" style="height:3pt"> </td> <td colspan="4" style="height:3pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares (in thousands)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143,862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic earnings/(loss) per share</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        0.10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.08</td> <td style="white-space:nowrap;vertical-align:bottom">)     </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:92%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Diluted Earnings/(Loss) per Share</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2023          </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2022          </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net earnings/(loss) available to common stockholders</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,810</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Add back: Undistributed income allocable to participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,202</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income/(loss) available to common stockholders—Diluted EPS</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,533</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,810</td> <td style="white-space:nowrap;vertical-align:bottom">)     </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Weighted Average Diluted Shares (in thousands)</div>:</div> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143,862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dilutive effect of common stock equivalents, excluding participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average diluted shares, excluding participating securities (in thousands)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,431</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diluted earnings/(loss) per share</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.08</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Diluted earnings/(loss) per share presented above is calculated using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method as this method results in the lowest diluted earnings per share amount for common stock. During the three months ended March 31, 2022, there were no dilutive common stock equivalents as the Company reported a net loss for the period. Total antidilutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-participating</div> common stock equivalents were 695 and 509 for the three months ended March 31, 2023 and 2022, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">There were no potential common shares associated with the conversion options embedded in the Convertible Notes included in weighted average diluted shares for the three months ended March 31, 2023 and 2022 as the Company’s average stock price was lower than the conversion price. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:93%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reconciliation of Weighted Average Diluted Shares (in thousands)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">159,887</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142,782</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Participating securities:</div> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,750</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Potentially dilutive restricted stock awards</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      144,431</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000; width:37%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Excludes 15,521 participating securities and 31 potentially dilutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-participating</div> common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands). </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:92%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basic Earnings/(Loss) per Share</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2023          </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2022          </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income/(loss)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,233</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,261</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Income distributed to participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(498</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(549</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Undistributed income allocable to participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,206</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income/(loss) available to common stockholders—Basic EPS</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,810</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1pt"> <td style="height:3pt"> </td> <td colspan="4" style="height:3pt"> </td> <td colspan="4" style="height:3pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares (in thousands)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143,862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic earnings/(loss) per share</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        0.10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.08</td> <td style="white-space:nowrap;vertical-align:bottom">)     </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:92%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Diluted Earnings/(Loss) per Share</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2023          </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">          2022          </div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net earnings/(loss) available to common stockholders</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,810</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Add back: Undistributed income allocable to participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,202</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income/(loss) available to common stockholders—Diluted EPS</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,533</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,810</td> <td style="white-space:nowrap;vertical-align:bottom">)     </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Weighted Average Diluted Shares (in thousands)</div>:</div> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143,862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dilutive effect of common stock equivalents, excluding participating securities</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average diluted shares, excluding participating securities (in thousands)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,431</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diluted earnings/(loss) per share</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.08</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> 16233000 -10261000 498000 549000 1206000 0 14529000 -10810000 143862000 142782000 0.1 -0.08 14529000 -10810000 -1206000 0 1202000 0 14533000 -10810000 143862000 142782000 569000 0 144431000 142782000 0.1 -0.08 695000 509000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:93%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reconciliation of Weighted Average Diluted Shares (in thousands)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">159,887</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142,782</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Participating securities:</div> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11)</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,750</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Potentially dilutive restricted stock awards</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      144,431</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    142,782</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:9%;border-bottom:1px solid #000000; width:37%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:2%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Excludes 15,521 participating securities and 31 potentially dilutive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-participating</div> common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands). </div> </td> </tr> </table> 159887000 142782000 -14750000 0 -706000 0 144431000 142782000 15521000 31000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. Income Taxes </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Effective Income Tax Rate – Three Months Ended March 31, 2023 and March 31, 2022 </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company’s effective income tax rate during the three months ended March 31, 2023 was 7.9% resulting in income tax expense of $1,383. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-taxable</div> gain on revaluation of deferred consideration and a $1,353 reduction in unrecognized tax benefits (including interest and penalties). These items were partly offset by a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-deductible</div> loss on extinguishment of our convertible notes and an increase in the deferred tax asset valuation allowance on losses recognized on the Company’s investments. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company’s effective income tax rate during the three months ended March 31, 2022 of 62.0% resulted in an income tax benefit of $16,713. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to a $19,897 reduction in unrecognized tax benefits (including interest and penalties), a lower tax rate on foreign earnings and tax windfalls associated with the vesting of stock-based compensation awards. These items were partly offset by a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-taxable</div> loss on revaluation of deferred consideration and an increase in the deferred tax asset valuation allowance on losses recognized on securities owned. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Deferred Tax Assets </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A summary of the components of the Company’s deferred tax assets at March 31, 2023 and December 31, 2022 is as follows: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:1%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:73%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="13" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capital losses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        17,740     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        17,541     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,781     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,821     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NOLs—Foreign</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,625     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,609     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,527     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,030     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill and intangible assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,038     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">865     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,526     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest carryforwards</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">260     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">313     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation adjustment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">173     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NOLs—U.S.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">127     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">255     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outside basis differences</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:98%;border:0"> <tr style="font-size: 0px;"> <td style="width:1%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="17" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">341     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,170     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,816     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liabilities:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets and prepaid assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">278     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unremitted earnings—European subsidiaries</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">246     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">205     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Right of use assets—operating leases</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">260     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">313     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">656     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax assets less deferred tax liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,514     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,020     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Valuation allowance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,643)    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,484)    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets, net</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,871     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,536     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Operating and Capital Losses—U.S. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company’s tax effected net operating losses (“NOLs”) at March 31, 2023 were $127, which expire in 2024. The net operating loss carryforwards have been reduced by the impact of annual limitations described in the Internal Revenue Code Section 382 that arose as a result of an ownership change. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">The Company’s tax effected capital losses at March 31, 2023 were $17,740. These capital losses expire between the years 2023 and 2028. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Operating Losses—Europe </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">One of the Company’s European subsidiaries generated NOLs outside the U.S. These tax effected NOLs, all of which are carried forward indefinitely, were $1,625 at March 31, 2023. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Valuation Allowance </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company’s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> that these deferred tax assets will not be realized. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertain Tax Positions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Tax positions are evaluated utilizing a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> process. The Company first determines whether any of its tax positions are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; text-indent: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">In connection with the ETFS Acquisition, the Company accrued a liability for uncertain tax positions and interest and penalties at the acquisition date. The Company also recorded an offsetting indemnification asset provided by ETFS Capital as part of its agreement to indemnify the Company for any potential claims. The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unrecognized<br/> Tax Benefits</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest and<br/> Penalties</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at January 1, 2023</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        1,353</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        957</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        396</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease—Lapse of statute of limitations</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,353</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(957</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(396</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:2%;border-bottom:1px solid #000000; width:26%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:3%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The gross unrecognized tax benefits were accrued in British pounds. </div> </td> </tr> </table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Tax Examinations </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company is subject to U.S. federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions. As of March 31, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the years before 2018. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Undistributed Earnings of Foreign Subsidiaries </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">740-30</div> Income Taxes provides guidance that US companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $246 and $205 at March 31, 2023 and December 31, 2022, respectively. </div> 0.079 1383000 0.21 1353000 0.62 -16713000 0.21 19897000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Deferred Tax Assets </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A summary of the components of the Company’s deferred tax assets at March 31, 2023 and December 31, 2022 is as follows: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:1%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:73%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="13" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capital losses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        17,740     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        17,541     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,781     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,821     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NOLs—Foreign</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,625     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,609     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,527     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,030     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill and intangible assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,038     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">865     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,526     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest carryforwards</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">260     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">313     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation adjustment</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">173     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NOLs—U.S.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">127     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">255     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outside basis differences</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:98%;border:0"> <tr style="font-size: 0px;"> <td style="width:1%"/> <td style="vertical-align:bottom;width:2%"/> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td rowspan="17" style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">341     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,170     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,816     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liabilities:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets and prepaid assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">278     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unremitted earnings—European subsidiaries</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">246     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">205     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Right of use assets—operating leases</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">260     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">313     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">656     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred tax assets less deferred tax liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,514     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,020     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Valuation allowance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,643)    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,484)    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: -0.5em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets, net</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,871     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,536     </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 17740000 17541000 4781000 3821000 1625000 1609000 1527000 6030000 1038000 1085000 865000 1526000 476000 0 260000 313000 254000 173000 127000 255000 -122000 -122000 355000 341000 29170000 32816000 150000 278000 246000 205000 260000 313000 656000 796000 28514000 32020000 22643000 21484000 5871000 10536000 127000 2024 17740000 1625000 The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:90%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"/> <td style="vertical-align:bottom;width:7%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">    </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unrecognized<br/> Tax Benefits</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest and<br/> Penalties</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at January 1, 2023</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        1,353</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        957</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        396</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease—Lapse of statute of limitations</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,353</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(957</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(396</td> <td style="white-space:nowrap;vertical-align:bottom">)   </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div> </td> <td style="vertical-align:bottom">    </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:2%;border-bottom:1px solid #000000; width:26%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:3%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The gross unrecognized tax benefits were accrued in British pounds. </div> </td> </tr> </table> 1353000 957000 396000 1353000 957000 396000 0 0 0 246000 205000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">21. Shares Repurchased </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On February 22, 2022, the Company’s Board of Directors approved an increase of $85,709 to the Company’s share repurchase program to $100,000 and extended the term for three years through April 27, 2025. Included under the Company’s share repurchase program are purchases to offset future equity grants made under the Company’s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company’s books and records. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">During the three months ended March 31, 2023 and 2022, the Company repurchased 604,505 and 588,694 shares of its common stock, respectively, under this program for an aggregate cost of $3,384 and $3,394, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company’s books and records. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, $96,591,597 remained under this program for future purchases. </div> 85709000 100000000 P3Y 2025-04-27 604505 588694 3384000 3394000 96591597000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">22. Goodwill and Intangible Assets </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Goodwill </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below sets forth goodwill which is tested annually for impairment on November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at January 1, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">              85,856    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Changes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,856    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Goodwill arising from the ETFS Acquisition of $84,057 is not deductible for tax purposes as the acquisition was structured as a stock acquisition occurring in the U.K. The remainder of the goodwill is deductible for U.S. tax purposes. </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Intangible Assets </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td colspan="12" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Item</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFS acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        —    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software development</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,822 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(101)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,721 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">604,069 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(101)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">603,968 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td colspan="12" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Item</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFS acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        —    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software development</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,370 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,320 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">603,617 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">603,567 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">ETFS Acquisition (Indefinite-Lived) </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">In connection with the ETFS Acquisition, which was completed on April 11, 2018, the Company identified intangible assets valued at $601,247 related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Software Development (Finite-Lived) </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Internally-developed software is amortized over a useful life of three years. During the three-month period ended March 31, 2023, the Company recognized amortization expense on internally-developed software of $51. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:89%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remained of 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">656    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">940    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">891    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">234    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2028 and thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expected amortization expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      2,721    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The weighted-average remaining useful life of the finite-lived intangible assets is 2.9 years. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below sets forth goodwill which is tested annually for impairment on November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at January 1, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">              85,856    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Changes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,856    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 85856000 0 85856000 84057000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">th</div>: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td colspan="12" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Item</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFS acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        —    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software development</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,822 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(101)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,721 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">604,069 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(101)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">603,968 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td colspan="12" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Item</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Asset</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ETFS acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        —    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    601,247 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software development</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,370 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,320 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">603,617 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50)   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">603,567 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 601247000 0 601247000 2822000 101000 2721000 604069000 101000 603968000 601247000 0 601247000 2370000 50000 2320000 603617000 50000 603567000 2018-04-11 601247000 P3Y 51000 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:80%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:89%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remained of 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">656    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">940    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">891    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">234    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2028 and thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expected amortization expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      2,721    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 656000 940000 891000 234000 0 0 2721000 P2Y10M24D <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">23. Contingent Payments </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Sale of Canadian ETF Business </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">On February 19, 2020, the Company completed the sale of all the outstanding shares of <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">WisdomTree Asset Management Canada, Inc.</div> to CI Financial Corp. The Company received CDN $3,720 (USD $2,774) in cash at closing and was paid CDN $3,000 (USD $2,360) and CDN $2,000 (USD $1,477) of additional cash consideration based upon the achievement of certain AUM growth targets as determined on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">18-month</div> and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">36-month</div> anniversaries of the closing date, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">A gain of $1,477 was recognized during the three months ended March 31, 2023, from remeasuring the contingent payment to its realizable value. These gains were recorded in other losses, net. </div> 3720000 2774000 3000000 2360000 2000000 1477000 1477000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">24. Subsequent Events </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">The Company evaluated subsequent events through the date of issuance of the accompanying consolidated financial statements. <div style="letter-spacing: 0px; top: 0px;;display:inline;">There were no events requiring disclosure. </div><br/></div> Gains on revaluation of deferred consideration—gold payments result from a decrease in spot gold prices, a decrease in the forward-looking price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations. Losses on revaluation of deferred consideration—gold payments result from an increase in spot gold prices, an increase in the forward-looking price of gold, an increase in the perpetual growth rate and a decrease in the discount rate used to compute the present value of the annual payment obligations. Excludes 15,521 participating securities and 31 potentially dilutive non-participating common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands). EXCEL 125 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 127 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 128 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 339 445 1 true 111 0 false 12 false false R1.htm 1001 - Document - Cover Page Sheet http://www.wisdomtreeinvestmentsinc.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Balance Sheets Sheet http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Operations Sheet http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Comprehensive Income/(Loss) Sheet http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income/(Loss) Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 6 false false R7.htm 1007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 1008 - Disclosure - Organization and Description of Business Sheet http://www.wisdomtreeinvestmentsinc.com/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 8 false false R9.htm 1009 - Disclosure - Significant Accounting Policies Sheet http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 1010 - Disclosure - Cash and Cash Equivalents Sheet http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalents Cash and Cash Equivalents Notes 10 false false R11.htm 1011 - Disclosure - Fair Value Measurements Sheet http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 1012 - Disclosure - Financial instruments owned Sheet http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned Financial instruments owned Notes 12 false false R13.htm 1013 - Disclosure - Securities Held-to-Maturity Sheet http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturity Securities Held-to-Maturity Notes 13 false false R14.htm 1014 - Disclosure - Investments Sheet http://www.wisdomtreeinvestmentsinc.com/role/Investments Investments Notes 14 false false R15.htm 1015 - Disclosure - Fixed Assets, net Sheet http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet Fixed Assets, net Notes 15 false false R16.htm 1016 - Disclosure - Deferred Consideration Sheet http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsideration Deferred Consideration Notes 16 false false R17.htm 1017 - Disclosure - Convertible Notes Notes http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes Convertible Notes Notes 17 false false R18.htm 1018 - Disclosure - Series A Preferred Stock Sheet http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock Series A Preferred Stock Notes 18 false false R19.htm 1019 - Disclosure - Leases Sheet http://www.wisdomtreeinvestmentsinc.com/role/Leases Leases Notes 19 false false R20.htm 1020 - Disclosure - Contingencies Sheet http://www.wisdomtreeinvestmentsinc.com/role/Contingencies Contingencies Notes 20 false false R21.htm 1021 - Disclosure - Variable Interest Entities Sheet http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities Variable Interest Entities Notes 21 false false R22.htm 1022 - Disclosure - Revenues from Contracts with Customers Sheet http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomers Revenues from Contracts with Customers Notes 22 false false R23.htm 1023 - Disclosure - Related Party Transactions Sheet http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions Related Party Transactions Notes 23 false false R24.htm 1024 - Disclosure - Stock-Based Awards Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards Stock-Based Awards Notes 24 false false R25.htm 1025 - Disclosure - Stockholder Rights Plan Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan Stockholder Rights Plan Notes 25 false false R26.htm 1026 - Disclosure - Earnings/(Loss) Per Share Sheet http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShare Earnings/(Loss) Per Share Notes 26 false false R27.htm 1027 - Disclosure - Income Taxes Sheet http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes Income Taxes Notes 27 false false R28.htm 1028 - Disclosure - Shares Repurchased Sheet http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased Shares Repurchased Notes 28 false false R29.htm 1029 - Disclosure - Goodwill and Intangible Assets Sheet http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 29 false false R30.htm 1030 - Disclosure - Contingent Payments Sheet http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments Contingent Payments Notes 30 false false R31.htm 1031 - Disclosure - Subsequent Events Sheet http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents Subsequent Events Notes 31 false false R32.htm 1032 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies 32 false false R33.htm 1033 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies 33 false false R34.htm 1034 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements 34 false false R35.htm 1035 - Disclosure - Financial instruments owned (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables Financial instruments owned (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned 35 false false R36.htm 1036 - Disclosure - Securities Held-to-Maturity (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityTables Securities Held-to-Maturity (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturity 36 false false R37.htm 1037 - Disclosure - Investments (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables Investments (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/Investments 37 false false R38.htm 1038 - Disclosure - Fixed Assets, net (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables Fixed Assets, net (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet 38 false false R39.htm 1039 - Disclosure - Deferred Consideration (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationTables Deferred Consideration (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsideration 39 false false R40.htm 1040 - Disclosure - Convertible Notes (Tables) Notes http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables Convertible Notes (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes 40 false false R41.htm 1041 - Disclosure - Series A Preferred Stock (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables Series A Preferred Stock (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock 41 false false R42.htm 1042 - Disclosure - Leases (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables Leases (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/Leases 42 false false R43.htm 1043 - Disclosure - Variable Interest Entities (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables Variable Interest Entities (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities 43 false false R44.htm 1044 - Disclosure - Revenues from Contracts with Customers (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersTables Revenues from Contracts with Customers (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomers 44 false false R45.htm 1045 - Disclosure - Related Party Transactions (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions 45 false false R46.htm 1046 - Disclosure - Stock-Based Awards (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables Stock-Based Awards (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards 46 false false R47.htm 1047 - Disclosure - Earnings/(Loss) Per Share (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareTables Earnings/(Loss) Per Share (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShare 47 false false R48.htm 1048 - Disclosure - Income Taxes (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes 48 false false R49.htm 1049 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssets 49 false false R50.htm 1050 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Lives of Related Assets (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail Significant Accounting Policies - Schedule of Estimated Useful Lives of Related Assets (Detail) Details 50 false false R51.htm 1051 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 51 false false R52.htm 1052 - Disclosure - Cash and Cash Equivalents - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail Cash and Cash Equivalents - Additional Information (Detail) Details 52 false false R53.htm 1053 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 53 false false R54.htm 1054 - Disclosure - Fair Value Measurements - Summary of Categorization of Assets and Liabilities Measured at Fair Value (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail Fair Value Measurements - Summary of Categorization of Assets and Liabilities Measured at Fair Value (Detail) Details 54 false false R55.htm 1055 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Recurring Fair Value Measurements (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail Fair Value Measurements - Summary of Reconciliation of Recurring Fair Value Measurements (Detail) Details 55 false false R56.htm 1056 - Disclosure - Financial instruments owned - Debt Securities, Trading, and Equity Securities, FV-NI (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail Financial instruments owned - Debt Securities, Trading, and Equity Securities, FV-NI (Detail) Details 56 false false R57.htm 1057 - Disclosure - Financial instruments owned - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail Financial instruments owned - Additional Information (Detail) Details 57 false false R58.htm 1058 - Disclosure - Securities Held-to-Maturity - Schedule of Securities Held-to-Maturity (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail Securities Held-to-Maturity - Schedule of Securities Held-to-Maturity (Detail) Details 58 false false R59.htm 1059 - Disclosure - Securities Held-to-Maturity - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail Securities Held-to-Maturity - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity (Detail) Details 59 false false R60.htm 1060 - Disclosure - Securities Held-to-Maturity - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityAdditionalInformationDetail Securities Held-to-Maturity - Additional Information (Detail) Details 60 false false R61.htm 1061 - Disclosure - Securities Held-to-Maturity - Schedule of Maturity Profile of Securities Held-to-Maturity (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail Securities Held-to-Maturity - Schedule of Maturity Profile of Securities Held-to-Maturity (Detail) Details 61 false false R62.htm 1062 - Disclosure - Investments - Details of Investments Carried at Cost (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail Investments - Details of Investments Carried at Cost (Detail) Details 62 false false R63.htm 1063 - Disclosure - Investments - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail Investments - Additional Information (Detail) Details 63 false false R64.htm 1064 - Disclosure - Investments - Summary of Inputs Used in PWERM Approach of Investment (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail Investments - Summary of Inputs Used in PWERM Approach of Investment (Detail) Details 64 false false R65.htm 1065 - Disclosure - Fixed Assets, net - Schedule of Fixed Assets (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail Fixed Assets, net - Schedule of Fixed Assets (Detail) Details 65 false false R66.htm 1066 - Disclosure - Deferred Consideration - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail Deferred Consideration - Additional Information (Detail) Details 66 false false R67.htm 1067 - Disclosure - Deferred Consideration - Summary of valuation of deferred consideration (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail Deferred Consideration - Summary of valuation of deferred consideration (Detail) Details 67 false false R68.htm 1068 - Disclosure - Deferred Consideration - Schedule of Deferred Consideration (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail Deferred Consideration - Schedule of Deferred Consideration (Detail) Details 68 false false R69.htm 1069 - Disclosure - Convertible Notes - Additional Information (Detail) Notes http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail Convertible Notes - Additional Information (Detail) Details 69 false false R70.htm 1070 - Disclosure - Convertible Notes - Schedule of key terms of convertible notes (Detail) Notes http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail Convertible Notes - Schedule of key terms of convertible notes (Detail) Details 70 false false R71.htm 1071 - Disclosure - Convertible Notes - Summary of the carrying value of the convertible notes (Detail) Notes http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail Convertible Notes - Summary of the carrying value of the convertible notes (Detail) Details 71 false false R72.htm 1072 - Disclosure - Series A Preferred Stock - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail Series A Preferred Stock - Additional Information (Detail) Details 72 false false R73.htm 1073 - Disclosure - Series A Preferred Stock - Summary of Series A Preferred Stock Balance (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail Series A Preferred Stock - Summary of Series A Preferred Stock Balance (Detail) Details 73 false false R74.htm 1074 - Disclosure - Leases - Summary of additional information regarding Company's Leases (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail Leases - Summary of additional information regarding Company's Leases (Detail) Details 74 false false R75.htm 1075 - Disclosure - Leases - Summary of future minimum lease payments (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail Leases - Summary of future minimum lease payments (Detail) Details 75 false false R76.htm 1076 - Disclosure - Leases - Summary of Reconciles future minimum lease payments (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail Leases - Summary of Reconciles future minimum lease payments (Detail) Details 76 false false R77.htm 1077 - Disclosure - Contingencies - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail Contingencies - Additional Information (Detail) Details 77 false false R78.htm 1078 - Disclosure - Variable Interest Entities - Summary of Information about Variable Interests (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail Variable Interest Entities - Summary of Information about Variable Interests (Detail) Details 78 false false R79.htm 1079 - Disclosure - Revenues from Contracts with Customers - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail Revenues from Contracts with Customers - Additional Information (Detail) Details 79 false false R80.htm 1080 - Disclosure - Revenues from Contracts with Customers - Summary of Revenues from Contracts with Customers (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail Revenues from Contracts with Customers - Summary of Revenues from Contracts with Customers (Detail) Details 80 false false R81.htm 1081 - Disclosure - Revenues from Contracts with Customers - Summary of Geographic Distribution of Revenue (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail Revenues from Contracts with Customers - Summary of Geographic Distribution of Revenue (Detail) Details 81 false false R82.htm 1082 - Disclosure - Related Party Transactions - Summary of Accounts Receivable from Related Parties (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail Related Party Transactions - Summary of Accounts Receivable from Related Parties (Detail) Details 82 false false R83.htm 1083 - Disclosure - Related Party Transactions - Summary of Revenues from Advisory Services Provided to Related Parties (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail Related Party Transactions - Summary of Revenues from Advisory Services Provided to Related Parties (Detail) Details 83 false false R84.htm 1084 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 84 false false R85.htm 1085 - Disclosure - Stock-Based Awards - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail Stock-Based Awards - Additional Information (Detail) Details 85 false false R86.htm 1086 - Disclosure - Stock-Based Awards - Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail Stock-Based Awards - Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period (Detail) Details 86 false false R87.htm 1087 - Disclosure - Stock-Based Awards - Summary of Restricted Stock Activity (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail Stock-Based Awards - Summary of Restricted Stock Activity (Detail) Details 87 false false R88.htm 1088 - Disclosure - Stock-Based Awards - Summary of Restricted Stock Activity (Parenthetical) (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail Stock-Based Awards - Summary of Restricted Stock Activity (Parenthetical) (Detail) Details 88 false false R89.htm 1089 - Disclosure - Stockholder Rights Plan - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail Stockholder Rights Plan - Additional Information (Detail) Details 89 false false R90.htm 1090 - Disclosure - Earnings/(Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail Earnings/(Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail) Details 90 false false R91.htm 1091 - Disclosure - Earnings/(Loss) Per Share - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareAdditionalInformationDetail Earnings/(Loss) Per Share - Additional Information (Detail) Details 91 false false R92.htm 1092 - Disclosure - Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Detail) Details 92 false false R93.htm 1093 - Disclosure - Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Parenthetical) (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesParentheticalDetail Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Parenthetical) (Detail) Details 93 false false R94.htm 1094 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 94 false false R95.htm 1095 - Disclosure - Income Taxes - Summary of Deferred Tax Assets (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail Income Taxes - Summary of Deferred Tax Assets (Detail) Details 95 false false R96.htm 1096 - Disclosure - Income Taxes - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail Income Taxes - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits (Detail) Details 96 false false R97.htm 1097 - Disclosure - Shares Repurchased - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail Shares Repurchased - Additional Information (Detail) Details 97 false false R98.htm 1098 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill by Reporting Unit (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail Goodwill and Intangible Assets - Summary of Goodwill by Reporting Unit (Detail) Details 98 false false R99.htm 1099 - Disclosure - Goodwill and Intangible Assets - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail Goodwill and Intangible Assets - Additional Information (Detail) Details 99 false false R100.htm 1100 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail Goodwill and Intangible Assets - Summary of Intangible Assets (Detail) Details 100 false false R101.htm 1101 - Disclosure - Goodwill and Intangible Assets - Summary of Unamortized Finite-lived Intangible Assets (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail Goodwill and Intangible Assets - Summary of Unamortized Finite-lived Intangible Assets (Detail) Details 101 false false R102.htm 1102 - Disclosure - Contingent Payments - Additional Information (Detail) Sheet http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail Contingent Payments - Additional Information (Detail) Details 102 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept AccountsReceivableRelatedParties in us-gaap/2022 used in 10 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d452823d10q.htm 428, 6128, 6132, 6138, 6142, 6148, 6152, 6168, 6172 [dq-0542-Deprecated-Concept] Concept AccountingStandardsUpdate201601Member in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d452823d10q.htm 4555, 4592 [dq-0542-Deprecated-Concept] Concept RevenueFromRelatedParties in us-gaap/2022 used in 8 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d452823d10q.htm 6216, 6220, 6226, 6230, 6236, 6240, 6256, 6260 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 10 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityFilerCategory, wt:MeasurementPeriodForDeterminingSharePrice, wt:NumberOfSharesIssuedPerUnit, wt:NumberOfThresholdTradingDaysForDeterminingTheSharePrice - d452823d10q.htm 9, 285 d452823d10q.htm d452823dex101.htm d452823dex102.htm d452823dex103.htm d452823dex104.htm d452823dex311.htm d452823dex312.htm d452823dex321.htm wt-20230331.xsd wt-20230331_cal.xml wt-20230331_def.xml wt-20230331_lab.xml wt-20230331_pre.xml g452823g00v53.jpg g452823g0508223256518.jpg g452823sp036.jpg g452823sp037.jpg g452823sp038.jpg g452823sp038a.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 131 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d452823d10q.htm": { "axisCustom": 2, "axisStandard": 37, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 873, "http://xbrl.sec.gov/dei/2022": 33 }, "contextCount": 339, "dts": { "calculationLink": { "local": [ "wt-20230331_cal.xml" ] }, "definitionLink": { "local": [ "wt-20230331_def.xml" ] }, "inline": { "local": [ "d452823d10q.htm" ] }, "labelLink": { "local": [ "wt-20230331_lab.xml" ] }, "presentationLink": { "local": [ "wt-20230331_pre.xml" ] }, "schema": { "local": [ "wt-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 770, "entityCount": 1, "hidden": { "http://www.wisdomtreeinvestmentsinc.com/20230331": 9, "http://xbrl.sec.gov/dei/2022": 6, "total": 15 }, "keyCustom": 122, "keyStandard": 323, "memberCustom": 65, "memberStandard": 37, "nsprefix": "wt", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Cash and Cash Equivalents", "menuCat": "Notes", "order": "10", "role": "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalents", "shortName": "Cash and Cash Equivalents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1100 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets (Detail)", "menuCat": "Details", "order": "100", "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail", "shortName": "Goodwill and Intangible Assets - Summary of Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_SoftwareDevelopmentMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1101 - Disclosure - Goodwill and Intangible Assets - Summary of Unamortized Finite-lived Intangible Assets (Detail)", "menuCat": "Details", "order": "101", "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail", "shortName": "Goodwill and Intangible Assets - Summary of Unamortized Finite-lived Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_SoftwareDevelopmentMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "div", "wt:ContingentPaymentTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P02_19_2020To02_19_2020_WisdomtreeAssetManagementCanadaIncMemberusgaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "reportCount": 1, "unique": true, "unitRef": "Unit_CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1102 - Disclosure - Contingent Payments - Additional Information (Detail)", "menuCat": "Details", "order": "102", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "shortName": "Contingent Payments - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "wt:ContingentPaymentTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P02_19_2020To02_19_2020_WisdomtreeAssetManagementCanadaIncMemberusgaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromDivestitureOfBusinesses", "reportCount": 1, "unique": true, "unitRef": "Unit_CAD", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "11", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Financial instruments owned", "menuCat": "Notes", "order": "12", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned", "shortName": "Financial instruments owned", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:SecuritiesHeldToMaturityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Securities Held-to-Maturity", "menuCat": "Notes", "order": "13", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturity", "shortName": "Securities Held-to-Maturity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:SecuritiesHeldToMaturityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:InvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Investments", "menuCat": "Notes", "order": "14", "role": "http://www.wisdomtreeinvestmentsinc.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:InvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Fixed Assets, net", "menuCat": "Notes", "order": "15", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet", "shortName": "Fixed Assets, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DeferredConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Deferred Consideration", "menuCat": "Notes", "order": "16", "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsideration", "shortName": "Deferred Consideration", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DeferredConsiderationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ConvertibleNotesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Convertible Notes", "menuCat": "Notes", "order": "17", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes", "shortName": "Convertible Notes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ConvertibleNotesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Series A Preferred Stock", "menuCat": "Notes", "order": "18", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock", "shortName": "Series A Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Leases", "menuCat": "Notes", "order": "19", "role": "http://www.wisdomtreeinvestmentsinc.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Contingencies", "menuCat": "Notes", "order": "20", "role": "http://www.wisdomtreeinvestmentsinc.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Variable Interest Entities", "menuCat": "Notes", "order": "21", "role": "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities", "shortName": "Variable Interest Entities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Revenues from Contracts with Customers", "menuCat": "Notes", "order": "22", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomers", "shortName": "Revenues from Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "23", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Stock-Based Awards", "menuCat": "Notes", "order": "24", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards", "shortName": "Stock-Based Awards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DisclosureOfStockholderRightsPlanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Stockholder Rights Plan", "menuCat": "Notes", "order": "25", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan", "shortName": "Stockholder Rights Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DisclosureOfStockholderRightsPlanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Earnings/(Loss) Per Share", "menuCat": "Notes", "order": "26", "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShare", "shortName": "Earnings/(Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "27", "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Shares Repurchased", "menuCat": "Notes", "order": "28", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased", "shortName": "Shares Repurchased", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Goodwill and Intangible Assets", "menuCat": "Notes", "order": "29", "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ContingentPaymentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Contingent Payments", "menuCat": "Notes", "order": "30", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments", "shortName": "Contingent Payments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ContingentPaymentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "31", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "32", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:RegulatoryDepreciationAndAmortizationPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfEstimatedUsefulLivesOfRelatedAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RegulatoryDepreciationAndAmortizationPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfEstimatedUsefulLivesOfRelatedAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Financial instruments owned (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables", "shortName": "Financial instruments owned (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Securities Held-to-Maturity (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityTables", "shortName": "Securities Held-to-Maturity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "wt:InvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "wt:InvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Fixed Assets, net (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables", "shortName": "Fixed Assets, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Deferred Consideration (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationTables", "shortName": "Deferred Consideration (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenuesExcludingInterestAndDividends", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "wt:ConvertibleNotesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfKeyTermsOfConvertibleNotesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Convertible Notes (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables", "shortName": "Convertible Notes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "wt:ConvertibleNotesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfKeyTermsOfConvertibleNotesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Series A Preferred Stock (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables", "shortName": "Series A Preferred Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleForSummaryOfAdditionalInformationRelatedToOperatingLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "42", "role": "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleForSummaryOfAdditionalInformationRelatedToOperatingLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Variable Interest Entities (Tables)", "menuCat": "Tables", "order": "43", "role": "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables", "shortName": "Variable Interest Entities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Revenues from Contracts with Customers (Tables)", "menuCat": "Tables", "order": "44", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersTables", "shortName": "Revenues from Contracts with Customers (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Related Party Transactions (Tables)", "menuCat": "Tables", "order": "45", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables", "shortName": "Related Party Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Stock-Based Awards (Tables)", "menuCat": "Tables", "order": "46", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables", "shortName": "Stock-Based Awards (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Earnings/(Loss) Per Share (Tables)", "menuCat": "Tables", "order": "47", "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareTables", "shortName": "Earnings/(Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "48", "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:SummaryOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Goodwill and Intangible Assets (Tables)", "menuCat": "Tables", "order": "49", "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:SummaryOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Consolidated Statements of Comprehensive Income/(Loss)", "menuCat": "Statements", "order": "5", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "shortName": "Consolidated Statements of Comprehensive Income/(Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleOfEstimatedUsefulLivesOfRelatedAssetsTableTextBlock", "us-gaap:RegulatoryDepreciationAndAmortizationPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Lives of Related Assets (Detail)", "menuCat": "Details", "order": "50", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail", "shortName": "Significant Accounting Policies - Schedule of Estimated Useful Lives of Related Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleOfEstimatedUsefulLivesOfRelatedAssetsTableTextBlock", "us-gaap:RegulatoryDepreciationAndAmortizationPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMembersrtRangeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:CashAndCashEquivalentsCriteriaMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Significant Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "51", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:CashAndCashEquivalentsCriteriaMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Cash and Cash Equivalents - Additional Information (Detail)", "menuCat": "Details", "order": "52", "role": "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "shortName": "Cash and Cash Equivalents - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:CashEquivalentsMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Fair Value Measurements - Additional Information (Detail)", "menuCat": "Details", "order": "53", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail", "shortName": "Fair Value Measurements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:CashEquivalentsMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "wt:BusinessCombinationDeferredConsiderationLiability", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Fair Value Measurements - Summary of Categorization of Assets and Liabilities Measured at Fair Value (Detail)", "menuCat": "Details", "order": "54", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "shortName": "Fair Value Measurements - Summary of Categorization of Assets and Liabilities Measured at Fair Value (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Recurring Fair Value Measurements (Detail)", "menuCat": "Details", "order": "55", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail", "shortName": "Fair Value Measurements - Summary of Reconciliation of Recurring Fair Value Measurements (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinancialInstrumentsOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Financial instruments owned - Debt Securities, Trading, and Equity Securities, FV-NI (Detail)", "menuCat": "Details", "order": "56", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail", "shortName": "Financial instruments owned - Debt Securities, Trading, and Equity Securities, FV-NI (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock", "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_WetfTradingSecuritiesMemberusgaapFinancialInstrumentAxis", "decimals": "-3", "lang": null, "name": "us-gaap:FinancialInstrumentsOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_FinancialInstrumentsOwnedAtFairValueMemberusgaapFinancialInstrumentAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtAndEquitySecuritiesGainLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Financial instruments owned - Additional Information (Detail)", "menuCat": "Details", "order": "57", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail", "shortName": "Financial instruments owned - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "wt:DisclosureOfFinancialInstrumentsOwnedAtFairValue", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_FinancialInstrumentsOwnedAtFairValueMemberusgaapFinancialInstrumentAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtAndEquitySecuritiesGainLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Securities Held-to-Maturity - Schedule of Securities Held-to-Maturity (Detail)", "menuCat": "Details", "order": "58", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail", "shortName": "Securities Held-to-Maturity - Schedule of Securities Held-to-Maturity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:HeldToMaturitySecuritiesTextBlock", "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_FederalAgencyMemberusgaapFinancialInstrumentAxis", "decimals": "-3", "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Securities Held-to-Maturity - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity (Detail)", "menuCat": "Details", "order": "59", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail", "shortName": "Securities Held-to-Maturity - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "6", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Securities Held-to-Maturity - Additional Information (Detail)", "menuCat": "Details", "order": "60", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityAdditionalInformationDetail", "shortName": "Securities Held-to-Maturity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "wt:SecuritiesHeldToMaturityTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Securities Held-to-Maturity - Schedule of Maturity Profile of Securities Held-to-Maturity (Detail)", "menuCat": "Details", "order": "61", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail", "shortName": "Securities Held-to-Maturity - Schedule of Maturity Profile of Securities Held-to-Maturity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Investments - Details of Investments Carried at Cost (Detail)", "menuCat": "Details", "order": "62", "role": "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "shortName": "Investments - Details of Investments Carried at Cost (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "wt:InvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_OtherInvestmentscarryingValueMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Investments - Additional Information (Detail)", "menuCat": "Details", "order": "63", "role": "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "shortName": "Investments - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "2", "lang": null, "name": "wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "wt:InvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_SecurrencyIncMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "3", "first": true, "lang": null, "name": "wt:FairValueAssumptionConversionOfSharesUponAnEquityFinancing", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Investments - Summary of Inputs Used in PWERM Approach of Investment (Detail)", "menuCat": "Details", "order": "64", "role": "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail", "shortName": "Investments - Summary of Inputs Used in PWERM Approach of Investment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "wt:InvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_SecurrencyIncMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "3", "first": true, "lang": null, "name": "wt:FairValueAssumptionConversionOfSharesUponAnEquityFinancing", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Fixed Assets, net - Schedule of Fixed Assets (Detail)", "menuCat": "Details", "order": "65", "role": "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail", "shortName": "Fixed Assets, net - Schedule of Fixed Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "wt:BusinessCombinationDeferredConsiderationLiability", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Deferred Consideration - Additional Information (Detail)", "menuCat": "Details", "order": "66", "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail", "shortName": "Deferred Consideration - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_ThroughMarchThirtyFirstTwoThousandFiftyEightMembersrtStatementScenarioAxis", "decimals": "INF", "lang": null, "name": "wt:OuncesOfGold1", "reportCount": 1, "unique": true, "unitRef": "Unit_oz", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - Deferred Consideration - Summary of valuation of deferred consideration (Detail)", "menuCat": "Details", "order": "67", "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail", "shortName": "Deferred Consideration - Summary of valuation of deferred consideration (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "wt:ContractualGoldPayments", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Deferred Consideration - Schedule of Deferred Consideration (Detail)", "menuCat": "Details", "order": "68", "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail", "shortName": "Deferred Consideration - Schedule of Deferred Consideration (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleOfDeferredConsiderationTableTextBlock", "wt:DeferredConsiderationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "wt:ContractualGoldPaymentsGoldOuncesPaid", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Convertible Notes - Additional Information (Detail)", "menuCat": "Details", "order": "69", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "shortName": "Convertible Notes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_AccountsPayableAndAccruedLiabilitiesMemberusgaapBalanceSheetLocationAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InterestPayableCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "wt:AdvisoryFeesReceivedInGold", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Convertible Notes - Schedule of key terms of convertible notes (Detail)", "menuCat": "Details", "order": "70", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "shortName": "Convertible Notes - Schedule of key terms of convertible notes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleOfKeyTermsOfConvertibleNotesTableTextBlock", "wt:ConvertibleNotesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2021To12_31_2021_TwothousandandtwentyonenotesMemberusgaapDebtInstrumentAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Convertible Notes - Summary of the carrying value of the convertible notes (Detail)", "menuCat": "Details", "order": "71", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail", "shortName": "Convertible Notes - Summary of the carrying value of the convertible notes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedPremium", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn04_11_2018", "decimals": "-3", "first": true, "lang": null, "name": "wt:FairValueOfPreferredStockConsideration", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1072 - Disclosure - Series A Preferred Stock - Additional Information (Detail)", "menuCat": "Details", "order": "72", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "shortName": "Series A Preferred Stock - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn04_11_2018", "decimals": "-3", "first": true, "lang": null, "name": "wt:FairValueOfPreferredStockConsideration", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1073 - Disclosure - Series A Preferred Stock - Summary of Series A Preferred Stock Balance (Detail)", "menuCat": "Details", "order": "73", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail", "shortName": "Series A Preferred Stock - Summary of Series A Preferred Stock Balance (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis", "decimals": "-3", "lang": null, "name": "wt:TemporaryEquityIssuedValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleForSummaryOfAdditionalInformationRelatedToOperatingLeaseTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1074 - Disclosure - Leases - Summary of additional information regarding Company's Leases (Detail)", "menuCat": "Details", "order": "74", "role": "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail", "shortName": "Leases - Summary of additional information regarding Company's Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleForSummaryOfAdditionalInformationRelatedToOperatingLeaseTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1075 - Disclosure - Leases - Summary of future minimum lease payments (Detail)", "menuCat": "Details", "order": "75", "role": "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail", "shortName": "Leases - Summary of future minimum lease payments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1076 - Disclosure - Leases - Summary of Reconciles future minimum lease payments (Detail)", "menuCat": "Details", "order": "76", "role": "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail", "shortName": "Leases - Summary of Reconciles future minimum lease payments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "div", "us-gaap:LossContingencyDisclosures", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_CourtofturinandcourtofmilanMemberWTPlaceOfAppearanceOfLitigationAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1077 - Disclosure - Contingencies - Additional Information (Detail)", "menuCat": "Details", "order": "77", "role": "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail", "shortName": "Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:LossContingencyDisclosures", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_CourtofturinandcourtofmilanMemberWTPlaceOfAppearanceOfLitigationAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_EUR", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1078 - Disclosure - Variable Interest Entities - Summary of Information about Variable Interests (Detail)", "menuCat": "Details", "order": "78", "role": "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail", "shortName": "Variable Interest Entities - Summary of Information about Variable Interests (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_OtherInvestmentsMemberusgaapFairValueByAssetClassAxis", "decimals": "-3", "lang": null, "name": "wt:VariableInterestEntityNonConsolidatedCarryingAmountPreferredStock", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "us-gaap:ContractWithCustomerLiability", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_AdvisoryFeesMembersrtProductOrServiceAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1079 - Disclosure - Revenues from Contracts with Customers - Additional Information (Detail)", "menuCat": "Details", "order": "79", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail", "shortName": "Revenues from Contracts with Customers - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:ContractWithCustomerLiability", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_AdvisoryFeesMembersrtProductOrServiceAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Organization and Description of Business", "menuCat": "Notes", "order": "8", "role": "http://www.wisdomtreeinvestmentsinc.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenuesExcludingInterestAndDividends", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1080 - Disclosure - Revenues from Contracts with Customers - Summary of Revenues from Contracts with Customers (Detail)", "menuCat": "Details", "order": "80", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail", "shortName": "Revenues from Contracts with Customers - Summary of Revenues from Contracts with Customers (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenuesExcludingInterestAndDividends", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1081 - Disclosure - Revenues from Contracts with Customers - Summary of Geographic Distribution of Revenue (Detail)", "menuCat": "Details", "order": "81", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail", "shortName": "Revenues from Contracts with Customers - Summary of Geographic Distribution of Revenue (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_USsrtStatementGeographicalAxis", "decimals": "-3", "lang": null, "name": "us-gaap:RevenuesExcludingInterestAndDividends", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableRelatedParties", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1082 - Disclosure - Related Party Transactions - Summary of Accounts Receivable from Related Parties (Detail)", "menuCat": "Details", "order": "82", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "shortName": "Related Party Transactions - Summary of Accounts Receivable from Related Parties (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_WisdomTreeTrustMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_AdvisoryServicesMemberusgaapRelatedPartyTransactionAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1083 - Disclosure - Related Party Transactions - Summary of Revenues from Advisory Services Provided to Related Parties (Detail)", "menuCat": "Details", "order": "83", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail", "shortName": "Related Party Transactions - Summary of Revenues from Advisory Services Provided to Related Parties (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_AdvisoryServicesMemberusgaapRelatedPartyTransactionAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1084 - Disclosure - Related Party Transactions - Additional Information (Detail)", "menuCat": "Details", "order": "84", "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:StockOptionIssuancePeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1085 - Disclosure - Stock-Based Awards - Additional Information (Detail)", "menuCat": "Details", "order": "85", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "shortName": "Stock-Based Awards - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "wt:StockOptionIssuancePeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_EmployeesAndDirectorsMembersrtTitleOfIndividualAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1086 - Disclosure - Stock-Based Awards - Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period (Detail)", "menuCat": "Details", "order": "86", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail", "shortName": "Stock-Based Awards - Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023_EmployeesAndDirectorsMembersrtTitleOfIndividualAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1087 - Disclosure - Stock-Based Awards - Summary of Restricted Stock Activity (Detail)", "menuCat": "Details", "order": "87", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail", "shortName": "Stock-Based Awards - Summary of Restricted Stock Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_PerformanceBasedRestrictedStockUnitMemberusgaapAwardTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1088 - Disclosure - Stock-Based Awards - Summary of Restricted Stock Activity (Parenthetical) (Detail)", "menuCat": "Details", "order": "88", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail", "shortName": "Stock-Based Awards - Summary of Restricted Stock Activity (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_PerformanceBasedRestrictedStockUnitMemberusgaapAwardTypeAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "div", "wt:DisclosureOfStockholderRightsPlanTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P03_17_2023To03_17_2023", "decimals": "-3", "first": true, "lang": null, "name": "wt:NumberOfPreferredStockPurchaseRightIssuedForOutstandingStock", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1089 - Disclosure - Stockholder Rights Plan - Additional Information (Detail)", "menuCat": "Details", "order": "89", "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail", "shortName": "Stockholder Rights Plan - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "wt:DisclosureOfStockholderRightsPlanTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P03_17_2023To03_17_2023", "decimals": "-3", "first": true, "lang": null, "name": "wt:NumberOfPreferredStockPurchaseRightIssuedForOutstandingStock", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1090 - Disclosure - Earnings/(Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail)", "menuCat": "Details", "order": "90", "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail", "shortName": "Earnings/(Loss) Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "wt:IncomeDistributedToParticipatingSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1091 - Disclosure - Earnings/(Loss) Per Share - Additional Information (Detail)", "menuCat": "Details", "order": "91", "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareAdditionalInformationDetail", "shortName": "Earnings/(Loss) Per Share - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1092 - Disclosure - Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Detail)", "menuCat": "Details", "order": "92", "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail", "shortName": "Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "wt:WeightedAverageDilutedSharesExcludingParticipatingSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1093 - Disclosure - Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Parenthetical) (Detail)", "menuCat": "Details", "order": "93", "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesParentheticalDetail", "shortName": "Earnings/(Loss) Per Share - Schedule of Weighted Average Number of Shares (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "wt:WeightedAverageDilutedSharesExcludingParticipatingSecurities", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1094 - Disclosure - Income Taxes - Additional Information (Detail)", "menuCat": "Details", "order": "94", "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsCapitalLossCarryforwards", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1095 - Disclosure - Income Taxes - Summary of Deferred Tax Assets (Detail)", "menuCat": "Details", "order": "95", "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail", "shortName": "Income Taxes - Summary of Deferred Tax Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "lang": null, "name": "wt:DeferredTaxAssetUnrealizedLosses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "wt:UnrecognizedTaxBenefitsAndInterestAndPenalties", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1096 - Disclosure - Income Taxes - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits (Detail)", "menuCat": "Details", "order": "96", "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail", "shortName": "Income Taxes - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1097 - Disclosure - Shares Repurchased - Additional Information (Detail)", "menuCat": "Details", "order": "97", "role": "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail", "shortName": "Shares Repurchased - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:TreasuryStockTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn02_22_2022_MaximumMembersrtRangeAxis", "decimals": "-3", "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1098 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill by Reporting Unit (Detail)", "menuCat": "Details", "order": "98", "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail", "shortName": "Goodwill and Intangible Assets - Summary of Goodwill by Reporting Unit (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "wt:SummaryOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn12_31_2022_ReportableSubsegmentsMemberusgaapSubsegmentsConsolidationItemsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1099 - Disclosure - Goodwill and Intangible Assets - Additional Information (Detail)", "menuCat": "Details", "order": "99", "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "shortName": "Goodwill and Intangible Assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d452823d10q.htm", "contextRef": "P01_01_2023To03_31_2023_SoftwareDevelopmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 111, "tag": { "country_IE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IRELAND" } } }, "localname": "IE", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail" ], "xbrltype": "domainItemType" }, "country_JE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JERSEY" } } }, "localname": "JE", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r788" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "trueItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r787" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r271", "r558", "r559", "r560", "r561", "r634", "r745", "r855", "r858", "r859" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r271", "r558", "r559", "r560", "r561", "r634", "r745", "r855", "r858", "r859" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r269", "r270", "r437", "r456", "r751", "r753" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r415", "r417", "r418", "r419", "r485", "r668", "r701", "r746", "r747", "r768", "r776", "r783", "r860", "r905", "r906", "r907", "r908", "r909", "r910" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r415", "r417", "r418", "r419", "r485", "r668", "r701", "r746", "r747", "r768", "r776", "r783", "r860", "r905", "r906", "r907", "r908", "r909", "r910" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r349", "r669", "r769", "r781", "r853", "r854", "r863", "r913" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r349", "r669", "r769", "r781", "r853", "r854", "r863", "r913" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r415", "r417", "r418", "r419", "r477", "r485", "r512", "r513", "r514", "r644", "r668", "r701", "r746", "r747", "r768", "r776", "r783", "r852", "r860", "r906", "r907", "r908", "r909", "r910" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r415", "r417", "r418", "r419", "r477", "r485", "r512", "r513", "r514", "r644", "r668", "r701", "r746", "r747", "r768", "r776", "r783", "r852", "r860", "r906", "r907", "r908", "r909", "r910" ], "lang": { "en-us": { "role": { "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r269", "r270", "r437", "r456", "r752", "r753" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r272", "r273", "r274", "r285", "r286", "r311", "r571", "r572", "r820", "r821", "r822", "r823", "r824", "r826", "r827" ], "lang": { "en-us": { "role": { "label": "Restatement Adjustment [Member]", "terseLabel": "As Adjusted [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r228", "r272", "r273", "r274", "r276", "r277", "r280", "r281", "r282", "r283", "r285", "r286", "r287", "r288", "r289", "r290", "r311", "r375", "r376", "r543", "r567", "r571", "r572", "r573", "r609", "r626", "r627", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "label": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r228", "r272", "r273", "r274", "r276", "r277", "r280", "r281", "r282", "r283", "r285", "r286", "r287", "r288", "r289", "r290", "r311", "r375", "r376", "r543", "r567", "r571", "r572", "r573", "r609", "r626", "r627", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "label": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r290", "r486", "r796", "r825" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r350", "r351", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r770", "r782", "r863" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r350", "r351", "r731", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r770", "r782", "r863" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r290", "r486", "r796", "r797", "r825" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r830", "r901" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r746", "r747", "r905", "r907", "r910" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201601Member": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-01 Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.", "label": "Accounting Standards Update 2016-01 [Member]" } } }, "localname": "AccountingStandardsUpdate201601Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable and Other Accrued Liabilities, Current", "verboseLabel": "Accounts payable and other liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r1", "r17" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "verboseLabel": "Fund management and administration payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r353", "r354" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "verboseLabel": "Accounts receivable (including $32,446 and $24,139 due from related parties at March 31, 2023 and December 31, 2022, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r177", "r179", "r206", "r244", "r816" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Accounts Receivable, Related Parties", "terseLabel": "Accounts receivable from related parties" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r95", "r236" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r29", "r30", "r31", "r245", "r697", "r709", "r713" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 34.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r28", "r31", "r145", "r627", "r704", "r705", "r806", "r807", "r808", "r817", "r818", "r819" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income/(Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r12" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 33.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r520", "r521", "r522", "r817", "r818", "r819", "r895" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r225", "r226", "r227", "r228", "r229", "r276", "r277", "r278", "r279", "r290", "r355", "r356", "r371", "r372", "r373", "r374", "r375", "r376", "r520", "r521", "r522", "r540", "r541", "r542", "r543", "r555", "r556", "r557", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r602", "r603", "r606", "r607", "r608", "r609", "r622", "r623", "r624", "r625", "r626", "r627", "r671", "r672", "r673", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income/(loss) to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs, Policy [Policy Text Block]", "terseLabel": "Marketing and Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllOtherCorporateBondsMember": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Investments in corporate fixed maturity debt securities classified as other.", "label": "All Other Corporate Bonds [Member]", "terseLabel": "Corporate Bonds [Member]" } } }, "localname": "AllOtherCorporateBondsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive non-participating common stock equivalents excluded from the calculation of diluted earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r52", "r92" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 19.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "disclosureGuidance": "Impairments", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "negatedTerseLabel": "Impairments (Note 7)" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r182", "r202", "r240", "r266", "r330", "r341", "r347", "r370", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r433", "r558", "r560", "r584", "r780", "r856", "r857", "r903" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r232", "r248", "r266", "r370", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r433", "r558", "r560", "r584", "r780", "r856", "r857", "r903" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "verboseLabel": "Total" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r154", "r155" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r554", "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r138", "r139", "r554", "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "auth_ref": [ "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.", "label": "Business Acquisition, Effective Date of Acquisition", "terseLabel": "Acquisition completion date" } } }, "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "definitionGuidance": "Shares issued in business acquisition", "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business acquisition, number of shares to be issued" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "WisdomTree stock price", "verboseLabel": "Acquisition price per share" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r58", "r66" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Organization and Description of Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDevelopment": { "auth_ref": [ "r35" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.", "label": "Business Development", "terseLabel": "Sales and business development" } } }, "localname": "BusinessDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Costs incurred to obtain or fulfill contracts with customers" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r54", "r234", "r749" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents (Note 3)" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash and Cash Equivalents Disclosure [Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r49", "r54", "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents\u2014end of period", "periodStartLabel": "Cash and cash equivalents\u2014beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r49", "r172" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r800" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "verboseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r241", "r242", "r243", "r266", "r294", "r295", "r303", "r307", "r314", "r315", "r370", "r423", "r426", "r427", "r428", "r432", "r433", "r454", "r455", "r457", "r458", "r461", "r584", "r748", "r795", "r812", "r828" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r189", "r208" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "Contingencies (Note 13)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r98", "r732" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Cash dividends declared per common share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r817", "r818", "r895" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value", "verboseLabel": "Common stock, par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11", "r780" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 32.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 149,291 and 146,517 at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommunicationsInformationTechnologyAndOccupancy": { "auth_ref": [ "r41", "r192" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of communications, data processing and occupancy expenses.", "label": "Communications, Information Technology and Occupancy", "terseLabel": "Occupancy, communications and equipment" } } }, "localname": "CommunicationsInformationTechnologyAndOccupancy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-Based Awards" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r32", "r252", "r254", "r259", "r689", "r698" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income/(loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r143", "r754" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r463", "r465", "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r463", "r464", "r474" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r3" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt, Current", "terseLabel": "Convertible notes\u2014current (Note 10)" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Summary of the carrying value of the convertible notes" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r9", "r10", "r110", "r113", "r459" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Common stock equivalents" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtAndEquitySecuritiesGainLoss": { "auth_ref": [ "r36", "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities.", "label": "Debt and Equity Securities, Gain (Loss)", "terseLabel": "Debt and Equity Securities, Gain (Loss)" } } }, "localname": "DebtAndEquitySecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r3", "r4", "r5", "r183", "r185", "r200", "r271", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r605", "r763", "r764", "r765", "r766", "r767", "r813" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r5", "r185", "r200", "r451" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Carrying amount", "totalLabel": "Gross proceeds" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r101", "r436" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Convertible debt instrument conversion price", "verboseLabel": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "auth_ref": [ "r24", "r110", "r115", "r116" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for debt instrument.", "label": "Debt Instrument, Convertible, Terms of Conversion Feature", "verboseLabel": "Convertible debt instrument terms of conversion" } } }, "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Redemption provisions - Convertible notes, threshold consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Redemption provisions - Convertible notes, threshold trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity": { "auth_ref": [ "r24", "r110", "r114", "r116" ], "lang": { "en-us": { "role": { "documentation": "Description of the type of equity security or securities into which conversion will be made (for example, common stock or preferred shares).", "label": "Debt Instrument, Convertible, Type of Equity Security", "terseLabel": "Redemption provisions - Convertible notes" } } }, "localname": "DebtInstrumentConvertibleTypeOfEquitySecurity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r174", "r176", "r434", "r605", "r764", "r765" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Principal outstanding", "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible senior notes face value", "verboseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r22", "r174", "r453", "r605" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Effective interest rate", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r22", "r435" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r249", "r763", "r896" ], "lang": { "en-us": { "role": { "definitionGuidance": "Debt Instrument Maturity Date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "verboseLabel": "Maturity date (unless earlier converted, repurchased or redeemed)" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r25", "r271", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r605", "r763", "r764", "r765", "r766", "r767", "r813" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [ "r23", "r196" ], "lang": { "en-us": { "role": { "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.", "label": "Debt Instrument, Payment Terms", "terseLabel": "Convertible debt instrument terms of interest payment" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption provisions - Convertible notes redemption price as a percentage of principal amount accrued interest and unpaid interest" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r25", "r110", "r115", "r116", "r117", "r173", "r174", "r176", "r198", "r271", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r605", "r763", "r764", "r765", "r766", "r767", "r813" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r173", "r176", "r861" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Less: Unamortized issuance costs" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedPremium": { "auth_ref": [ "r173", "r176", "r861" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt premium.", "label": "Debt Instrument, Unamortized Premium", "terseLabel": "Plus: Premium" } } }, "localname": "DebtInstrumentUnamortizedPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]" } } }, "localname": "DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r526", "r527" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "verboseLabel": "Deferred tax assets, net (Note 20)" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r52", "r134", "r539", "r546", "r547", "r815" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r6", "r7", "r184", "r199", "r535" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 16.0, "parentTag": "wt_DeferredTaxAssetsLiabilitiesGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "totalLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetDomain": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.", "label": "Deferred Tax Asset [Domain]" } } }, "localname": "DeferredTaxAssetDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 13.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest carryforwards" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.", "label": "Capital losses", "terseLabel": "Tax effected capital loss", "verboseLabel": "Capital losses" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Goodwill and intangible assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r536" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 3.0, "parentTag": "wt_DeferredTaxAssetsLiabilitiesGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r893" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic", "verboseLabel": "NOLs\u2014U.S." } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign", "verboseLabel": "NOLs\u2014Foreign" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": { "auth_ref": [ "r132", "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 15.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.", "label": "Deferred Tax Assets, Unrealized Currency Losses", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r537" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r894" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 19.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "terseLabel": "Unremitted earnings\u2014European subsidiaries", "verboseLabel": "Deferred tax liabilities undistributed earnings of foreign subsidaries" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r52", "r93" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r489", "r516", "r517", "r519", "r523", "r777" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]", "terseLabel": "Stock-Based Awards" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "verboseLabel": "Additional consideration payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "auth_ref": [ "r407", "r811", "r851" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "terseLabel": "Recognized gain loss on sale of business" } } }, "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r118", "r195" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends", "negatedLabel": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]", "verboseLabel": "Basic (Loss)/Earnings per Share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r260", "r280", "r281", "r283", "r284", "r285", "r291", "r294", "r303", "r306", "r307", "r311", "r572", "r573", "r690", "r699", "r758" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic earnings/(loss) per share", "verboseLabel": "Earnings/(loss) per share\u2014basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r260", "r280", "r281", "r283", "r284", "r285", "r294", "r303", "r306", "r307", "r311", "r572", "r573", "r690", "r699", "r758" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted earnings/(loss) per share", "verboseLabel": "Earnings/(loss) per share\u2014diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r60", "r62" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r308", "r309", "r310", "r312" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings/(Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r593" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "verboseLabel": "Increase/(decrease) in cash flow due to changes in foreign exchange rate" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Estimated effective rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r267", "r529", "r548" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Federal statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Compensation and benefits payable" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r518" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized Stock-Based Compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted Average Remaining Vesting Period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r109", "r227", "r255", "r256", "r257", "r272", "r273", "r274", "r277", "r286", "r289", "r313", "r374", "r462", "r520", "r521", "r522", "r542", "r543", "r571", "r594", "r595", "r596", "r597", "r598", "r599", "r627", "r704", "r705", "r706" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of equity interests that are issued or issuable in a business combination.", "label": "Equity Interest Type [Axis]" } } }, "localname": "EquityInterestIssuedOrIssuableByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.", "label": "Equity Interest Issued or Issuable, Type [Domain]" } } }, "localname": "EquityInterestIssuedOrIssuableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r231", "r266", "r370", "r584" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r231", "r266", "r370", "r584" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": { "auth_ref": [ "r799", "r814", "r844", "r898" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r77", "r331", "r801" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r76", "r201", "r784", "r785", "r786" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ExchangeTradedFundsMember": { "auth_ref": [ "r865", "r897" ], "lang": { "en-us": { "role": { "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange.", "label": "Exchange Traded Funds [Member]", "terseLabel": "ETFs [Member]" } } }, "localname": "ExchangeTradedFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r575", "r576", "r582" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r159", "r160", "r161", "r166", "r167" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "verboseLabel": "Summary of Categorization of Assets and Liabilities Measured at Fair Value" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "definitionGuidance": "Summary of Inputs Used in PWERM Approach of Investment", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r159", "r167" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r442", "r478", "r479", "r480", "r481", "r482", "r483", "r576", "r641", "r642", "r643", "r764", "r765", "r771", "r772", "r773" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value, Hierarchy [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r165", "r167" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r575", "r576", "r578", "r579", "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r442", "r478", "r483", "r576", "r641", "r771", "r772", "r773" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r442", "r478", "r483", "r576", "r642", "r764", "r765", "r771", "r772", "r773" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]", "verboseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r442", "r478", "r479", "r480", "r481", "r482", "r483", "r576", "r643", "r764", "r765", "r771", "r772", "r773" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Deferred consideration (Note XX)" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r163", "r167" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r163", "r167" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "verboseLabel": "Summary of Reconciliation of Recurring Fair Value Measurements" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.", "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementInputsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r164" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "terseLabel": "Purchases" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r164" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedLabel": "Settlements" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r442", "r478", "r479", "r480", "r481", "r482", "r483", "r641", "r642", "r643", "r764", "r765", "r771", "r772", "r773" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r575", "r576", "r578", "r579", "r580", "r583" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Measurements, Nonrecurring [Member]" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r581", "r583" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Measurements, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r168", "r170" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r362", "r366", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r450", "r460", "r562", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r761", "r840", "r841", "r842", "r914", "r915", "r916", "r917", "r918", "r919", "r920" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsOwnedAtFairValue": { "auth_ref": [ "r181" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.", "label": "Financial Instruments, Owned, at Fair Value", "presentationGuidance": "Financial instruments owned, at fair value (including $45,214 and $25,283 invested in WisdomTree products at March 31, 2023 and December 31, 2022, respectively) (Note 5)", "terseLabel": "Financial Instruments, Owned, at Fair Value" } } }, "localname": "FinancialInstrumentsOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract]", "terseLabel": "Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract]" } } }, "localname": "FinancialInstrumentsOwnedAtFairValueByTypeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "verboseLabel": "Finite lived intangible assets useful lives" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r238", "r404" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r86" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Remained of 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r86" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r86" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r86" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r401", "r403", "r404", "r406", "r670", "r674" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r80", "r84" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r85", "r670" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total expected amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r670" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Finite lived intangible assets remaining useful lives" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FixedIncomeInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments that regularly generate a fixed amount of interest income. Examples include, but are not limited to, bonds, certificates of deposit, notes and debt securities.", "label": "Fixed Income Investments [Member]" } } }, "localname": "FixedIncomeInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r43", "r71", "r793" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "verboseLabel": "Net gains (losses) related to certain WisdomTree ETFs" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r52", "r102", "r103" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 20.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Loss on extinguishment of convertible notes (Note 10)", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "terseLabel": "Loss on extinguishment of debt (Note 11)" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r237", "r388", "r687", "r762", "r780", "r848", "r849" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill", "verboseLabel": "Goodwill (Note 22)" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r399", "r400", "r762" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r850" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Period Increase (Decrease)", "terseLabel": "Changes" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "auth_ref": [ "r74", "r364" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain", "terseLabel": "Held-to-maturity gross unrealized gains" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "auth_ref": [ "r75", "r365" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss", "negatedLabel": "Held-to-maturity gross unrealized losses" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before other-than-temporary impairment (OTTI) accretion, of investment in debt securities measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Amortized Cost, before Other-than-temporary Impairment", "terseLabel": "Debt instruments: Pass-through GSEs (amortized cost)", "totalLabel": "Held-to-maturity cost or amortized cost" } } }, "localname": "HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount": { "auth_ref": [ "r360", "r694" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost", "terseLabel": "Held-to-maturity due five years through ten years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": { "auth_ref": [ "r359", "r693" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost", "terseLabel": "Held-to-maturity due one year through five years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount": { "auth_ref": [ "r361", "r695" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, after 10 Years, Amortized Cost", "terseLabel": "Held-to-maturity due over ten years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": { "auth_ref": [ "r358", "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost", "terseLabel": "Held-to-maturity due within one year" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfMaturityProfileOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "auth_ref": [ "r73", "r363", "r688" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Fair Value", "terseLabel": "Held-to-maturity fair value" } } }, "localname": "HeldToMaturitySecuritiesFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfUnrealizedLossesGainsAndFairValueOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesNoncurrent": { "auth_ref": [ "r70", "r835", "r847" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.", "label": "Debt Securities, Held-to-maturity, Noncurrent", "verboseLabel": "Securities held-to-maturity" } } }, "localname": "HeldToMaturitySecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesTextBlock": { "auth_ref": [ "r836", "r837", "r838" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table Text Block]", "terseLabel": "Schedule of Securities Held-to-Maturity" } } }, "localname": "HeldToMaturitySecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOfInvestments": { "auth_ref": [ "r357" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.", "label": "Other than Temporary Impairment Losses, Investments", "terseLabel": "Impairment Of Investments" } } }, "localname": "ImpairmentOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r33", "r180", "r190", "r213", "r330", "r340", "r346", "r348", "r691", "r760" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income/(loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r408", "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r126", "r127", "r128", "r133" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r267", "r530", "r534", "r538", "r544", "r549", "r551", "r552", "r553" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r268", "r288", "r289", "r328", "r528", "r545", "r550", "r700" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Income tax expense/(benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "verboseLabel": "Income tax expense/(benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r187", "r211", "r805" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": { "auth_ref": [ "r810" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.", "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities", "terseLabel": "Accounts payable and other liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r51" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r51" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Compensation and benefits payable" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "auth_ref": [ "r810" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.", "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable", "terseLabel": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r51" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r51" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r402", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r87" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Intangible asset related to its customary advisory agreement", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "verboseLabel": "Intangible assets, net (Note 22)" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r81", "r87" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r237" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Gross Asset" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r79", "r83" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "totalLabel": "Net Asset" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r175", "r193", "r258", "r324", "r604" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r261", "r263", "r264" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "verboseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r188", "r210" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Interest payable" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Investment advisory, asset management and administrative service. Includes, but is not limited to, distribution and shareholder service; and accounting, tax, legal, regulatory filing, share registration and shareholder correspondence activities.", "label": "Investment Advisory, Management and Administrative Service [Member]", "terseLabel": "Advisory Fees [Member]", "verboseLabel": "Advisory Fees [Member]" } } }, "localname": "InvestmentAdvisoryManagementAndAdministrativeServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r42", "r323" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r216", "r720", "r726" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned, at Fair Value", "terseLabel": "Investment owned, at fair value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r369", "r912" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r839", "r843", "r845", "r846" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r714", "r715", "r716", "r717", "r718", "r719", "r721", "r722", "r723", "r724", "r725", "r727", "r728", "r729", "r730" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r714", "r715", "r716", "r717", "r718", "r719", "r721", "r722", "r723", "r724", "r725", "r727", "r728", "r729", "r730" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Investments": { "auth_ref": [ "r209" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments, Carried at Cost", "terseLabel": "Investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Schedule of Maturity Profile of Securities Held-to-Maturity" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Investments, Fair value disclosure", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Fair Value Disclosure [Abstract]", "terseLabel": "Investments in Convertible Notes" } } }, "localname": "InvestmentsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r802" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Investments", "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Cost of Investments", "verboseLabel": "Investments (Note 7)" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r809" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Labor and Related Expense", "terseLabel": "Compensation and benefits" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r619", "r779" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "verboseLabel": "Lease cost:" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee Disclosure [Abstract]" } } }, "localname": "LesseeDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r613" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "verboseLabel": "Schedule of Future Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total future minimum lease payments (undiscounted)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "verboseLabel": "2028 and thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r900" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "Remainder of 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r620" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Difference between undiscounted and discounted cash flows" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r899" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "verboseLabel": "Short-term lease exception - Lease term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r266", "r370", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r433", "r559", "r560", "r561", "r584", "r759", "r856", "r903", "r904" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r16", "r186", "r205", "r780", "r814", "r844", "r898" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and stockholders' equity", "verboseLabel": "Liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r233", "r266", "r370", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r433", "r559", "r560", "r561", "r584", "r780", "r856", "r903", "r904" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "verboseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r5", "r185", "r203", "r441", "r452", "r764", "r765" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-term Debt", "totalLabel": "Carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.", "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate", "terseLabel": "Convertible senior notes stated rate of interest" } } }, "localname": "LongTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r25", "r100" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r413", "r796" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Loss contingency acrual" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r413", "r414", "r416", "r418", "r419", "r420", "r421", "r422" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Securities Held-to-Maturity" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Marketing and Advertising Expense", "terseLabel": "Marketing and advertising" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r262" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r262" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r50", "r53" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r34", "r53", "r191", "r212", "r231", "r250", "r253", "r257", "r266", "r276", "r280", "r281", "r283", "r284", "r288", "r289", "r300", "r330", "r340", "r346", "r348", "r370", "r423", "r424", "r426", "r427", "r428", "r429", "r430", "r432", "r433", "r573", "r584", "r760", "r856" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Net income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income/(loss)", "totalLabel": "Net income/(loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r280", "r281", "r283", "r284", "r291", "r292", "r302", "r307", "r330", "r340", "r346", "r348", "r760" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net income available to common stockholders", "terseLabel": "Net earnings/(loss) available to common stockholders", "totalLabel": "Net income/(loss) available to common stockholders\u2014Basic EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r293", "r296", "r297", "r298", "r299", "r302", "r307" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net income/(loss) available to common stockholders \u2013 Diluted EPS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r59", "r225", "r226", "r227", "r228", "r229", "r275", "r276", "r277", "r278", "r279", "r283", "r290", "r311", "r355", "r356", "r371", "r372", "r373", "r374", "r375", "r376", "r520", "r521", "r522", "r540", "r541", "r542", "r543", "r555", "r556", "r557", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r602", "r603", "r606", "r607", "r608", "r609", "r622", "r623", "r624", "r625", "r626", "r627", "r671", "r672", "r673", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other Income/(Expenses):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r330", "r340", "r346", "r348", "r760" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r614", "r779" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "verboseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r611" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Subtotal" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liability [Abstract]", "verboseLabel": "Amounts recognized in the Company's Consolidated Balance Sheets" } } }, "localname": "OperatingLeaseLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r611" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities (Note 12)", "verboseLabel": "Lease liability\u2014short term" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r611" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail": { "order": 3.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities (Note 12)", "verboseLabel": "Lease liability\u2014long term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r612", "r616" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "verboseLabel": "Cash paid for amounts included in the measurement of operating liabilities (operating leases)" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r610" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of use assets\u2014operating leases (Note 12)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r811" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "verboseLabel": "Amortization of right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r618", "r779" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate\u2014operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r617", "r779" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term (in years)\u2014operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r131" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "verboseLabel": "Tax effected NOLs - US" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "auth_ref": [ "r104", "r156", "r157", "r158" ], "lang": { "en-us": { "role": { "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.", "label": "Option Indexed to Issuer's Equity, Type [Axis]", "terseLabel": "Option Indexed to Issuer's Equity, Type [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.", "label": "Option Indexed to Issuer's Equity, Type [Domain]" } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r247", "r780" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "verboseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of other assets.", "label": "Other Assets, Fair Value Disclosure", "terseLabel": "Other assets fair value disclosure" } } }, "localname": "OtherAssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r239" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other noncurrent assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r141", "r142", "r144" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustment, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r141", "r142", "r144", "r251", "r254" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Other comprehensive income/(loss)", "verboseLabel": "Other comprehensive income/(loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "verboseLabel": "Other comprehensive income/(loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r40", "r215" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "terseLabel": "Other" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInvestmentCompaniesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in other investment companies (as defined).", "label": "Other Investment Companies [Member]" } } }, "localname": "OtherInvestmentCompaniesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingGainsLosses": { "auth_ref": [ "r44" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 21.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.", "label": "Other gains and losses, net", "verboseLabel": "Other losses, net" } } }, "localname": "OtherNonoperatingGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r48" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Shares repurchased" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r48" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r47" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of fixed assets" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r890", "r891" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r890", "r891" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Non-cumulative dividend" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared", "terseLabel": "Cash dividends declared per share (quarterly)" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10", "r454" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par or stated value per share", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "Preferred Shares" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10", "r780" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, par value $0.01; 2,000 shares authorized:" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredUnitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Preferred Units [Line Items]" } } }, "localname": "PreferredUnitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r246", "r385", "r386", "r750" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "verboseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from divestiture of businesses" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "auth_ref": [ "r45", "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.", "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities", "terseLabel": "Proceeds from Sale and Maturity of Held-to-maturity Securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r218", "r220" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "terseLabel": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r97", "r733", "r734", "r735" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Fixed Assets, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r94", "r235" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r96", "r207", "r696", "r780" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Total", "verboseLabel": "Fixed assets, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r214" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 29.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "negatedLabel": "Losses on investments" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Information by nature of uncertainty related to unrecognized tax benefits.", "label": "Nature of Uncertainty [Axis]" } } }, "localname": "ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r831", "r832", "r833", "r834" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivables, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationTypeAxis": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Information by type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Type [Axis]" } } }, "localname": "ReclassificationTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationTypeDomain": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Type [Domain]" } } }, "localname": "ReclassificationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RegulatoryDepreciationAndAmortizationPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for systematically allocating capitalized costs to periods that benefit from the use thereof. Includes, but is not limited to, methods used, such as composite depreciation, descriptions of regulatory treatment for estimated removal and disposal costs, and description of amortization of plant-related regulatory assets.", "label": "Regulatory Depreciation and Amortization, Policy [Policy Text Block]", "terseLabel": "Depreciation and Amortization" } } }, "localname": "RegulatoryDepreciationAndAmortizationPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RegulatoryIncomeTaxesPolicy": { "auth_ref": [ "r221", "r222" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, including investment tax credits, and the related regulatory treatment (for example, whether deferred income tax accounting - normalization - is allowed in rate making).", "label": "Regulatory Income Taxes, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "RegulatoryIncomeTaxesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r484", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r224", "r630", "r631", "r902" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r484", "r630", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r902" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r628", "r629", "r631", "r632", "r633" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReportableSubsegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies division of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Reportable Subsegments [Member]", "terseLabel": "Reportable Subsegments [Member]" } } }, "localname": "ReportableSubsegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r89", "r90", "r223" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Software Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock Awards [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r118", "r204", "r708", "r713", "r780" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 35.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r227", "r272", "r273", "r274", "r277", "r286", "r289", "r374", "r520", "r521", "r522", "r542", "r543", "r571", "r704", "r706" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings/ (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r476" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "verboseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Summary of Geographic Distribution of Revenue" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r38", "r219", "r425", "r426", "r427", "r431", "r432", "r433" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "verboseLabel": "Revenues from advisory services" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r755", "r756" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition, Policy [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Operating Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesExcludingInterestAndDividends": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Revenues", "documentation": "Revenues from operations, excluding interest and dividend income. Includes revenues from the following sources: investment banking (underwriting and financial advisory), principal transactions (sales and trading, and investment gains and losses), commissions, asset management, and investment advisory and other services.", "label": "Revenues, Excluding Interest and Dividends", "terseLabel": "Total operating revenues", "verboseLabel": "Total revenues" } } }, "localname": "RevenuesExcludingInterestAndDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r138", "r139", "r554" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Summary of Deferred Tax Asset Recorded" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r762" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Held-to-maturity Securities [Line Items]", "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "auth_ref": [ "r362", "r366", "r367" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table]", "terseLabel": "Schedule of Held-to-maturity Securities [Table]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r87", "r88" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Summary of Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPreferredUnitsTable": { "auth_ref": [ "r119", "r217" ], "lang": { "en-us": { "role": { "documentation": "Schedule providing details of the units of a Master Limited Partnership that have priority over limited partner units in areas including liquidation, redemption, conversion, tax status of distribution or sharing in distributions. Details include the preferred units authorized, issued and outstanding, the cumulative cash distributions made to preferred partners, the cumulative net income shared by preferred partners, and the aggregate account balances of preferred partners.", "label": "Schedule of Preferred Units [Table]" } } }, "localname": "ScheduleOfPreferredUnitsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetScheduleOfFixedAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r178", "r179" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule of Related Party Transactions [Table Text Block]", "terseLabel": "Summary of Revenues from Advisory Services Provided to Related Parties" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r487", "r488", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r105", "r107", "r108", "r110", "r111", "r112", "r115", "r116", "r117", "r118", "r241", "r242", "r243", "r314", "r454", "r455", "r456", "r457", "r458", "r460", "r461", "r768", "r795", "r812" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r778", "r892" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Changes in Balance of Gross Unrecognized Tax Benefits", "terseLabel": "Schedule of Changes in Balance of Gross Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "auth_ref": [ "r146", "r148", "r149", "r151", "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table Text Block]", "terseLabel": "Summary of Variable Interests in Non-consolidated VIEs" } } }, "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).", "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "terseLabel": "Schedule of Weighted Average Number of Shares" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Summary of Unamortized Finite-lived Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Group of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased.", "label": "Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]" } } }, "localname": "SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of financial instrument held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased.", "label": "Security Owned and Sold, Not yet Purchased Fair Value, Security Name [Domain]" } } }, "localname": "SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned": { "auth_ref": [ "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Financial instruments owned, at fair value", "documentation": "Fair value of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes determined by management based upon quoted prices of a financial instrument with similar characteristics or on a valuation technique or model.", "label": "Security Owned and Sold, Not yet Purchased Fair Value, Security Owned", "presentationGuidance": "Securities owned, at fair value" } } }, "localname": "SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r352", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r411", "r412", "r762", "r913" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r333", "r334", "r335", "r336", "r337", "r338", "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment and Geographic Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r803", "r804", "r862" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r51" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Stock-based compensation", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r777" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Option vested period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r501", "r502" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Historical stock price volatility (high)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Historical stock price volatility (low)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "verboseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate", "verboseLabel": "Historical stock price volatility (average)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "PRSUs - Monte Carlo Inputs", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "verboseLabel": "Share-based Payment Award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Shares of common stock authorized to issue under equity award plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Equity Award [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r866" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Shares granted and outstanding, Vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r615", "r779" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "verboseLabel": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r58", "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "The nature of the uncertainty for which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]", "terseLabel": "Internally-developed software" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfRelatedAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r230", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r352", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r409", "r411", "r412", "r762", "r913" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r241", "r242", "r243", "r266", "r294", "r295", "r303", "r307", "r314", "r315", "r370", "r423", "r426", "r427", "r428", "r432", "r433", "r454", "r455", "r457", "r458", "r461", "r584", "r748", "r795", "r812", "r828" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r27", "r109", "r227", "r255", "r256", "r257", "r272", "r273", "r274", "r277", "r286", "r289", "r313", "r374", "r462", "r520", "r521", "r522", "r542", "r543", "r571", "r594", "r595", "r596", "r597", "r598", "r599", "r627", "r704", "r705", "r706" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/CoverPage", "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfPartnersCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Partners' Capital [Abstract]" } } }, "localname": "StatementOfPartnersCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r272", "r273", "r274", "r313", "r669" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]", "verboseLabel": "Amounts recognized in the Company's Consolidated Balance Sheets" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfReconcilesFutureMinimumLeasePaymentsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r10", "r11", "r109", "r118" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Restricted stock issued and vesting of restricted stock units net, shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r109", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Restricted stock issued and vesting of restricted stock units, net" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r10", "r11", "r118", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures", "terseLabel": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Common stock purchase authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Share repurchase program, extended term date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchaseProgramPeriodInForce1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Stock Repurchase Program, Period in Force", "terseLabel": "Stock repurchase program, period in force" } } }, "localname": "StockRepurchaseProgramPeriodInForce1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Dollar amount remaining available for future share repurchases" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r10", "r11", "r109", "r118" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Shares repurchased, shares", "terseLabel": "Repurchased common stock, shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r10", "r11", "r109", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Shares repurchased", "terseLabel": "Repurchased common stock, value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r14", "r15", "r68", "r780", "r814", "r844", "r898" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' equity", "verboseLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Axis]", "terseLabel": "Subsegments Consolidation Items [Axis]" } } }, "localname": "SubsegmentsConsolidationItemsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Domain]", "terseLabel": "Subsegments Consolidation Items [Domain]" } } }, "localname": "SubsegmentsConsolidationItemsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfGoodwillByReportingUnitDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r600", "r636" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r600", "r636" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r600", "r636" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r635", "r637" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "verboseLabel": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r2", "r106" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Preferred stock, shares issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Preferred stock, shares outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r2", "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Summary of Series A Preferred Stock Balance" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital": { "auth_ref": [ "r2", "r106" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 36.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Preferred stock \u2013 Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding (Note 13)", "totalLabel": "Preferred Stock\u2014carrying value", "verboseLabel": "Preferred stock\u2014Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $86,638 and $77,969 at March 31, 2023 and December 31, 2022, respectively) (Note 11)" } } }, "localname": "TemporaryEquityValueExcludingAdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Text Block [Abstract]", "terseLabel": "Text Block [Abstract]" } } }, "localname": "TextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]", "verboseLabel": "Schedule Of Trading Securities And Other Trading Assets" } } }, "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r362", "r366", "r450", "r460", "r562", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r840", "r841", "r842", "r914", "r915", "r916", "r917", "r918", "r919", "r920" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Treasury Stock [Text Block]", "terseLabel": "Shares Repurchased" } } }, "localname": "TreasuryStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r225", "r226", "r227", "r228", "r229", "r276", "r277", "r278", "r279", "r290", "r355", "r356", "r371", "r372", "r373", "r374", "r375", "r376", "r520", "r521", "r522", "r540", "r541", "r542", "r543", "r555", "r556", "r557", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r602", "r603", "r606", "r607", "r608", "r609", "r622", "r623", "r624", "r625", "r626", "r627", "r671", "r672", "r673", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r757", "r771", "r773", "r911" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "U.S. treasuries" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r301", "r304", "r305" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Less: Undistributed income allocable to participating securities", "negatedLabel": "Less: Undistributed income allocable to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "auth_ref": [ "r301", "r304", "r305", "r794" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted", "negatedLabel": "Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r52" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "(Gains)/losses on financial instruments owned, at fair value", "terseLabel": "Unrealized gain (loss) on investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrealized gains and losses on investments.", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "terseLabel": "Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity" } } }, "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r525", "r531" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r532" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "terseLabel": "Reduction in unrecognised tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r533" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Decrease\u2014Lapse of statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r63", "r64", "r65", "r316", "r317", "r318", "r319" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.", "label": "Valuation Allowance by Deferred Tax Asset [Axis]" } } }, "localname": "ValuationAllowanceByDeferredTaxAssetAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.", "label": "Variable Interest Entity Disclosure [Text Block]", "terseLabel": "Variable Interest Entities" } } }, "localname": "VariableInterestEntityDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "auth_ref": [ "r147", "r150" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).", "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "terseLabel": "Maximum exposure to loss" } } }, "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r829" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 5.0, "parentTag": "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Dilutive effect of common stock equivalents", "terseLabel": "Dilutive effect of common stock equivalents, excluding participating securities" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r293", "r307" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail": { "order": 3.0, "parentTag": "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "definitionGuidance": "Weighted average diluted shares as disclosed on the Consolidated Statements of Operations", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Weighted-average common shares\u2014diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r291", "r307" ], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 4.0, "parentTag": "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "definitionGuidance": "Weighted average common shares", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "presentationGuidance": "Weighted average common shares (in thousands)", "verboseLabel": "Weighted-average common shares\u2014basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "wt_AcquisitionOfEtfsBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition Of Etfs Business [Member]", "terseLabel": "Acquisition of ETFS Business [Member]" } } }, "localname": "AcquisitionOfEtfsBusinessMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_AdvisoryFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Advisory Fees [Member]", "verboseLabel": "Advisory Fees [Member]" } } }, "localname": "AdvisoryFeesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_AdvisoryFeesReceivedInGold": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advisory fees received in gold and other precious metals.", "label": "Advisory Fees Received In Gold", "negatedLabel": "Advisory and license fees paid in gold, other precious metals and cryptocurrency" } } }, "localname": "AdvisoryFeesReceivedInGold", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_AdvisoryServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AdvisoryServices", "label": "Advisory Services [Member]" } } }, "localname": "AdvisoryServicesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "wt_AffiliatedBlockchainEnabledFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affiliated blockchain enabled funds.", "label": "Affiliated Blockchain Enabled Funds [Member]", "terseLabel": "Affiliated Blockchain Enabled Funds [Member]" } } }, "localname": "AffiliatedBlockchainEnabledFundsMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_AmortizationOfIssuanceCostsConvertibleNotes": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of issuance costs \u2013 convertible notes.", "label": "Amortization of Issuance Costs Convertible Notes", "terseLabel": "Amortization of issuance costs\u2014convertible notes" } } }, "localname": "AmortizationOfIssuanceCostsConvertibleNotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_AprilOneTwoThousandFiftyEightAndThereafterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AprilOneTwoThousandFiftyEightAndThereafterMember", "label": "April One Two Thousand Fifty Eight And Thereafter [Member]", "verboseLabel": "April 1, 2058 and Thereafter [Member]" } } }, "localname": "AprilOneTwoThousandFiftyEightAndThereafterMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_At100thPercentileForGrantsMadeIn2019And2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "At 100th Percentile For Grants Made In 2019 And 2020 [Member]", "terseLabel": "At 100th Percentile for grants made in 2019 and 2020 [Member]" } } }, "localname": "At100thPercentileForGrantsMadeIn2019And2020Member", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_At85thPercentileForGrantsMadeIn2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "At 85th Percentile For Grants Made In 2021 [Member]", "terseLabel": "At 85th Percentile for grants made in 2021 [Member]" } } }, "localname": "At85thPercentileForGrantsMadeIn2021Member", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_AtFiftyPercentileMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "At Fifty Percentile", "label": "At Fifty Percentile [Member]", "terseLabel": "At 50th Percentile [Member]" } } }, "localname": "AtFiftyPercentileMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_AtTwentyFifthPercentileMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "At Twenty Fifth Percentile", "label": "At Twenty Fifth Percentile [Member]", "terseLabel": "At 25th Percentile [Member]" } } }, "localname": "AtTwentyFifthPercentileMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_BelowTwentyFifthPercentileMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Below Twenty Fifth Percentile", "label": "Below Twenty Fifth Percentile [Member]", "terseLabel": "Below 25th Percentile [Member]" } } }, "localname": "BelowTwentyFifthPercentileMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discount rate used to value the deferred consideration.", "label": "Business Combination Consideration Transferred Deferred Payment Interest", "terseLabel": "Discount rate" } } }, "localname": "BusinessCombinationConsiderationTransferredDeferredPaymentInterest", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail" ], "xbrltype": "percentItemType" }, "wt_BusinessCombinationDeferredConsiderationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Deferred consideration (Note 10)", "documentation": "Amount of liability arising from deferred consideration in a business combination.", "label": "Business Combination Deferred Consideration Liability", "terseLabel": "Deferred consideration" } } }, "localname": "BusinessCombinationDeferredConsiderationLiability", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "wt_CarryingValueOfConvertibleNotes": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value of convertible notes (with maturities initially due after one year), net of unamortized issuance costs.", "label": "Carrying Value Of Convertible Notes", "terseLabel": "Convertible notes (Note 10)" } } }, "localname": "CarryingValueOfConvertibleNotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "wt_CashAndCashEquivalentsAtCarryingValueHeldAtOneFinancialInstitution": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value Held At One Financial Institution", "terseLabel": "Total cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValueHeldAtOneFinancialInstitution", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_CashAndCashEquivalentsCriteriaMaturityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalents criteria maturity period.", "label": "Cash And Cash Equivalents Criteria Maturity Period", "terseLabel": "Cash and cash equivalents maturity period, maximum" } } }, "localname": "CashAndCashEquivalentsCriteriaMaturityPeriod", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "wt_CashAndCashEquivalentsHeldAtTwoFinancialInstitutions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalents held at two financial institutions", "label": "Cash and cash equivalents held at two financial institutions", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsHeldAtTwoFinancialInstitutions", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_CashEquivalentsMaturityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents maturity period.", "label": "Cash Equivalents Maturity Period", "verboseLabel": "Liquid investments, original maturities" } } }, "localname": "CashEquivalentsMaturityPeriod", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "wt_ContingentPaymentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent payment text block.", "label": "Contingent Payment [Text Block]", "terseLabel": "Contingent Payments" } } }, "localname": "ContingentPaymentTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments" ], "xbrltype": "textBlockItemType" }, "wt_ContingentPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent payments abstract.", "label": "Contingent Payments [Abstract]" } } }, "localname": "ContingentPaymentsAbstract", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "xbrltype": "stringItemType" }, "wt_ContingentPaymentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent payments.", "label": "Contingent Payments [Policy Text Block]", "terseLabel": "Contingent Payments" } } }, "localname": "ContingentPaymentsPolicyTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "wt_ContractualGoldPayments": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Contractual Gold Payments", "documentation": "Contractual gold payments.", "label": "Contractual gold payments (Note 11)", "presentationGuidance": "Contractual gold payments (Note 9)", "verboseLabel": "Contractual gold payments" } } }, "localname": "ContractualGoldPayments", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail" ], "xbrltype": "monetaryItemType" }, "wt_ContractualGoldPaymentsGoldOuncesPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Contractual Gold Payments \u2013 gold ounces paid", "documentation": "Represents Contractual Gold Payments Gold Ounces Paid.", "label": "Contractual Gold Payments Gold Ounces Paid" } } }, "localname": "ContractualGoldPaymentsGoldOuncesPaid", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail" ], "xbrltype": "monetaryItemType" }, "wt_ContractualGoldPaymentsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual gold payments.", "label": "Contractual Gold Payments" } } }, "localname": "ContractualGoldPaymentsPolicyPolicyTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "wt_Conversionrateonconvertiblenotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ConversionRateOnConvertibleNotes.", "label": "Conversion Rate On Convertible Notes", "terseLabel": "Conversion rate" } } }, "localname": "Conversionrateonconvertiblenotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail" ], "xbrltype": "sharesItemType" }, "wt_ConvertibleNotesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible notes [Text Block].", "label": "Convertible Notes [Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "ConvertibleNotesTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes" ], "xbrltype": "textBlockItemType" }, "wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes Due Two Thousand And Twenty Six [Member]", "label": "Convertible Senior Notes Due Two Thousand And Twenty Six [Member]", "terseLabel": "Convertible Senior Notes Due Two Thousand And Twenty Six [Member]" } } }, "localname": "ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible senior notes due two thousand and twenty three [Member].", "label": "Convertible Senior Notes Due Two Thousand And Twenty Three [Member]", "terseLabel": "Convertible Senior Notes Due Two Thousand And Twenty Three [Member]" } } }, "localname": "ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_ConvertibleSeniorNotesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible senior notes [Line Items].", "label": "Convertible Senior Notes [Line Items]", "terseLabel": "Convertible Senior Notes [Line Items]" } } }, "localname": "ConvertibleSeniorNotesLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_ConvertibleSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes.", "label": "Convertible Senior Notes [Member]" } } }, "localname": "ConvertibleSeniorNotesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_ConvertibleSeniorNotesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible senior notes [Table].", "label": "Convertible Senior Notes [Table]", "terseLabel": "Convertible Senior Notes [Table]" } } }, "localname": "ConvertibleSeniorNotesTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_ConvertibleSeniorNotesYearOfMaturity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible senior notes year of maturity.", "label": "Convertible Senior Notes Year Of Maturity", "terseLabel": "Covertible senior notes year of maturity" } } }, "localname": "ConvertibleSeniorNotesYearOfMaturity", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "wt_CostMethodInvestmentFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost method investment fair value disclosure", "label": "Cost Method Investment Fair Value Disclosure", "verboseLabel": "Fair value" } } }, "localname": "CostMethodInvestmentFairValueDisclosure", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_CostMethodInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost method investment ownership percentage.", "label": "Cost Method Investment Ownership Percentage", "terseLabel": "Ownership interest percentage" } } }, "localname": "CostMethodInvestmentOwnershipPercentage", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_CostMethodInvestmentOwnershipPercentageDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Original fully diluted ownership interest percentage.", "label": "Cost Method Investment Ownership Percentage Diluted", "terseLabel": "Original fully diluted ownership interest percentage" } } }, "localname": "CostMethodInvestmentOwnershipPercentageDiluted", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_CourtofturinandcourtofmilanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Court of turin and court of milan", "label": "Court Of Turin And Court Of Milan [Member]", "terseLabel": "Court Of Turin And Court Of Milan [Member]" } } }, "localname": "CourtofturinandcourtofmilanMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_Debtinstrumentredemptionprice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DebtInstrumentRedemptionPrice.", "label": "Debt Instrument Redemption Price", "terseLabel": "Redemption price" } } }, "localname": "Debtinstrumentredemptionprice", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail" ], "xbrltype": "perShareItemType" }, "wt_DeferredConsiderationCurrent": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Consideration Current", "label": "Deferred Consideration Current", "terseLabel": "Deferred consideration, current", "verboseLabel": "Deferred consideration\u2014gold payments (Note 9)" } } }, "localname": "DeferredConsiderationCurrent", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredConsiderationGoldPaymentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting policy related to deferred consideration - gold payments.", "label": "Deferred Consideration Gold Payments [Policy Text Block]", "terseLabel": "Deferred Consideration\u2014Gold Payments" } } }, "localname": "DeferredConsiderationGoldPaymentsPolicyTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "wt_DeferredConsiderationNoncurrent": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred consideration - noncurrent.", "label": "Deferred Consideration Noncurrent", "terseLabel": "Deferred consideration, non-current", "verboseLabel": "Deferred consideration\u2014gold payments (Note 9)" } } }, "localname": "DeferredConsiderationNoncurrent", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredConsiderationObligationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DeferredConsiderationObligationMember", "label": "Deferred Consideration Obligation [Member]" } } }, "localname": "DeferredConsiderationObligationMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "domainItemType" }, "wt_DeferredConsiderationPerpetualGrowthRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate at which represents the deferred consideration perpetual growth.", "label": "Deferred Consideration Perpetual Growth Rate", "terseLabel": "Perpetual growth rate" } } }, "localname": "DeferredConsiderationPerpetualGrowthRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail" ], "xbrltype": "percentItemType" }, "wt_DeferredConsiderationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DeferredConsiderationTextBlock", "label": "Deferred Consideration [Text Block]", "verboseLabel": "Deferred Consideration" } } }, "localname": "DeferredConsiderationTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsideration" ], "xbrltype": "textBlockItemType" }, "wt_DeferredTaxAssetUnrealizedLosses": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 14.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Asset Unrealized Losses.", "label": "Deferred Tax Asset Unrealized Losses", "terseLabel": "Unrealized losses" } } }, "localname": "DeferredTaxAssetUnrealizedLosses", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredTaxAssetsLiabilitiesGross": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Liabilities Gross", "label": "Deferred Tax Assets Liabilities Gross", "totalLabel": "Total deferred tax assets less deferred tax liabilities" } } }, "localname": "DeferredTaxAssetsLiabilitiesGross", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredTaxAssetsOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 12.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets operating lease liabilities.", "label": "Deferred Tax Assets Operating Lease liabilities", "terseLabel": "Operating lease liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLeaseLiabilities", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets, operating loss carryforwards, net of tax.", "label": "Deferred Tax Assets Operating Loss Carryforwards Net Of Tax", "terseLabel": "Tax effected NOLs - International" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredTaxAssetsOutsideBasisDifference": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 11.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets outside basis difference.", "label": "Deferred tax assets outside basis difference", "negatedLabel": "Outside basis difference" } } }, "localname": "DeferredTaxAssetsOutsideBasisDifference", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 17.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from fixed assets and prepaid expenses.", "label": "Fixed assets\u00a0and prepaid assets", "verboseLabel": "Fixed assets and prepaid assets" } } }, "localname": "DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_DeferredTaxLiabilitiesRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail": { "order": 18.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities right of use assets.", "label": "Deferred Tax Liabilities Right Of Use Assets", "terseLabel": "Right of use assets\u2014operating leases" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAssets", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesSummaryOfDeferredTaxAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_DetailsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Details [Axis]" } } }, "localname": "DetailsAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_DetailsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Details [Domain]" } } }, "localname": "DetailsDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_DisclosureOfFinancialInstrumentsOwnedAtFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of financial instruments owned at fair value.", "label": "Disclosure of Financial Instruments Owned At Fair Value", "terseLabel": "Financial instruments owned" } } }, "localname": "DisclosureOfFinancialInstrumentsOwnedAtFairValue", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned" ], "xbrltype": "textBlockItemType" }, "wt_DisclosureOfStockholderRightsPlanLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of stockholder rights plan.", "label": "Disclosure Of Stockholder Rights Plan [Line Items]" } } }, "localname": "DisclosureOfStockholderRightsPlanLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_DisclosureOfStockholderRightsPlanTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of stockholder rights plan.", "label": "Disclosure Of Stockholder Rights Plan [Table]" } } }, "localname": "DisclosureOfStockholderRightsPlanTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_DisclosureOfStockholderRightsPlanTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of stockholder rights plan.", "label": "Disclosure Of Stockholder Rights Plan [Text Block]", "terseLabel": "Stockholder Rights Plan" } } }, "localname": "DisclosureOfStockholderRightsPlanTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan" ], "xbrltype": "textBlockItemType" }, "wt_DisclosureOfValuationOfDeferredConsiderationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Valuation Of Deferred Consideration.", "label": "Disclosure Of Valuation Of Deferred Consideration [Abstract]", "terseLabel": "Disclosure Of Valuation Of Deferred Consideration [abstract]" } } }, "localname": "DisclosureOfValuationOfDeferredConsiderationAbstract", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "xbrltype": "stringItemType" }, "wt_DisclosureOfValuationOfDeferredConsiderationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Valuation Of Deferred Consideration.", "label": "Disclosure Of Valuation Of Deferred Consideration [Line Items]", "terseLabel": "Disclosure Of Valuation Of Deferred Consideration [Line Item]" } } }, "localname": "DisclosureOfValuationOfDeferredConsiderationLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail" ], "xbrltype": "stringItemType" }, "wt_DisclosureOfValuationOfDeferredConsiderationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Valuation Of Deferred Consideration", "label": "Disclosure Of Valuation Of Deferred Consideration [Table]", "terseLabel": "Disclosure Of Valuation Of Deferred Consideration [Table]" } } }, "localname": "DisclosureOfValuationOfDeferredConsiderationTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail" ], "xbrltype": "stringItemType" }, "wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation of deferred consideration.", "label": "Disclosure Of Valuation Of Deferred Consideration [Table Text Block]", "terseLabel": "Summary of valuation of deferred consideration" } } }, "localname": "DisclosureOfValuationOfDeferredConsiderationTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationTables" ], "xbrltype": "textBlockItemType" }, "wt_EarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings per share line items.", "label": "Earnings Per Share [Line Items]" } } }, "localname": "EarningsPerShareLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_EmployeesAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees and Directors [Member]", "label": "Employees And Directors [Member]", "terseLabel": "Employees and Directors [Member]" } } }, "localname": "EmployeesAndDirectorsMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodDetail" ], "xbrltype": "domainItemType" }, "wt_EuropeanBusinessSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "European Business Segment [Member]", "label": "European Business Segment [Member]" } } }, "localname": "EuropeanBusinessSegmentMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_EventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event [Axis].", "label": "Event [Axis]" } } }, "localname": "EventAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_EventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Event [Domain].", "label": "Event [Domain]", "terseLabel": "Event [Domain]" } } }, "localname": "EventDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_ExercisePricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per unit.", "label": "Exercise Price Per Unit", "terseLabel": "Exercise price per unit" } } }, "localname": "ExercisePricePerUnit", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "wt_FairValueAssumptionConversionOfNoteUponACorporateTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption conversion of note upon a corporate transaction.", "label": "Fair Value Assumption Conversion Of Note Upon a Corporate Transaction", "terseLabel": "Redemption of note upon a corporate transaction" } } }, "localname": "FairValueAssumptionConversionOfNoteUponACorporateTransaction", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionConversionOfNoteUponAQualifiedFinancingRound": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption conversion of note upon a qualified financing round.", "label": "Fair Value Assumption Conversion Of Note Upon A Qualified Financing Round", "verboseLabel": "Conversion of note upon a future financing round" } } }, "localname": "FairValueAssumptionConversionOfNoteUponAQualifiedFinancingRound", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionConversionOfNoteUponAnEquityFinancing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption conversion of note upon an equity financing.", "label": "Fair Value Assumption Conversion Of Note Upon An Equity Financing", "terseLabel": "Conversion of note upon a future equity financing" } } }, "localname": "FairValueAssumptionConversionOfNoteUponAnEquityFinancing", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionConversionOfSharesUponAnEquityFinancing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption conversion of shares upon n equity financing.", "label": "Fair Value Assumption Conversion Of Shares Upon An Equity Financing", "terseLabel": "Conversion of Series A Shares upon a future equity financing" } } }, "localname": "FairValueAssumptionConversionOfSharesUponAnEquityFinancing", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionOfDefaultRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption of default rate.", "label": "Fair Value Assumption Of Default Rate", "terseLabel": "Default" } } }, "localname": "FairValueAssumptionOfDefaultRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionOfDissolutionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption of dissolution rate.", "label": "Fair Value Assumption Of Dissolution Rate", "terseLabel": "Default" } } }, "localname": "FairValueAssumptionOfDissolutionRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionOfRedemptionOfNoteUponChangeOfControlRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption of redemption of note upon change of control rate.", "label": "Fair Value Assumption Of Redemption Of Note Upon Change Of Control Rate", "terseLabel": "Redemption of note upon a change of control" } } }, "localname": "FairValueAssumptionOfRedemptionOfNoteUponChangeOfControlRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueAssumptionRedemptionOfSharesUponACorporateTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumption redemption of shares upon a corporate transaction.", "label": "Fair Value Assumption Redemption Of Shares Upon A Corporate Transaction", "terseLabel": "Redemption of Series A Shares upon a corporate transaction" } } }, "localname": "FairValueAssumptionRedemptionOfSharesUponACorporateTransaction", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "percentItemType" }, "wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability net unrealized gain loss included in earnings and other comprehensive income.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income", "verboseLabel": "Net unrealized (gains)/losses" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "monetaryItemType" }, "wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings", "verboseLabel": "Net realized losses" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfReconciliationOfRecurringFairValueMeasurementsDetail" ], "xbrltype": "monetaryItemType" }, "wt_FairValueOfPreferredStockConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of preferred stock consideration.", "label": "Fair value of preferred stock consideration" } } }, "localname": "FairValueOfPreferredStockConsideration", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_Fairvalueassumptionexpectedterm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value Assumption, Expected Term.", "label": "Fair Value Assumption Expected Term", "verboseLabel": "Time to potential outcome (in years)" } } }, "localname": "Fairvalueassumptionexpectedterm", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail" ], "xbrltype": "decimalItemType" }, "wt_Fairvalueofconvertiblenotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "FairValueOfConvertibleNotes.", "label": "Fair Value Of Convertible Notes", "terseLabel": "Fair Value Of Convertible Notes" } } }, "localname": "Fairvalueofconvertiblenotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_FederalAgencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Agency [Member]", "label": "Federal Agency [Member]", "terseLabel": "Pass-through GSEs [Member]" } } }, "localname": "FederalAgencyMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturityScheduleOfSecuritiesHeldToMaturityDetail" ], "xbrltype": "domainItemType" }, "wt_FinancialInstrumentsOwnedAtFairValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instruments owned at fair value.", "label": "Financial Instruments Owned at Fair Value [Member]", "terseLabel": "Financial Instruments Owned at Fair Value [Member]" } } }, "localname": "FinancialInstrumentsOwnedAtFairValueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndThereafter": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite lived intangible assets amortization expense year five and thereafter.", "label": "Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter", "terseLabel": "2028 and thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndThereafter", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "wt_FnalityConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fnality convertible note.", "label": "Fnality Convertible Note [Member]" } } }, "localname": "FnalityConvertibleNoteMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" ], "xbrltype": "domainItemType" }, "wt_FnalityInternationalLimitedConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fnality International Limited Convertible Note", "label": "Fnality International Limited Convertible Note [Member]", "verboseLabel": "Fnality International Limited Convertible Note" } } }, "localname": "FnalityInternationalLimitedConvertibleNoteMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_FnalityInternationalLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fnality international limited.", "label": "Fnality International Limited [Member]", "terseLabel": "Fnality International Limited [Member]" } } }, "localname": "FnalityInternationalLimitedMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "wt_FnalityinternationallimitedconvertiblenotecarryingvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fnality international limited convertible note carrying value member.", "label": "FnalityInternationalLimitedConvertibleNoteCarryingValue [Member]", "terseLabel": "Fnality International Limited Convertible Note Carrying Value [Member]" } } }, "localname": "FnalityinternationallimitedconvertiblenotecarryingvalueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_FnalityinternationallimitedconvertiblenotecostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fnality international limited convertible note cost Member.", "label": "FnalityInternationalLimitedConvertibleNoteCost [Member]", "terseLabel": "Fnality International Limited Convertible Note Cost [Member]" } } }, "localname": "FnalityinternationallimitedconvertiblenotecostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_ForwardLookingGoldPrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Forward-looking gold price", "documentation": "Forward-looking gold price.", "label": "Forward Looking Gold Price" } } }, "localname": "ForwardLookingGoldPrice", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationSummaryOfValuationOfDeferredConsiderationDetail" ], "xbrltype": "monetaryItemType" }, "wt_FundManagementAndAdministration": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fund management and administration.", "label": "Fund Management and Administration", "terseLabel": "Fund management and administration" } } }, "localname": "FundManagementAndAdministration", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "wt_GainLossFromChangeInDeferredConsideration": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain/loss from revaluation of deferred consideration.", "exampleGuidance": "Gain/(loss) on revaluation of deferred consideration\u2014gold payments (Note 9)", "label": "Gain on revaluation of deferred consideration \u2013 gold payments (Note 5)", "negatedLabel": "(Gain)/loss on revaluation of deferred consideration\u2014gold payments", "verboseLabel": "Gain/(loss) on revaluation of deferred consideration - gold payments" } } }, "localname": "GainLossFromChangeInDeferredConsideration", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows", "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationScheduleOfDeferredConsiderationDetail" ], "xbrltype": "monetaryItemType" }, "wt_IncomeDistributedToParticipatingSecurities": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends to participating securities.", "label": "Income Distributed To Participating Securities", "negatedLabel": "Less: Income distributed to participating securities" } } }, "localname": "IncomeDistributedToParticipatingSecurities", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "wt_IncreaseDecreaseInFundManagementAndAdministrationPayable": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in fund management and administration payable.", "label": "Increase Decrease in Fund Management and Administration Payable", "terseLabel": "Fund management and administration payable" } } }, "localname": "IncreaseDecreaseInFundManagementAndAdministrationPayable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_IncreaseDecreaseInGoldAndOtherPreciousMetals": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash realized upon sale of gold and other precious metals.", "label": "Gold and other precious metals", "negatedLabel": "Gold and other precious metals" } } }, "localname": "IncreaseDecreaseInGoldAndOtherPreciousMetals", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_IncreaseDecreaseInIntangiblesSoftwareDevelopment": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in intangibles software development.", "label": "Increase Decrease In Intangibles Software Development", "terseLabel": "Intangibles\u2014software development" } } }, "localname": "IncreaseDecreaseInIntangiblesSoftwareDevelopment", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_IncreaseDecreaseInOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase or decrease in operating lease liabilities.", "label": "Increase Decrease in Operating Lease Liabilities", "negatedLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilities", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_IndemnificationReceivableNoncurrent": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification receivable noncurrent.", "label": "Indemnification Receivable Noncurrent", "verboseLabel": "Indemnification receivable (Note 20)" } } }, "localname": "IndemnificationReceivableNoncurrent", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "wt_IndentureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indenture [Axis].", "label": "Indenture [Axis]", "terseLabel": "Indenture [Axis]" } } }, "localname": "IndentureAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_IndentureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indenture [Domain]", "label": "Indenture [Domain]", "terseLabel": "Indenture [Domain]" } } }, "localname": "IndentureDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_IntangibleAssetsAndGoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets and goodwill.", "label": "Intangible Assets And Goodwill [Line Items]" } } }, "localname": "IntangibleAssetsAndGoodwillLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "wt_IntangibleassetsandgoodwillTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets and goodwill.", "label": "IntangibleAssetsAndGoodwill [Table]", "terseLabel": "Intangible Assets And Goodwill [Table]" } } }, "localname": "IntangibleassetsandgoodwillTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "wt_InterestAndPenaltiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest and penalties.", "label": "Interest And Penalties [Member]" } } }, "localname": "InterestAndPenaltiesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "domainItemType" }, "wt_InterestExpenseOnConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expense on convertible notes.", "label": "Interest Expense On Convertible Notes", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOnConvertibleNotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_InvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent reporting concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investments [Line Items]", "terseLabel": "Investment [Line Items]" } } }, "localname": "InvestmentsLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" ], "xbrltype": "stringItemType" }, "wt_InvestmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This table lists the investments. The line items identify information about the investment.", "label": "Investments [Table]", "terseLabel": "Investment [Table]" } } }, "localname": "InvestmentsTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" ], "xbrltype": "stringItemType" }, "wt_InvestmentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments, including all tables.", "label": "Investments [Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentsTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "wt_LossGainOnRevaluationOfDeferredConsideration": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss Gain on revaluation of deferred consideration", "negatedLabel": "Loss on extinguishment of convertible notes" } } }, "localname": "LossGainOnRevaluationOfDeferredConsideration", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_MaximumConversionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum conversion rate.", "label": "Maximum Conversion Rate", "terseLabel": "Maximum Conversion Rate" } } }, "localname": "MaximumConversionRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "wt_MaximumNumberOfSharesIssuableUponConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares issuable upon conversion.", "label": "Maximum number of shares issuable upon conversion", "terseLabel": "Maximum number of shares issuable upon conversion" } } }, "localname": "MaximumNumberOfSharesIssuableUponConversion", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "wt_MeasurementPeriodForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement period for determining share price", "label": "Measurement period for determining share price", "terseLabel": "Measurement period for determining share price" } } }, "localname": "MeasurementPeriodForDeterminingSharePrice", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "wt_Minimumpercentageoflendersrequiredtohaveentireprincipalamountofconvertiblenotesrepurchasedbythecompanyuponcertaineventsofdefault": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault.", "label": "Minimum Percentage Of Lenders Required To Have Entire Principal Amount Of Convertible Notes Repurchased By The Company Upon Certain Events Of Default", "terseLabel": "Minimum percentage of lenders required to have entire principal amount of convertible notes repurchased by the Company upon certain events of default" } } }, "localname": "Minimumpercentageoflendersrequiredtohaveentireprincipalamountofconvertiblenotesrepurchasedbythecompanyuponcertaineventsofdefault", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Minimum regulatory net liquid asset requirement for certain of the Company's international subsidiaries.", "label": "Net Liquid Assets International Subsidiary Regulatory Capital Requirements", "terseLabel": "Minimum level of regulatory net capital" } } }, "localname": "NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_NumberOfPreferredStockPurchaseRightIssuedForOutstandingStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of preferred stock purchase right issued for outstanding stock.", "label": "Number Of Preferred Stock Purchase Right Issued For Outstanding Stock", "terseLabel": "Number of preferred stock purchase right issued for outstanding stock" } } }, "localname": "NumberOfPreferredStockPurchaseRightIssuedForOutstandingStock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "wt_NumberOfSharesIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued per unit.", "label": "Number Of Shares Issued Per Unit", "terseLabel": "Number of shares issued per unit" } } }, "localname": "NumberOfSharesIssuedPerUnit", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "wt_NumberOfSharesPurchasedFromRelatedParties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Series A Preferred Shares purchased in AdvisorEngine.", "label": "Number Of Shares Purchased From Related Parties", "terseLabel": "Number of shares purchased" } } }, "localname": "NumberOfSharesPurchasedFromRelatedParties", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Threshold Trading Days For Determining The Share Price", "label": "Number Of Threshold Trading Days For Determining The Share Price", "terseLabel": "Number Of Threshold Trading Days For Determining The Share Price" } } }, "localname": "NumberOfThresholdTradingDaysForDeterminingTheSharePrice", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "wt_OnrampinvestincpreferredstockcostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Onramp Invest Inc preferred stock cost.", "label": "OnrampInvestIncPreferredStockCost [Member]", "terseLabel": "Onramp Invest Inc - Series A-4 Preferred Stock - Cost [Member]" } } }, "localname": "OnrampinvestincpreferredstockcostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_OnrampinvestincseriesafourpreferredstockcarryingvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OnrampInvestIncSeriesAFourPreferredStockCarryingValue", "label": "OnrampInvestIncSeriesAFourPreferredStockCarryingValue [Member]", "terseLabel": "Onramp Invest Inc Series A-4 Preferred Stock - Carrying Value [Member]" } } }, "localname": "OnrampinvestincseriesafourpreferredstockcarryingvalueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_OperatingLossCarryForwardExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carry forward expiration year.", "label": "Operating Loss Carry Forward Expiration Year", "terseLabel": "NOL expiration date" } } }, "localname": "OperatingLossCarryForwardExpirationYear", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "wt_OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other assets seed capital (Wisdomtree blockchain-enabled funds).", "label": "Other Assets Seed Capital WisdomTree Blockchain Enabled Funds [Member]", "terseLabel": "Other assets\u2014seed capital\u00a0(WisdomTree blockchain-enabled funds) [Member]" } } }, "localname": "OtherAssetsSeedCapitalWisdomtreeBlockchainEnabledFundsMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail" ], "xbrltype": "domainItemType" }, "wt_OtherInformationRelatedToLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other information related to leases.", "label": "Other Information Related to Leases [Abstract]", "verboseLabel": "Other information:" } } }, "localname": "OtherInformationRelatedToLeasesAbstract", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesSummaryOfAdditionalInformationRegardingCompanysLeasesDetail" ], "xbrltype": "stringItemType" }, "wt_OtherInvestmentsCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Investments Cost", "label": "Other Investments Cost [Member]" } } }, "localname": "OtherInvestmentsCostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_OtherInvestmentscarryingValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other InvestmentsCarrying Value", "label": "Other InvestmentsCarrying Value [Member]" } } }, "localname": "OtherInvestmentscarryingValueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_OtherRedemptionRightsUnrelatedToStockholderDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Redemption Rights Unrelated To Stockholder Description", "label": "Other Redemption Rights Unrelated To Stockholder Description", "terseLabel": "Other redemption rights unrelated to stockholder approval" } } }, "localname": "OtherRedemptionRightsUnrelatedToStockholderDescription", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_OtherServicesIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Services Income [Member]", "terseLabel": "Other Income [Member]", "verboseLabel": "Other Income [Member]" } } }, "localname": "OtherServicesIncomeMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "domainItemType" }, "wt_OuncesOfGold1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed ounces of gold payable pursuant to deferred consideration contractual arrangement.", "label": "Ounces Of Gold 1", "terseLabel": "Fixed payment ounces of gold" } } }, "localname": "OuncesOfGold1", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "wt_PaymentOfConvertibleNotesIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of convertible notes issuance costs.", "label": "Payment Of Convertible Notes Issuance Costs", "negatedLabel": "Convertible notes issuance costs" } } }, "localname": "PaymentOfConvertibleNotesIssuanceCosts", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_PercentageOfAssetsSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of assets sold.", "label": "Percentage Of Assets Sold", "terseLabel": "Percentage of assets sold" } } }, "localname": "PercentageOfAssetsSold", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfBeneficialEquityInterestAcquiredOnRightsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of beneficial equity interest acquired on rights issued.", "label": "Percentage Of Beneficial Equity Interest Acquired On Rights Issued", "terseLabel": "Percentage of beneficial equity interest acquired on rights issued" } } }, "localname": "PercentageOfBeneficialEquityInterestAcquiredOnRightsIssued", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfBeneficialInterestAcquiredOnRightsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of beneficial interest acquired on rights issued.", "label": "Percentage Of Beneficial Interest Acquired On Rights Issued", "terseLabel": "Percentage of beneficial interest acquired on rights issued" } } }, "localname": "PercentageOfBeneficialInterestAcquiredOnRightsIssued", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfCommonStockAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock acquired.", "label": "Percentage Of Common Stock Acquired", "terseLabel": "Percentage of common stock acquired" } } }, "localname": "PercentageOfCommonStockAcquired", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Discount on future equity financing for preferred stock.", "label": "Percentage Of Discount On Future Equity Financing For Preferred Stock", "terseLabel": "Percentage of discount on future equity financing for preferred stock" } } }, "localname": "PercentageOfDiscountOnFutureEquityFinancingForPreferredStock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfEquityInterestAcquiredWithAffiliatesAndJointVentures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest acquired with affiliates and joint ventures.", "label": "Percentage Of Equity Interest Acquired With Affiliates And Joint Ventures", "terseLabel": "Percentage of equity interest acquired with affiliates and joint ventures" } } }, "localname": "PercentageOfEquityInterestAcquiredWithAffiliatesAndJointVentures", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfOutstandingConvertibleNote": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding convertible note.", "label": "Percentage of outstanding convertible note", "terseLabel": "Percentage of outstanding convertible note" } } }, "localname": "PercentageOfOutstandingConvertibleNote", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "pureItemType" }, "wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of voting approval required to redeem all of the outstanding notes at maturity.", "label": "Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes At Maturity", "terseLabel": "Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes At Maturity" } } }, "localname": "PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of voting approval required to redeem all of the outstanding notes before maturity.", "label": "Percentage of voting approval required to redeem all of the outstanding notes before maturity", "terseLabel": "Percentage of voting approval required to redeem all of the outstanding notes before maturity" } } }, "localname": "PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingSeriesAShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of voting approval required to redeem all of the outstanding series A shares.", "label": "Percentage Of Voting Approval Required To Redeem All Of The Outstanding Series A Shares", "terseLabel": "Percentage of voting approval required to redeem all of the outstanding series a shares" } } }, "localname": "PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingSeriesAShares", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingSeriesBShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of voting approval required to redeem all of the outstanding series B shares.", "label": "Percentage Of Voting Approval Required To Redeem All Of The Outstanding Series B Shares", "terseLabel": "Percentage of voting approval required to redeem all of the outstanding series B shares" } } }, "localname": "PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingSeriesBShares", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_PerformanceBasedRestrictedStockUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Performance Based Restricted Stock Unit [Member]" } } }, "localname": "PerformanceBasedRestrictedStockUnitMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "domainItemType" }, "wt_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "performance-based restricted stock units", "label": "Performance based restricted stock units [Member]", "verboseLabel": "Performance Based Restricted Stock Unites (PRSUs)" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityDetail" ], "xbrltype": "domainItemType" }, "wt_PlaceOfAppearanceOfLitigationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place of appearance of litigation .", "label": "Place Of Appearance Of Litigation [Axis]" } } }, "localname": "PlaceOfAppearanceOfLitigationAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_PlaceOfAppearanceOfLitigationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Place of appearance of litigation .", "label": "Place Of Appearance Of Litigation [Domain]" } } }, "localname": "PlaceOfAppearanceOfLitigationDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_PotentiallyDilutiveCommonStockEquivalents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Potentially Dilutive Common Stock Equivalents.", "label": "Potentially Dilutive Common Stock Equivalents", "terseLabel": "Potentially Dilutive common stock equivalents" } } }, "localname": "PotentiallyDilutiveCommonStockEquivalents", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesParentheticalDetail" ], "xbrltype": "sharesItemType" }, "wt_PotentiallyDilutiveRestrictedStockAwards": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail": { "order": 2.0, "parentTag": "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Potentially dilutive restricted stock awards .", "label": "Potentially Dilutive Restricted Stock Awards", "terseLabel": "Potentially dilutive restricted stock awards" } } }, "localname": "PotentiallyDilutiveRestrictedStockAwards", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail" ], "xbrltype": "sharesItemType" }, "wt_PreferredStockRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Preferred Stock Redemption Value.", "label": "Preferred Stock Redemption Value", "terseLabel": "Preferred Stock Redemption Value", "verboseLabel": "Preferred stock redemption value" } } }, "localname": "PreferredStockRedemptionValue", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "wt_ProceedsFromHeldToMaturitySecuritiesMaturingOrCalledPriorToMaturity": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from held-to-maturity securities maturing or called prior to maturity.", "label": "Proceeds from Held to Maturity Securities Maturing or Called Prior to Maturity", "terseLabel": "Proceeds from held-to-maturity securities maturing or called prior to maturity" } } }, "localname": "ProceedsFromHeldToMaturitySecuritiesMaturingOrCalledPriorToMaturity", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_ProceedsFromIssuanceOfConvertibleNotes": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of convertible notes.", "label": "Proceeds From Issuance Of convertible notes", "terseLabel": "Proceeds from the issuance of convertible notes (Note 10)" } } }, "localname": "ProceedsFromIssuanceOfConvertibleNotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from the sale of financial instruments owned, at fair value.", "label": "Proceeds from the Sale of Financial Instruments Owned, at Fair Value", "terseLabel": "Proceeds from the sale of financial instruments owned, at fair value" } } }, "localname": "ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of financial instruments owned, at fair value.", "label": "Purchase of Financial Instruments Owned, at Fair Value", "negatedLabel": "Purchase of financial instruments owned, at fair value" } } }, "localname": "PurchaseOfFinancialInstrumentsOwnedAtFairValue", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_PurchaseOfInvestments": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of investments.", "label": "Purchase Of Investments", "negatedTerseLabel": "Purchase of investments" } } }, "localname": "PurchaseOfInvestments", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_RepurchaseOfConvertibleNotes": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows": { "order": 36.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repurchase of convertible notes.", "label": "Repurchase Of Convertible Notes", "negatedLabel": "Repurchase of convertible notes (See Note 10)" } } }, "localname": "RepurchaseOfConvertibleNotes", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "wt_RevenueFromContractsWithCustomersLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue from contracts with customers line items.", "label": "Revenue from Contracts with Customers [Line Items]" } } }, "localname": "RevenueFromContractsWithCustomersLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_RevenueFromContractsWithCustomersTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue from contracts with customers.", "label": "Revenue From Contracts With Customers [Table]" } } }, "localname": "RevenueFromContractsWithCustomersTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfGeographicDistributionOfRevenueDetail" ], "xbrltype": "stringItemType" }, "wt_RevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues Categorized As Revenues From Contracts With Customers And Other Sources Of Revenues [Line Items]", "label": "Revenues Categorized as Revenues from Contracts with Customers and Other Sources of Revenues [Line Items]" } } }, "localname": "RevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "stringItemType" }, "wt_RevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues Categorized As Revenues From Contracts With Customers And Other Sources Of Revenues [Table]", "label": "Revenues Categorized As Revenues From Contracts With Customers And Other Sources Of Revenues [Table]" } } }, "localname": "RevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersSummaryOfRevenuesFromContractsWithCustomersDetail" ], "xbrltype": "stringItemType" }, "wt_RighttomanageassetundermanagementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to manage asset under management.", "label": "RightToManageAssetUnderManagement [Member]", "terseLabel": "ETFS acquisition {Member}" } } }, "localname": "RighttomanageassetundermanagementMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "wt_ScheduleForSummaryOfAdditionalInformationRelatedToOperatingLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule For Summary Of Additional Information Related To Operating Lease.", "label": "Schedule for Summary of Additional Information Related to Operating Lease" } } }, "localname": "ScheduleForSummaryOfAdditionalInformationRelatedToOperatingLeaseTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule For Supplemental Balance Sheet Information Related To Operating Lease", "label": "Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet" } } }, "localname": "ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Accounts Receivable From Related Party [Table Text Block]", "label": "Schedule Of Accounts Receivable From Related Party [Table Text Block]", "terseLabel": "Summary of Accounts Receivable from Related Parties" } } }, "localname": "ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleOfDeferredConsiderationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of deferred consideration.", "label": "Schedule Of Deferred Consideration [Table Text Block]", "verboseLabel": "Schedule of Deferred Consideration" } } }, "localname": "ScheduleOfDeferredConsiderationTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleOfEstimatedUsefulLivesOfRelatedAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of estimated useful lives of related assets.", "label": "Schedule Of Estimated Useful Lives Of Related Assets [Table Text Block]", "terseLabel": "Schedule of Estimated Useful Lives of Related Assets" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfRelatedAssetsTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finite lived intangible assets future amortization expense.", "label": "Schedule Of Finite Lived Intangible Assets Future Amortization Expense [Line Items]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "wt_ScheduleOfIncomeTaxLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Income Tax [Line Items]", "label": "Schedule Of Income Tax [Line Items]", "terseLabel": "Schedule Of Income Tax [Line Items]" } } }, "localname": "ScheduleOfIncomeTaxLineItems", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_ScheduleOfIncomeTaxTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Income Tax [Table]", "label": "Schedule Of Income Tax [Table]", "terseLabel": "Schedule Of Income Tax [Table]" } } }, "localname": "ScheduleOfIncomeTaxTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_ScheduleOfKeyTermsOfConvertibleNotesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Key Terms of Convertible Notes [Table Text Block]", "label": "Schedule Of Key Terms Of Convertible Notes [Table Text Block]", "terseLabel": "Schedule of key terms of convertible notes" } } }, "localname": "ScheduleOfKeyTermsOfConvertibleNotesTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period Table [Text Block]", "label": "Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period [Table Text Block]", "terseLabel": "Summary of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period" } } }, "localname": "ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables" ], "xbrltype": "textBlockItemType" }, "wt_ScheduleoffinitelivedintangibleassetsfutureamortizationexpenseTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finite lived intangible assets future amortization expense.", "label": "ScheduleOfFiniteLivedIntangibleAssetsFutureAmortizationExpense [Table]" } } }, "localname": "ScheduleoffinitelivedintangibleassetsfutureamortizationexpenseTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsSummaryOfUnamortizedFiniteLivedIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "wt_ScheduleofkeytermsofconvertiblenotesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ScheduleOfKeyTermsOfConvertibleNotes.", "label": "ScheduleOfKeyTermsOfConvertibleNotes [Table]" } } }, "localname": "ScheduleofkeytermsofconvertiblenotesTable", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail" ], "xbrltype": "stringItemType" }, "wt_SecuritiesHeldToMaturityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities held to maturity.", "label": "Securities Held to Maturity [Text Block]", "terseLabel": "Securities Held-to-Maturity" } } }, "localname": "SecuritiesHeldToMaturityTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldToMaturity" ], "xbrltype": "textBlockItemType" }, "wt_SecurrencyConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securrency convertible note.", "label": "Securrency Convertible Note [Member]" } } }, "localname": "SecurrencyConvertibleNoteMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" ], "xbrltype": "domainItemType" }, "wt_SecurrencyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Securrency Inc [Member]", "documentation": "Securrenc, Inc.", "label": "Securrency Inc [Member]", "verboseLabel": "Securrency Inc [Member]" } } }, "localname": "SecurrencyIncMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsSummaryOfInputsUsedInPwermApproachOfInvestmentDetail", "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables", "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincconvertiblenotecarryingvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securrency Inc convertible note carrying value.", "label": "SecurrencyIncConvertibleNoteCarryingValue [Member]", "terseLabel": "Securrency Inc - Convertible Note - Carrying Value [Member]" } } }, "localname": "SecurrencyincconvertiblenotecarryingvalueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincconvertiblenotecostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securrency Inc convertible note cost.", "label": "SecurrencyIncConvertibleNoteCost [Member]", "terseLabel": "Securrency Inc - Convertible Note - Cost [Member]" } } }, "localname": "SecurrencyincconvertiblenotecostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincseriesaconvertiblepreferredstockcarryingvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencyIncSeriesAConvertiblePreferredStockCarryingValue .", "label": "SecurrencyIncSeriesAConvertiblePreferredStockCarryingValue [Member]", "terseLabel": "Securrency Inc. - Series A Convertible Preferred Stock - Carrying Value [Member]" } } }, "localname": "SecurrencyincseriesaconvertiblepreferredstockcarryingvalueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincseriesaconvertiblepreferredstockcostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencyIncSeriesAConvertiblePreferredStockCost .", "label": "SecurrencyIncSeriesAConvertiblePreferredStockCost [Member]", "terseLabel": "Securrency Inc. - Series A Convertible Preferred Stock - Cost [Member]" } } }, "localname": "SecurrencyincseriesaconvertiblepreferredstockcostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincseriesbconvertiblepreferredstockcarryingvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencyIncSeriesBConvertiblePreferredStockCarryingValue .", "label": "SecurrencyIncSeriesBConvertiblePreferredStockCarryingValue [Member]", "terseLabel": "Securrency Inc. - Series B Convertible Preferred Stock - Carrying Value [Member]" } } }, "localname": "SecurrencyincseriesbconvertiblepreferredstockcarryingvalueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincseriesbconvertiblepreferredstockcostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencyIncSeriesBConvertiblePreferredStockCost .", "label": "SecurrencyIncSeriesBConvertiblePreferredStockCost [Member]", "terseLabel": "Securrency Inc. - Series B Convertible Preferred Stock - Cost [Member]" } } }, "localname": "SecurrencyincseriesbconvertiblepreferredstockcostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincsubtotalcarryingvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencyIncSubtotalCarryingValue .", "label": "SecurrencyIncSubtotalCarryingValue [Member]", "terseLabel": "Subtotal \u2013 Securrency, Inc. - Carrying Value [Member]" } } }, "localname": "SecurrencyincsubtotalcarryingvalueMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyincsubtotalcostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencyIncSubtotalCost .", "label": "SecurrencyIncSubtotalCost [Member]", "terseLabel": "Subtotal \u2013 Securrency, Inc. - Cost [Member]" } } }, "localname": "SecurrencyincsubtotalcostMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetailsOfInvestmentsCarriedAtCostDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyseriesaconvertiblepreferredstockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencySeriesAConvertiblePreferredStock .", "label": "SecurrencySeriesAConvertiblePreferredStock [Member]", "terseLabel": "Securrency - Series A convertible preferred stock" } } }, "localname": "SecurrencyseriesaconvertiblepreferredstockMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsSummaryOfCategorizationOfAssetsAndLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyseriesapreferredstockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencySeriesAPreferredStock .", "label": "SecurrencySeriesAPreferredStock [Member]", "terseLabel": "Securrency - Series A Preferred Stock [Member]" } } }, "localname": "SecurrencyseriesapreferredstockMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_SecurrencyseriesbconvertiblepreferredstockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SecurrencySeriesBConvertiblePreferredStock .", "label": "SecurrencySeriesBConvertiblePreferredStock [Member]", "terseLabel": "Securrency - Series B Convertible Preferred Stock [Member]" } } }, "localname": "SecurrencyseriesbconvertiblepreferredstockMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_SeriesANonVotingConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series a non voting convertible preferred stock.", "label": "Series A Non Voting Convertible Preferred Stock [Member]" } } }, "localname": "SeriesANonVotingConvertiblePreferredStockMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_SeriesARedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "SeriesARedeemableConvertiblePreferredStockMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "wt_ShareBasedCompensationArrangementByShareBasedPaymentVestingAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment vesting award fair value assumptions expected dividend rate.", "label": "Share Based Compensation Arrangement By Share Based Payment Vesting Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Percentage of vesting payout" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentVestingAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsSummaryOfRestrictedStockActivityParentheticalDetail" ], "xbrltype": "percentItemType" }, "wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price as a percentage of last reported price and conversion rate", "label": "Share price as a percentage of last reported price and conversion rate", "terseLabel": "Share price as a percentage of last reported price and conversion rate" } } }, "localname": "SharePriceAsAPercentageOfLastReportedPriceAndConversionRate", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_StockOptionIssuancePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option issuance period.", "label": "Stock Option Issuance Period", "terseLabel": "Stock option issuance period" } } }, "localname": "StockOptionIssuancePeriod", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "wt_StockholderRightAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholder right agreement.", "label": "Stockholder Right Agreement [Member]" } } }, "localname": "StockholderRightAgreementMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_StockholderRightsPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholder rights plan.", "label": "Stockholder Rights Plan [Abstract]" } } }, "localname": "StockholderRightsPlanAbstract", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "xbrltype": "stringItemType" }, "wt_SummaryOfGoodwillTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of goodwill.", "label": "Summary of Goodwill [Text Block]", "verboseLabel": "Summary of Goodwill" } } }, "localname": "SummaryOfGoodwillTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of revenues categorized as revenues from contracts with customers and other sources of revenues.", "label": "Summary of Revenues from Contracts with Customers" } } }, "localname": "SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesFromContractsWithCustomersTables" ], "xbrltype": "textBlockItemType" }, "wt_TaxActNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax act name axis.", "label": "Tax Act Name [Axis]", "terseLabel": "Tax Act Name [Axis]" } } }, "localname": "TaxActNameAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_TaxActNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax act name domain.", "label": "Tax Act Name [Domain]", "terseLabel": "Tax Act Name [Domain]" } } }, "localname": "TaxActNameDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_TemporaryEquityIssuedValue": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail": { "order": 1.0, "parentTag": "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity Issued Value", "label": "Issuance of Preferred Stock" } } }, "localname": "TemporaryEquityIssuedValue", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail" ], "xbrltype": "monetaryItemType" }, "wt_ThersholdConversionPriceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thershold conversion price [Axis].", "label": "Thershold Conversion Price [Axis]" } } }, "localname": "ThersholdConversionPriceAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_ThersholdConversionPriceDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thershold Conversion Price [Domain].", "label": "Thershold Conversion Price [Domain]" } } }, "localname": "ThersholdConversionPriceDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_ThirdPartyDistribution": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Third Party Distribution.", "label": "Third Party Distribution", "terseLabel": "Third-party distribution fees" } } }, "localname": "ThirdPartyDistribution", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "wt_ThirdPartyDistributionFeesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to third-party distribution fees.", "label": "Third Party Distribution Fees [Policy Text Block]", "terseLabel": "Third-Party Distribution Fees" } } }, "localname": "ThirdPartyDistributionFeesPolicyTextBlock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "wt_ThreeYearShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three year share repurchase program.", "label": "Three Year Share Repurchase Program [Member]", "terseLabel": "Three-Year Share Repurchase Program [Member]" } } }, "localname": "ThreeYearShareRepurchaseProgramMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_ThroughMarchThirtyFirstTwoThousandFiftyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ThroughMarchThirtyFirstTwoThousandFiftyEightMember", "label": "Through March Thirty First Two Thousand Fifty Eight [Member]", "terseLabel": "April 1, 2018 through March 31, 2058 [Member]" } } }, "localname": "ThroughMarchThirtyFirstTwoThousandFiftyEightMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_TrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tranche [Axis]" } } }, "localname": "TrancheAxis", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "wt_TrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tranche [Domain]" } } }, "localname": "TrancheDomain", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_TwoFinancialInstitutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Financial Institutions Member.", "label": "Two Financial Institutions [Member]" } } }, "localname": "TwoFinancialInstitutionsMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/CashAndCashEquivalentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_TwoThousandAndTwentyThreeNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty three notes [Member].", "label": "Two Thousand And Twenty Three Notes [Member]" } } }, "localname": "TwoThousandAndTwentyThreeNotesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "domainItemType" }, "wt_TwothousandandtwentynotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TwoThousandAndTwentyNotes.", "label": "Two Thousand And Twenty Notes [Member]" } } }, "localname": "TwothousandandtwentynotesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesAdditionalInformationDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "domainItemType" }, "wt_TwothousandandtwentyonenotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TwoThousandAndTwentyOneNotes.", "label": "Two Thousand And Twenty One Notes [Member]" } } }, "localname": "TwothousandandtwentyonenotesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesScheduleOfKeyTermsOfConvertibleNotesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesSummaryOfTheCarryingValueOfTheConvertibleNotesDetail" ], "xbrltype": "domainItemType" }, "wt_UnamortizedStockIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail": { "order": 2.0, "parentTag": "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized Stock Issuance Costs", "label": "Less: Issuance costs", "negatedLabel": "Less: Issuance costs" } } }, "localname": "UnamortizedStockIssuanceCosts", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockSummaryOfSeriesAPreferredStockBalanceDetail" ], "xbrltype": "monetaryItemType" }, "wt_UndistributedIncomeAllocableToParticipatingSecurities": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Undistributed income allocable to participating securities.", "label": "Undistributed income allocable to participating securities", "negatedLabel": "Add back: Undistributed income allocable to participating securities" } } }, "localname": "UndistributedIncomeAllocableToParticipatingSecurities", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "wt_UnrecognizedTaxBenefitsAndInterestAndPenalties": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Other noncurrent liabilities (Note 20)", "documentation": "Accrued for unrecognized tax benefits and interest/penalties related to a tax position claimed or expected to be claimed on a tax return.", "label": "Unrecognized Tax Benefits And Interest And Penalties", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "UnrecognizedTaxBenefitsAndInterestAndPenalties", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheets", "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "wt_UnrecognizedTaxBenefitsIncludingInterestAndPenaltiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits Including Interest And Penalties [Member]" } } }, "localname": "UnrecognizedTaxBenefitsIncludingInterestAndPenaltiesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_UnrecognizedTaxBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unrecognized tax benefits.", "label": "Unrecognized Tax Benefits [Member]" } } }, "localname": "UnrecognizedTaxBenefitsMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetail" ], "xbrltype": "domainItemType" }, "wt_VariableInterestEntityNonConsolidatedCarryingAmountAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest entity Non-consolidated carrying amount assets", "label": "Variable Interest Entity Non consolidated Carrying Amount Assets [Abstract]", "terseLabel": "Carrying Amount - Assets" } } }, "localname": "VariableInterestEntityNonConsolidatedCarryingAmountAssetsAbstract", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "stringItemType" }, "wt_VariableInterestEntityNonConsolidatedCarryingAmountPreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nonconsolidated, carrying amount, preferred stock.", "label": "Variable Interest Entity Non consolidated Carrying Amount Preferred Stock", "terseLabel": "Preferred stock\u2014Series A Shares" } } }, "localname": "VariableInterestEntityNonConsolidatedCarryingAmountPreferredStock", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "monetaryItemType" }, "wt_VariableInterestEntityNonconsolidatedCarryingAmountOption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nonconsolidated, carrying amount, preferred stock.", "label": "Variable Interest Entity, Nonconsolidated, Carrying Amount, Option", "terseLabel": "Preferred stock\u2014Series B Shares" } } }, "localname": "VariableInterestEntityNonconsolidatedCarryingAmountOption", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "monetaryItemType" }, "wt_VariableInterestNonConsolidatedEntityCarryingAmountOfConvertibleNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Variable interest non consolidated entity carrying amount of convertible note.", "label": "Variable Interest Non Consolidated Entity Carrying Amount Of Convertible Note", "terseLabel": "Convertible note" } } }, "localname": "VariableInterestNonConsolidatedEntityCarryingAmountOfConvertibleNote", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesSummaryOfInformationAboutVariableInterestsDetail" ], "xbrltype": "monetaryItemType" }, "wt_VestingCapIfTsrisNegative": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting cap if TSR is negative.", "label": "Vesting Cap If TsrIs Negative", "terseLabel": "Vesting cap if TSR is negative" } } }, "localname": "VestingCapIfTsrisNegative", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "wt_VestingCappedIfTsrisNegativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting capped if tsris negative.", "label": "Vesting Capped If TsrIs Negative [Member]" } } }, "localname": "VestingCappedIfTsrisNegativeMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_WeightedAverageDilutedSharesExcludingParticipatingSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Participating Securities", "label": "Weighted Average Diluted Shares Excluding Participating Securities", "terseLabel": "Participating Securities" } } }, "localname": "WeightedAverageDilutedSharesExcludingParticipatingSecurities", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesParentheticalDetail" ], "xbrltype": "sharesItemType" }, "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Weighted average number of diluted shares outstanding excluding participating securities.", "label": "Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities", "totalLabel": "Weighted average diluted shares" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareReconciliationOfBasicAndDilutedEarningsPerShareDetail", "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail" ], "xbrltype": "sharesItemType" }, "wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares": { "auth_ref": [], "calculation": { "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail": { "order": 1.0, "parentTag": "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Weighted average shares of common stock issuable upon conversion of the preferred shares.", "label": "Weighted Average Shares Of Common Stock Issuable Upon Conversion Of The Preferred Shares", "terseLabel": "Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock" } } }, "localname": "WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/EarningsLossPerShareScheduleOfWeightedAverageNumberOfSharesDetail" ], "xbrltype": "sharesItemType" }, "wt_WetfTradingSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WETF trading securities.", "label": "WETF Trading Securities [Member]", "terseLabel": "WETF Trading Securities [Member]" } } }, "localname": "WetfTradingSecuritiesMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDebtSecuritiesTradingAndEquitySecuritiesFvNiDetail" ], "xbrltype": "domainItemType" }, "wt_WisdomTreeTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WisdomTree Trust [Member]", "label": "Wisdomtree Trust [Member]", "terseLabel": "WisdomTree Trust [Member]" } } }, "localname": "WisdomTreeTrustMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "wt_WisdomtreeAssetManagementCanadaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Wisdomtree Asset Management Canada Inc [Member]", "terseLabel": "WisdomTree Asset Management Canada, Inc [Member]" } } }, "localname": "WisdomtreeAssetManagementCanadaIncMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_WisdomtreeETFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WisdomTree ETF.", "label": "WisdomTree ETF [Member]", "terseLabel": "WisdomTree ETF [Member]" } } }, "localname": "WisdomtreeETFMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "wt_WisdomtreeManagementJerseyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WisdomTree Management Jersey Limited", "label": "WisdomTree Management Jersey Limited [Member]", "presentationGuidance": "Manjer Issuers [Member]", "verboseLabel": "Manjer Issuers [Member]" } } }, "localname": "WisdomtreeManagementJerseyLimitedMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "domainItemType" }, "wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wisdomtree Multi Asset Issuer plc And Wisdomtree issuer icav", "label": "Wisdomtree Multi Asset Issuer plc And Wisdomtree issuer icav [Member]", "verboseLabel": "WisdomTree Multi Asset Issuer PLC And WisdomTree Issuer PLC [Member]" } } }, "localname": "WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember", "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20230331", "presentation": [ "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfAccountsReceivableFromRelatedPartiesDetail", "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsSummaryOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesDetail" ], "xbrltype": "domainItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/subtopic&trid=2208821", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e845-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e848-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL75039408-165497", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42546-110969", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "740", "Topic": "980", "URI": "https://asc.fasb.org/extlink&oid=6501382&loc=d3e54053-110423", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "740", "Topic": "980", "URI": "https://asc.fasb.org/extlink&oid=6501382&loc=d3e54136-110423", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2793-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2814-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(6))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/subtopic&trid=2127163", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/subtopic&trid=2127197", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7,9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r787": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r788": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r789": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r791": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r792": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2740-109256", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org/topic&trid=75115024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org/topic&trid=2197064", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r914": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r915": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r916": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r917": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r918": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r919": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 132 0001193125-23-139497-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-139497-xbrl.zip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�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

7A2AC^/I)S-+$F"GTEU/?B0>T M5VWMWN&.VN@3,3O[DB([MP[S6?JCXQG6>14NK3=# MGVMV#P/LZ>8JH&%XS#+>'M>2JNF+EQB_PJOLL9?2FVW.P"M6H2]WGP4)I3UF^R'@15//MN_1+)4J8 MRNC5Y";^ME>.PUEF*][>=+,.63(L>>7!63C&'GHN[&TU$UMV'*L3)#K >$&W MQ=DYMSF'F/ #_Z#Y;M>3ST&FZJO",E%RI"HF3F*CF MV[2ZOGXU]<+X2J?/9G]XK@@CHL*6N[C;RL_!E=M# L>FYE/^&78HE;XK?ZX' M%<[@L%[$>HR#?^CN2L]-H&W;T*FCITJ9P8Z^8H)A _28XIR5V#8N>$:3U#NA MSJ*AW/#"_=@8,[7XX_D,DCC]AC"*5*9VN+J,H]]A8Q M?2M$O)9'WR^B8RLI#RENIZ7!B(WTAUMLAR/%+Z")]:[WIR"[\W,S'.E MK6=-D!9Q"OHZ/")R.7DL0#>)"=S1#DCGW8'-FT[#SM:.D0UIU*SOD=FV@PO& MT[.T:U)];P;?SL93S<8KL62,.+Y*ETAS_\N1""H#9!A1DQDM,>-]3A"30KL9^+[K5HYWN/J] MK0T3/GM?C\BW>RS5KOA5V=?7+/RO!+I"+FM@:;?5BU[&#'"( MHU>[$REGL#D;;MWLB4\UOG0#Y\L[U)ECD/99S2=WT_TL<%]-%C%5[;]:4Q## MK"!;OC*?\#-= Y_@.10\=QS^"]'_\@4%=,'RT5^J!L-Q/^.G>984&!KVW;DX M'U*&"JS1ZVA)^]Y\_$P GDE3N,'^+1N,#GM1 ,/_%O]?4-3X$UNS_[[X1_,G M%1C-]'&=4PSW3 BLS;.:@WUONM#F_W]J+?^_Q?\M_H\M_D<9ES^8QIBZLFS13+/>%[4JA"RZ./01#ODO!6QZ;_RUC\W->U(2?C,2$5NOLOLC5'G;2F M^['G6&*&%,[@VLK*$BF4=1+,4M*4FP*V-?6-U$%I/9MQ!.TT=6]LI!_2A#YV MB^L@A3C^Z!P10D228QDL3T4N%VSOUS6,IZ0'K&WLX$9;]8AUNTG<)\ M0XQJ)Z_GQ,ZWF06R+?% "'V,"VOGS.K'?,60KJ^/KO<%6MU M169@AR+#@/Q^4W[NW?2:N!-.&0&*V',8U7NN>UDO<%)H?1IA!+18"7KOW.*N-54$!U,PK@ M)E6I!PF8M9*WV3C3YSR(MRLIG[@B+)&05D\=,AR@&ZO6NUMIFR>SJ%4U4=T%H1-;C1\V^S2O:,+=.HH#K"Q0"KE&1$>^&YEL:'KV;E;D7FS= M!L/J:.3O_]8#'RJ>E)>=L/'K?O\GF4_851M?CT:.OM@/&X-E?-FN V&':\5H M;Y)" 88CIPTS!"K=:6(5JWR&,8\F)59$9S& E='H1&ZK'N@L?=RZG^-%(L3T M_B:CX[NB4!/&'^",GD[3F.NUZ;C&1) MEOLHLN4E\UUDCO+XI-_[;&\X,_/*-WC,S5W8/D>U]B1'@:_V85?7 M2G'5-VS%4T9J[J\![0$&NZ:Y_V9Z\S_>]_^#UX@EQ7.EL(_T/O!"EIRYA7R6 M_20^EA[)SO]+-+:MCI&BZQ2(C'V88=:*7'(NP3^;J48;)4OLW7XF'ZNR9J;&/UQ]X4C, M#@"M\0(_K\>/X[.8>B3%X26F\&W+A*C[@4WBTQ?037LCPX$BA,Q(19E9D_KN MEF6X+<]NC4QACYN@UNO;YK(QC;.D+>M5>7EK0Q5IQZ<[\#3MF90^:784<"<; M<6LC6O!Z/8!4?[@L;1D%O&AZME:A%ZX>__2T%1,%8.01RL@2]6,P<_IA_670E@%K^]7$6AHG-*JL0(2O\K:YSE2,QEU7 M%FS%Q;N^.S0F(DB=8T^OXS$$O"3S&$UB6,5\#JR9FNR.'E,LB['P1,% M2!Y,K)FY+1]]6\P$3ZX MV3F[1LHIK!@MS,,< K*S5Q9>TI^;DK% 4^X2DU7'=18TU;]KY#"-J;9R"6E9 MI1>_*$OA*%GK1P&'#)=N!"J3>>=UTL<.6S<>L_N0SC@DUZ7Y$E=%UOS\O'NR M9552CGPLSZ 1S]#@1I;$\O>\W&U?U@L)I)SV^-TSV)*Y(8VQ[$IG((NT[5A. M,,,#%:&X?$-KYTA*GH/$QZD[<-Z@@#50 MV]K>RE'/)?_RV@$HZUQ_V;#7^GLMB2PF@U".E/5&%_.-DN;;X\7QF)0Y8PE$ M_=D";/6^5\)V\][I\30RX$S"\-/^;C/U7*N/Y'B>JR-+E#'7VHGE+.[3-<1 MELP&>V3663*KFUP[-]@T.?O+*P=Y.VC>P?'5#CS+_W9M&DZ88^GB$2$T[K/1 MLR<:/SSNWL$5CC7R,).O*IPD=.) F'9*.B6Q47/E0U7ZGZ@ M^O[17%:+;?5'?3;O/U]D1O%32I"Z%/_,%]SE0O0BF]S4T! M9&$_7L8PS:J;J'JR&/2,[IVE%U6_L_TC21#O>LR<([C\FKK/U*DR92% >M'' MAWHZ$KZ:)5Y5]SW"4$6N.9SJ N])\MLO++%!V/@T5"P4.&*,KS6Q2]2O%T(7 M#KDO:I[/..O.N<*:=M#AY]CPDVZR[WY*WF8PY=DJ# 6\"WWFC5'G_OC Z95K M'NY#M\&3!<%G2.,\1$S@^# MJFP7;;KCOC_5B3\4X*A\]_ZA]"[TC;EQY+9GEKSLR>C;M'E[?D?N.A1PK ?* MA)X>\[\?CO [;H"7S/3<5,!2R>[M!)\\A\(@8P6&O"2*0]W[UGUM(F1&P)%Y_G$57JX_! S,*FJ3S(XL3BPK:]]Q6/]=%%Z"H4.0D-'Z;) M%C]N58L'<_H&Y3P0QF&YZ])UOCBJY9DQLYM2#H6>7:2I+X:?P!;1#&EP^&AN M-0WV6J7E*GUM6OF1#(BW]*Z)YB-#])@9M%,!PC"]N85"@$?,"A-V(<\%(@ MORPLT>0<.B [7K04]V4S@BV&IT2@S_DBA9-&.7Y>>1&C[BOPI9ORRO,.72OM MNZ:I#DF*+,.#J;,%>=..C/0Q%*"[WVR 9/_\A4WHMT%(RK'7\4T1_5LH]Q]N MV_W1WP]D%>6]E%-Z<8^'>2JI6(^]MR5*2@QWUZWXWCHIZ,0*A&+Y @X*-,KS>C!Y M!>&4$TA]COWZ.H&$5VUMDOG'V_J?#CE\NG2PB+!2\7HDE7-;?FU?E/"=L%1U<_.P.]5OC<+U$:CXQ%^LKI%=5SV ME]_^/0>K1$E&P8?F!UO-M(VUT!35T0J*T:^S?78DU<[W.P;7/EF(T14]6X@/ MW]X[&4%T\GJ8]J Y'!@-RKKBAZX89&]8]LNY,:D$B[!X!2,I1$>_DTX25>=> MZ4P..TY1\5]FJ];4Q"^OS>,NU=S7NRW7&?O.\C8*L#UI&5!VO0 %1B](=6E> ME#G!4L#J.SD5'T-BR"?MJ#V:ECM= IVL^ Q;K=^NI@:9RP;+/.'TVJ"U M>9!TIN0)ZZU3,H'O%?2?0^>5EF)(#+T+E!QEQZ>WIW1MWG^MEZGB9/J!=4O! MU+>F-.&@*,W+T5/87AD?*#$K?%KX_(!HS3:CD\OI\5#M-B[BZ076O1\%CJ3[ M-,(-%$7_16=1_OW/8!-:JWRHKE.%1$Y496#!>O: _G"2>+O^.YH BCC%X-P@JZ$QF7.?DDEEA0O]@U/[L@!9RB,^FE ME6A]L;,.0>AV4F03"X4=ZUXC[.U$#.B< M)?6;F9DLI\[NT0#-L#Q2T%K=_;J-#.P,,@5Y3(X)=OL.^NK/=,H/=0O"T#]6 M$E$$F]"U'D46#W"P-%&>O*SSH9K#K6JA+1CX]JE/S:20F="QW)DP-=7^/CCS MS,1Z\-OJX20IZ&MVNV[3((NWGL:MFRYG6.B8BX7$A3]%5H$.C#91F!67L%GD M)OOL>FVS@AXV=\EDE"RCCH8NYE[H\[K2,"J6@)O(_'CG,@.93OL.#; ^6G*L M5-ODC%V$]Q$(\B8/BY<6H?T:1!(I3:8&8MNAV,(?+#1M=)U[,=70+/FM,(YWT;HBUJ(1GMPN)S6L6CS M[,=&O\"((-,+,W.>,S5N]$Z)>CUB&]/VY"RTW-8)3/50:""E$8M#_QS0I9<, M98G6@20MBYI[GJKSA4^WT#3\BD]OR:18BR*E6N#;!\>4 M!UD0PX=KV'DX883Z![/ Q1W>R6[/&I#SRVFL:D"B)'T^HN*)VP YM.E@6H7. M2F1,J4,MR 3MFHF>1?&")1!IAAY')398>)BZ:VKM]O"*:8KJ;\BF"VJHOY8R M);'I\7[_?99;5G).&*/:%QQ>O)?I"V+/<@2GI?9Q<'CU2(. 7/357F^[)5^7 M&- H6KWV9%UR!Q_75B5KLG%'*-KXPUEVW.HWGI+&>(\NZ"<#Q\2KWYQ[!G M2D$S6A^X2P-(9V8*\,98[CC$0,>J752WNU@9KV0+_]%-]D*;RV?)Y9>/(0E# MX7'#P:/V()GL*7+&[8S_0)J1[L0W)8IKK.,6:0 =-8##WYRTI(O@[9^ST>Y/5!??0=^#6WK4S)/WK=!6,WFHO>.WY!C#5)!7KT'%T]%$\ M7AH,(>T=Y^1NLQ3O*>%#U2=3\,M?O46TM1ONVO %> \:ON+9[UG7,H+UD3N, M9I$FGW8O+S%YWW2J2N'T(.+^>\\ ML?>IU()FT_9@PUAOSMJ]V;XW2?D)'/'Y26/:5E'&H*[A3^L.4OIUL\$<(CMU MD:(H^992C@[9JC8C)A^AD.(SD M[M^0$K20;<*OO<'+= HB'QL"6'Y?$6W\LF)Q*W0Q 7#0)8W +:/MH=\4T%?7 MCM^T]&@T_YH2D!S^5).ZNL?0$#N(D#L6K4'>M^D8&U^A&Y M'(W8X\R>W, 3ZV:A1[\5''@//<5#T7C=)4AE R$I_US51=;W15?N="_-^4@@ M/.V:H=!<1\4G1+6OV!Y/J_KQ82=_2$&2/*5>1$?2L_C:L.+UT$/EY;)TCR);-L?Z>.<'VYK"'P]*W@6!WQCL3=>:W/AP M6HO#J[WR?BS?TQM?\@ 7'#4O_.>;DJ)Q?_AZ;J<[OU:TB*^K$.A"COJN@J:* MQJ,%HQ\U5M>,OFG(P77AF<I@SW9+'DMF0(Y MA'\;93,,L'4_V*.BIK]M=^QMI-DP#SM,ZQWAU4+VCT5+CX$70',6@(> M[>1X@.YH#61,B);O8<,GGYRWQ5*)%@3,B1H6VP!+#1U>[5N/2F^6&19*FOSA MY52/TLJXLYQ7IE!W217";>?,D@Q4-)C:^(RG\F*WJ#EMEI2%C8V6/1)^;:#D M6W)M5Q0^>\L9!1E0[,N5O;$4Y&F+Z#L J2)NF:OGQ*Z<:).LJ"LF9R;^Z,6_ MUDS(6'NM["LC/U?LEURFZ<#P22M\ =(M05E:B'@EY]ICRX^,0EY!KQZ@&ZAW19-M!YXO"FPX4)L(C+ D+VUO<&LP:1>3H6 M=:<7.4H%YKY=:3TRB)$M?L4>Z7 D=*4A0I6I_#%X]FJEE$A=%4(.R4V0K8&7 M;[W([=H>OE73T#1U/)8[Y];]+LC21; !>939N!E9M!9:,4,Y"+\YY":\-+6H?Q1=28-$.7_M2 ^^ZN]A2MT#,]GIJV\%@]EA+ZZQ#FKA)MV5_CU#1E1<", MG,T@/4/3*Q_O5..!_W-18ZN\1I6,7^QQMJ/KI9NJS\Z7%E2^'@2R1M RJ9Q M@+. %UF5Q7"FE\'X"3@8 DG]+M2]]7V^Y3 M\TSGN/>.X(N_BQ5X]JF\=54$AH)^PAD<6V7J45!ZQ9FI-%\"\>=2B%M&R?H! M561*/SB8'AW/7U32BK.Y\<9L7X?#G;$1?:7](2[BSG!P\>JS1HE83,J M?H*3N'5*>%A(RI5MSU>G$7(U=;D;GWR]4&4X=[9[/2YOZ_:43[37=.V)YSYA MZ-0P-20C(R#3/7]"-/N=NMEU4.=".\(')":" (DD)QO4M=;J_ONJ8_^.R]^P M ($HJ&!$^HW-#D[58?@55 4?U";_KF*J(#K3 #GQI"'G2VXA']G\;$T,#4

7WR[O')B$ MGY/SN-GVO_$X"6M[1JI_YFDR\V(?SZO MW?.,5,U4]&8NSF/@1,;J_J^0,;K<'9=8L/O-)LNT"O 7UJ=UR/-4P\'10B^%DD,WZ#N8# M;F.FSA"K3DVCR*T%,^C^"YH!U"^ROL/?GFQ_AR]@>F!0Z)3T+:+@_&*..UC4 M.W^J2M #!@GSX.\O:+?D(ISOD33DL0J.4)(WD,\3E=N_]B\7-OY:-6)N-M6L M'+\6[?&YR?H*_96ZE@PLSSJU%*,1#[2>A@VWLQV:ZJ?N2+_'2A:]$6!_6*\E MT4QWW:OT,#(K"U>LHD+NJ1V+Y:(*#./EE>6YI6+LE%TUFAZ_R-RZ^5'%/-$' M(-8LNEDBLTYE?+N\I5)M^ _LL[Z[S:G\C5M)*7]L[/U(7:&PTSR:96K]=M;X MD4%\=FD3$ J\=ZZC*4OWN+MS/CX[C#B;<>[UFV.O&OE30T+3]A[[ MX2!!\.\T +C,3_X?W"70H<\;6CBM[_X,HWCF9=>YJ@A\PFFK%Z0DT.SD>9NC MG*#YS-^[)+*-__4!!->FLCJF1%64S8DY4*K.SDU#X0\Z>L"=.5-D54Q"!@KN MD+NF#&=5EHZA 4*H:84?1P,Y/=F_W_$T.4\#/'G_!C+ZU3=BB?2%Q8M7>7=W M(:LN(77(?7*2-:37\ #1Y#K2/RB_R!9IQM3M8T[SG)/WTX,-@!;>6A[S_(? M@P^>.^ 5+T>15]5ZDSE;$X+:?JQ="K=T;^4_M\@?96X4+253?>F@@ )_G[?3 M$U3C?BBQ4]XD[BZ" *L6V8LS8(Y&77P*K):6RF2SB'$'7W)U9F3ZX#)W3=QK MCM&'@B]^_OUL. / )TLXF=Q?P*G1/Y(:-^@46U%<^KTP7\FM^*R[P&P&[N:U^ MSDE%D74LR*5^R]"5+8]UY.Z@#O]U^O]PIBG(/[@PY\^NQ0]/- CTM32 'PUP MR][?(3Z[ALKQ9-PEZL]=B1L6L]J,].)"5([QA1"^2_NS!32 !L+RX\;'7XO[ MB$W!J> T,A6D4_7JT3^C HZ>)4JG0T3BK"=O@-0&@!%/A]WYO6$Q4F9_+C"G MB,K(O38?-[N-6COI3C>P_&9O&_S-:I MU+Q\]XSVAQW%J^/(RLZI(4]'ZU/((F:6\TPZ/Y LJ8(*F8[>0= @^90FI 6) MX!KXKBEHO?9U-_FZC(K,.T[JI0MV.+.1]L M^07Y^JFM?8$D&D 3I7&\C9[79/P+*$[L]TGOT2LI?NNRY]K7>I;*)?7P2EV/ M>(G_G0-1\ ON7<;1YB-?VX'L)6*(IDI@S2+_<^C 1L3<2#3PD:T8]^8YJMD?3L<7=$] $SB7AEEU1JW_;N%MOY/Y.)>][SS0*X&Z^,D _X<$IC1C@&N8UK92;);52!-VT@ MOB?+^E%N #R_T4]G\]NI8_DR;FMN4N4O<@UNQZS9>%=>6,Y,@@FF\AZCJN.. M35=@>E/XSPL/#?=#+J=2>7[2DV+.N 1N=YP]_VTU:0O4TRQY#MCPD?(J'_Y3 M>I!*ECDTX_HGW( ^3U B!C?F'YKI"TM\:#TW\(-Q[LP')K]_YWZ^_Z++'UTZ ME&R83*PHIHR-R3_+1A5AL$3R"GJBB7UKQK:TMZ4=D^5@,47Z/$QFH[ZG;+E[ M/$MI\; DE2=IAQ %HZ%7TMJY6%6K02PI(<4,OMZLYMWV9FB1(F%E@&!F8U%F MC$'(. QL7[[9DKM]*OM=66YCJ=N02K@:7#JJQ%<>%2CA[2Q9MF)4;>390!(F M\,1D$:.<[9LU+L]:^!>6[D(WGP[N>.#9*T]Q#)GD^EX"[:?K?*5*&93L1 M%J?#K;ZMUP1G,><^Y4HC,I8VH?]U2K _ M?O3QX0GJA+"^L^^O$=;U=;NA8E[7T/F#7+@%A[6(V^Z2 TCJQWZ"ML%4?K70 MV._M1QK[B;_4?]'_$I&-?^G\HK[H;7S4\Z4B9;HLD]]8Z"'TAV)M(Q45AN-' MQR_FVK1$XJ^G2HR70*]4Y'K?K!:WV&-TZSUD(K(T;\H>^,]N;8/(N:1G;.Z0 MVO+#*1RZ)'47+?#[*,?298,M*KU-WTEI.DF6^5O,H_TY-A_O\;P-8I#800(F M36(+FCXT]7=-::R>A&7C]>9S?*Q);S6%?VN[]RBA;IH:@/EF&Q: I1?:W\:6 M9 ;6:%6EKL%WE472 VZ*?[-8)48>L)S*M8O@"L40D ,TP/+ANP6LC(PM]3+" M[A"KGV"K"XGZ09B>H;QEJ$T[@%;42RJLT#^*_!F9-<>N-QRL$Z+QG7H&:)N. M+YP^@75H@QZY\_I6J$9T]9C6%[NI#KK'9WXQP!Y4*#O5GV;D[A+,5G3-3 Q MTV-P6GAUR]IDL@V%V8$YL(P&,&^RVB3?^Z"WH]JVULL4 %K4G4CSON8ZU6W: MNZOVQ&)I)<1:0W\BT;9^K[G97V%NI^Z%;Q!GOB)"CG!#RZA:CT77E8<4V&TA ME-O$R/-ID$A6))$\-=9WC\LQCTM7$G9+PM0AVF==ZR. MWRNV(I'UF-K+NHN MTE_4OGD["Z8?$M1% UR;&J>HXSO\:8 "^!**@AV/.A;D7+T=/5C=/(YK.):> MD/P.>E& MC?)YZ46<%9@0M$E'JJI2<<6MN M!LLI( U0H\P4&1$&=.,H<"F=3L2YU^U-$ D= 6BN+I4FE[](C$4P'Y MD4M:C?6535=7Z;[H2&5U)(W="]UQM),^(Y+%?-$W\N'#^J[T8 HV#1*K2^+:WN7M=II]$5JW/6% M)KX@:CK20 M\//4J'B=]DG#E, Z9!I+]0W&L_2(/[+P]%_>GOW6JEHYYYIR0#@Q@^3:W5$I MZ/KR@4-9.W"!PEGJV&"](FL$J']-04"S]2'V1%:N/NE=@N>X'T&2=4>MU]T0 N7\A]E0:I:KH4Q\&=\\V!GP8PU$:; MF2U_#^A/!E#?HJ1:5CGE2_[T6I4W^W08V;>P#,B3:I MPY<-\!1_1Z%MTO[B780K+B M(%C-3U0.[XG&+(XT7'K5I'DT7E+2_K74X]E0D,A4#]/S7A"S8/*(T-RI,T<_ MDY=0L_CPL]3&-WW895MKC8YRU+V/^<;&IUD*OV!;4%RO\FMK++6GI_O4?D"N M:F?6/6>UUF?S)=_CWAI^%X8[!H8KT@!" 3'V,+(4O/]BS\(Z1+2@=KR]..1< MNIV-M='-(&LA=7.6TXRJVX%ROMH8/#IM;SJT;'\+F8,A6XM0Y7^6KB C0&4O MTUC//F9R4H$RZ /.M@J8.ZE?-1@Q!N]AM&D!.SST?8W(]U#?/J$C?,U$V M6L5J,ZHKZ4I\RJ\BXP#*1IQ3L2I 5TER ^L&M6^$D2Y4@Z$$)!R#_#$Q(J^O M9C^"5S"YUAKCL2HG^_" M^5.S'B&U,4S*I0Z#Z3RA>8E)1X0X#. M?V;J ]X?4?A02TTZ#3L*T@A>-X=_IW(C/P=^YMZXUCPJC[]E4DN\;]Q?, 6* M^-4G_9/@V?JM6Y5YA3M_ X'>19$\,(_-IP)6232 K52?^R+XU'U8PMZLW(V( M=:BXB:A27,0E!A#WM-*>G$^S&H1X$N!>H0%2J/IW(T]\CUYMB'EZ66',O+0H M\<-(8;L'._[*6^ -8261.>^U/H-!3W9$V[1_Q$M< M,M84/[Z<E!T:#012.CA]:CR2_MTNZN=NCIR10/'(9T:&^.>ZP/LCYI MC,HRSNNCY-(![^*'C+9$IHV$Z1B5%C-F0=K4.GOX>/0-3XO5@DD\Y:F] _^A M__@\8M^":[N)L# ,33%^?N+2Q_29RT].)=,]/"-<47\Y#^-T/]/]Q,R_@'XO%4WY$A=?&L&ZRHNJ :1J(*8]8I&7^D>RB86 MDU&WV9F3N2"E:'$L\RL_O>.'@:16:8&FN:U[CPMOT(:7T=, >/+Q/B<&UX+O MU[OW;Z?Q3CX_LX?/J0R"Y:^]\8"&+]@6B=01#2D?89U3T6V:/-V.77K"GY9# MX#GH]_J6/Y GO_6NA:E>1M)KK4B*?AALVR7: $MPLS"Q/HCO(U9./?<)W].W M? 7

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

2_-+QJJSZ] '&T,[W'YR2@/Y*!0?6%QUAM@VYA"4!755Z/Y5-/]*TK( M9=CSKNOLU6*'3R/PZIIM-!3^L""9@B[,)OKF!Z*=7]N;(LCN84&\/8?.RRR0 MG>#2D]=[2SH?=N]QN4-S$WII.IE3_1[_"&2^N<(Z1!C 6ULN.PHB!3 $H6S= MY[2,YS9>>8$L(URU,(8/G0E.18W@CE0$11 -PWTFN:O/5[1Z1XEL?(IK[:S? M@P&P@[R0*\%8U80D\('O =,5IW"="7A?F C/E==;!C/OHF'H6 M(VX-MOEP[X4"XT=D$9)#X;-J_" TA#X+T*#W79YZ'U&:(F1T[A55(0'ZBTNL M+KM_F#- RVM27A%#.3V!-A8IY4E M=EZ[YT9W&'?6[7@KOP BIO$X#/S=Y'8;>&M"X4^G&S"- NXVI M.R?W*H5\S@VQ63*_N;',OJ /%.6(QG$C>PLRP:6_!]GR)D^S>(7[V.&"N^U, MN2_EKF@LJ9HMT"OMLT&GHU#1-9U!J-L$@P=\I#2E@C\VC2%_LK/F-N/ILY=D MF[?$BU(L /RI;D%4^H1LZAK6$Q6PP-6IE>0J=QUN- -/H,@7ZJ M(RBU_UY[*?+'W[W$[]1!J/0,Y"9>K1$6/8&Y)82&TWU=8O[?2?=VD99U'(D: M-8Q)[O;%NG9WK\O=U1G##5O&D@!>7VTPR1_U5D3S^6:"91QB#"_!8IFEQ%M8 M?SK@/>WAM2@9OZHJ^VOC4=/7%F7VN9]4N<9JUR_Z#&06,A+JX5BI#_13#8P[ M+XF":)$2T_0S2NBLT*4[X?;SNT_K.!8*JDPO1]V>!X\[HK-H">O@W@.'%9/+ ME;_0*.!\JI%2BH77X0#9?]7H@E!2"S/3;4@53E]T1HJL&L8 ? ^A%#!_O*A! M?:HA0^>$M,@=TV5\AKJ.ZI<=>ZF_)320QT;;48M? ?<;V$F+)T?^*) A^%3Z M_R6._>]!&(XC_P%_)EJ05RKLC6R'(T'2"Z-%Q:@=S&:WSEU:O=,97V8-89S M+PQJT,(?EG6 ?ZKANG?-R78FD486@FIS.$RN0J\:.1P/MLXJ3/DM>IC00$OI?7(-P#7EFMB-UIP'R<(+Z8W.>YH-#MT5HE\^F-(*4OU M-:-VFUB@P&^*ZVE+0\"67AP#:= WDF#\+LV"EI=JJMAK_BMBY!/M''*UNX?HHQ]&FL+GY\7U(E,?VPK:N(! 'RC6V]D M:\'BTVV<5Q5L1E_D(6EW$6VLW^4CC32N5V[%2PTX*O,NK.\ M(42^7ACG1P4[W?,=2TT.^EHM3$?05VQUS_P&\ 26GHXRI7(6_[=ED+!W [GHJE<6'7-L FI[8\7C9GHR&.4Z]?&$V,\QK@].H 9] ML?#APPO"^-Y#G0E 70G/>KVTWJL0"5CNBP7O8;7V@H0<828)GMS6<>J%D_EC M'"T>@X]=?/^':!;F/A;\XA8[B5=-B;(Q1H!1],3)^]9)_HHQ,PD5Z(:4FB"OA@=(KLY,N(@'+ M'1D4+3P-21Y9+2T&!6>!;?561U)J.1KU< M9I20!$1W9,?4S?M5O86MDPE,T@J]Q;WHE;6R"4H!ZWTQ6Y)T4OK#FE.:"J*? M3JGEZ<7+92Q>S&B %NM&1R5#K)9VV]Y&T&GGV M-3@;]FKC9H9+0&5?#'W'\47TQ[:B)C[_]-*57 N6@/2^V/T*/YI2R!4#!Z-* MK>GHJJ=WC0I( J*;6__<>X='0W_W^A7>E5$6#E[$N7T*^IW'N/\M1?,\)#>$ MZ62^]3%B9AXJ+\7ZV*!!#,?A*Y.K2@8.&V@_U:/7_9WA5QJ+A25(Z'R0[7M1 M2H6B,Y'^B)4.6#;^Q@3&? N6(M3Q?VW?8FT%XR\8\V42X2*X%L4OZC7L2K!\GOO*Y'N$_.Y7)E%/ MQMF>T.O-&^Z!SGIEW-CNAF78<;CNM\0C_F6%/PFQ&:$D\X)H^Z?M_D@K4)UA M6WO0%\ 7* WYXL\#S<3QR;)B%%+X&PK]M_BKEY&?-YV/\[VT-89QI>STB*"-%MO,(["H$VR"M104#MIZVQ M6%4.3=26ED=C^GG79M3"1D)I/42SKVCUCA+^1,XIN,_[SCZM(%9BOIE@[[2)N%1DBY>4)+)PODMCJKWEH)S@=L&:IS[CP^ZIT ^ M'BJ*5(=Z'HY^!^&R<<5-ZF^O$6?+*/A7CKIU.E!^GS@@]TGA.A2*I5!A/IH' M+ #EESSPO6B&8&][?^S\K9Y0UKGEZ3F)UWAIWI!,G^31&UGIV0,XM?5)67=Z M>=9MT@IACW2&M[HRQ@-\)Z IG;#>GYQ=G[5-/%1.='O M?L*=S,7R,=#08C4Z=NRK92;FR4[: %-1T+'6CKLV_41-,N,#>E0:4 MUP/WR1S1CH[MW5^+D;>;1MD9^17H*+PP\B&3#IG_1)LWE*S2R9PK(>UQH]L. M>-T\*;-Z%WN'B41FO;Y4EJ/"1KX1M5(!\Q@M>6- N39 MEQ#?QN==UUF2WZZGS[K9G\].+B\Z3ES[BKF@SV]*T?N>XY2>TG7\(#2J[Z]] MH/VZ!-+F#QYC9):F3DMWSG540.1FPB\X/;T\!XY)8,R1@NHR+K=<".K027W+ M)G,Z!0K\2I1UB#" GUIRV5$0*8 !Y1?0?&-3PB-T"Q$7)O"!XT^JJ!'L8$10 MH+P'FH].W@9%>$6M4:N8WX#=YX5<"<:J)B0H_P)[\[#L,EM,X(=H'B>KQIE$CS$N'-LV!P\U-2/E&K4 M&A,A\"69H1[9@-O>'8J5.6B]#NFBY8777DA\1UZ7"&4M3$1V/L3$"GQT;C@; M699$"Z=OD"W";UX2L! 9&<*?RNZBC#W][7K3,$D67K3-[$AN2>,P\'=9'Y]+ M0BA9Q_9[/YU';E;:GUZ>G_7"G#DK<8>[WM9]=BR>5"?!- MA8 F4ZOG#DJ_'YPW-7Y2*0#OY]0<:1M =W#:>@/>#^L8E8(KUT]&H[2*P9(Q M&XK)O;N)<&.D<5 S:&7JSKUCE4L!^:;H+%F]W7#*>$$?*,I1>H\%N0MRD?X> M9,N;/,WB%>YCYUOG;9?*/2IW2&-SK-D"C79@M@/FG81WEJ&=*&^P B[BA(2= M&:=J^>+MXR1;DHPZ>3)CX699%:W3<38+BA>)MUX&LW&"//V78@U:G5YJU_-J7PJ=P"MX:J9R_) M-F^)%Z58AOA3$.L.OR-:"XZ\ZO1R>&K)X#J9;^.;IT7"<:),!UTP\K@V;0^# M 3ZQZ8E;:$"M"[GGEI@]>NF(,SL0Z#6%Q0=\*JBC,XD/\.BE]-J,I*!$6/:E6XZ;.,U2FO;FG71RE_Q(YW%,HX8QU5?6YG42K7(6 M+R*R'2T$7N[4W0_R3QH?>/R!$F^!7A"Q.P71XC?,&\EX@9(@]LWF_[:^.[V\ M ([-;H-)3T&;G\6T M .][[.MS=W+[5.OA+MD:"2F\2[C6_4NFHXQO.F^:!%6FER.C'%06IX?C+I'8 M)S.L7[=!F&=(O90U;!$C!S8KR#E1#=<:8#_+PO(["A9+DI>+K:Q/.?%/WTY@ M=$9HI3!^VGFL-+F1,[G[KWWS;R*I;4FEY>=IMOHAH+ O>+ M%^VJQD T:A$C!]Z5*6E1#<4:>#_+'%X^0F'XURA"<[R1?(G#\#Y.B*VAAOZ8 M-DHL]F>COFM1;=2?:E;_$L?^]R ,\1!ZP)^)%B3"0BES9Y>SO*0O1O.^43O3 MRRNC\'*R&^W=AW4OH2OE<6> O?5JR$Y\;RS U_=4D.64$(4C?6%EM"Z+=7Z Y]3%RA@PR1/,H5@=[G&1'F*DZRK5?UUEIJK&DV M/E-(O^\35NO2^50)CJ2IY8T2@]^BS O"'N>A/SWM-J-H(5UQ#%;5,Q'-)J9X M@^-L4GHJ=]4RHH.OWX="(<)M/E7YFQ&-VEC0T$$;C.CDJX0VT'YO(<0"PA]5 MOC31J(V%!!SK09M)0T4XQMCOQRA[6,I /$OX>)9YG MW['L;M$'"F,]6H5U=IO2TRO@M;TASWH VWIUTH!X1>Z\%WS2D"5-W/^]P E\ M_&^R/HL1N15F28M1W4+SB6!)70V@#99O3@!1TOZW5Q]"4UT[\"DP:T,&/933I,7N$QD&#M,E- M1/Z>!G[@)9M7CSY[TXE+**K#9 +L0-SF(%C :$H.!=SKP[-D2@=2@A]W M>4%SXZ7+<>23_Q#3^ =>0C&JFR3 7PB\7;('%ON#_Z;&I(7I:5]7FBJ5AZI2 M2Q"MW3ET=.KDY EY01'Z[H4D8;3L^"FO23)+7)ST])2BTA13&0B4I+]IZ;G# MQ(T[*4'?U/=2\HIXM'<I*FJ3$]'9]"/>K@RK^QC=6 XD3DY1;._+.*/7WT4L(&& M_U&,+_P#WF,MO/".)$?8".9,3JGI\.3B[,25]*JR&5+6>2%V&\K#GC/!O7V/]^F_'J(4=S:G(8)E,YR\#D,)Y& O%'EE M?M,$X9:WO0V?4&O/4X=7H\&)*YL/G2VD":C>W@:T_Q"5BLC5IXH<*@V5@8.T MMQ<&33.CT?'4ASV0!@9;1O?N63PV@F0W7I)L2$QN+\QE=AUYQ>DI=(8D"5M\ M>G4 V3*G6TP^+3!F'?;^;RCTQ]DD0KQMBFM O\EC_"C^8%[3(0]+>YL9;!YD7OB!<)V&W$7P-L=#P].ST M:G@._1C,0$ML8A9H2D<.P=I3"=-YT9'&9/*0MT0\I\X&?5DUFH(4D-_<'1CD MQNW>"Q(Z07Y%'HG)MG+GPFW?M2)BG,YUFZP:B19[>6Z4[,8>#%Y4Y*W4_4GT M@F9YDN#E"A=XBDD47/8C"86?JJ[JK'V#"F@(?'S78I"_%;0O"+=N"*T%*Z'P M@+TH[)-UJ!1\Q&Y=!EH-9$(A0H=>.!"V@)"C_D)=[=6BI!1.$^\=LLU7E"UC M_V&_OE9_BQ!Q.9<,RR9-4B&.@+WRNQC)5H3DQ-VDKJ:)$ GMM>I*3!! 6W5K M+%:50Q.U$Q>?4)M('6NOU>]0L5\ WPFT/36U*SF'[H2/3LNZ[M_"*@PCL-6@ M'=:X!@>U("S=*KOBS,LU+>RS4-QX&5K$R39>^V0N(V"<%4?"3V*%&)W^VPHA MG6I'T+&EM!CLP HQDD2@ZM'&Y7JS_^?? I1@+I:;1Q(K5N%SHM< $]1GVFI0 MVA7JI2<2MPP>=72GO(!4$2O=5XS:H6(;NJ))>@PKU,0(MENVF#K:\A"M\RRE M4AHH@QM):C&1N&(C-2)1H1 2K/V.=<-#>%I+!T[+6HVI(6'&/M>2RI#J3$K!KNPF; M!N8_$51;'NV.*$1Y.JVG$]46F*R -Q0MJ84$K2UW=XC@*3-ZRS[Y'B$?K[&O M<8C7V>P?*'O.D]G22P\NEE6V >/&IIGKI@.V[89U!>/0,%ZX)2E 7H/ M>5=6ZK]GIV$F6>CG./45HK:&Z2P-M.WNQXP&%GQ+/!]CS2-?'(Y# M68?) _J1IQU*^?JBABY0A;X$^O[V^I;0"7RSE0V=T14*(:Y46!B@'W6VJ16: M^ 6J86P-M6D'V>U"Q6+4WU)_CD.0RJ$ MFSA9QXF7H>M89\,@JX;%?36X@,[_T>;JH(5>H!A]"I"@O\<1S,L;TI\ M63CZ%GK+GRP8<<4&(]49A;ZU*1R!NO; ^$MGZ^+QH'I]XU<@2[XKAMTVB>;K MF%0F MUHW_PK]0LQ\!-05"KDXXI[7W<*8"@=@2KTP%!;*+=&D--JX;UI #J^ M95>['(4(!(K0 QOJ(;##)XC*M4-=N9 2\-LU!8$ZK"OQ";2@!TZ@;5E.3X S M9Q@26-M">B).J=,@L5(0!\_P*.VD,H'T,K;"N@5' > _B'=\'/Y#_$,WB M%3(Y*\BJ%9(!MJ!:85\;J>!Q8 \\3X\..3?Q:NU%.J-?7K&0#O#]BA4],, J MT(0>^),VCGY.MLZNF)2Z>@I4A2]0@![8.)G,..$=-,)Z*.LR^4 [WXAI$UQ\ M:,,2T-Y1Z&,K0?.KD7\YP"4ZH-T&$QJPDXT^M7S5,$H%*&9L>?30/(AK:^DL>^%XT0]UO0H725&U"A16+G1WP M+6Q313& *="(OCQ/+S;9;% 4KK!:!LCC2E2NT"D_F[*O 4_ >E]<-NL,??%P MH$(!OI%HRKD:G8!R8T,C6#22DD6EWIE#KX'"?Q7:T]/T\%$#GT I.O+L;%DE M:JM"<5L+/"O48+2.:AS@%02N,C9- F\12W:<>K.%7@-L>G4ECHGN3&&(3: 2 MD#G?=GFS;^+5>Q!M\^JPKMS$41H09W86CY3@8(#E0\<@^C.S_G*K?9JXREV]"DF M+E?.1MC[D9N\AX&"[ESIFY5AMD5_]W6F:WL MG+UM0XZ6PEE#O]L^*][DDJBE[UW7\7C9GCSR+-A6+I M3A_*"%R=%517^OP:A4R@XS@V9E2PWFC@MG1O#Z0+6"Q1BKM)Y/2*5]!@AH4T MF?,6#O(4/.7_27E/;_,SA?2AO8TTM(.O5ZV)P](=O#6CYN\HJPY)V?6[I$(! M%#A&2FOL52P>NM( S;/<@]#46U&-@*W,W2F.-7'U^[K;=%^@XZ51N\V",6#+ M5%N[)3N2Z7>F:.&)6^]1KD[U0EK0+VZL\*V]\Y8+HJWK7+?L-F/?#QC$AV@> M)ZOMLY6N7UMHD'.]H<$B-=Y@&#=6+%"G3J\F[1IG1M#FWV:\M6&:&8F-N#UP M-K5NE1E!9^1J3&8]J\Q(&#:H!Z\I^FR0&4&G/=90C X-,B-Q; &(1Q$Z$[8T M&9AV_4("P ^]6J.UZIM23SB@AIM/>KP>]?HR0KSLV9&,)8-.]PLCN0SDW/WM M'+<4%\"2FH5XH -M6B&8KSPF,FC+ @-RE"ZP_@V%_EO\UKYH?B./-"AU:MV2Q?Y2%Y M0$>FBEF\B(A@_A:'Q#BHL(;6;Q2+U)U0T&UHF*8$FA[ H9] UL/_17[@KM\H M%JHS"6Z[5ZM" J GZ]:42L?K45D7"PC8VZE=%3D"VM:!W*GMKANNC)UO7_M^Y#7L*LQZ>?VM_@G$CHAB"81^@?RDB>4W7A)LB'N M!:LXKW5D-6D>R\297.=Z_)FMZ>:RZ/<-KIX4-1FSJI\R4L_!Z=B:WHI+Y8/N=! MF2.2EA51)N8>&?JL:)]"%OV^(N_/'<89=-+A=A6OECALW;P?WV& '!H/Y$L. M?>ED7OH=&7L!>31!!-3YJ; XN9:ZI'$0E-:;GIT9G?TX/DZE5D4>LIQ2TS/H M%'T:4 M+6._4/+J;Q%Z\E9(,'Z;-HE'$Y!*: YM.P =W% K]$2$23CTU97P$@AD K5# M8E4Q=/"">I**@I65-'^V/?\I'T1K5)R>CLZ!##FZ=%1V8/JP++EEVGC!-K6C)NS&N4!@]<1\SM!I;"N>OFWZ&J.UE3RC M'64H08GB#-6;(]2-[,)HG$/%'[##OR%0 ?4=.0F84F\R[(5U"_Q ,?;:(9J/ M3\ OW)OOP\DJ?Z=76S77?7'M[=S6M[.@.3P!OW#AX_D0C-;K2J4M7*#K9;(&2=!1< MO9F2*(9_G98*V?3-[M,8K4 3X-)?3Z+$6ZV9VTAAMIC'>5+S>-^@P4)2?3/] MV (M4 \X<^ 1,+.CO&;EO02@'M+;HET+H(#BCJQ\#@6,.SL'HMO0ET;:?X$7 M34>VN#]E5+BS<^#X^E*%X.N0?0$(%*\OKGG% *29*N0S2+4PE@&0I==P\A!U M74!?7Q[X',*Z\3*TB)/@#TJ"<$>@7QG+R)F'$(>\Z; L1B1@'!'WCD #).TWA&?XN7 MG;_'^-3Z&RZ>)])( XW:G9X-G=C4'5&M&K6UD0ITR-CZYZ-Y$-&P'%_RP,<+ M/W+DL8AST4+&87CL=646,D#2 .;TS-Z$:O1DY,*=I]!* Y%Y71C!Z"#3]TA7-*'@*X+S4FL*H8.7M>"FA>W?@_13._20FK94 LO17Y0,E[;)N?K87]T.*JQYBD*KO6/>LOB5K87'L(E-@>HHS'=\$[59V=S$# MJ(@'M9EOA-320Q2+<[D$3DV^#V!?GKKL069*, >:NP]'#$:OHM(.\. 4Z-F] MA6E:#P @'L4PKPD"AG0^B(17)Z^)R*@,"^FW#)PVH(Y"EC.#BE M_8=])?'G]+"Z (X&*%4(O@[9%P#LRX[&BO<5>6F>T$GU(5KG.EMT4162;VYT M!;29,YQ+E!ALO<7H_KC%@Z:<&,25F$2 8\$KZ=)G^0B5K9<6W?-,'%#0OW)R M[_:A=[86U""VW\'@K!^';"4&6V\CG"!4.6Z%=;8" 3Y:*]G2)OD8E:WW$> T M*TTHW/);00!/RQH\:1%\C,G6S&8E3CG>9STD< MX7_.$/.5DD_51NT49F*78E.*Y_#ZX&P]9^A>,2 '[9 M4I\_P:%,!=;6,PB ^6 OF=?,BWPO\=-O:]_+T.G)X.)DH-0#K?J%K("7>R61 M@OG &*2M%Q(V(B8V?1PQ!%K$-2=M:;___3BBC<<1(R%IYS,-Y/YZQ)+*WW.D]G22Y%/4S A)"UFR9)WJ6$Y.Y(?0&N'Z@ 3$ MPP4M87&6#WW4)]\CW/PR6$O9U*^,H3MQZ%(-8B,X B;AO,8T>W\;A'E6O&FK M1>BV#2P()VY%+?%Z@$I +UP$X:*?D_EMD-+3P"2ZS\DN@?G5;6_AH@4^I44 M4IR_>=-^B!'DA21?YQ0NBQSA-)U%)HI(S@J+F5D+N M;RN-\0@8AWO)R=L]W7M!0I/ID/4TC(D#@?Z&DE-Y9[@\N>CMAE*%2L!K9V] M&X]EDDRV\._:98:]Q8=(^Z MA97_Z O%&ZW/OW.401>H$]QST^9(6>+HME7I\"N%3-W?-;0-7Z!2<&;(,MH2 MCJ,7?VI%$=##L=9?MCRCA-44:NFQ\#[ST( W(YN?4%]R?1"WUT31:=R'^*\=EU^^.U MEP8IJ4_UX@W-EE'PKQP)([1U\=E"E, ^7_J$\R>!SH1D*9Y<]ZYB>PE=;_;_ M_%N $LS3M^GU4 A+* 5I'.-4"BDOK0LA: #5*W2@YBTBEKYVL"H MG4)TP%Z)-9A6J(PQ?$L1[ UAVU?J+3.E%ZKDEJ%6(#?+M0G4Z$<"LR6PN59 M4H6>A3K="7( ' <7:.VR*C]+\?VZ4<0V8JGNA0&8#=@:FU5%,4!O*>:?#6_Z M1K%5=Z'LKMP-VE<6>\4PIL)D*3R?79[LQW$[';@;DT^3/S4^2X'Y;'"YC2AH M'DY3@;*GHU ;7&\C\K6T?7F4/'_JZM,%0<"QJEPQ;W0A9UL1#JU,9B7@^8KV MB8WD%/]K]XCEVQKK0G3D("N8ZFJW5RS=P%FJ.M6%ZG1J1X"P\13U%(W<6;-_ M'>"ZB9-UG'@9HM&GO!DIH*UL!FT6\@(ZT3BK<'6%"!OP44_IJ.-_&H.<*PHD%Q5L*$GS19#L9^TM@<+6"AD!>24YJT[FXH.-;]E Q?YG MCD]3\P#Y>UPO<1X)WN@U;+20&'3NWUXHG(X4;86WM)D20A->HVV7=HN%M#[G M?;IEG5.*T%;@S7:W7.4-Y0[;S=*+B$LCQIWA+AANQ31;+&3ERJVZ*^I63X2V MXG^VO,-'GC7;V C'9BB1J534^2.^]?>_1CS6:9U;[*R[O1\?S[HVLM:V#>5D[%N$]-SZ!E>4_S\:PLS MF [FCK:AX]<;C6#>&K6QH('/)&9T\E5"&ZB#&:)M:(-6''"-VEA(P%9=;28- M%>$8(VB^Z,:*L(>E=+,]*HD'$?"=MS9#?(*Y>"SYR[HVJG5\)=25L32A(_RW M.<,?X03-2-V>*GQ)XK26&M"*6+# )S==^@S)+Z$#S4EM(P9XOLIIH-1;DGR; M!,/%2/"_0T2IBOSQ*DZR;1))H4 D*F+K$UC,;6+T()T MR*$9!Q_SZ\PWN!H6#'#2MY9FFSTV6PFSX\P+P4T[M]LNW\11&F @C"S?#QB\ MAV@>)ZOM$.G8PO.&X5V')'^GVJ)3*3L].[D<7IT &7&NE,HR MO=Z4?M(WYN@UQ> "+_-B$E2F'$.0;KW@5KV0VZ6D?9VAR$N"6/;TC5>6P89. MK%N7JT/JU2#=>D*M?/W($'R+TC7>2A!/">E[,V%Y!A_("4I-"H=$)1*H%\V< M:[&W91+GB^57\E[W;1DDQ(4J2;.W[_';,LY3+_+O@WFVN0L62[%-I58[3!I MOD9Z/%5NNAJ@!#7%<(@?KY,@G$2(VW>\N7M;H@1Y<_P]&>VFK3!Q !G6:Y)> M&Z,EDPM88$][25)W;N'N&-P:+=4F<*&>![?!?H.,JGN10%^J:5"F338'&]0K MX\9T4+R2::3^9H]B+;F(XZA:>? )0B":]P,D=L%=-BR>L36QVKK M;:TU]KG]OJ%Q#W@V/$4-AA/8,:$>IUJPG'NVRNWU4QS-C!DL*E&TT#&9+)+( M0=;:2U!W[@7VH6KW;K34-[I:T/2N@*>%^T02ZL])+@AJMC0=#4:C,Z/K@X88 M1#<"=9IAO0>Z#6@J\>H K W?0>]/A4'YA;Q%D5P0[/_.,,*E :Y/2M667 7E MH*.F#G%"(^)1"883,/A15>("5H[ZZU:44@4E7X,H6.4K*2D'91A,H(LVD:GW(9AA7PDDR3'VZ?'71-5/#S.R*V?^2//_ \KIC4V3;K-L4$ Y=;Q-;&HS%^2T9P>V\_X^2[E_B/*C7)#("Z^!.-,_> MAASB'R*L3_A KVU/-6R7BNX<+B.=906Q*!#73/!W?(Z+>_6[1BZ@-V"SZ_.!N>=.P6O'.M4SK]'A1D M706^I!0+4. _P(?@EL-N'>YN0B]-)_/7C,A"X1\DJK/SH0#/;")@24&I%(Y; M;KL&#)=1*5U_JH4+(4"[@&C1Q*=8 ]8D4H+)D/K1.ZQ<\R3_&:7J/9<$BX#WP_8WXU&I7 M9X( WL6:T&N.S)(AT)5@7T=935(W'H/>HO>L..QK'/WX%>C!_;*I7T=)1*\H M"N*$"DKBP2&IP'H$_')3(2S>'*C$XZ#SA:&^/418#CD-3"8_\54+3T\AK:0Z M]/ WD$(DO3W?'2*29@1452&B -YQ"OG1H;."Q*4GFM_C;/ON#/]?]AUW=Q,1 MK96^QY17(BB!P[PK"*A,K'J('#K+/>#=1I2118,_11X78?,/G-^:^=0H1 #J MT2&C0CC!50LQ,$">:$+)B@DXZG6_PSX]QM&"Q XFDX3&NU-><28)N/NW^CL- M*1I0WPKKO"HW'/P*3!K "YB4)CUFC]#8"I]D:]KDJ_!M7GX*3Q[ T[7X#3PMS<#H:7)PX-H+KD7J,R*6$GD9J M^!K\L#9^]VT1N0ROSH&O=5L=OARLL"\7K<1^"/S 2S:O'G%OT;K;%]5A4H;S MG*R_$5-#@LUQV9SG A8Y@$_FI<12ZF ?RLI,3- >'4H2!>3KPX--8=G!:SJH M\(FU1B^_^[ Y(#MZ. >5+)LO<@$M1_VUE22Q0V*:QZVDX/MT"Z*& IM[$#A& M)16"I3J1T">7TW^@8:81.X$W04:K4:X")"SB;@A&O]53C"*U .=I_ M+<*9VVD43/'BN_\SZWR?[N&XO1>(OGTW'Y'H96MHJ0 # &1HYTJ2+^RCW@K$ MW9<\=/N$O->;_3__%J $BVVY>40?*%2LB'H-,''U:1=;$Y] '?J2R6X/<9N+ MF;H65W$K%T>C=ICP@*VOACPKE,4(MD!G^I+R;H_O(5KG64IE=:I,:RFI104# M'6BR'I4*M9!@%2A!7_R@QOY_Y=N7"/=X=D7?Q[-9G$=9$"V>DSB*R:L:^E?% M)5Q,J6-/-<0HTHP=154K;8KJKU3">BZI,1Q 8UF M>"4B ;\]>'/'@Z:!*NO19/D(EX!GF&5Z"IZ^E[+JY*#"]/+D\ M/X6[I:QWN\SIOX D/=TV_Y)[X[+12B(,[A3+$^>(J$?]5@@=F/357LNY(_R M^+F*2LP\TR>G0@-, O+@XB+O G+>_5BC*$63Z#B.!9]#937RY!;N?:0N'14> M=7$)>.S+4[O#]]7WW@R-5V0?+=EGB*HP6;IF*U!1K8U*0'1'[^ZLO*E\V[YM M>4;)C'"S0-?(2X)H<1_\0/Y.XP5!;>LU1,5WZMJ]OJY2U,0J4!77GN7] ^.8 MS+]Z69X(,PCJU&2XX9P':L_Q1N $,2/ZXG)U.+]M@ZX1W=:/RU.N1,4"F#[) MYF3/Q26@NR]O\PX1EJ1UY%O*R_9JW 836M\V>?5A"G2C+^_YA(#I")C,"]SW MB,R"LMV <5M,B*X]:FFL*TJX ITQ-E)QHAQ":PV]1F7>J*]H)MI,U&J'VOB@ M8E"UJ"TRJ )-Z8L7FQ@T_@!]WO"6>#[>/]]Z&_V]AZ(=-LP^Q]E3%ZI 3_KB MN:8&3:+%XL&1!1^HA+_6CD75)A.J:RZR]O1'!5N@2WUQ@#L4P ORT8IBH?NV MXN"NK3G"%JC SC_'L4<-4J 5<*\[MYDABUV6. $3MRA#UK?-IQ*-@*>^F"9W M-K2MZ\8-RPL_COPB2;QDY&K4IH("#-+8;-2: !1H ISE<:NX3SGQO)G,7Y=8 M5BEYP$:@?%O'4:'2TG<P"6PM59'^V0=3 *@J=V9([D,+WK/6_/>A\GMXA$ MU@HB_)NW):(0)>DU:S;&KL;[-M MX!5H0T?62MZX+]QV\,8BB/U#%"K^M:LS M"?1Q13=&*."X(ZLCA^.BC^-T7&P?)_-'+\6[RW6<9(@EC,6+EK4$I] MNV>TA%F@&1T]@^6-?JS#>$%;[^'$\Y"D54G2!/TK#W!_LGCI?2#\1_S#.@FB M6;#V0H_>N,?S62%,&KL=%\F3V=)+D?^^R99H%J_67K3)\WDHR-X+W2OVMN2BA\N3.Y(3J'I'QE%>UG O2#[(\\(J3+X62BI0F&!) MV9HHB!8H 7=],5B2Q%8IR6R%TDET]X.\.6+'(Q< M\W?4/:::013H0G.#HQ,IOXJ4S_^)-@=7@T69WF8 (^/Y;'\G5WOSN!51//\G MVI!M;UJ=.B0)P;2KLZ7C!/A!NTJ4U6VA.;[>YHANFBJ,20#N#%B#*QW[_"&V M?^ .C4$:W/(Q64I*YDE OE98)19571J[O?C%T[E9-1ETPR?I41GT,OGH^1! MG:+&5L/A?*1:VB9Q %K*?@9-=K/76'OM!X[LH61+AV0!+DNIT)HEA[?,^N[A MR:W\&9:XTE:RGX%V/BQ+2<\<\:0NOR"C ?K]&@YKLD:V@@,.[&)%'_1@VDJM MYH0S8]M/=ZC43ATPCS56#BV4ME*NU9T\A(\S26<3K-%QI'>-I*JUA0SDJEJ3 M6"-;+)WKUV+_5RD5;90@>/VF%.H":JU?&AN7 'EJY67;(A+ M%[KQDF031 L:AI;]YK-N3 DB>1I\Z"=PC&TO6/ M(RF_ZZ9RA[H^UV&(SZD4BJ5;'T=(;9+'?02\DY'2I,?L$1I+=SY.G%+J7=H. MAT[M;71&JPP)U-6/TPR%PF' 92S6N:"F>/]^]T-"!+9*Z'N+]Z'0Z.'4Q%J;0RXN2YGBR*W7Z%5 MD*^T^:Y694)R:ES7XUT"S=;%BA.C?&>P-1SIA]689)WRK:K'N@"6M?N7./-" M:,9+FDVLLD:T<^IN=S5.[;@;#_DJN,97.%=,!2*T()?Y,!;*78!?A5UR5XQ) M#\B-KAFS7!@"#LU?5+HPC,L.(G?S.9J1B%<-_6DX[3#A?8+1K8M3H"3-GVZ" MW-6^HB1 Z?AYU_77+)[]<^S[ 1BT& GB;+) K?S#I@.GML[SK'(\:E*;C&19) M2L>&*HLDOP83!?!&6(ZJ[8TO9S=RH@(0B1 M/TEVH0BO-QJN6;I-,!* SU#U=P7&,'O[ E&.5,NO2[<))BS@ERK&S-91$ [F MWKY:/#Q'*Q<77G$J!.A7*,:,\8F7XNOM)?=-O%K%D1[#E;(,/K!KKB5ZQ> L MW7-WSRU]2D=O>LCJMUT+%89LS=,=M];>-Q+:7">A2W9H4X.R=6L-.WH?-9S,N.79 M8@7\EJ+^["S'9.M%H0U[W"1;HJ1(L?(2+)99^BU*4$ANNM]B"H%$>D?)+4IG M24"+\KQCK::+*"Y%]2SV M-3[ R ,V\)FH54OP;5V( X>>*;U#/EPYRZ"5:5H:M,8$"GSG6T>?FF 5* _( MJQ,2N7O[+OT0!TD9%^".>>)U2:\N@^W0?E)C)3)$)B"T![8[SK0HS[XLNV#CW#_>NV%9*/1)]^VBRLHW[:]Z+[A;9J!=QNG'@,"?/86R%9@5-&" MTUL/-[MV;RH.X).1'F&FEN\=LMYZNC4U?%,!0#LP*NG1-GSOX$"YKSEH]Z8B M<@!A.%,Q>2YA.S"I=+D4GPGCM.\-9S:UNC M5A#)(41[BUOB$8TB/WU&"36-W:)9B/\CNWG2;&$Z.+T:G4+[ ME]33#V.(;<5$ ;%!/2(O+46\Y;ZD?,$37T)&RPU+]IJR2IT;H1Y1FB)D%/I6 M5&5Z?C*X.NDV^"V5&EF9M/I]5)9V&/H]CU*:_!$F!F/)_ 06>&:RIM=)T6(/ M4<)IM3"3 _"L*6:'SZ8$AB4C$QB=KTN\F211%G3HK!:F\A:&U:1+]W!7F+K$,;V$)*E4+\R!0\=%-YP;:R! MSI*MR)'%\MG;T-VH]H*YJ\!4'<@F6(,VG56T@LV2I63XDTZ:H#,^!5N&6],, M:6GB$"NM%+8NR!F).+1-M!17;WA M-,4D")>*O .]D:&V9>ERT:IQGV=X1?Z*A\PJ7QU,N+VW85QU;<,@?3E4LL? M>P_"(-OLA,JF)Y\X8-_C7GOA/Y GN]RMW^C^>= E^"%:P9%H_VX%><_S!^D( MX39'3WAB>/N.P@_T-8ZRI33'4,TF,5U8'"Y;V1KJD@QSWZTWN@(@P^?M>VQ! M?;8M,0D">RFTK#7'4/MO&S+ 3;*0V%(7TA:3XB=>LKA@+9FF>J$R]W'>>,=3 M:HK*< #LG=&!PAQ@[;N]2Q?X>(XW7A1]\&%CFCEHCTD3W*S=JN;P ??=A*:+ MWH+&,)D!.TFWK"1[C+8,9,4IR2(V"QRJ&WKX'$LST M&I.*HN9T-+@\NP+>8TL8T['WBT'U_;PNP'F3)XG)-=!Q129=8(.?+H=&&G , ML.^G;P',)[S?J:L#15TF)6"#3"MJP,'8]W.U *DY_U0BT'Y#K;"^1V;I$ ST M?D%ZMOL6^=OK;.3?_9B1T!^JE'^UVF.R=&7;I[LO: :UWTXD75M.1J[$5;6B M'#QT;3V# K&9W,0108VB&7F![43J,!*8.F!='4?^00>-["9&[4S/]UZ4;EM2 MMJX.9R?0L0O-I:ME7RGC@PK(P@M,%7HS-)F/UVOD)>15[63^B,?*@HF='VI% MIUJ!%_C<):'AD#=C5%#6%5,6A0%5]"H6F.'.5@]*AM&$W<9YD\3S+ MDR#R(G_&?EP%H1?)$H^=AJ> MGN^MLV[;,8:CB]$EL)NX#5%K&35V8-V*,)LF68EA_%/!+OZ!9 9(XS#PR<.[ MW8 4;*1EQ=FEC5MK\8Z/0_*T4+CE*U*#0N%V65Z!"0#(2*7%C!Z91VAZ&SK6 M8.Y2!I0U;HN)#VCVUF26/S'7A^I6 %K%P"_"M+) ?U]1MHS]A_WVJ_I;A)Z\ ME2@G=M,FZ81[Y98-1;P&6$'JEFE%H2XB1-*U0EZ)"0+(O&*-Q:IR:*)V*#KN M*V).3[/-0S23&<,Y!1D>P%5?4]P5D[<,BR5#2K.49[P45K@[NT1ND<>Z]QBL M KS&R6A35MO;#:"BZS4AT@Q=6U:1;O9T_(F*>"V6MCL[X2GN-(S;VLKQ<@B= M;%-KG;8#L[>9SHU@*R](:K16B!'8AM-, 2PH%4<>_'W^2NO-^,T1>R:5+'R">OL=@JG ^B\ MX28KG!Z<_J:#W^.CZ+#Z>L3*[D^B%[J%#Z+%M9<&Z;$HU[NV/EDP GP'J:Z;/[AAD0GW]YC*)8]?H9 &\).; M3NCF:YJ&9 1ZTH.T7WQ#LXY+BZ(F62XN!WVX3S,%9"L7O0VCF>B>("K?/.R\ M,]B#(3: Y$&\&S?+A 6\[]4EM&+,L0??5NKY>I8>.PISF&S'FL(<-CL]'P'9 M(*QE?&^?3V:"7%-:/<-]4?5'!8/G,<[A-[H"42@+QU9F#7TY4A( M#-X1GCDN\8&2+,#UGN),D-/21LN%<1[H1-2M,C46D4"]FN=3ZV;3R^0FV=NR M LRG NANN$6-$* 4N(P9FX.! @_P[9'F=T_I=' Z.CN]_+R\*W$+-*$'AEB^ MZ-C_?O5^T,!Z<9K>_5BSA[^JZ!.UVIN>7WZ^9<2"1 1J96S\=>,QP OZ0%&. MTGLL??(F@L@N_3W(EC=YFL4KW$408: MSIQ@2,TAM4I0O?+LWR(AL3>V6.2._<+R##Z@*[>4$R&%$B .1248^Q]!&B>; M>YEO!+<<13,"VNWHR;DRSBGY \U)2X&A,*T*ZH'GW\ XH6R-Y&'>"ATPFG*:W'Q (7#ZA5[JLH M>QNAX,9;!YD7!G\@?X>4)))6#'IA)280N.L3>[2K(5KRN _=MSJ4$DNHBGYR M6\3>[[;AYBN]\3*TB!.B7^-4P^X3^=1GZ#7.$[P?+9A0FR[L?HI*80CL16K* MF&ACUY)H_G2&D2'X%K\E)@WL*$/AYO]/84<9 CUQ5G)B:D<9"E\P]\!%M[AZ MVUDDOGJ1MZ#^BACNV%\%44 FQRSX0%OP2C?>^HTR@0*^A%93S=_]68#LGMV' M37A;,3Q$>/\GYEY6G$$$.M;7854+#' ZC ZVBGIF/?N?8R(&OSOI9(O0B1Q[ M:VG:0;K[,0MS/X@6NQM_#/XV^ A\?)25>==HU6=B K<\M<@_?\TR$TY;J3U< MMV!\0?$B\=;+8'9+%O#@/2>=VDO[$YLO+DAP**-,#S"N%+2?P,\\3&5:UY5B MA[57%H/]"ZAB+'FA+'R6J#R%?PGT"M"POB_CC5YJW*]DP/K<_%'1N?S']]LKAKO@C@P9DS=43 M^B%1G*X[$9W0C)6_WTE8^?L=@P9D4VW"2JGK3OA!F+'R(&/E80L-T,Q9EY52 MUWM[E>-S@3Q6G^?&,3G+I"YJA@$;H($.L5(T$1^[^2,_OM=99 M7EYU>KX/)=S1O+L/)2OJVO7FX"^J5 AUVL.H@0>O'B^":;L^9$MF : GL7IP M%2'-]!O!(H,.WUF?:=$28 ;>DK7! 7U1!C*K%L8B $YI9DJ7FO0R,DO6!VOA M%WZGR_<;7K[?$KR-E5TE^D\8U& M/&W-RO02"2HK:$WR]$&YYPA00I"'64!?'CRD:8Z2YW"&3P/%W]EO'V;>AR;- MANU-3T?0D6?K\%X/96^-)8)U2,=THJJ*90T=?Z^C3=81Y+;NR[O1B.HY^?", M+-$(5=7I\ 3(4FU&()]\/72?*N.DTJA2]J;8N3_N7.>>DYA8GORW^!,;688G M'2>2=,+(XM2.3LR+32.+9+_W;R,+_^ Z/(&VH]=GNK&1A8+_BO!=*2J:6NS:VM75B];=?^^>(I\,&ZJZW6 > >N[)PP1EMLBKU MF%B TP?KT&9$^!&V%@)IU)W]C^T=.J'+#LLR5&[>1![)O3*-*Q#U-F=DFP;Q MX4DOO0[,9^DCR+8R/8*=@_<>F=JF<&$=O(EQ;%JUSX5)Y#KS?S<7^ M-';M ? VSI0N?;OV0+A;@[9KDV7Z[NU>SWRV+XB5WD&[V*"ROY+U'M2B7>MQ M\(L7+63!X?9_GYX-3DZ@]\/69E,^-"=>-QHQ)QQC1R481,"0755A"P@YZF]O MO?6*6&-O^"N*'4VU\"Z)VN"LEXYYD@V, FMO#<6'N/9A@BA?!L'X1)4+(0$; M(17\Z9"NQ.>2Z7@^ISG!D7^-J_QSML3;@KN(*+E_GT>^W)2L5;= #KRZ&I)4 MM3.;P[5D>W;@=&+= #WHIT>6\H1RR[,;MAXS*TK1'FCRE00@Y+!,3UIBCR[&UH+&/2?Y;DNX3B-DAG(4VUJ7/M MT.IWI\55>M=W%DIO)62'E7TL;GIL,S8 L^1RL$\TQK\%V[ MDGE&"=V\1#.&Y061^,@SO"6D^YUO42!]?J!=?7I^>G)Y#GUF;8W6BK'#7#!. M1+2L=Z8EB16*2&?D(VHW:$FM*?BIJ),U2BD!2_=-8*8.+CSETB.MAP4#/(#BW-@CZQ6!S4?KENW559OC"E$P&#?56'+;XQW_86Z M.ZI%R5?O1[#*5U)2#LHPF("AO7DBKQ+#[[-;+PU4U 21FIIR&083,+ZW)C7< M/MNZ=NF&F_TR^SI#D9<$L4Z>BG+9Z?G@;/2I#25JZ+:N:#JB? OA6Y2NT2R8 M!\B79[$0E6?X@$O<8W"^/O;=PQOE 3K=F=>*),SB']/BN MQ;,Q.@'!'47PY!#\&TJS(%K<>.LU\A_F;VD2I$]H05-*RYA5U]L[3H*F8#-G MU1"9@%$H TX7KCJ/.MF/&C<^'9Y]9@.M;4$)]-#86F4Q8CB]660N-B3@$KE[ MQ)-E$/O\*458' .$CD%DB:3*9*/ +/ 1Z8MW<6VQT?_93L1,'H,VYAK.9[#< MH1\-MJ)K[9"62\=YMF0)U]M06?57,2O0AF(W M-5A7= *%[K=GGK$N8EFX[AW5@AHQU (-,+9P@D6"I.#>U:)[E\WR+\%BF:7; MXZVWD/J2M_$]>MGW.7=^WM % M!#>W$COQH&F?"N1;E*!9O(C($ET4*DO\[@?Y)W&&'>,Y%X^!%T2,/%B"!SO6 MSE]#%<]))O-R?[>OW&[B-$LK USGN5.SAJ?#X4FWZU&_WC,-@=\%V&!7L.#8 M%9*##Y84?AEO04;0/T0^25Z=>Z'$%8=;%@.'WI+8Y;#JP2'![>"C)5/"2<9[ M.I#(R[]EL'Z+[Z(LD,1KJ]$*%A;@?;2$/PVR=9"Y]FKH;K4.XPW"9WF2E1[O M%G E::@3206,$-#;JA8=E>VC$IZ#D=\^T\W5$/IX@HKTWPLKTQ7P_9H-=ENW,EV)'QST9%FM&1;GZO.$'!!GO>=@ M=M#"]"<+BW-Q NQWR=&*FB?0VO!!#5P6 KT>;$R4X9RYY:<7T(D_VZ.7KTX2 M,?3;7L8)]I.^O'XSU8O#>E@PT%8N6/W@B0/4EE4OG);43JY??SH<75R=N!X( MTI)&U)-,W_,+.V]VOX)6OR[VS+8$U9:-QG%=O/M7'F2;APB/UIP2,M$V&.S>%,;\A=M06=,^X"G(]:V8IM)95NEZ@K04[+ZC4X3H&I_V 5,%[2C64_5GB?'Q@'# MKIC>1\0/>UOVDVC^?9S,40"M_)5>8-X^P4M,"/T7B+)Q +7/.P3/PO86F[R5V_MJ_]M-H6J) MH@("GHDL<=RVL\).5);\%3J,LJT=,QW*-;X]L@Z5@H_8DD^"JV'3AX"!2JO" M%A!RU%]+%_0NATT? D8]Y(F\2@R_SVXECFDE;/H%D(>, 37EV0H!*/0.<8^YL MY+H1OPFI=;QBCF3C5OZ;3^0-0Y<+Z-=\'2U^%L5EZ7[41_. /8GZD@<^&0__ M#@!F^CVV;87>O]E3+8GNMB8Z6XF2^G;??^\%R6]>F*-QFN8K=C% HD21I>BW MF(13"(-L\^)E:'M2:F,R-NY$$=T+VL[6B=9W+U-;2:0^\7!@-AW@X< Z45 ' MO8_Y#,.!(U-;MZ*?83C\CL@:BG81! ^%U]5PD':"+>JNGR>=&@IZ\K25T:Q_ M+S-X,GL)TG_>)P@]1'A8X^UEE_K/^S:CJ?^^8!VJO52,MI+ V[PZ_NE]_RS*C.4,&'3Y;DU?6OJ?6??9O-._WT9 3;P7#': MRA'(F;[A_!B7<8AA;*U8H1<5.3H>(GJA0'XP=5H4I:2J?$SL9:BJLI^%1D:A MCC@]*_NX<3\IKX#PW&1/0XH MC[MZ$J^P)@8%Y50G(T?H)U M5&"!&TUBX8IYX/0>RI=.8W[>=UMV(:^H5& % MVG8KQ%_=0AO@<G[N$YASP%R>V]EZI:B[*WK6QF59%/M9Q6HJO!DU:+,0$M"^O3VI%.:S)H><>-Z6=[+.7 M3!*Z@OKT_N(9)?2&0V]G+ZI=" OHB9TMI:F+N?>^*$=#Q%Q+]!K8"^W"X?." MB:+4@&W+D\-:N.'=-$F[FK(9$?>8L4? M*)D%*=[[!C,D99)7LL &= JP2*$2GZU[>9NQO[>O02;S:Q2A>3 +O' 7/HDY MAHUG^$?&YC26A4!_C(V'K>A/:<^[@Z96 M#TZE G'_3Y F4 7D=A2D5WLIL;>(Z$Z<0/<_K2\?!O@%;C,=/>A4Z,8X35&6 MOL:A!OM%V0)?S\_\>@@%##9_@PCBOOG_MW=M38W#R/HG'4* )"^GBLLP114# M% QU:I]2GD0)W@UVUA<&]M#8F+;NC:1H5BUZA^C985W,.] M\7)3O%!!@V*75*SHME,7-#Y%[NWHL@^ 6\;Z(HM7$<;XN4'/3296_-G?'"? MX&J+5I8L9^(4Q(Z^:GN$6."$ZO?(^JCW+R>UK.=CZ_.!>U(G)5;S<-HAAV"Z MR(@;2J"8VT,ZH52*JE-,)Q/"YSE5D"L3N/!>C08HW!;)5X]W6IQ/)B=8;MD^ M3XL=3M16BH);R9'"Q!%Q5:E 8W5!<9JJ( QVX5W+NTH[H&U#>;$URQ8J=FG4 MZ>;B4D[.Z3Q W0(0>MN(8FP1,]]<]1)E/1>GX@ 5%'>D8)4?_[H[#'*MBI[N M,/+\>&MS*G*Q6R'X,!3'PL\.)&-0LT8,EZ MD$'Z]KG8Y.P_5KHQ\$LX-9$+OUIJS5V1 "H*&NGP:G@XM1J-9 0G"'*:'(1A MI8ZGL]!E;YS@("6,_')UGUH5.8+++]9V.SQZ<#XZG9R?G7AK?SJ5%Q&3X/"H MCE$=UKTZC5#Z. E<$\#<%^CW.E,@TR/UTV>&D@!MP7+VA Z$!%FOP]+ZM>,DB*;B8/UU>2VXX25.44+%>B@;F=/T5^'2P"'<>@LTIB= M@:_;..(U#])B2_KY=E#WH!AF=!=N]8:"G#-?+\)BR>F*!$!:!5RT=TPW_RP, M-INOF_)@J_>;+[K12^*_#4P82O3^$@7#Z<$F)[.?(WAD/+<'E]7*AO*#LR##WX& MGR3UPZ"]_Z J8\]@C3%A24C"J?S"5X)(IME:0IEL'7_1+XP7DT@IR6MPS+8ZOXB9/K%+!W$"8+<(U'+ M+7,FUU#Y5>]?JU7M!)V7K/I!LK=X>;>_+39_2\A#\$Y4>G.+*0LB8C43=-&P M(;#ZU2= (S R1$I=7#V($P))?P/C8E,X#%%CM1* ,]5&+R8O,:-,N5M#A-84H#5_*:@GDH3Q4K-4 MCYYCSL>S$[P:C2XK5 P *I$%D7':]5A[DF-'CM,2#;#JX]LLX;D'^]=1?KJ.U6]7>M/<3QXUPP)=15)\'VC05NF+A?ZL\7OES$+G+.7A@I$*C2\CV9#,BZCD;MB)$]7^ _ M1XH"-..,@)M:-%"EW_O7,5@G$D[_S2;^S>Q<5U\WY2>SK8C5N]7HC:93<&H- M2Z6TQ@95Q+U_2:C#TBJ=X@&<$LBZIS7;Q-S7((2JZ=X_KU_R7RGY=\[L7!\L M58Z^2M?D53RBR)8:8[GG'!>U%@M4078O&*M=Q](QG" CY)A]+;>,F5Q'!56U MO7\V/Y,@I1_]:_/U%*4/7$'H;JWB%ZB:P-P IE#OTN;1+N(H^(LXL'OQ>72=#-8(>/L-P?AKAD/ )U3)I<< ] M;DE29/:PE+3K($F^5G$BRWC5#YI?(/8\TC-+?%+HX$A8;&VN=&UA+%B1S4^^ MY9_\[7,;)@7-_T$"RTH]!UFM.]EE=DLHJF##C/TY M_8:OHX<5NSK [)3*7L4P&VW_8+@ETM53FTN FNE"Q54A,9(1E!I>*7A&4J#$ M(DD\ZJE));AW@VZ1VY#50[#0^8SGF)]=3";CX6@.[@ E4H&:#]KZ-+F.(WJ0 MYO0L+0_5.%*)A?DD\[.3LPE6%Q7PXT&)4"(8J-FF+C&Q5'$F44K*O= D)/9X M!"7(Z'SL50R8$2YANF3[.2CD])&"<\ M0I&%*L8\F<]!+[":GCF:)UAED.#U"#?L$D'K*?P04N^X#X-?5)EFQLZC'C+T MBD["=;2K8V*F@!A.-I^RC)/A;3\MD$H$QMH:*=B9L,NUO.3O[T'R];AJ*&I_ M0LV6O6*$="/XGK!^/'H0ZH'SBPERP(26R(;*OP"6A]5?O+T#%KE^R#4,37C: M]BJXPPE47@;00U#'P/228,.T$H9"5@1/-XK%#XW'V-4I[3EK!6W8968LC..E M%F&SXK634>HCU\0#7/>&:(&*UZ!=!QNXV?E9_JZ\ M-K"TFHCG89+2\7BR0/ M-E8'A=&$E)C( 2. HF.!&*@ CB_[S?\A9B)AC,SWL7TC]FFE!"!:OKT$4[#S+ '=C7K M*)K:^/GY;'(Z'ISBXH81J':/)VL^K>Z USG]0[3XDEZ.K>?81?.>8U=!!CP[ MC+""->KV1$CDE\";^)WNA\IVW0ZS48X@=^SNY09]#!>JPE"'%K2B?4FX9"I1 MF-Z$*_I74K2R,CL_A(.+-B?CP;'; 6#K2D0SSN"(K(.L?!9Y7\C>A+DSZ@&4 MG,@96)"KNT($UN':DUV_((JU(VP^'8^F6+7]NK!,'($"JX:$T\5<[%>W] M(>6:ZK2V!@M5K&)(_!D1#J0$ #%49JN/-XYEU07M.1E#Z^E&YOR7L1+J@*3'ZT43Z,"M_'V/,*+^E=5+:L>5P5.Y\T M'V/P,>/T?C:>CGI=??O/X>EO:^8!DG4&U8[A )!OTR8$%J\[/2Z@@/'_5MB3 M%0$K"(U\L=:+@5A\@$D %(#^WPI[[E7!"E8@WP"!I4HLNET3$"C^OL.B>@YU M\\H2;P7&/[0LWHY_C>NI&4FP6L *V&Y;*U%1TZ] AWRSZ)WA!O08;-=7T8%_ MKZB&:#2.DP6I.$9;5<8,&58 N_FNSL/O&X)KM7K7"Z7(8=W%ZWBY)UW[>[;XLG; 1L8.8\?G%],^ZV% M49F07[)X\:^KK^M-D*8ZLZ9BU/QBAFR4$E%4.Y4^,Y.0HC/I_N]4A9I- ML&K[.NZ.8@!^69],^"-=:;4G.$0D@Z.8V!*&U+[7KP('&I;\"#[#]UR^_36> MX3"1[EDRDC<9(_YF(%,.@G,1K-4C*^U[AMT,T$TOU$$"2MWW@KLM^CT6Y,#6 M_#6L,F9P#1.0R:-_%A<27LJ[B9-%^#Q=',-7\:SX'6EZ54WEE((V:,!RO8#3 //LA=O;<^$*2L4;K7' M5<^XG@0FDU*:(H=< !T.YF#!4OA]$B"^3.ZBVSA9$'M1.1X^'YW.)J?8.6! M@B&#AIO6WY$85'T>;]2=[DR&4UHC&SJ!1$ $"RJEO\%^%/^WHGSJOFG$[IFK M+TJ@.&%1!J]1F/7N%%=\JU5BD-4\\\G):;_K]D+ ]2Z6)C7<93&FW!9L*G8L4P,KJJQE$#8X=,JSBE, MB\W#& $K[9LJD@S354X5,9*F+R5$W5:O&L?",T^QS38N.[T1*+_B#6QXS='H M=_/#YXI06^RX'C/&2)@J1.-7A(+#I+?^^1#F)"QSTP5HCG\F&E5IXHE?ZKY])$*4!+P+!O/K57[3% M!TTGH<RTA>6@Z!4PUGXZQ"U?!K-DF)BACJI_IYQ0CTH5:3&T)1VK?"Y5( MU;]2_(,$S%3(-HN[:)N;9#G+ALS'IS/T\BEP.J\6YL"3J$3XM-JN?! G"[)9 M7,LS$*@&L7@TK;,=J?&V+^)8O@Q5O,'K?Q!O;Q0RW =BB MALJ.ZO\0D"(UVA,,1E=T0C:)V/+44C(DB*$2IA B^.)5]IM2]H9\D$U<8-1; M5V5C*II@UUBSY)_$E&J$$RI;JG_>:_;/JZ\?P3_CI$@TNS>(#729CEYUD2/1 MX(X3=_RXG5![C7*ZF(YG$_1*YZZ,$C.^ 6[@W4\U]/GVN=CDRS!:&_#==BKN MTD3O= K'\Y$@.JJ6KZ>3O,]#Y>\$R9N@,:WU8HL,DH-EG7\N#KXBRI!WVZB M@HS8]2BA9UZ^LT3__Q3L=9(=V63[VP%VDD5_DF1$"K N ML[[M06E58.< .\]J4!UGCC/N%^OXK]FIS.DA$;+V9ES?LA#VM4L:X>%_1R9" MN;.<[0LXND:=5N\*BG<%T7*M*4MB,*KZ/F0OM3M5CQ>I+>9AYQ!8;&T:UXKE M3!4-D2XNMGQN;0MKH!YLLV(-Z JR4=\2A]DJ,B('O+=AOY- ::GA4=?@YW!- M7T(_,0K6?(7E%%S"?U8Z8,P'5]C]UA&U?&L<0BX$&'9^A$(MMCB'+&:I:(=T M@84Y@UP1#S;_00'8\NRQG*FZYB/'AKBRW%J M%08;#68;@("3I##0MJPTC4X MX$0:&-)];QSE/;4'.1VV](+LPR'C%K34;1M2P MIE"M\HR^/#C8J\CGED0I43A* ":N4"('\[CSIJ%M0I,%R-WBE=&B6^O6.59Q MIPZX#V8 .PP;WW0U-C*@R?>TPZHPT_GAU!&M_D2GC0 \CX.C MV!CMTD6P^0<)5!L3P.P[,H^F2&=;1Q)C;ZYQ(=BP"V794>.!?&8_?Y/-!_D1 M1]F;H[YN,''%1SQG@Z\BJ:25AY6].I-&MA1__H[!A+"TT8K>GOGX(OWK,/HB./8.\4O$GNP%4^ M/Q^=3DYFYU9>VO:6[%V/0VUSG*,'RV_%VY)-R"BQ24N #-8[N@=4V.A MI@)R=>2S,G/9UP^2O;%VAKO3J_E;0C1%ZMM,R:EX@5U6S6B5PV'%\C,Z28P, MDK*@O7H0I\0$*4!%.B-7/64Q2P=/\ !3+%KV1LM5]F78R4[ MR4DO74GU1SB(&=*ZD1%41O;Z-V.E%P%$A=/K'*F:L <;5I7NY8T05JZUNL]5 M897IU1?]81NGP>9[$N?;E$[!XZ+9,\6-(2?+QRU)"N;IRS+T\0$EIP9Q%F-1 M9K!I5%:8C:(.'6=DM!R=8.?>]BTW8NEM34(@MQ'$6?9_>U-88=;[L2]Q<$W_ MMPPH.%6E"-/1)73D!-W6?&L)@T2**)'06\*4^A=#.1?Z8K@]96KZWCU[2LLB3Q]6NC0#1=(73C>;2CMX23L$\,;NMH V\ MG$!0 1!8 !$ ( !MKP" &0T-3(X,C-D97@S,C$N:'1M M4$L! A0#% @ XX:I5G0\7;^=N0 K-, !$ ( !:<(" M &'-D4$L! A0# M% @ XX:I5I8U]XU<%@ X5 ! !, ( !?W4% '=T+3(P M,C,P,S,Q7V-A;"YX;6Q02P$"% ,4 " #CAJE6571BU=9X #2CP< $P M @ $,C 4 =W0M,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0 ( M ..&J59>&0Q[4[8 %=5"@ 3 " 1,%!@!W="TR,#(S,#,S M,5]L86(N>&UL4$L! A0#% @ XX:I5G*()&0XD 8$0) !, M ( !E[L& '=T+3(P,C,P,S,Q7W!R92YX;6Q02P4& !, $P"V! & $P' end

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

%.ETZ+#1N8V%&0OZ-(-WA3H M(LZ:VWH&.SAXP"P*PR]W7UV5IQ"Q2=G-V+H\7RC;B'+_9,96'(*.5)=,(S9[ M0"V1/I2?=H-I^ 64#$0NL^(AV7CX)'E'\N$S?3J6X+BENR@@,T;GB8:T$KY< M1@DL.F_F=HA[_6P_4KF2;-[XZ[!'!#8=ICD,[.09/ *\[#8 W;YV5#NU:9US9<[58X[!;XMDWNU M9.Z5W&^3>&42KZJ3>-5<:>7ZE]]N$J_JGJVS9XE7N[F))N5J?["@SZ9U;G3DOIFH'=Z4'QX06MP,[@0*[#Y%(!ZL&"K- %R=\3TJPEDGV5T M.8$877M/\JY6E'LC9FP$\<*0JCK(X;72PS[+7:,:FQRL.N5@;9"K7IQ^T^R^ M.@&KYAM?;W'ZXHTO*!ZP4-[5,WU27M+R:(L-CD"9[Z9=BS+_K+9_$%NZ9<]V MN^1@Z"+3*B>_-K\E/Y+03MY&(7Y/PA2L,*I1L".K;ZM3BGRX#8,Q<.CTUK/] M^-QWD//&R()I!$Y4#2Q@BV,32SP OQ-X7 MPAY6M2-K$!O/.'2?]3C4Q.&0* 0+[DJI3V'QF_Z^Z.%1T')Y6<_>+'[_/0]@E.ZT_NPE^>P6[ M'6,=[53W[6LR/K,+51B?L>]6$E .8MNKAVWW0CW[*]^43G!<4%]V'PVKE6[4.@[[ MXZ/9TM ;L6IV\<3O@"QW@@G&/ZIYV*QD@&8?JC' &?Y2$(="A$.FTFQ1'/0I M?O])ULRZT,OGO2[\6>6BMF<-IF;,,E/.!HTW&+]-AI,M8!CR)+W>]EG0 T(4 M7^@E+0@?))+I\_5'L/BAW8?#)7+UFDB7$SQ_X(FJML9A'-H.O7TT"AQJMIUT M@J:B+Y4O7>EQ8%?0=YU#&.^A2ZE;/%/#LH<%2KAHMGQY?W7'+NPQ%;7,E__4 MOU0%N&3=)%EXB"I[GH]#5]8G:%&ID58W^XCS=.'58T0%*VT?W8@*HHCX?%+I M,@ZR(X01CX?3"(41>PBPI-+$\ZA^S%\345T4[B@%DMU@L=?H9O [W-F:[YB_ M'X*B_S"D&.7]T VQM%X8Q?=/P?TPF$2PM%?N()Y>(F^E(+#8CJD2Z%V?^W;H M!D7NU^"_NIYR_?5J88#7F75<5&R72MC29M**8&$ZA'YB41B4V$N1=^45@//P?*.N"3L5I)N2NB;EZ'W)!-+!D9=X:F$ MH:C,YSRZ$=8/''!.17U'G#UPGXO"OCV4>E,E8$$(42%;+%Z4U+ =AP%03FF,!8:AR@9%XF:<7 D<<0J:6^(L%J?SYWL M0-G$BX&^J3H0=VLFWP%+F7 MM'^7][>B<&;X#HM%9D9ONQ[):%AD-Z:)J!DXSQ4J0ETK >3=#)):0Y0Q4:"" M+5]X:$$];(T<*%9)*Q0F*@.1'B.+]T@]Q"G6>LHK2+]4YG'>Z!=K-IM<\*SEU@T8(B:S3+&50+ M 5JTPG I0C'%M.\@'O'T*,4C2B3O^Z8$\2Z/3CQ>&IUXO'ITXN*/-.C$.@/3 M83Y1!78#^!\ M>T^Q769;S%_ 4ME M-!DEYO W=$FM%L/5LL[.SHK3Q*H0AMJ53=5P>QO9U.YQ2=+G_L+Q*B$%AW"M M$8/+BD'[Y[HYIF,=G\P"GXT87*,8W,2FMMHES4B"BC+( .FU[.BTDJX[G24J$'8:LZ'IM[65KALZ M,]>WSYFJ;*O/7\,?C;*:@$8,KF,3UR/DUGB6S0?ZYNM0*;&10#B4C)@C\J1(T:55 M 4J$I!58MVDG)ILP9$6@ .ROK>% !!# ]F5?8&$$RZ:H:2]@A(/8T9 -L+L4 M]5ZT$7'D.SB0'SQ./A-@RD&IF1V5816>.#8Y_AG#P@._Q:0"C@4=UT]Y3RJ(_E!:]ZLBK#'JY%B%UP4Q>%W)X M/WR4A<=$"A]C^SXNE,2%:KA1V0IU7"2]2V>=W8R>C0VXDCZBKH^=ZA'MY>OS MG[>Z"FF)"X'C<:,'YLJ\J1CU9V&(/K\E? M/K-.R?,1MIIKB[:55I(7!!6/$Q2<@AH2GY5#GPJEMWS6QD!;UEEW-@_J&S3I:7;,K%9('X_1(%PC:+ M*,XIYUCQXGWU(=[:HSHK@Z#=RZ4W)36KYW5^U[N@=-EIRJ.4NR-.T47X^SJY.V!#YKYV^A@^;&# MUKNES(-:*)Y+X\9P^*5N#J M69&L7Y#)GQ_4FON@,>WMC%X_YW"-7G6L*KB"J(Z$O#H'&I']/BY X?Q_]MZT MN6TD613]*Q7NXQ=2!,7F3LJ>ZPAZZZ.Y;LO/4D_'^>0 B:*(;A!@8Y',\^MO M9E8!*! 5Q $273,R!*)I2KWS,I%9+_(UE)I-V1D;F#7I'7I#[XK.A&-[=G< M]WAV>YE5Z3,HZWB>(%N73I*RK75 2]ZQ FH)"!\ :(J-M%7?R8P3U!2AF+,J?)4SII7]S0XUX?,VWJ!RU1)V'>^Y]73/HP[W M#.=Z'G\2IW"-287(,;GN7@D701\^K@_!)L)'/7!3-/<4-M"@U2CW6,YFH\X4 MD#""R=%:K-Y;[#,?.;[F+ 1+-SLB=R2>,D)-WT3_/A?E=T;&4=#)^R,?>7>6 M"QA#<0D&*A]2TE5:LE3K1[,CRA<5J#QPR[ = LU'7VT:B:TB7^"9BP?CISK[ MZ(MM/6%V%[XY_V%'S7:CUDCKMXEYC$]/#G]";0*:RAH;<] 3(L4,>7(UG'#5 MCW+5W[B#? F"Z#W7,-&'AK<&E2E96??%06\Y [RS>09XMYX2AWH=XP*Q9,D, MV)UQ VFB;/-_ &3WD]\U#QL9+G>#BX $@N6 ,-CU4&BN_05\I'L$$I)6?2: ML(4N@-7U,1\7>V&B;8-\#*!F.N7Z9C'GB'LOG"^U/ ;N_*/^4&?O->MO]@A+ M]8+O:NPKF2M FT/7M>7(G1IE'.-UG+,K #]V1G;],9AF+OZ%RQ'D)Z2!W,6C MN"/80HVX *G_&;G GH"I*+OO8D:[2'4&2]PS/%^N8>0ON./&]O[=!RIH=CI# M(#NP+^E]2F/*H@MZKX:W'[/7*@C3?_L6C^&J69@@[4G* M;I99D';+*DB+@]X>@K1=;QU5D(9 D%Z0("A(.VM$Z3-[01I&F-F"5'\6PJY MG(7;\:52CS;?*%(J]9!,&MN1"64V5G*I6/CM(9DZQY=, DQ",AT.9#)M<85L M0F8C'MM90(4\>@P!!>)BZ#_!L^5BV@4+C,&/9KO\ J/5+:F\*!)\)RPO0C"! MO#@HR-+EA>8)GAUS6?8+/-AL-%\'\>8$Y7A8!FE/:FQN^F[HE@'L^4R$L*?: M,\M?2HF.^9E*O',*GNDD.% MJ%PX@B']';G[RP58P#GC*=4:'R22!N3J27*%_WE$KA:N0R77^*-SMJ>:N\I' M"3>)Y#H;@J\?G"G1UX:KP"^SL$UCF%2#)UD (R!AWW"GXNAF(DKE?P93,M8@ M@ X1Q;G8O?4I]BRL*AQMUAOH^!BYK?5;*7,8]&UK"H_!;D.<"[2&P]A5NC") M9KXHPBFPH2(W,B9D$N'Y*-2EDMM4RY5](V(IL^'3[NSJ*24//6S?0OM$ [88BHL+-%$D+8M$%S98GN&0X%N6WD M6'O;ZVQ=>]O,O_;VJ(^L*B)/N2Q/W2!*)_&;U$#JWJNBR>-CIUEAI\38:12- MG7+50 3J(Y';>S*5$=]""U*Q$L^H/BQ'QZ&K>IGI_L'7_5W-UC;9,BEM34^P M_J#<> \[-353HPNVQ7,(,&R!]6Z%]2*QWCA43&ESE/?2,'XZ]87GKD*#LP\Z M8&17OF7BH'>N.:;!:: U[ICKM5@\VG:PAR(=*UR?D;I-C2NELU\ MH_)$[;L MX.X>:E=E,<34#85@<84WNK:XP>GC-QRCH.(4I=FE0&PBT;"2M(= =%/I_+Z? MGMT4S73Z)9&<2(*JD'P()#<4).^A5G?!<.)H^'34YUZNZ8]*M*Y0\TF>? P#RG*.EE]1I6GJYE[:4%IQ.0)XO@@;F7N.<\5AG/ <&XN M9.Z)8*>C!<]*V8D#:!?IC9+33D+?;15;48[8H\W2-+UF//^;<^?$P MU>)\<_?U<\@YC74)/?5NLJ/ZV8O% R+[4/'4_5&-8\(J7!\$UWE&4?='=+=> M3!.GRB/,1TF>N$\8YL[C9G OMC6.V(B8H(@ :)R17&0@=V=1V>C4![UNLO_5 MV4O+W%&<7^@S3P3?-NK=_NW!I@U?$'YSBGKFRKV]0?VV.;@]81UX[H>*W[G. M9W/O,"YB*0_I:8S6R#-"NG="$,Q3QK 7H"+S<2I:]4Z5KU$,*1Q*E>9#")UZ M.QF"JPCA$(1P$)V;"Q7TZ_WB7J2UOAZ8 MG4.OVM[K%>PF1]!MULV62NMZF8]IICUF8PF39Z_:C6RFA+FU::_:).'C[^$% M6_?GS'B>X<%:QLG+8Z?<;]0D>1S90=3J\IDAVJ":"RKVZD#AQ183,1#HCJ M6^,](\;V; :7NYX]_KM&4^$/>9:WKF'9#C74Z6978V.CZX"[7=?4Y+QVNZ[E MTWGM=ET/TR/LMIG:%&"'#U);!UC"1.#_^,8S+$?IH960/:*ICLL]7*\W#?J^ M"S6KC>QG?EUCKC_Z"Z=63GL6K=I)UF"M6[<8.[8:]VFN57EL%96ZDE;J7'[]+]M4\?FAC-M$50X MH9T**L!PF"W.+@?A5^$?^OP6&,V MX[HAFD?-'? ^D1_8[]HBYJX.:FKWI*">@YS/Y.?M%(^XICBH=)O:$0V,ZCEV M'WN&1=1@E;"4J&VVZ!:#BQH;SMB?8?7TF+MOV)4AIT 9PAXW-?3X^=S&,C#F M@F:-IJVLL]=IQ0!)D^-#=C1V\ #$G0+*'AT-H?@11VX<4DDL&3[POD*-NPWW MFY^B.8']YJJL3F"_N1IH>>VWE8_M[HEMHYAT@]9R&CKVAJVO;WZZ'JSPF;,C2/P MQ$4:IRXT@55(YI/R?6 VI1N(N -+UQQLR^UXU'&7/8'S(EI;:A96WD>]@-N- ML!=P(K@1V(J1$9C66]$2IR#:? X&-+EORE+?@BT8&(-*"]!_83.HP J_ 1C< M&#]OIH:N<^N-^ =G;/5:S1;0X*;7-E^]F\ :__4KWK#Y;3C&*[2[M[NYB>^$ M709WB7\"/:11-U'T #9]7./VU3N/6ULNHM%_%2>E;>_OP5LERK:]M:/N/]BX MVI)Y!F:[[W!JB2N^#OO4&Q9[F1ICT3XU6("@/ K14Z@OLW=ODA*17(D44U@E MN0SVHKF,&E404V2F7U"LDD*D0W<8E;O=3[X 5WZ7/HWXWM(C;W'7\2_[MD9O M;5X15^"6?L7)[#EO%V,/;9\FY:5O_4'2H]\6_?'H>!)!C/<+:(9 M05+ \BEFH$9=/R[ 2($&&M2?8U0)3RGDZZ)L,("4";(?1^>.%O$1&A:VZ[<= MG?I9A_VJ8PV!PQDA+JA"3\1YZ$JI^H/ 55+H DI,'(\&LE?."!"?7),XCM;W M%LV.*^-9W0D^T1Z/?\T36F]RX;-7#+GN M-0;]G<^0-]A,OD<0ZS?3/>1F\HVWK]M,JSREQ77[CAY) I,-30I MN!5E"VP;W=[$.-C$&%#)?1!KX+]BHE4*ET5,MMFHG^1H!*$CP%0S?9T'IZ_! MG^%^]_/PDG^KHP\"PY=$O_O94V2QL$ MOV)#_IK]I*R06'W0AA5&>V!@+-5[_>@SL8_H8W5:#:-Q-; +C4T=-.)_ :7X MZAW-JI-3\3P,I/[K5RUUI[\6Q^&T_S@4-L9\[*X4=1?[7J!C4.\:5L+. *>8#;<]$^S$FSN)C)TDV?8W"9E9)N^,;>:>L12W:1#WS]@:)RE[ M4.-!G*)5?W]+ 76 7)FSR0O M-LC<"[-C14@R%&ZU(J0;YE>H>357V?9Z2'FUQUZ;^7034)(%T[,?+"4?(YA[5V-STW2),$T@O-2T/Y!C=7 +F6M8?^/W$Q]%HAN(,3T\YTBX MD4$R!!.N,)UXL.#(@^45\LDY_^M,XA"]57&(W0^*TYZS_J1X710DY:6%AD5. MY*SXBS$S1!K3,[ NGI("XU(TT4VO'<],C)IJ:/@@H^/=*#4<;$GB\)BA0A\' M S63A\Y+1\Z&(V60MEV,J#)2*B.E,E+.RD@QG(29$I@B(%96F",UEI&W/P;P M:(;%0!193^(3@*MCF^B-6:YXOXMBR31 D.F:C!09KFN;OI!23CR; ^L97 \M MFJ 8*6U4AD9E9%Q"49&5(@5=#\< S6X^$O$A3ZP$(!GL=27)6:$W"G7JU?5 ME$PIEYYJ6Y8X%A0E05I8VJG]S6]>IC:P"3H=&DI:[)%&,D!6>;(KS056GL#B M]:!%6E1L="VX/GJ=.*?>L<1(IN"YONE1T9,5 2?HNQ,'7BURDKRI:-Z3J,NB MG'@PG"C='2[,+*?[7?MIS/S9RD*Y/ K='XR?^VJ>SL;QO&:O7^\/NNUDB$[D MV-?VA$<.#32*A4>G4[]MI4R"#6H.4&GN!Y(<>D04"I*]"6#?3B&%[K;5;]3A M_\GA:9D4L4GFZ@;E[CLD[(HZ?*67969CG A;7WV$Y/V$BH/=.]?UT0S">J4( MCT4Z?ON-^3G0;@_F^I5OMX=TB/;;;?>VUN_U:YU6;Y<3ILV9JHJ"<+.YJ/*8&.1W-^EN>FV)]"D4ZL7)6#$@11[M:/.09,JA+ M;P5Y@L?$V/,@*DUUQ8$)W@E\"Q2,%:+"^5A^1]35(/YTY6%X"?HYH:^DGOR* MI[CLRIC0:E\P+4_W^?52P0V6]3QPQX!-#^/YJ]9L7F\NOA1"[V64J*CSX+JOMRI9>45%5$K_"=0_ M<2=6=*I (_M9VYI /)X1A.X;A27"G D D8(>? \-70'1;1*9"7I09(Z90S( M@F,D@T?071[G3)Z73:,H/?I_&[0*^MVP4,_.P_"B/<%67/ 0&;[7/1M#^_ E M_!%:>L+0LR?CI7F*47!?'RU@16-!IKA5N5.Q47LBM[E+\YT\VZGM$>%L)5VJ MU^3$[U!6;OL>QC*(.# D "\Q T$B0)_Z,#PW655%KZ C)5I*G4M(E 6A4A(* MBYJ\6\U$ 1%!=#@7$V\B5EQ5SJLLBW"@49_NG]Y[$_AZHTE2KQ@'=,PQ;QZ6 MG*W.#L;E4;]@84]JECFCACY/SZ3M@NQ3').4"N64%N M1\@UQ/XJR&T'N4?;T\P*7EOQ:,6>.[!G!;1\./- !M+;1&>"7\9CSB>3-9;3 MCL7CL:X$U,)"C;JP&_I(<>-OMSME2#]"^+84#8M%AM=[?MG&VR9W_=<6Y"Y< M3(;!)TGY!#8&1$__(@A5ZJ2 ?\0.6V2,?M;&?$C 2 NJ1L/9,V.GB1/1^/,S MIF.JT=.;=A@^;:]+2VDW,L9B)H_'E",'>>*P$CW;HO/BT.])],/_/$*_;8GP M?6'([U;(+PWR"\5\KT+\6L0?#/WYH;'=J?!8-!Z;+8G'5B7#*Q(XNB1O]KL5 M_H^&_QQ%>>O >#S.,9X<_R]F1S8+[4G*^\&68;)OD#OL1* MX?_%:4\$M1*ZO!/C)]=O_I<[MLC];+;>EE185B1R%+?X= ADS^M/#O&%&E*M M[DD:4:>-]DM W\6*]>-ZRI58+ROB*[%^[F@_$?2EN,1*9OK\YQK?=C\,;WO7 M"B>1I=-6H,_W>=Y0G'$M2K)1:[Q(HPJB56A%$ML2*, M:HD5851+K BC6F)%&&<-]2,OL4J WOG,^#?'=JEC.K;XZKI+D*\T?*>JZ. PK&>K[)SA7Z"D%?E>-<8?[XXAI3FRN&+QCM M^68T%WU\6V4TQ[S3+]QUWS#E\)X9V+L71V^,;=<[.W_U:L>3%Y<)(XNG74JO5[@ZT)XD*T9/'H+Q3W[5ZRA_E^ MF*=N217BBW)J>[7N[6W%O(7AL&2>;:MV.VA6Z"\+^HMU;VN-E/%(%>X/C_O\ M<-BI-=J= ^*PRE ^JX/V,UEB11C5$BO"J)98$4:UQ(HPJB56A%$ML2*,LX9Z ME:%\JF? P=G_,3HT'ST- F?//$K2N!&,WGZ7J'ZX*@N.(^X4VO>]BL\'Q3/>28.-VNM9C*QJ3I5W=[S;H/G MK=L^SA<+]V&NL MJFK7G:A^FDSXV#.>.3-PA#%W/>9H'D_,(J97]C$>D]SL\G#BM\H=]2Z&(*Z: MU^JHXM*$XJ)%;2MYI%?A-Q_\YHBG3KUW2%%;G;V>6;S@7-98 MT4:UQHHVJC56M%&ML:*-:HT5;9PGW$]AC15M7.8:A7,,/S5X2.9J4DY#&^&Y MIO"C&\OGG$L'G'&'>).?ZEHHT*'SL>UH&!UXPWP+@$#GF,SDG@< P;! V$Z6 MA3!D#>'*_%4_EE0$PJ+=C&0#LSAJ;O@XO MDWWNB.V8/6'>E"^U]&::I;.YF-%=#X$@XWE?_1EWC'$F5'J'@$H0UV3\YYQ; M+F>P=%SW!]LBJ*"\I(-[IOL.%JKCEQX>Y[,9/'?J,@YOUMGOFC.>"A2WFS6& M)TRT68Q_LA?-9?^5'FU]\=X$2_@D5G!O*>^F5R\%5QO-'PUQAO5H*^>5RET/ MW#)LA^[]Z//,A 0UNHZ5-)ZLI'E*UD$S#0O4PQ]Y&-:7^RK5IS0:B"LF2&$N0Z_,$UN M.Z0[?)(- M !HS')ZC53_#/?0+?9D'+W3 M2I%;2YR7O[SZ@6OY#Z[ESIK[GDM;;*EWA1>\7X2__G>P4[H\9UX&"NRG=(=? MHQ&V@ZG"P!IG)LZNF-;U\J8W$@<_SW(Q#>>Q-^VX '2%&:C82RZ7Y"%PARX4 .]Q89 GE*5-!M(;LU!3=+V;*Y9"S8Q3%0Z[ ,2^@0\,(_(_R-WP0TC(G3Q M[Q \N3,A&$ W_[&!@IXDC%6N6T;&%2[]__ME #3U-ES2BJ73I 6A/ M^/L_/KBK]&I\&PDM#QA5_H4L;QHSPY-P=.#='CW;IL=GTMR5SB< '9V-N&F_ M7 OQEWDUF4R>\ 'AR7/'?C9TSCX]?GY@'[0YO-X4^^? JO8,Y(C8%^/_^ 8( M/"#@8$62*A!LS?Y;%WA[!BXFX!O? []H5OX$H+D)*3S27,-=L^LIF#Z6S9Z) M=$),&2[)9\_1+!@R^205-/53EA()6;E1Y4=BH=N^=@C:%!0) %E8^C&&6,'2 M(/KCZ?*,VKQ55]Y]A,G+X=(= S@ MT- ;\D*B!'ITT/4!T6;[)DH*"V3&V-!,$R3:B\5F-FT-./:V?GO[.K)IXAQN M@^'H =20B6*;-&8SKAN 'B>-@'4LB=@#[B*4^H=0FII#W$N6.UN91\8*(0U M(-J.!RT/%O%7LQ,QHY [(CL13#WT1M]);S?X,R-PN!1;7;+GF*%GFD@K[*CA M? Y2*;ST1S.^L@R84&G7$DPX#;(+B]5&',QY_D8S7[2%^RI$7&R;RR;I!IM* MKG>+S;66-C<-TR!E ]);^N^M/"YJ \V(QC[-1N/UJU_7+7_[U;>V67T[OGJ6 M'O%F]4$;4!$ABX$4K??ZT6<"8=''JA'+R(J%%VD,W$2P\7\!AGWU[C&(RWU M\]_"X95:C$Q7X7198\7Y(*[T"=J#>M>(\0R6& :K%^6&FN_9P2>.6#E^]&H' M'+2S/8B#'%3<3_YY$W/6,^Q%X<@LQX$- M]*ZH6%PD"6P0RZ7XW?TDCI$/ZD-6(B''AH'M5BK_U-!S [*4X?BQ:;MH,8*_ M->99!NBRBYD2L=C@L"F%=(A4O^&K5Y.F8*O[R9U%_I^/%O3=##8/GVMFRH,W MH=D46/^8<^<'+4J%>FMCPKM-*_%C\%!!=D+S@.-+IKRN+82;&WCV 2XD%K1H MN7756LT,-C[RV=QV-&0Y:GD$974NS&G>>/FJ*L?E'P<.&- M81;I"OEHF>HGG] $<37WY%2+7QKT7WK]6]+SSCNBM3+Z'S^LB84P<-0S*VXE M*"7C(92>B$ND++ER5E&)NY=D$&G.D9+RJZ@ M+CP;-'S.KC;.S(C,LKJ7K![A8Y 9OCJ!(C\_-W\CO=05Y25&KY++<1'H/93$ M+$ PMHH2C%_ \WO#[F()QB?3CBQCA#CPA3(OG"@WV. 'W-\)2+Y!SN-)K@\M M]LJ$S++)N8,B\X*Z;5S"&,0S66)%&!>XQ,I#W<,06W4VUFR]'0BR(_J"#+C+:-MT+FNL:.,RU[C<=NR8W8)2LS1?O#?W6"[VG>M\-D=I_)T* M(O^PJ.:4ZX\V*82I;0)8/E+=W3PE83A_,^-=&,2@%V-9^^$&A7@Z MZASX0^=\IHG$]:#UNTM?B?1V)]PC\T 3/W''I91WK&3#NE>EZQ/F!H5IQI;G MV&8]7F<7E(4J-8'X=J:9YNK,3NQ-(/IUP$VC,-\>_E9Z-(&:-6R=%@185.[9 MHMPQN)8_4YGN5 -2O=*NZ3.+ZD"HFC!,/%^;8JWYWM1V\#20C1;, -".XV\W MK+'MS&7K.E%<[/H3K"V4A<*PK9GA+9=-2@@0Z-;EQ2+"N>N))<00L@3-MPS0 M?C6Z3J_IK 65F&I5CL;&4\UZXB(+GY"^!!BVI**2>53\"^=<0U(4RVFS$X*YMQ2Z(6J,S(K+^,YW,L;J[/_ME^ ,IR, MHE@ I3T"24K]<. A,^UO+@I;_3@CA<7-\DT@$!#9=%GX75!H"B!&_Q7W.Z&G MC6T@3@VNAZ7*]QEA1QZQ)%@F/9Q^GQ#9N7SL(U3&\,/P;.!BN!W(C;K[O!@N MUFG;4V-D2#K1YG,3B!0%@ZF]U)-"N/C^/L,44!+P$4C "K+R8259<>PA$,!= MMTUP"MBS;<*N9/8CMF< %&M/7#X.1:$F7>/ETF3\SCM$KY1VXT;6%D@X4X6! M$'!<4+Q$N2[E" %&@[< 8!#-2KVTDR1E42 =HKC&9K[I&?"G0'X3"V[J["&= M;D.@SS0=U08LA8??639#%>B(8NAF@XUDR09NP552^W'QH)L\VEJ&*)T8#EPP M,=!/8C(L05(9W@ZD19VH- &"^(/IHY@4XS^Y,P8R=Q,D1-I(5 TIG\9:TV22 MT^HJHK@&CZR%$TEI'/1JO79R'MF:EDW;;KIDYR7]?NTVY;AD_YY*1VJ(%I[% M2J6["46C,M/TOWRR&:0BEA^#DAB14B N7/TDJN5O952J\X$)+);HA1!9('=@08^528$EI8=X LT M("T3-2::(S::N%BF.0Z:"EZ)1H14]85FLK2*.9MR39>RW[TFAD,'9HYB0$AM M]>V@?B:&1>FAXHVKZ^U 7CV,IUSW3?[9=AY$H=G])#KMO;.$M$ ?+_#MXD2X M0VU>B0KL1$6;;&($)D&X<[>!)NG3H);]MX'S7M;LWZ M#U@/6F$W/^RV2H3=*IUXCYR4[2B%K&XJ_GH3=WI*50)6U/7E7-7)YV,55M-X M'_>0B:[S)NC-\T+2$G0VO7O[G)VX(XT5LCX/,<57]AXN]A:CO># 1 ' L(=A-3N4X+QE8 M:J0>2!"V^D? Z@5EDEY".86( %?8*-$2S\6]*BRT\&AC\D<93(MB+?&C>53] M[IE;$WGC<=L@9B8T]Z.' ]DA[=X1Z.&"[)#+J @X'4OD4O%QCD&0DIY_4.F) MFIY3'8.4>QDLO2Y9HBJ))&K&I]-C)EG,[!B?(9>QG[NQF(\C/]-5J04[4FTSCTN>,V5 MU?4Q)_7&Y>,WNN\@J%^]:]8;RZTN*CU>'M2U5J*N73CJ*N/BS-59A8TR8:.* M+>1I=8!O/Z:>(-AFX:)LC(U"Y$N:ZJ.$UG< UC?N8(GD&B,C'C2?^_$&L%'0 M_*:U)FK>JR>3:%Y71LC1<)LX$-D#MYUZY^"XO2 KY5+S;RI\''V-*2SWKU+T ML/V*_?DR.NS)MDPRT8(]:XXA.@+)\V'J8F;HV#11=,1[\C5' \'(J8$DMEV" M"SS8D^B?BLT&97]*[#1K"EM"]EMNFN:ZN630"*>36(5?.O>ER*1;?4\6LM.I)M%H3FXC1IB+_#:=K*GVJS M-(5^PH_#UE9J)S5FZ)D-S59T/1O.YP#]\-(?S?C*,F!"QNH23#AU30@-\Q$' M%0B&N?FB+=Q780.&V#:7F\%ML*GD>K?87&MI<]-0-4H'X);^>RO9'V2$[)S4 M;#1>O_IUW?*W7WUKF]6WXZO/ZKE5'[0!%1&R&/@2]5X_^DP@+/I8S3YDE'X( M+]+8U$%3YQ?/'K]Z1_W.4)Q\0/O(P@F\6HQ,5P E3K5+/X/U)WPQ,GK"DT@6 M'D7&[DIAJWA;5M'0J]XU8BR(/MC;F#^&W;V"3QP!"-'P:WN4MM=$QM)Z&GZ1 M1Z*+WS7/=^#? _:7RQ)GN?>70T_3M*G_GP^[XFQF6,;,#VI^PY['&4TV7PQO M&G33S-(E*XZ6P\YTJ*:/U4JNI[22VZEY7*NY??.XC%ODBCJ'[D9WB'"-VG/+ ML5]$]Z-FA+,2Y/ON8XNG-'0ZH8SD7>-HV^XIC[C;3:/>.4B<31QIZ&)4 ,JO M8\?0BJX\7*'4@K33$$;WD\_4W?M_\ AGFW#:'CU"4H8I%74X5,11^%DQ$Z"^ MA7+9+$,=I>NF*920%MP4[_BI@QN^FS[ M!_*%SHZ9+HQG!C3^!.O_N3;QN%.Q4 H+#1$RQ$?&\P4HI>(R.4W(96WKD-[2JW MH80/#*NZU/\U]B2G@A8RWN#AA@0KESZ>[ MWS853*'?],%WG&UKT?;QF1J=YFG'C"M!GLE4IHW6]5%YZNBE@2%C?;6Q!*5( MWFI5T8AC1R.J*')EINPXR1@OKD2GMRC,&&GV*F/D]%GGHS&9<%"TX"&. MN/?"N<744Q4Z]%;^'&.O\(EIOUQ6=XJ5IR=_*/#Z]',,EPI7O;"TX,IRJ2R7 MRG(Y2?%[>L?=MT/=/D36(J+C^(\%T36 MIH-)-CN^9LU6EC3>7?!N.^*IV:ZS:*]XYAP?\53PR;L\VX%G+\! 9ZX_^DM6 MXCO\V> O;HV!IIUSV0,&S77#>N:N%[1I82-L$_/DFYIG.POLIS"U'7&8KKGL MA9LF_FOR)]!#<\<&!PB/K^%+QW#Q#%Z>,0'!&I8&#P ]Y+C4A&+DPP4@==KV[-'A\.OC'?O@ M8/^?>\-D[9_LHP:;9U^XZ(ZFLT^/WV(4>#1JO+/81S[FLQ%W,%T#A-2?OP_O MX.?C[\/?O^"_?_Q?HC]E=W?8A@@^^F+,#'0?KS#8W6J\_?,Q^(H^:+Z]!DH$ M^+C<>8;+J.F$QEZ 3A%DKC^;(24#T6OS.=<<)KK:R,-/WZ&K?C?@>35V!RA8 MU!FL]M\:2#>@6%AL4R[O!4A]GW?\ 4S E7<@H]F.RZ::SB:&B?ZR9$2P1?Y& M]M&U&: 13VU=WZ2DEHECS^BIX_V((H!E^_[N2PA%X%;*K"$,U1E*$&!JW0>1 M@7O7.79)H1%>@JT=P*@QI[V%]B8M4&/NBS;'F[$QE(-P<4&@N)-%<*':"RI( MW3$"B-09F%H$3!Q%X>'<,*;IL'P0'3/[&:]DMA%8OD&[JF<>Y@!%W\EC;0(7 MPF\.^@EP@%?1$E$!H7V%<0ONF N\!F%"&\8#%9!;2'L@!\-[@FW5&)AFU-G0]@]7K+TM"R6#_DYA8\MFZ8F[L#- MB#.E#5E(75MR%R+M6-@(N5$"3X(+9=$RH!! [N80>O0=I$%1E+(CX$A" $N* M5VN(M"?@@_0Z;A M3_CNOVQX("W<)8%F1F>AN(& Q"1IN3[ +VT%1\&H\-<#LG-M'TP. K:I0ED# M$ +F'/LG[-WC(+J!O=J]SCH7-FYF#\=C8#USZ'W0' ?%VG^P"^!*__4'D8$] MP?95%D!O+/Z<(4W\3JK[S\=O)KB7]Y,A418*K_O)%R,P%X<_#7?9"?[TQ_== MG>!N;9#B!;.K_SI)0.P1#>C7FH/D3,6L3-CCD+;B;1@ND^?O0+LX7N1 ML""6=@6+H]B EW('Q0R&J%QN@O(@W8@X \O(!2,;> 1/%F::SM,ZBJ%1H*$! MGMF&#"5!8'W&OFI%L%IV<*?. ABQ $B,H'14E_@_=Y^$>.7!4J2-L0C,Z"A5?3S5D-$ ^^ -C]TW M[,JX%K2#U]$#%DRWN2#0J?:,'Z)$9_P?7_9&%9U/.=$Y,NUS]%+;]U)ZI,)O MKC^?VP[LY,J(O5 \= KP!D*OH=>M,3Q^G-<82**_A;J,KQDWI0D+%[9%]DWX M&D-BY2VV;(57I6P.V-@%BARC'2V-C-R'T@&+W;C^R/5 R8,1(&GBV29KC,*[ MQ]'441*L--TU!L2#('$0$PB0P(29:PY2 @DC[@TY4%XH[W!+3XQQFA[ MU)@Q06(+/*O$!?C\Z)$O4YL$(&QJRJXT!4%S^T4X53JL!.4@?*;05[A<;PH" M<68#[[G&DV7 6S22R0;(:7F;P'5HOV-EACT#@3?G#NDD)%\4GU>(> 4M%\R W9L"? -7A=P/%K#PX R/(*U%;90#_D!&@V_CC+X! M#C8%O1&YJ&FPK[,'M&#%RU"OVF F+I#0I@X)F[0'C6S-T0D58FUD5(:6OH!4 M?$-21C#PK051BT><89/F]@&;-(->WK03<+=S6DV::;U;;*Y<39II05NL_C2; M-)>[JS*!=0L<=-:T8 ZJ*>\GJ=8XB,-#6^&-$O1GGL.&*>QJ1)6C6"?I>ZGA MN81Z(QUX$*MNK)012?I%\_M0593K#RFI7_GV1-O9A-)5DCAF/>>@']5SQMA8 ML.P.!9ZW^S>OWN3WTCWV2.E)3"Z-2<*)2+[>C=E1Z[:XX8,VJO64^0;R"3([)-FW"B+[J+5 -ZL0?V<>V.;9J49BU@NW M3YY=QOWF:;(*\S')?1F)<#L$-IK[!=%CBQ.9JRN3]*J?V_Z,I366K>XGCT3R M9E$39X.C4B9J4621\=!U.6:4/W!QO#=>7+\YP]8/Y[&+(SDP)S58^9O#)]S! MPQS7L\=_2S)_X Y&\(?L8:HYQQRD7$R7BAFMBZR(C%#,/DIYU]AQ?GF5K1KW<&@ MF$J+(Y3;G#0%-5O!U.924]"@UBF*@L[1IBF'L']_=&&_]R/RX==Q)K_>4QKS MZ4KZ;JU;5$U=13@;$) A)][[#-()A0G&ZNMHW3%M>3Y!+KKWOD-:S/N)\$' MKE"%OHOOV^I1.:O VUJSJ)Y?9QOP7$LVBCUT'F33.H,HYSE)[-4'M)\M#>NA M\S^=/;);O$NUQ?CLUT3VV&C(@*S\YZ.E;Z#T%686_5I?FL&0[U M8WF_($1\,#77S3G#I]FJI'4)*401Z9="(=69P)E'H2MLE D;Y^C"%F8MB5YU M5WC@R_I'[!M?DHBN8L]D*4-0>=1RYGW4<29T2!*'[ ;/68FUP-MHG*^E4Q(R M4(R6R-SJ8M6S;:^!;64?-XUM'O MVD\:ML-_SD6C:,^F#GCG8R>I"]ODYVJ%FJXLQ4\)2VS;^TF"Y8+1K[[42+QC<-MG-_QGYG^_Z,G<,T M4MSNL8?P9 >GU%^Q=_A>QB6GCTOYB#V^V:F4M6(K72K*EG(OL3Y\D/]V:!Y MF1-^_!X\Q1XU!^S]B>8Z@"0-(HW@(GXT<,ZHI6\V*/M'E$$7P/-WS0)2HT\L M?:C/#,MP/8=FI3YPY]D8\S!H^4T,>KUWY!X0#X>/31K@Z+JVB[H2/$R,Z\K;)0)&R?L@1:<[F[/.9JZ.'M6BO1CVS7' M2+@IROC)L0=SJ];H=,[6F#DS(HA9/#DZC(-:NW>\'C7G:L%<:A).A8^CKW%M M4I0R\+/PK)=@DK;#Q_:3!3>Z&V:UL)O++.AL&UN35\2W S MK,S3P$@,AH0K*W*X3/6!^T8+NBMX%(XP)G4C=^_P)\T)%R874V>/RN7!$/*I MAB-87<8-:LD@9I(#!FB:O,L0,/ $.W=1(3&NX83V]+?3&'B= MSXVQ3(<2[PRSH=3;<$,!(O EX5#V283H!&)7ETT(2ET\4@,L>^>/E( M0V:T)1'B\3UX5X@V? C>))_ -'@??J5KN$F+P\:HT) 6ZQ!O6D" ((>-";ZH[^0QH&:4(+-;9PT;LBT/,?5S#K[%E XK$G0/3S6=RG)CT006E>P(JR MX;J!2_2!GASZUO:]N>\%G ./\4U:M2$DB\0 ,0B*"4$IP;=B:\198F<**D V MP$Z$8,'5RPT?A0T$RA"DJTWEM$S;+X8V,K"+T>H2E^!,YG/8"#+G*."-R\=H M2+^ [@8YOB[.F;85*I7]RM<4ZQ2_$\M.> *)#T*Q)/D0-8PI48/2A*0W2"27 MB!,NML2X;R%[4DA9E38!7=?9'7"AKM-%-;QK,[+1YH8'-AG(J0#L'VSW1" - M*Q2SY:F1,*E5844@A">^.3&DULC2"S72*P#1F'#;5AT<12X$C:0P=(__@'^L MFH;J4BS?--_&HEOIR5RJ!$0E%42E2%.Y+]H<#1)TNE'.NZX]-@@* J1@WQ/@ M)^DZS7?L.=>L&]-P\1Y45T2D0(X>%C;&<"!-LKT5'I&!:;]D+W!F+)UFN*S1)J=OY])/:'IIA)ZB*3JJBD]/)Z:R*3DIT?3E7=?(I/X7E+6/4"UR$ M!T_SSB_/I[ $YC\>L-\^PA"]J=\49RSG=.7;6F]POG,73@C_\83EPO#?J[5: M!0TN.T?3H3"Q^F\P#/@1)P>>6OY_7)S^^U,Q[-2ZK36Z[;,5IZ>#_K@T+0S] M@UKWMIKG5QJA>82O6MUPORZ^#_I MJR![96D5G#( 0O-LQ$%X@GEFOF@+]U684#D-Y9>TO&[IO[<21X!(F4+6;#1> MO_HU,]^O/FC#"Z,E,3":ZKU^])E85O2QFOG */4!%J6QJ8.:X!?/'H.]1(F M]H2ZD&.BX[]^U=ZE@R6"COHS3/U8MB])Z(>Y%BQ,MHC=E8*6V/-6(H M1*/R;CX8Y-FLQQH$[TF59S M@8WH>]B(7E0I$ "8"H&EYO/'J6A-EO#E6Z179W\$:>Q8H!=>7$NDH9L&D*6*_WP6M\E)E)*' RL+7BQ&(+A)Q?UF7CE'_6'.OO3<'5[]@CO8Y\>/XM\ M?>6S/S[4\J Q0DI>IY& RT8SH55Q. MG GW/J(1-9[\WD"QJ/W-IT">7!8M3+7GJ!0GJ,10D0'PEQ4F]-0G>*(##M_R M0I1N@6!7!T6K IK!HPQXI>G:B3T&D,-B!\"YFP&I&HN +0J(7+&SH) 8%F2- M%S61I*3#+Q,_N31:[7B,51#PH!HS^9-FUD!VZ897HV]M*G2)"47%G&;2GMZZ MH@!DXHVNU 9(3@] 58/M![L#;G8TL#P,2P.>"L "3*+]E*08$ANM-;I"+5VA M\B,="S\(#JLQ)LM#U/E%+(RK$D;NA8L/%U!9&ZQVJEE//,ZZP!<<9(4K:FYS MJ(X=PKK_LATLUI;W(7_#=E'6L9FH<@N^2F%;JOJ-*KPUR_)%K< 'X)#BHQZH)!ZP_J,_Z/=ZS5ZW!#4B+HU@H;X+ MDI5=27GT-6FG93&;PAE4[80U(+:%Q(1%G"E/2^.,]YI)=?L/4PY4>JBRD80W M0 ;"TO@?9N@K,'7,RI/;VT3EB; ==RX^N6UO7WS2/$SQ2:&/KG6K!I[_OR!22 M=72Q[<\D8LMVTGEB53%Q\_+/Q\=C9VP5FS>>=#\4UP,,[-6M22(7BKP@T9W$ M=_')62'!]POUFYP;7O=KS=;I')2>'64H4Y;+1AF]6OOVQ&L-SEGN_JY9_^8. MNW-=GSM'+]TJ.Y\E)+ '?!:->1'U&E^,&5;#'9WS6K7^;95A6QJ17&)2Z=0Z M@^YIR^C+-)I_']Z)H[?'NP_#_U32>Q?IC=V^J/.BT('?S/'0TJ/OQ:=W8^WY MV%S:JG7;K4J>ETJ>GPSQM&NM[O%$_+FF/5YFBG^%C3)AH_)Z-RRJ.+9Y5+[1 M,WO94#GJIE:MT^F=K65S%GB/S)\<#=I.K=D^7FSP7(V22\W]K_!Q]#6NK<50 M,ZW6U2L<+/U-P^PWRC>C;%F'ZX;'3-NE5%EK\Q0X ]ORJWW4:>"/-I^;"\RM MFQJN9SN(*GHX<[ Y6HUI^E\^]8>GEV-3?^J<;(FI!B(;TO7G<]L1F698D3'6 M7$KJMI6>XRXV+L?I,;K2K%S+*1.NX%*D_KB M,E.5$4DKPX(9#00#:,KY>.X&)Y]XU%FVQ,7.;:TSZ%=!Z>.05+PKX;F05*_6 MZ!>4D5>="NXK]R\X,_:H&J#$>9*M3FW0J5)J3U\EE)G&>K7;1I6,>^K:XY)3 M.K?MCT4:5.JW^!!'F<7/!_FNUC+Z+'KUI0?2GQ\_' M]D\[W5JKF6PG1/&TO3:<6L1;@@VW8,.#Y A1IGDLGG''$%D$AT3G._RJ5:-F MT)AA^PS4@>VB*4F=&K2ZN1'+<#(Q3 -A06G8XRF0ZR<+^4S_[%MZ3)5'#WU< MS/E2R*0$H&^V:IUF&NASI+6S@E>MWTL>3]1B4G1]KM1&[EO"\]LV14OEA1KU MM$^7M&.U%[$6(HN-0FS=<($N:OWMBB1\T9+ZST?VT7@R<&A7=**$;#CACFR2 M/>4.QS(+EV%_[E;CK>@R+EIR4\ONYEN7P[5C;8X/JM-ES;< $0_P!JZ["4 0 M-1CA'T^P*O?7*U&V:_M!])VCW[F&R+YM1GB_#_M]ZIJQ! M(H[/4WB!+:UCC]]@A5]@>?=6-J/D,,$+"W#@LW4JI94,>-+>KO+K8Z[BH5UO5.WR,MA75]@A2$U12HT[P]E:=Z;.*/%:5\43#1^XG:.QP$$SX M."F4/MBNYSY,8:7OL9_]-VU!;SYP54^WO\)(;;9*,,ZD7P<\P/YO""QL^*(Y M^A''F-Q;[-^^N1#BH-D-[ LO9;J)B\L.IV"(20#4TE](CD__^#AOX)NI6< 2 M.*]$T*HZZ #;_1MX0,+\.0JQU4P948]*7T/'P0D*2$WO%PD"(W@"P8+VO)\, M=5%NIYETG3OTO:F-Y5;Z,O7U?C1[ 6OW?S2[J:SMTD-4[FZ$S-U8WR&QT6C@ M_Y,"2CR7!K/8LQD. D%(LRLJTK,M+BZ@2D(.CME"_OT$<$"V]H/A,("'9B^& M!]? ^L>DP&^14"2+T07!@J^6B]">-<.D*JT5C]5HL2F/O0XJ%!$6]%3:B3V/ MBAZ%J*+/;\2D"XU8H'YL1XW "3I2[%,L"FF4S^:FO0BFV>CA$!M!W=+J1BGM M@8RDDDG:LWS E30&OC\,7:GPA4R/7XV$IE[\AW(QR&DB+4"EA-B:V[^I]XM* M4Q4-=?9!6D1RC> TC!UCA)8.-^T7TBZN/_H+-DK3/\9CD+)RXHF@"L6DD@6M MJ>C+JP;QN*6#W;Q+!YNM[4L',VZ1@\=ZX;?5T=#ZHZ$'E1O>%#1R=V?@R#%Q MS?K@(,#X38RF,J5B%@7K.(^'9'SF@!T$X3U!$!,>4#9]HQ+P#N'S\ M!CR6%^ QEX-0]KC%%EBJGICCJ-% I@5#"UU6I&L>^(L:_+FZY'Q72X)^_ => M!P)&;+"9PPY1I^,.$QM$C2D.2J(Q8QI.C>+.&%Q1G'@&7X&* C]4M@E(M=+D MA=()(,W&T >(3Q;#;6& 43:PV\V*AS+NJ&2BQLT'@4;Y5>T M'2Y=)DJG#.T@8@@]FLFV !)8.!*IRJ)T>KX?,-\-QQ M;J$,V9 $3&,>Y:PC[+4AAN#Q4Y]TVXT%(H)-)L_SM5]_>9O6=^.K+,U!Y#4Z5918S&7D[' 2=?2J_\33\QF_2 MYCB,L4&O>!2#1X5>'YO&9"*TL:)K1>.EN+TLIL;"ABA:@O+Q;ZZT\<)68 Z7 M$TLM"CHB2]%^&.:)R^/[9^% 8"LQSY"G1?9+JBWA8=JB",:)4"MSN.<[5AC< M>7SX'H9V< HG1>TP2L/F'*Y&E3/'18@XV]P?F<88EH#'132\TX4-B*&V. 'V M68;X" XW"(>PE=>087<86*'FF#9SC9EO2OYS<8XT[4*X"YX"W/IEVOFE2=W* M_8 C*[TVA>(#,B>O6O+3!A'^T7J_?+3*+_^.2W._A:.2-\MD_=VP@*1GXJ#= M=;SO^$HZB/\6Q5LI'O ]C+92U ./ M3C>5I*<(J_?&0P]QVN'ABTP@.#F]:: M$X/D0<'K#8],C@10[6>Y =I*.7MY'8RL]H!I0#(ND[0,>=3PR$,T[XN] @>M9."@=1!_F112#\38H'G;%?]T\!^@B[=WRE1Z/&H"_84: M1)PTT.E2-QV2?3S-2>KRY2/5MTJGJ7H;G)YNF&+WGF/T'A\ M@5L6GXV)-_T6KCQDI_#P_@&^T4!%%R!N-N(-]F*8)LG^-*JM.&-;SM \R1;> M](0H>.@=EWR[%?V6A7ZQ+?$*$L87@9N!B)4^$744QK-LG])%) /(&]<@47&M M2LP;R!6+(W!%,]7DD0#N-F+H$;XNX +=1*_,T(1=J3+FL^W\1KD;OX.+>V>U M&LW;H:7#M8W"X%QB8 VZ*V'5:A8&I#3[>V>AC:?42F),0-.#N,AA5W 9D8OZ M(=XKLWUF ;,64)JN7Z++%!2'= LM0Y8CF))56#Q)U(-M0TE^#KI\^*]D=SP M09O?31Y=QW"_RG=LQ@_1[?"BI2<<62H[L Q'%SE_*9HUHM^-#@4+3*)[4'+Y MQHJ 8_PG_L[W24=_T=;6LZ3G=N2?@;YFMFJWGWJ2\9+OE'RCUO%6[35G^ M8J:OM3Y 8>EE/:I4XJJ_<4^A87XKY'SZSM&ID",$ MXFVO3VN?E&NOI/W[*06@D@V1TMV_KS95(7,1 72IEYGZ/1;7?K6]_^'@"06B M=G4SAQ!#X'%]#+ 21CP>#0_]MCL+L&3HOF;FW(FR4>LT5W<[W@O@)6KXM84 M7U6PAKZQUN)QJEFB M(MX-#7/1B&9UV[@E^W/C3.A]NM&T:^W;9JTQ2';+.H(O5=%-'G1#?@L(S$+H MI]EIUFY[R7Z*%?6<"O5L4)/A%D)*O=Z@UAP,#D=*)]SY(27%ZS!FP6\BJZY2 M_[DPHLBPO+.VZ(AS)"N@U8?_5W+\[,BG4&, :&C034;W*QHZ,1HJC4G0[?=J MK90)K'NA-^ O0$C(YF;3#(V6.]7D,6E<8HDHR*-3W:.4?0*EHZ M*BV5Q@!I=6JW>4?6CF6 G.L@U(N90'[Z2ZP(HUIB11C5$L\W6'^,/,+,PN"S M<:EW*_0Z9J+/D?WK;JW9[=1:@]OJ4/CYQA1E M%7.6&7G+,6\S5@H=5B8V6UG=P\)LO8V!DMHSX#@EXV&AN#)B;+,(0\:\I^[K M5;:BK+=>-C,P:K\\:2N>_DC?@I5CBYG.;\109XKO;]W+)Z\>'M7/H*'52DO)[1^[>5;*'XR&A@T3JI!A;'D$:M':11GLG89T6GW_D<7%=TIS=I MB([M8VW?A)3'I>OIB&*RP-IJO&=57CNLH(T!7CNK#MT,SV+2^<4GB3 MF%*(G<.SQQ0J(\Q%]R+\2W-=?R8GGN., *6S/;&7F$H2#%E\PZX,F:@SXB ? MJ%US[KT2;QLWNK:0BB1H#ZT,G';?PC*"=> ^Q>YI>&7BLN Z *!G.R@5U6O8 MLXVP,PW/ '& )(@[VE0L[!(W_*P9SG\0-\,(\M@9'&GM/\%B%M]A+Y+]<\O? M*8* 4[+1-Q4)!P:F8/V3 F8WV9[^-;L*&*) D ;-2V7OTCAD3PJDG13ZO$8Y M\8R391TQ?0* .;;Y9&*,#;)$1#LY?PZ?DS@DP0'21@N%+;Q]C$)8S(!21(TJ M7N USU(8:PMY4T^> MC+VFF38 [$#T:V+@ "Z.4:=&#E\O#&[J!8,[$$T?Y2+* >[]#+YH1,867N5I MM46\)*^R=8Y>);J%T^TH3,G,>TB#:3'DIM0:)9- M*/13=*IPQ<5(%UUXXZ@9I2/R LH&GRD2U==(D$2_7/@;H6-8PN[/'L[ST7#' MINW"SNXG!!$Q75[ZCJ9F[=7EELE%@%D$D,%'/7"3T_Y_] ?]7J_9Z*[@AV8K M?X;8MME@4VA(>'ER8X[8&.S>HK'6+O>0_KPILC_>G@*%X1,81LC -?(L]?15 MC;CWPKF5\)L_$'%@<,(4#V>/("3<"7=DI%F;@6?\"*SI!??1RL*7XQC0*WPJ MC:*3\R0R5DB7--]>1YQ4(+Z^^8[K:[!:L(,I9L>=68B6U7#-0"E(%A.$*"(Q M--> =D&VC7R2QW!U&(?(E-4B[>9^\LWA '5'"D58[7@*PI(69[>*I+3@(TA>P+%P.0+0MGIRD1FL$AP\A,@%B MTL4$\6L*U'!M/%6#GXQ>CZ 9V[,9 (+HOP9ZSY&QH#5#V3[0;0)(FG/OT$1 MG;05*!I2:^DY3!(EQ M3UAN0;YI:6.-E-!EP/*KZ?4!M#:(E"$+(2/$AI1J-10LBC GV8+3=K"?>RAH M4-'3TT88Y:2!DC$]TAK(]NVJ3/TNGO(1"#02H7<60\<"-P"HM[AD0YJ8C4W0 M 0AH!9L@YST/-P7+H\VE,B 1!D$G ,86#\J"3 W5%ETZ!M*!OXAN8KI(V5H8 MQ^6:8QJ1,?91%:ET88JH">_].3<<)?<#$!5/$S"4^&XSL]D[MR MN.<3O)/C/J1.P)Q)CL^RV5QR@HB^QO0I42JR@&L(HQW==DRK"'05.I?V%]FD3CE1; !;DL(#,% MN^_9OV%[P"$@=8$@C+E&6_S@B[#^,T]B?V.9OB1K=A+K8IG#K[;U'YOFR&)> M*ZP4K//XXU.%_@=3"GC!S:Y!R_'AV&[5TX0^ A)?$H-;L$%&.PR@56.N/_H+S#X4 M )K^%UC#PC*D[!PV!CH#!Q+A( 0R6.[@+!L3 \"^@>5.TDM,!Z%YI"33UAG) MV9EEBF,VB#6B7_6XE+C'DI>WUL9.MJ073?;XS['IZ_Q=2YP3!'^&WO2RXRP_ MUH.!MJH7S0P]TXE=X>D.YW.PSL-+?S3C*\N "=5G+<&$4\/_,(HVXD!Z_(UF MOF@+]U78##^VS=1 P.I-)=>[Q>9:2YN;AN$_6?-V2_^]E?&G-M",$C'\==WR MMU]]:YO5M^.KSPK-U@=M0$6$+/:&->N]?O290%CTL1IF8!1G@!=I;.J@L/D% MN//5.QHIA (0O6(T_?_UJQ8CTQ5 B5-MQ&KJSS S<[D*D31\J+-9J+19(C4P MSEUQ,T&,L:EW#2L1\(Q5(J)1%WSB"'B(J3G;8[:]#68[V6&F+.FSE\=_AR.T MT'"M*38@0V/'LKU [1'*:;ZSPZ6!*\[*R*)T-)V#)>Q-&3Q'J%TWU73.,H%C MK@2Y 36Z7IK"H%9<_H_/*2Q16[:(1712M<==#C85VK6A\;GY2O!+>L@(WC#C M,0"$AX:*[1V&+C+]%A%&L3RT[TU -9A[NK90LC8HA\-P7 ^LYI%IC&$-%I#] M6&@]RGC24 ^[&"R1N1MDE$XFAFE0- L^!LO,'HN_Q+4N6*M6H+&'8_#7:3C6 M-_HRM'# 2&<:?4DJU>)X4*J9S'ZQX,*I,<\^50-+)\K9N9^\#V\.JJG$,>10 M/OW>$C@2?G$13O >8?!F6NK.%8!Y(U"D ^!/X)!A@#.<0?=OV\ 3!@7 MT\N6:91N2!! H3?;T"A#I GOE.0]W?^)+/Z7.D,D;/#Q[XC+IX+.3M"#V M1"#@HGS3$['"(+3DAB,B\=4JX=J1LVE8FHX!#O(?QP(#H\72@1*YMD$@C/80 M ^"(XU)#.P&M'B&*U,,<1F+!-<+X6^05PW*B#,<-S(3P4S034.?0DC A25@. M\NTI9RTS^%;G>&8##[A>,C$0PEPA"@U?)XYS)_C3 5M'4J'XA"R/L>V;>@!_ M,H ,SZ7H'7KBPOZU4B0_F4]DSEELV?@0 %>,*-J@3N)? !L#B?#8;)@GPIU1 MR'>8HH7L-(+=TJHY/WLF8,S*KLD S))],PB"LB?&7 C/P8].* 59Z> JVSZ@[79J8M?#"X%H2)3?=+ M!R'3/Q!G]2*JIV5[@.C'D,YZF8J##= 8GO"UXLQ9L6;%FCFQ)JF6N'&A1*D# M,P$T'Y=U$]LFE!PE3>,S@ $@.[>E&;0^.R.5=8WHA!" 85@4MXNSMAL9J2(2 M ;!7P_SP ,=X%D=;'B;%2"(EKRZ(*RC71,^KLX<7;8XK ')PT#!60AC"402Q M@A3JV"8E5J/=X@2_X?GJ,P:>*(M["UC0%@3"X444(B(B,69SW\L(@AP%R7BXB$>(6U :1<6SR&#ILE=,@0E+DI MJM6=8K4A[#$TJ/CJCN+(U]#.B+54>U@9'"4?&3<->"XS[UI"=Q'$L0 M2GOT*E<9Q#0M+CSC,IRQ/T/]/T; ",ZB!-6)V#<1H0%&=%"8D/4B/$M'>]Z3 M!_?RX W>,4&8QCRY&IW4Y00'00P1N];$.:CM2"+S%N39"!Z=C<#14NT2/.]Y M EWSA!'&9_(#D#_^!LDJSKKQNA>;S %AV,?/%&,;8U?$H((XUGIC_L@=.X:P MDM3L!9$-$N>H&ADE&.M LR3N+Z6S6BT>\0T( !TB[.5(;('"BX SX\Z3_%O$ MLRV,7Y,Y1] 5CDHMS,L(G@9RF:DU@\JZ-EQ3J'KI'4@FNF 0V[+$N8=XK7)-C0*#2%^:$T8M MLDQ)X![AJ\I5*]ZK3AE*DDV=!!T']JJ* 8H82.I6OE/IG(H/-S/%ABX8$.X# MR->=,@_WJ3%;93%E^"D:K98 J#E4 CJW7V#W@&L@'\ :W.P]:4_BE($@\X)L MZLD,6 >C4Z>C46K+*B5-K&OA0L>2\M.%&/_'!RL!F>8@HNQWP3M+0@Q/NY*@ M)@ $IXSXJ! "ZE/0\R*4 )Q1PM!BY,/P)"@ BV#[I"BM![@(;4%X$!4 I <$ MTY".0:JKI90055UNEQ5RG4H01['7E&-(W.,(4^1T7"5M!$@98^0CWR/(PR!'J"T0]B'3'X4V-'F*.H=E#E! MV"497+W._HK9%A"]#[QGKCP>)B-#\^01BJ*J!0F[63(R'CW.2-Y<[:/>S6"C MANB9$1YC2Q*3#TC;%Y;*"1FE\]D\>780RQD0,IB"STJB:B"1*?2/L6*.Q M..$NI%-G0X(\"7EZ0/:Q06I4Q#3 [Y#'5EL6V1 $UKOB1!#X1A]=(K0XP9-X M0A%4P\@$KH<\?IDMS*WQ0F203VT\T\$O36X]T4EE!#B:E$)6&UPZT_X.;$6I MMH*@)AX,N<@0FCA5P]4&]=LJ108T>B42FP+_(';I#M;-<0I\_B I%5@-AJ+R M:PI#"BXD$\*R@X(K.HE3S\V6G> 17]B$=33:-*))_E,F>2OW7:L.<[8] M+M$6\'YP..G6V9]3PQ0TO%P_M"R$$+TH0K2?I!,2)04.Q[X@>=8UX6 M+C&4ETM>/98M/%D ]_!%2*BS,#:I!&Z4!:;D%9&_LO(D-.Z^Q/VX%+T&S\-G M+INV:(4O6[;'MI32$LTB39JL:@CSLT@-\N H?%W%2+-'%2.=MR(VII.%"_<: MZ4Y1C!PD&U!/!V&7KI5K4O!G'O2*8Q\ZS V5X_(:J,!%LRQT,6:&W"SHP87E&==)I1W!,M05RU4IOD49,W.'/QNV M[Z(>#XS;F.\=/[;*+3W[;6PF1$HS@2(3MM,6$TOA[L?R8)F:'+LJ'W;KQ-+. M-HFEW1/+YMXJ5;U7MFSNWC:K[Y]D-G?I\Z[[!:=2KW4/I.YQEUV?(#TG5-9A MN%8;46LF.NWZB0X0*G&9GF,'!VQDZH(9C(VD,!G'$C9!J'34^+QZ1F=8S[;Y M3)E]\;P_S1-'@\([#L)1_S]H(F.R0&5S/Z':=U$5J!8:;A2Q"=.R-ZXNQZR> MY=?#$DE)B9(@++@/(!.F0(D8%.#Y+]M!*,HW(7Z14LAC$^T#XTYP$#Z3D:@Q M^@\8= #' JS9L1+^>A*Y?J .Z5A2%V$\T)+R*!77HUP^MM'*P2BDAMAY)FMW M"ILU%U)@"(U#(PDM.OA2G_8VK-L. M.T4IB6Q T%'P6I+I"#MUQ?RX=<:@"+]NQN1*1LPR#BWP;EP7V]2(?0E.EL=, M(7N/^%H>K 5,N'S$N.P1X,6"/S4ZV+ IR*L* STOIL')K9%"C ML*?:%S#!$]O87H**(R[3%-U44*ZM_BVK!P).@O*E,O\!G/MGB: M%1XS1&HKKWW$_9+ W8D,^B9W;QG)6HAAW?86GE];5*CC5^20.7MW@ M".>@G:RZOQ_U#4DTRC(!"647']39IM<+*=(:6+VG@=]8@42WW3D"YH MUIRS^)28F,=[VWJ]^3"8("81OV63W_-_["&FRP[FWIIY<$RNF$FL1U12[\:Z M-*S;^88/2IL7$CTZG/?3#TE-#B223VO6&PTT;FB,[R\-^F_]P$,918R+Q6U] ML>U$ZN,4NQ-CI_FIRSZAGZJ*T7^-G%_C3'S8U<0G[L964F;:RY!R0F#O ['# M0IN474*AS@.%&@?_9NUB\^6N]JESUS[SB="8R&.^T0$05R$K!5FM?)%5#7'? M8XC[5^[),W=IP>XUMSV+]'>W:+[)7 M:[7;91AJ75KD7>6 O9:"O=96V'-A*?#9VD+$6JN7S++<"YK7*D8.)>L*$&FM MHD3:%^ZZ;Y@@ABC/21XKQ7I*1CE!99)ZQ?#-B_=&@.AC!*%'.]9S,^JN4; T M[-PFIYCDQT-'D(4GA-+=1>3JNIK.[0F*Q6.:@ 7+RS\L553*-$S--.UQD !: MRQS4YR-^)\9/ MKM_\+W=L!,Z@U6R]3>#](-!/$<2*1,6)2EM0QD$D2L83MD^OE;$;<>0W_RG# M-L[3Z*I18_B_ZRV&3U=++&J)%7E<[!)/V'D^7CR0:<^:808VH)IQ(_-)I'Z1 M1R3?'LID#AXQ@#@,P/9H*Q7#$F9'L?XZM6XK9R?L@D.,N^.W@"#D(*4CVD&] M;=7(2\C#L&+$2Z.8\%BL\RKW&\XQ+E"8*@BF7(Q M4:%"?VD6>##5C/("7&5NV>XB?[]!9)UV;=!KG978SQF_L=4='MN&[5 M^H,#XKKR[L_6-SJ3)5;D<;%+K+S[]2:=<-(S<];+9,3E[=MMG6>VTA)(K8;8 MU:%/[^W5VJ*S5][NWF7Y]5LA5<53E75U"VX8!K HLWMN0T_(O-SFOQ)-BT'Q^%265A;I=:=]W+@1J MT,+0WUGFABU1X;ZYC]ES-KI4)>+8*]$R66)''Q2ZQ"B[N81LF9M>!LK'%L*0WC*;34\K#ULE) M8=VQ++-D@2WYD%UX_.:01F:N*NG0UY=S597'E4_5?9E\J4)=J:K,_KQ#Z%5I M?66)["PS/\KC1P;[XF,O,2.3_^,;SX!GRW-K3$SCQ7/-*K-D$R:4UE>"$X?Z M7[[KX6"WXL5MMW=>J7JGC.76>/G,PG5.HGTUL MODMO9_?B9;E@69;!IP"F>:8=[^FD=6J==L[C=R[!,BP.^>?EH5=6XGGHV#-9 M8D4>%[O$*GRX;_APU2SW,EF#Q6:P+;=&VS-/K>IT5ZY.=WLFI96_U]U%FVZ7 MT0WL7-984<@EK_%?2SWMI# $/YP[QCAS>;VD)44FD6HV=5\GK+I5)N &]A"; M@Y^.K7-TIHWL9\X,EP%(Q[Z)M6[,=S&VYDUY;-6J[&92>&^=&^:]V#=C4W.# M,]H9]Z8VK,*%U\$BY)^P.M_T7$8A/;@87KH8Z*'1S7 MV4??"?;B41>SF>ABQK&+&8NW$F.H)6MX+3SQ!7]8=E@9FWD@+=;.V0=[-M>L M!:Q];CL$669QCR'D:5UX#2S8L/4Z>[0]S62:Y1GAXW.'-!#?32Q8*B&>N0_: M\6KS8ZBL.(H5B5@2US\[]@RAX'N40W@_6;96AH2EG.**=U\_;QQ;ZMUV$]8) M@%\_YG:WC*1ML]UN(WFZ'M+@1FS0)N@(?H"%S/D886 NZBP0>MM*6\7I&\1Z M,:YZ7(J?&4F_S:1ALEN8<)G$B0)_UQ)V:_!G*-/CXCO\6/P#7R)2#/<)['KC)"=P_^H-^K]OKW KLPX5<'WI+%PWG.F/9GQE&3 A%WH) M)IPZLH7A@A$'9/,WFOFB+=Q78;^PV#:7MK#)II+KW6)SK:7-34-+7H8E;NF_ MM^$DJ)]!X]%&X_6K7]I#%@49 $OX"(?O7ND6KU[ DH& L;-H#FU&)DN@(H<:J-6$W] M&6PC$2@B+13J%18JEMA=*=P55V6B+6Z]:\0X$0-$;V/!(NR1&WSB"'B(MKG; M8[:=;0UF"92]S*W'F,$0MM58&K<%-H\]-LB^>C&\*8LRZU]9CC5D B MST9'CB%D$=,FE>9-F MJ42(0U0OR84$XL^XKWB[ZBM>]14_>BO=JJ_XY?85_RY5H!%V-=NE;+!J.[X' M"E#/5^V_MP=:JVK#763V9]S2"VW@#6S>,AW['[]")#L9\ B9GMW;VF#0/ZM4 M@%/$\,'2.2E*\QF6+L(R_7[[0!F>Z>9/']WTI$Q<%N=O%4NLWL8\@JNFM"RJ MLO==.M5^R\C.K]H[7')[AZ-;,8'>"9DQ#]S! MVI4A^^;P"7<<,F;PQBN,];)F\YP+63)RW9+%#%*=392F;'<2L'\ 7#^$8+V? M/$YY",H'J;\.8-QLV+.M4^MW#SFJXERMG()(X"PKGT_%,FD599E\2^ESCTD- MGF.,R@H=8;4C .:(D[><]B.12Q.B^N#U+ M$7GRN>,9\K5,15/5$H^7.%Z6C55+K,K^CGAN<("LDC.V#[-6&EMUU7KB<@\D MRDH454N*4[--CUX15JVQY.9I!?VRK'&YKE%-M%&>,:@K*;3I&;6M>3SE_S9( M:0US@$)K.D@ 8B)'M-U_78I5A)X1KU<)E',&?<: MKR!E5=M3YAX>@/)Z1N_/H&!9G.=F5/8EK9*8-5)"$Z1;Z[:29FEV&[SLJL;T M:*!RH/(I*@8M?J,IMG?JA-H2%,IN54G1JFU?(,RNI >+A47@A*)C&MX5RX*- M*FLV*4)/+YO++,@1@[$>M9\?A4?L._O5W:RHMZ,LH1XX82O$2K.5OUS9/ONS MS@18&, %Q8R2"IJY\I2ZHJ(7GE0A^'LH./=*%%>>9W@@H\?)RS]17W=DWPAZ M[#N&9.@LH/F6)6L!,LN24IB,I:6#K\+)P4J]EHNS>+AS.:?;@YT[%(S:LC5! MFTKMUO0'"MX6\BX"^8/@.WA;E!N[4XAE[L<[!47B_::U[@2OGJQ)?RT;/2 8 M0*PI .(_Y]QRJ>SUOU;O.-SH)W'+>V[QB;%;DX%]AG&W!\DYC'6&%+&" @SX MR@'I[]@SHH,)!_M2,X%>-<_W;&<170N0V 7U\3*+H?=9O.$A>$'LXEQHHK4Y M3:08-J^Q8A3XTD"5[].,4NTP*A\@BUI2BHDG#0@08.IPT/)^6).B!UE9 !BT MY@7SD!32UE'F'Q:6>3Y9(#QT + D3/_![2/C22^@=YWOI'VAVN_ MV:ZQ.Y?N1<;=)!D#4'1?[!" Y"O;(O([5^\WQ5VE8$<@"5MION6-K-T+VWHEW\R+CI+I#*=U(H#RW]6R"2?\=^ M$X[OXEN_@URS+5"*"] _+HJ^!R 58V*,-+^Y I@]_&FZ. MVNBV-KA-U@CEIX[ -0]:5X0T:>&:P).RHC9C>!->\ ("=0(B/;V7!\IL?!=0 M-84,;D::2X;##-E9Z@/*M3JB%HP;/8$*W,+HR5T!*J$K^\7B^K:]0C[*UP,M M#O'E+E#W%T,;@7S A^[?+62#J$6SY%&+(SO_ 8K(Z1=(*H>_/F2N/X.'+H)R M#&16VPH*2=-LLR2U@S3P,D,58.R3@%VR@ PJ:A5=8=RJ4\F*3B7-[1N5M-)O M$5_V=^A\TCI,YY/M'GOH[A,.4")5Z#>C$OTCMT$IWX-6-#9HG7IC@Q7M3PIN MQ'*POA05'6P _83*.C(II'3;R(T4RI9^NVU"5Q[INC< F,-,Y4B:2ON5@9>S M:/H\=G&D0L)C$'RCWC\(O7_0YN@!23+K0LBDLIB.9P Q] VK!(#D^60X445"2^S6 2(+P2'@L1OI]8?'(VQ*O0> M6G"V:X.4T[$3EYL7)!Z_WG]Q9>7^9W%$=A'R,=,.D5D(UE/"$I'@*BE3?DY53$>I!&VY,'\(8=NK-=I'BPM5INO>,O4WV]9? M#-.DG S#\C3KB3)[Q:G$94O8 #; 573LP^9.2]7K: 31HR'Q38 !L&.=14@_X>H:=>\,%VEXL #B6(![TJ MCG#:5'$8<=UM);NOGKBXOB"I')1]L+$:K;IHF1R 1(W?%77(U3\:+U583L5R M#C)SV^;&)R@P*_OVU;LP]L],JH RHSJCBQ"G*6?)RGD(@D2IO"I(GK9ZEY2P M=1)H/DCR0$HM\HE+U L2G/)HE(U]("IKO&">HUFN*6M$];]\T>[@(H1HID<8 MI>5\D& J-/NJU>U4@K1\J#Y,"NO9"=/*/(TE:/U1?ZA?MC3-SM/Y:,^P5<.X MJ-.M*F>@W$@_A(1M=<_N@.N"!"D.)0 HL9'F&JYL:01*^I*]? &1]PB0CR$\ M\I.@&_:D:B5G,52B]'C(WE%REA[9_]J@C7+L[[!AD=IGR]_4)C-,E;2#1-.9%8]*:]RS1:.>9$,$ 1(N M>KV_:XD\Z.#/H%- HM=UXI.H>?:&"$SB9@M$MC9!9!)'6R"T%8=+!D9H&-<2 M1C@U3 BMA!'')FAO-/-%6[BO5(A&0$X"<^O-M;;97'MI<]/0O)'^WBW]]U9J M\_;\ISJFX==UR]]^]>UM5M^)KSZCUQ.K#]J B@A9#$R:>J\??280%GVLMM!@ MU$,#7J2QJ8.B^!?/'K]Z1RW0L)\5-M#$WE;_^E4+9=8ZG";AI"P\A2_C;>M$ M1ZAZU[ 2\R-BAARVAPH^<<1>1,>H[;'2V?XF8DW2&\=JFG4[B)IFE:)-UJ!1 MM-4H;+;'"1IF66)U,';RGYF5;++\YMEM8 MAM1MK=FOLDV/C=J#&"VMVJ!9IB*GRFZY9$U98:-,V*B"+D5U"5<*:JI6X>5; M567&YU4/@?6"X?@@G$GF\+EFZ)=DTL3! 6A%U*[D3 "?Q#DW]V9#[-R#^VE MDRV+$XK4X6)'\^M?575SDZC-HA92?3#CV!*7ZNK:NY;^T1H0*>MBOQV])W:( M 8=OPSZ6(M\#?SC#C#]>R@]"W[R) FBS;NY:H M.U28I:,Z))SRGN]%_C95O41UQ>QW_!LS#*,@[JDHQ:R7[YAP'A)VJ:5#>/HZ M^A$" #I]=5'N-I[.X^;)O^4!W,*VUZ&MI4[<8I[<89A6[V=OY^Z^',8FLQKY Y M/ CR7YR;B5/4'"&C_PZ:>SC0NKIJT'8:&[RG#,1FJW8SAJKD)>Y-Q'X"0?J: M_:_AR')TPW&\1\,U>)X=PC::BY>#'&?IE">L MS'EG3/%B)@8T9-KKLWR;I_3G,OSVEG1")45DNQ9WP]?=%UMU1GWV]G;,&.YAE+).%2:M@%WAMJ_DFGAC0TM^\9$;(\LW-L)E5 MFSURG[/GJU7C\K[K1VRRKS'0<>:8\5]3&Y9@N^RW7-_>- :\"/X' ?XUWDI< M\W_YR\#.B$S8 MOKL9"^%.&W;8I!1;PP4^=D! 3( L$3(\HPE,W[[C.-J&<0.?(ES'MTN1^,[2DSQX9[SV-Z7RH] M"LB;+= WRQ/X]M)D+;V;DE\EI>] U OVGA0%1Z/QOM;O+)X0$&G!%LXM7%+] M'0\?D9Z0+&9 PX%8/THV^&6P=E>53IC3"3D](*J(3D,3?'6IR6]8P""%Q4[L MGKNX*. 95 /,DT,/\ &DWP19Y9@++]3P_ +?)*2KX7,28C9\+1F"X1)&-E [ M=V;:2EY;/6INGM%@)[Z.X+K-!'&) Y![K<7RE"6B17'4>HY*C\*24X'3X*$B M[?*P>&X'>CH0:IH':&;;P1BH'QM-AP$I^;PLUH 2XWE?B5X" >PM&S.BH3ZV M0P:?YMII9UQV)GWVK;=JXOG\TK%_ FM>@@'@7KI>'+R DKB_*!WFT@>_A M:E@YBY>CJ'T]M?^ +?5# VPS$%WLFQ?8PFP[#8H'D*8)2"C,N2!XV/LHM&&3 MR1$JGP[#1P_PQJ=RS5/? \(/A)TL69"-;#\(@1;AP1.X"TAPS+&3)<,O00,A MNX4+"S@HRWC(#4$4X/XBRJ8@!?@O0+9+,D-#YH;/ \^!NU%$H'H-N3EV,9C MT#N 14B]':^CP;ZBE!$2(%F^)0WVY#*X&_DR',-5/C>]>U=\'([!DA\#*VBY MI^+#)MP((I]Z3]!W#I 3CH8W)E[DDNE_!U;!R [%N^".>V!U #_=EFW^8() M1(A+D382R49K!P<"E&8(. $D.QRG>IZ(Y_#11:O!%4X0"+-P3!BXOOUPPZ[, MOR);8$G+6E#,,$T_0G0EN6\SM!5 H,<\/4=_+EH_8NRX:.S!P0_#"#$3LA6> MF+R*68"H/,6#:>+17OH6OA7(JTE M#EC #D\-/XSYQ("-I.U FHT?-&_TX]'!-APS-,Q[ GP)2%CG/L)]V8 MH/TBAW\=8;D]D>%_R)S[79!2\-US'.E0TRP*',7PN^.9/S>TX\"]-:;PPA"V M8M7,#3G/H3T0BEQ,<[CCH+09*3!8G]QTXQZP<8]D*IS;(/:<[PR'%+Q@2%"$ M]Y@"1OH[7ACMN.22X'7!<"!KJV% "&WQ,!"]E4[A63J49RXHB.' HPVQ:*9# M+"2@KYMRCL>R(X,5(RUZW>U'4/3W,X*B>PJ/WT MJSX^@-*N]S(HH,Y8RRH8,6\![==8SRAT;HG.CQE+1:#S6VRN+.+RU%*$R\B0 MH5%H.2OS4M]+QLSOTJX (_"_#3 )_)F@*QDTVBEQIA*I%:OS$PH6LBQPAD,](RSQ@T,CG) MQ2G*F1QF\@I;<8YPDBR7N,YQIAP3V;&MWHN32&Y.4IH%6'JS^6(^GWF)JUZ< MU]QYL4*[BTO:+^8M#4!NUM)#5!86(B'4?:R4*+A_+OWO328-N-%&P^1"?[EI M\F0Q/-N3[0ZQ@,SK&;U_68/C\=HL?E&B&M=ZV"[[W;=#.QBS*09.@K2 1378 MV+483LP1H+3=Z[1,ZE2*X3+%,': U=+_YB85S%!!](B#(# <(!!:@RB-!-IQ MJ-@F\ZDW8A,\_)N"K,+T#:XQQ\-R+ZP(B@N'1F+0'OMWY-N!98M3PP:[HFJP M@CB6)FJ61@ N_V7R*5V?KU9Z!#!<#]X%SI6?!3\#&\]B_6Y&!3_P.57Y1>'8 M\^,2I[1CP!U'6 $(7?4+V*C>,S-.D<6#%'%7Y6Q%=I,MPS\)RK^Z>5=^W62_ MT[QL-^5J4L:'-\NBM8#=1[9%L5LJ-_QQPTPB9<2+Y5&QL(W;FO!<&P*XWW8?>!!BS7*6SW'<,&P6,&F0/D+6S,6/SK5-0![& M(E3!%%@)GM$J1G'#?"J7W+S=R.G/8R4L'&)!AQHVNJQ1#*[S/3CZV4)Z5-\^7/ZI()FPA Q9+49Z];3?3517]DQ56 MF8]R4"X<0)%H280%2Z3%LK71F='E?Y2'(J*O& )- 4Y 8:+!&KY]^)L!*/\ZJ*$8Z"H RV-A' MXOU'Z)E8=X^.#$B%=TCQ+A8O&?.XS&+Y*1C-WE2PNSEY3W@8-+JVNV#7YP[U ML)PS_L07"Q05GBM+A&]]JCN?W<#:?^Y4_GM0'V-;PZ.E-]C-&%1/P+[S:032 MA(K_C]@2B'W@=WY:;H122\BNHC9!OWO8O =H\KT-*BWTP/0SIJBJ12DZ&)&4 MH+R!+J-]3E'PS??N?6-R)>Q+T)-7U&Y +U)@K7^U6B*#_A;XA6/?-4+IPM.R MAPW?',/] A"4F[HVZ&K]YG!158 U4H2^ ,%$>T+"B58. HK7'P)?G\&*GT02 M+X$??LY"1F@2XN&M1FPIL<>%/R(U8W3J@<-W?X$K/^NB" M=6#R^46G"P8I40*Q9-9[&7#SM17YCYYO!1SX!QMI2"=HOLP?FVQXT?WX*>M+ MNPJ^![/S<.M[C?TF+B?PMC&">6D9LTMY;;*&2NK\38X9M M7?@O[ILV2O"1#^H]M-&%]NA?+>M=^_P^<@R0ES/<2HS_B=V5W6S@^KB9*+P0 MFS<"7\%N47&'T!9^1EM0FR6+PQJHI93!'M#O$"[$R!!BV:;-P*?"XDR QO3\ MJ8?-W.@U&8!\Q)=/C3\"+48*0&EE&I9XU%,G?81CPST6(B)[MT V<*9/=KQ8 M6\%F2^0%43 5X@!C"=3!AA"/OAF&'!"9&-#PHE \%;T]6$NB0;,XBL00$0OZ*;=@L*;TD51W(5Z:ZZ>.7 M#XER:JZ; MOL:-U"U\[='QY:&3R49K+LAH?N8*#UAHNC;V)A(X,;ICV$@0*JF@^#;":]Z<"E9N)[1>3^2>;_=SXQ;(R+I7Y >LT*C^"$F&;8T[I# M'?Z_6'<&6S61/?.*A8TT#A/S+A]ARW;<6F6!_^%Y%EI4(L<-/"+,1!-]9M_; M@>EXV YOSPW)NKT580OJ\G7LN$6KP6)$$1NEJ&("5QO%,)8W\CN;LY\$B\M/ M=9;TH+^))H"YV==1_(C]A,GV=FZZI-O>?8P0T2T:>#RD0QC9Q]X19XW8WM[V MJ3LA",&N3]A^7F+,./%QCC@]C-L<;1;V.2);;5M!=!"6FBLEVK*2:'=Z6W+3<@XL MMII+*IZN#GS*PCE4H7?5#9PG&R.G(35/UABIH^3Y_X@P$/$:P1#H%?I-$'&EV3@X6JN+( K2^G.$$ MHO-'K]A9=1:P/K:]."9F_B#FRK62H/?.\V%.)O)==%!II[B,AZHE0Q2K$!?O MG7M8O*_O,2Q>C4?N-WB?A,GU$N+D!:;CNM#Y.N]'GY/]@Z<7K4=NP:ANNP+"?8+)R M/-#I:@+6D_T?"D>H/3G*GN# \_WRA J!/C4$2K&%C&=\U-.D YWMK@Z=S'N3 M)-BO?\D"B0T#I@A!B-@',B3/C)(2Q=_H?F4#+!^3LO)/]@-?2"O\??;9^+?G MOW/@.>4&7GI-76MU%B,O^SL MH'J5Z#JW#)2#&0\WWBA\Q%BCQ1^XXTV1/,XF':4,.R%&X/L4?UGV6J$L]L=: M+6W0:M7-)BB7,-;,\BE;QY\BE>A-?8%&EDW2402S;Z5]BA32TOJM11I161DJ MGVU-3H;:!;4+:A=48+.&N9U[B13LW4TITVWO:,W>8@NLBAN+)6_H8=T+Y1-4 M@F^W=@K*Y-JV-NP-E"U_(@G,)P^@VH?3 %#MPVD N*+B0/6+4(FQ*C&V.IF1 M&;>RN(U[E7*<5&ZLRHU5N;%GLPTJ-_;T]D3EQIYN"%GEQI863,YV-E()9K4) M89Y@;NRI4YK*C3T5X;5A1/W4"4KEQIZD\:!R8W>T$TXSIZW=7YQ65''A7+W# MZQ.GDNXBB=3I&+P"I^ G3B @1EI[%B/G<9Q^;NF :A?4+JA=4''-TE)C5Y]A MUB%6L'='I=P\NYZN8HZGY& HKZ *;+NU6U NTW9[!X^VU=&:/[]D0+4/:A_4 M/BQ-CMVP'3?3!V??57FA1_A%>OYT2=;0RQ5]E@_8X?BCBWK9%0,M:6)W88]S M378RQG;>IC>9 OK$O-:5/:$+>I5?CT9BF.Q[L/N^CC+?S \[73(RY@;>PP/L M,@U8LBUJIOQQ @8!?&XX!6_^ M[3"=/#-],,\2^4'=-FZ)/;(!4XN=H1]P-##-2U_3.W[-P>5&54BGUF-^V9DH M\SGY _'(8#(_\0]QILNN?GS&V>E>=#]F9A3@V:\_8X;U8 <>_G+OG0T QLEZ\:6P\X)4QFED4\%'D@-1\X&+L,)X;KNE]O[[5O!**R1EL M)OC/+CZ?$IG2=D)AL2N/ & ?46\73LK,B$@=ZW[MB$G@F M!L#XKREW@7_A5WOE9JR?O7'@]C\;(;VT(,9BA>]:0;34E)S+[9\K95KRN()8 MZIQ06\MOBRF_(M[ 2;/QMVVQR/C/96/"LR(#OI)CNP4YV=;2T=TKYGM?38$( MK>32?^EYN)9@A(+$): GEODW!(V6-,BN%NL MK36WMG$2VI!1]R']]T9Z$>!JR (JO=E\\>Q5^="WMH&^G8=^61U?8]"&G4CW MBH'&;?3ZZ6=BO]*/LRJ5D4Z%%QD,Q!WP[C]"SWSVED::H!AZAS(#3(_?7ADY M&EV.E!R814R0^5K6]#6Z=HY?\*CB3>[8 @O\XD]\ ;BH^=M^"]I)W&_UR!=O MM$+&?HAP\D]6O%X+V;['63#+A-).1L%5@+M0X #!<^R"5,!FC\#D(D1%0"%DB>+'C>(]!:<-=WN0.O2I3U5H$ M]M9UKH/AUG6N[6-6D)[)$>EWF@*&YO;HS/H%K;)>%V7J]WA:VE<0R6A#_A^( MC>KU*NR=PD1)E4"=8T$@EL[9)$QOQW5?X/&WC]QYX)_1!0ZJQW##SK+\QZHQ MW!DH0Z"BKN+$0DY$=7?[Z%6/ 0?#9;UYJ\: M>*SGN*SY7R&0=_J<5JKW:D) MIYV'JNLK%ES*@A^\Z/2]NQ.HL%:J;CV?#>:"B[5GN\?P*1P'UUZYUFV")L5^ M*EU6%?PHJV8;:7OKA8:S^M"H3@'N9=(E!_13+:,O/#QY$;S5+!XEA8^? WWR M .Z>I+V7O#DPBYC(E@"3PP#L8905L2Z#,>AO[TH#$!F M8/8*"\; Z)3@LY"3E=W)K5'_IQU8WN06TVA)++'/27,R@5]#8Q]=LR%Q&'KL MW4<&4LUP31MLQ'>>/Z54]FS"+"=A^>[]EW69KR"AP'*V@@^^-WF/R>RAC;E8 M7T?Q9O+YH\IFZU_Z$(5"$P1$\ON_Q"I"6 4M(EV#6 (L(-]I#?#.;T(CI&MD M>?O-F',4DU>6104%AO/>#DS'"P B,+7@CZD'._0'6/[3 !XABAKPFC@+\"N( M6Q*$A=;8NZNG6F-ML,86CS_9!=AW"L-EV;O]Q:C[2U#XS#2",1;!()S(B!B$ MPB*CJ6%O1..Y5:U>%"@)=$K]I3G>Z79\-G[9DV@B*ULEQ1:4W8H>)=EJGOU@T^)*, MN@18H5+,+#;9G1& R11-X5>T_ QS;(-31U88W&N"&P>^(E47WOO>(]; @L&* M#BAHHDRMH+P]EY>?"<4P&8M99R4NF)6+=J,^$.54TBZ41S.'>'.[-_=F%^P: M/S"PZC;VVF-EC86R&IBDP534]#JS==5'>_$&KM@];M_Z4K M];J3\_%?X\ MND9VB"\#I_4_5'U %=1QH2]2@"SN17A\B^))S,,#308(!$M<8RX/\^&57*!L M9:E+=!?POR( Y/H!HPN[15@J%F#I-%BZ?B80L%%X96]!QM@;YD@#5# >I !R M 6!<)X[TA((*Y8,=!!'U6I."S#!-\20D/%09>#Y&SQLE/G@0\RB&YG881$)G MQH)"72\&T@>8;2)[*V'T1B[FBY-A,@6"QPKM+BDJHJ+VK>-1&Y#.7NI*BWBA MW4H$0A:J38*'2X\57G\6S-IJL,]77Z[^N/Y\_>66TBSZ;V[8^X\W[W[?;SZQ-Y]_?+^XVU\S??KFQ^?;NF2K]^NOU_A M%S>TQ\6HV(39MUPY[").+X+3A8A#(X(L&+CXT?"M2\?S?E)@.EU7.#9"6-0(JW4)%2!5 M7;!J,.J(_6_$&N^X8_,1Z*JO< 68:1' $*/:)-Q:]F@$*(A;YC@S88.%8P_L M* F3L)X$N,L :K /\'S/EY")AYM&A&T;:)]"W[Z+0/&*9B[T<'PS!P4 M>"W [SW"HSULJS$!29=$\<%P#4S?GA+NI0+W[>!G0#L,A'?G/7#"@=AC\=TB M;(MXH08S"38D?@@I1'&1[Y-=00D;@DXU0#Y8K)P%8.3B"$*F7S'D^U;SS7=X M;XP:^DA_0Z8H/.K*=?&]@IC0G81E3EB.W1;/]G&2^^7__/8*KWJ;E :/J+Z/ MS@RE>5W'6QN M5HJXWH,!%*4!EH$Z*50.QJ3C7%KDGXLV4T%D"T/W^O8;;-+$LT"2$4N :(J( M^&3J/6(!N8MG%L3"'IZ!39$?N>W'VT9W1E.BUA28J>^-.,DM\"+QSCLR M ($7_(?X 29(H5@88TQ%?GR7G(L0' Z720)(T2BM@S O.GTC )?))&#@128H M!5@@ ("-F"1SPU\/MD7&/#P9A*P/8G%JH)R928T$'#)&N]_"' 2?.-FW40XU MV.^1[= 1H"=8%*@3U-R]7OHA#NT.4TQZ I+EV# M*#5^WR.(+AYJ+'/@^,T'^OH-MF_1;N\C:19ET(&\Z@PP0Q1NHU8RAZ9_ZL5E M3 %]OTBI@2AZ/FPV^D*HW=F.(Q0U!>N,92T9A/83KXG9(=8XP1+R :(@]POI M#"52:.-V@?(!+I)_4"XM/L>;@/A:*[;77A"3OW4)NW^)S.B#7$S$GQ#X0OV8 M,X#%GTW!_I1_"])VJ#D2D0)0&2#LWI:\19ATC,C%+AW80&U6 L0CVP]"((!+ MV/J?."4S!VJ.Z*>P49RC7,\"*00NDC\PE(E'\5)K?@99Y<.V.M.QH<5J4S0= M!'3?H=2(3^V!>4G#H",_]=!-06F!06"*0K)T %C:T/ .6'1D"W-S"MPU=QWL M.!%W<_2_HNTF5@'H.&\HD:94P;F&$DK; @ M@@LQ8(U]$<$D0-/0\#$%BA1OY@7R#M+B(%$#4!0(.RETX-T(*&E&#?%^P7O0 M9C)@JZ9D_'^!-CO?)"6I#R *"-Y>4J0;#28 M,II,=# -RD0!WB9Z4;DOZJBMQ);N)]3FB^]XW)LA/ M@H33MUYR%_UY*_:W.$K*2PN6R]W4(LB@%A4]^">V1]X,:2U2?F)?8-\\4ZK# M*86 S1P3H?ZW3>F'Q(HI]#QA)(RY,RU:,KA3/JXT@RP@"]!F[CW/V ^D1S%6 M76!)',E,"V,'B8.O((Z24HLA=<;()L*+A79/OY7B/R8)V T'I 8^)M7S^2@SQV[O"!V M\<;D38U2C0MM0X,& 1$.F(,R"6U-@Z&A&&>+@-86?5[E&D"/$^/FGQYSPB*J M8GF5&-:!T!H&.3.[JTP+?!N3=";R%,9NYQ6\$()"&+, >W !%!I(E8=XC4)8 MT5\^IS,=;C7854!*5![]D#**_" 2+FZ,1YE)*XV#66+(@JOH4[P6A;L'JG0: MXE= RRA"/%0D4C/C^1Z>IF)D\#W_8,]IY\=4WD73,3A2P1RMD34,,L:>.N(( M$00U-EV4Q$NT%O.-=.!!?9H_G1G1'B&!4)J7K4C I&MQOP/Q,(![;MU$XB*" M((Y[Z0Y;(-.,PPL8*-O L-=8[&+-Z'8?G=F(["UN3(2( MRD<[\"IQD'P,V?0HXE:P.!#G%(VBL:C2QWI,3G')G<<_WG/XF)IINNP&Z" 3 M1<"\2GTXZ"(YI&F)[PW@P9L9*%O4NYB_J,5';WAL9F4%Q<=$%>EZV MVS'T?_];]OR!(N_JR& _1P:[18S6!+6%W R M,CNPNST!?>V;_WQV+T[*[IO-AVZ[\>_I_3/$Y#^???KZQU,S%_'_STOR(@-. :V0N1V1,,85'0D*4= MLD6 )DB;Z%*(-\2@$# =!>U-$<3%!"=]'.0@ CS MR6F)7S&&%R= P"-,$<]=RX58E'[Y#J-O20 )+"]S1EE%!KCYEN>*@ZAW8[ ] MZ/"-.$!C]["9:%7*DR0,8H@54C_VYY2QB:$9 !S!R2,0[ LZV).]V^D(!78A MQAD#H].0OAC&D7^*HPF\_P8^!82R_T7G9,9^-]R?\K 7$>TXQC00!NPH\BF: M$D;^7>1@I#D.<6#T@BQ:CC&8@]N'N)DW_\^83-]\8]UF4V.?;]Y]9-=7'Z[9 M!7KW3B+V7L;?Q=O]66XW#J3XQ2Y^-&X:S,)%^R(ON7A/ '/]1O>%!C_[\+/3 M:+Z@JX>-UHM\[J"631^31)X[&(!&<1AR.DG1R+7&P-X=JO1$Z_2\9VHE2+A37%8M,9^Q]!?, 8V MB5PK.=%.<##C[CQXE/Q4@-4JF\D=92;7S$PFCOB$P5N+B@T_QC'H#]C8^D@* MF(!R4J!@%F/B?B?/7'B$H)PK[*0 M[2HA6S,AF]A-B:#]=AJ"-@',20%+A:V0GGV]H>=3 +83P@UV'1N(9)YG1>]& MHK8*DK9_WI+VD&$$3"^1I3;RB":-CG^7685'B*811)R2\ESB(SJYP51*U\H= MKON:S'L1#G_^M!Q'Z26G8R(5;?[ .[H+X%Y1%"8=6[)>\#V"GY_BV1[4RCR6 MN$,/').79"@P:V;R7W@6B.EPOF'%F2,:)F_,&:,BCTQZV)2H^KS;:S3S$M(( MEX420X\][X&+N7!]D?EJB:-%E,BV*V0R[K*,E20>-IFT5;9X>LKBV:O%LZMV M&Y2EW0YN9IV(I)FWLR[2O!\Y8U&KV MNOIF^C%=0V_;)21C_^2CRAGKEPSSRW+IFL&" I9U?8?E97,3_OHO'PK"XBH' 3X7'XZP"*9#!') H&^-6\:13GKB?SXS'%3<2@ MIB 5J)IDA&[T':;R.U1$%8.0^,XC+KW?HOZLBA,5)Y;(B7(VP1).]!)M+?N* M9WFRWQ@^C2=[W=A@CWDR+8O(9/V7! M3.XN";A&P9!LM0&%M*R)[=J4VRRJJ -9?"3X/UYTPLWRY3E0 MS*R8^2#,_)6H]J,T4V/6?CG/VU\SRNW514SD+],"QR2#*W.XG'R6,!2U3!+6 M,-X-_./+?CJRP-["6@"?&#+33$U"(;)]9+-E#?._#-N7?^ C&?$NRI[(#L9) MJS7/I5U >D_[,F2[-(E4(@2MP3[(+*I)SVU7LJ=CS(.SY9=Z' MG&?,/[$" FOH>-;AI,9T>J_1RNM,TE]TF6"7$;MXKC<;[9E42H1W05;-NV1H%.K-WMS':'7! M(\6]L0H)V ,8BL:=2*^UJ><.%G _\!SXFDC7I%)5/UNA*L[H[UT[Q.8Q<8LA M].I$02$UXI$'_IR)T(/.ZS0?6@RXP:)S(,8<:N. M48]$]=ANTN=T5@#.[HVL5SP2W>>!B8LG$U-(DX<#LJ#2X53N/6??PX:;9@3 MRZ8*/)[DH8$)E)XI"(F='=94Y&F\W[X%IBC7+%P'9L(_U]MSNH,*(1=9==6# MMA #<_S>G>=K8O?NND^UC8)R:;8Z05#"]E?Y,L9P#E15/X MZR=R;+)W8AT'3Y;_XH5I3S"9YI L2;:;\K,]*-:6/+B>>^EC#PZHPL'!9::!!O:]FVV$\%R?WP/X+B*+?6O3X03ES!]X"(FPHK ] MCG3Y$YN.C; !Q#T!(R6_@87F^?A*$O.DEE8;Q"I2B?%']M'P0-2'&$]$=6PX M9B2ZV,$[Q]V8$/P/8/J>%%6$!.F4(+6RD**1/F^6+NPM6J5E&*5;D%W6 M[:-$*S?NRQJB9SAOVV[D]<70G2 E?8Q#R,:YW%\(8N1?B M&=.JXH/_CEPN7]A<;O(\[\3U#/(M<:,WV?\8'HZ^ )@@Y D\;R^" MWWO2PR.J2HR=@(>ADPPY>=Y;"-N@)7M_[_-[T5.36O1@YYP)GR']%>UO;ZA\OHJYO7]#Y]E,F]Q:A0UJ#MXC5E1UNT4 M&XLBS_X$(%-Q%Z1 DE@5S<&Q4PP89Z9!'6MC,RI[4",%22PT2FUOE)SESYVL M+YR\EW76/P20!*T-^R_20W\!Y>MF0DM$P;^%_EOYR_SI??O%LWCZ>_[[P@GU M;^+#>'F3N&7U[]5[,!UE;Y02P3;>+Q++&\"[(IEBY?6+=X%$1./AG\_T9I)K M(256_$1!-C%-ZXTF*A,R%-D_FO3??-)%_-)%PS@G56[)>_DLO)=K]%X2LWB[ M9=5Q/UH'WXY\S#W>BCL?%.*:.]'OVF7KGGA]@JOVP7&UX-IOB:Y6">BJ*JGL MM';B\E1AE<;IJ"GO#//GO8^]K2ZEH6B:'+RV-2+@28EB62L/-P8MV=RXL/C# M/(B[1";H\18.IR3?XC5UY<7N\L_>_O'IZ^]7GT2MZ 4>,XD(39)AEN1O[23; M5M]UW"L5M$^Z[,<9UR..[9V]\Y/-.E\3TC="-L+YZ=4RK++(: ME@EN\8CGNSPC5B;D;SY[.]"UX;"]V >E!#!+(/AC8J;?U ;]00E K?Y9=2SU MM4Y_N#_ZV9,(.IHU4)IL^BA:%+RZ\**0?GMY5)E4(DGUM'9'KXM$*A$O7:W5 MZYP]%G2MK5=/WE1&K'Q>[';RZB*;IUP;,=/2.LV>$C,%8F;0U<\>"[UF]81, M]8V::Y&J5$]7:]C4^IUF721.^4ZHPD-_"#JI?U"YDSGPG/[:\#1DW['";461 M#(3C-6V,@O]BEA?A0:P,@V=/:4\.BO(H5V&S(E"H'=R0'\[=&;N*>S^)06^9 MHBIA(=7&--HD4)K].>AKW>9 &5&[X+#?UWJ=H<+;$_ V4,[AP<^_,](PTPGO MQ&1BB639;+1[+ZK)G65@(B+9.LS2TG;O9]B7"Y#$,9&'*#=5. MM-XD57AU$U3M;FUB6F5BI5-&ZD#5<;#'8]PUL:P%:2'+07KX30$,F:_3U,O. M7B]5AE[9B8X_;MBGCS>WU^_%!!Z5ZZB@W?C*"RVMM4_W^=R-FO/) M9M2UUG"@Q,QB#$+K#54DYD+7!NW!RPJ)F.J;-+7.9>R!O!DH5VJIDZGP *Y4 MK[5'PW=-_%?E,AX!"I7+>'90J!U4N8PJES%G RU3KLV1^*E8@:;E5/_Y)OK']^_?KN^^I*F MX*AV8PK:$TC!J;[=<@:Y.:V>UFS5QF I%3,M;=!67M/;UE!K]:KG-55&R-0W M!:>EM5M[))S*.@*ZUE0I.&\OAFU=G8RKK)S]<)C>5%DY11)9[U;TC+Q4+'0Z MAXW%G)5!4^L$'+"&.]T]$D^%_03R)!4>VDVM/^BJ!)QS33A0Z1MG 87:P>,F MX%3?'3N;S)S60&OV:^..E8J9MC8<5K2W?,DV4[N"]9^5$37GE8#3ZM?F0*M4 M_TREX+1Z'96#HSKC'"XYY]OWK^]_O+ME[ZYNK__X^OWC]8U*S5'0[I2:HV1* MM?/ZWGF3B6?9X4RRL3&9OF'O(M_GKCE3@D!!JW+T5([>?"9:J?O0F9BZ]QULHK6R2R MU.4,^4+O#/>2GU#9DU-=:[8JFA!79O9.OWH-ZZIOS)Q/[DJWOTCKJ(J6_5<64LX;:VKUT:RE(J7]E!-)]*U5N>P-7_*ILEDK^03 M5EYEDUGJ(G\N^@.5-)=CN4%%S9DRB4(?-%7:RMF=U9]:J+]JN*P"$&K[5-K* MN:>MZ .M7Y^1L.4'NA0>NEI'5UDK9WM*?VJ:M'K8K 04:@=5UHK*6MG,,.AK M>E]EK11AIJT->RIKY6U'Z^V]U0K\,$!RX?,R[)_G_C<+O,^R/#U )RP5>,L? M4R1#,D9:-HX$==2O [IOS=R2%-[^NO-HVV%8UA. M\\4S]HKNZ;[]S6!CGX_^^>P?H6<^>WN+.$=O\!TL%Y8"CJ !D,.%,=2PB/A% M!-VAT[1R&4"J_R4IH9D2A%W]"%"8^>B;>^1O1 3.Y@Q.F3!"Z_WS6 M?$9_3PW+BO^6+_W]Z_?WU]\OWWW]].GJV\WUZ_B7K725@'S8?_%&*-3730G> MZV8"F83-CX&T\LON]5](HWW^^T+ZEZ_LO,A9^JM_K]Z#B;%CQ)5F70S6QEIV M$[Z+=R7#SG0]$8V2 ^(G2DM,\C!%IL)\9&J9(,R-&%Q,8+L%=N7L,WP^#M@U MV#-6,DMP3];;$?';/CAZ/QN^.180M74M1NV=#P)SS9VM9JN=W8HG8NR(:W_/ M38[S@I^Z_%:UE[_3UK?VS87UG*?Z$;?6I5-VPV'O^0-WO"FWF#R45^WE%+2' MS].M3$CB'-)QFYI>2M+IZI\5=\B'FCXHXRBGUDC2=6TP[!P&2W6S %1V[_J@ M6%?-[U(CS-Z6-[_DW*V;\VDKUQ\,%-_T*WJP4B(.+KJ]W?KHO3RKQ).J)1U6 M 0BU?94&0FW?J0*Q1APOF&7)N6U8*(,S7Z+U4^[5DF4.M:IZW2A,L+ M1%8=#T /K=),]?H;J=7+!JT$%&H'JPZ%VL$3AN+<8X]GD^R]R8E6]B>808-^ M18<]'!EOP&<*;UOC3=>ZG=+L+Q-?#8)7P.MUU-&S=N^UN^K="RJ:BC/QE7I5:?F M[^XOO>H3%Q+3DK+.F$S?L(\N?!BHP;H*6I5D=:9)5KK6[U;T5*]<-'1;JFH2 MJ4'E6*D%6=W(KJ *&VK]) J.T[52!4>E5M/=I:IU?I6G^@"O!4I#!&PZ![ MJ!.X&EBH54JJJ! 4:@>K#H7:P1.&XMS#CF>37H5&36D3(*ILU/34\2?9=NW2 MLLQ4=M6IN;O[RZZZKM^K\I/J ^VY&Q5GD$W5UE62\MMV4R6LOVWU M]EF#5VDU7)I N?@:YT^]LD5*57V2(7:;,%:/9 B5"]%2G:I4IZIMV::BAS1E MBD\E/=^J+*H:IE!4!PBU?94&0FW?J0*ALJAJZ\_6.HM*1854?#!V:I5M6LNL MB0I!H7:PZE"H'3QA*,X]VG@V^5/MYFZAMEH8-.VF*@]XV]IKXPB5.573S*EW M_FP:>F;D^]PUU;@_!:W*G3K3W"F]K0)$;_6>2L-^VRXO);]NBECUH-I CE23 M@\K,?]@M!:0>^0^G+D,J(RK.)W5J6-'3F3)%QXYU8+60'1<[CM-1,_Y.,W>B M.D"H[:LT$&K[3A4(Y1">8_)1JUW1KKPJP%9V;$FU%ZUGRD&%H% [6'4HU Z> M,!3G'J\[F^0CO:KQNE*1T*UHF72I5EVKM*)7E7QT:B[N'I./'"_@%KN^_::Z M-BEH5>;1F68>_;]_#%IZ:T]G4%52HPH1!VZ>H*IUJQLPKV\&5:7%@,)#^1EU M*F)>OX/0Z@"AMJ_20*CM.U4@E'%:=>>\UDD;E3:_%"+V@(A#!?EK8(A6Z<"V M0E"H':PZ%&H'3Q@*%6P\]YP.9>LH1.01<>RV,GIKM;]+WV_HQ99P;45=WOTE MZY1Y#PV->A0:87UE&SO Q"IQ"/M[& M4/GBA?PU^^;S!]N+ F?&[""(.$)OA'8 8 ;PAAF[X\SG^!E\946#'PS1)@O_$B'[#*_K0#RYO<^IR+ M%_[];\O?N?!*EGWG8!IF;=RG@JXWUXE%$JMB^TW %/>?O>WH,?2X\9;]\%;\ MA-70_^#30BI @3P'#7Z443)W?.3YH&2<1V,6H%J U\#3QHE"DC;VD/Y[DT1P M?[UYM*UP#,MIOGC&7M$]W;>_&6SL\]$_G_TC],QG;V^10C&H^0Z6BYO^VRL# M((<+8ZAA$?&+"I:=_5J\;M#HVCD,H4)ZDU5.S(A"+_Z$N$]\].SMJJW?=<\6 M5=GM&&GN,WP^#M@U*$F+?39\P![#--]SA)G+_5W!@0#2 -X,L_\%V#=>T#8=]=('( M)M1? J#'I[V=6T0*8"]EQ*5\F>-#E*A$9R9WT+XRX?W_?-9\1G]/#K;S?7K^)>-+2Q"H23'WHLWPC%^W91@OFXFY$9$_AM) MZSFY+VX>O)!VX/SWA4H@9K@7.4-S]>_JPBEU@8 M4EC&#Y1Q&LDL='88YL\.E]D8BVR^1J#]=N>#Y,^+J(2]]Q3#8[[W*##0V@!+ MK=SUA\98%KQ-?KX;&^X]W_:N;3%>@,$]8;]]5.Q_XSZ^2A#IX;>B9O+F]+D' MS:E]\\Z9XK5U2+Q*_S8VGDIC'C+;3KSNZ2G6^=6/S^S"=AE<[H"!77+J\@D7 M%"F8SPSF?:A4O7DR\?*US)\>'0+/U^:4<-#7NLW!_D/XU<-,OZ\-FD.%F47, M#+7>L#:(*1$O>JNQVQ'KBR);[BR2[*J3ZBVC6B53K<*HPJC"Z*EC],A /#'M MYH0:JFQQZ;[P,NKK"RV+2M=;M]A1>"H8'#!J[]0%28>+3 MC]6H$)S"J,+H>6+T],+$9Q83N?5"PV&^C(76)B@R:&G-3J;&.WJ<;G:X-7J0M*52P'>BUH(986&%=NBQYX-^?/O*B]MQRP27A_!R:C[/IH8?.C/FC48!?'HWPU7_ MA-\L/O6Y:5,A=>/TZL +DD">O*E9MZR][::N);OLB?61""\+0^(H9LFOT4WH MKA>3DJSQR?8,"ZDL=R+*+=<.RV[V>@T7SQMI[ M=>T"D?4G]B\6C.U1^"36VBO!9D_SCB4HLR!DR!3/$F)"U1O#,NBTT^AL2:93 MWX;U MSQ?CJP>LZ$-+5=^"! L+T1T>5UY'M3#@B?^IX5F6%PTK+T^M>4N\%2 M.94!HU6EUAG#]@ZM,[K]I[3.:.^K$47-'[R/<&ZVE#W;)$ ^_ZG5SV\6XR?/ MEC!V0=L?/<_7@^W9>A])KTEBV46^,U3TP3JW7 MQ6I<'QB_:)24T%OBN"MH+6RQZLJPS#K&-FY@I8D69]C\[(Z[?&0?>8)'^8W:0>B3 *Y+OK/>U_3R^@97EXNZ6F=8VKB@ZJ)!ZW55 M,W$0J?V*B-0:F+6?Z=PI;NAK6 1I '_71<1VM&:S#-.MVDP%6&@I/7.A]W8" MZ&4MD-!L=%Z\/'716AT)>F,X<@+"702"DPXK6C=0:[ MV29U8"K 0K=Y]EAH*T)H5D:X5D>&?O.]$1BGMN>"$#UZ(Y\R^47KZ\H@0=FI M3-.+?FQQ+<==3;7:YT]"O2VWAA61(C6P%Z]'=N^=8GE?3-F85*5?1>1I*U36*"E ME3B2O;*E.@*V.G*4*F;K)"^5,:9K@XX*)G>4SGC;:C7:^Y>8 M-6O<59T.EM4!0FU?I8%0VU=I(-3VG2H0M0OP=)_>A]A+FLEPV4RF9F7)V>>N M_MGK:IU^10,_1\5;4^OU*WH@<4R\=;2^RHS? E_9G_U#!*5JYF)5J3-IA:!0 M.UAU*-0.5AT*M8,G#,5O_&6SL\]$_G_TC]$SP M\JB)IS=B6 DE"I\,@!PNC*&&1<0O*EAV]FOQND&C:^4QJ+ZOMJT[G5@_<1\=BV"]_NEG'2\ZYWG&Z7 M B+1\E+\7EK?RWT?CQ=L5E7[J%X%S&"R2R4*MKBA_.N26ZH>OO5F2:TAJ[CN MULX,HQI05JL!98DAI'8[Z:6W3_"JAQ<<%*&2ME1WP:TS6)I)>%4Q5#;':]@8 MG#Q#U4!CU;^WG.*O(K1T&_K)LU=UN.@\^HNU&SW%2D5H:9\\*]5 4]6^OU17 MN5;%:.F?/'M5AXMJVV&HH[BGJMQ3 ^5T;MUEDK(;Q6PYM#1/GMFJPU-GT5^D M"7ZXXJ1"M)PZ)]5 ;9U'DXED5HEBL1Q:3C_ 7AU.JE>;@:2UK^*8'%HZ^^28 MFM5 5*=(4:;OE4RH"J/*"*MN=6B)8K,_5.JD$"]]I4]J6H=1%8U2;9S^-E?M M4EP5TEI2I)(5YNT76\KLQ31;^OVU#:+<-E][J- 8"X_!WM$%9G:1Z@^9$1;"2U\# M!!KS>3#E9F@_<&?68,NW[#@TMCY)\DC$M@%@A537CZE.[S:Z95"=WF^TMJ2Z MJ6\#.F!9,?U).C- [,%ZV-6/SQI(]!@_W)V=BP M6+_/?C1N&LR!50.,U[["[R9??@F7D*&"%BP"807/),_O- M+9[9/CU:7IJ&>"027@Y/3+DH3'@0P--MPP%R04HPW'M /-'PYI1Z>INQ.IOM M2#NR!J@"@8+3_V(UUNB5(4_ 4'FR. %=$CE$4012#&> EYJ>.^(^=TTNCHL? M,*V)@>YQ+2+!@#URQ\%_)T27S#)" ^X*PN#TJ&=IGM;13)]E\.R!E6_'=OZY M1A!X>(8)-SS:X9@>9K@N B/AP,*ZH=9M-AD8*2; #G\3G$@*^ BPM/H3"+\JYM!"9M.1Z&T1 M#HLG,JF7&CF=']9*+B>H1)>GHTLC*SY$B4L1JF O.&QG$D!-$L19@TMZ8(*4)R MP((*"KQ1^ A>2\Y&.U▪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